https://www.trianglehealth.com/phase-1/15-gpc3-car-t-cells-nct06815432 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815432.jpg 15.GPC3-CAR T cells trial for Glioblastoma Multiforme of Brain (NCT06815432) 15.GPC3-CAR T cells trial for Glioblastoma Multiforme of Brain (NCT06815432). GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma. The body has different ways of fighting infection and disease. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815432.mp4 2026-10-18T18:44:59.499Z 73 yes no https://www.trianglehealth.com/es/phase-1/15-gpc3-car-t-cells-nct06815432 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815432.jpg 15.GPC3-CAR T cells trial for Glioblastoma Multiforme of Brain (NCT06815432) 15.GPC3-CAR T cells trial for Glioblastoma Multiforme of Brain (NCT06815432). GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma. The body has different ways of fighting infection and disease. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815432.mp4 2026-10-18T18:44:59.499Z 73 yes no https://www.trianglehealth.com/phase-1/177lu-psma-617-nct07223034 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07223034.jpg 177Lu-PSMA-617 trial for Glioma (NCT07223034) 177Lu-PSMA-617 trial for Glioma (NCT07223034). 177Lu-PSMA-617 in People With Gliomas. The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07223034.mp4 2026-10-18T18:45:39.436Z 76 yes no https://www.trianglehealth.com/es/phase-1/177lu-psma-617-nct07223034 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07223034.jpg 177Lu-PSMA-617 trial for Glioma (NCT07223034) 177Lu-PSMA-617 trial for Glioma (NCT07223034). 177Lu-PSMA-617 in People With Gliomas. The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07223034.mp4 2026-10-18T18:45:39.436Z 76 yes no https://www.trianglehealth.com/phase-1/177lu-rhpsma-10-1-nct06066437 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066437.jpg 177Lu rhPSMA-10.1 trial for Prostate Cancer (NCT06066437) 177Lu rhPSMA-10.1 trial for Prostate Cancer (NCT06066437). NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial. To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066437.mp4 2026-10-18T18:47:42.318Z 66 yes no https://www.trianglehealth.com/es/phase-1/177lu-rhpsma-10-1-nct06066437 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066437.jpg 177Lu rhPSMA-10.1 trial for Prostate Cancer (NCT06066437) 177Lu rhPSMA-10.1 trial for Prostate Cancer (NCT06066437). NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial. To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066437.mp4 2026-10-18T18:47:42.318Z 66 yes no https://www.trianglehealth.com/phase-1/18f-v-6-bp-nct05452005 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05452005.jpg [18F]-αvβ6-BP trial for Metastatic Non-Small Cell Lung Cancer (NCT05452005) [18F]-αvβ6-BP trial for Metastatic Non-Small Cell Lung Cancer (NCT05452005). Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer. This study investigates… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05452005.mp4 2026-10-19T00:32:10.364Z 72 yes no https://www.trianglehealth.com/es/phase-1/18f-v-6-bp-nct05452005 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05452005.jpg [18F]-αvβ6-BP trial for Metastatic Non-Small Cell Lung Cancer (NCT05452005) [18F]-αvβ6-BP trial for Metastatic Non-Small Cell Lung Cancer (NCT05452005). Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer. This study investigates… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05452005.mp4 2026-10-19T00:32:10.364Z 72 yes no https://www.trianglehealth.com/phase-1/2141-v11-nct07818018 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07818018.jpg 2141-V11 trial for Advanced Esophageal, Gastric or GEJ Cancer (NCT07818018) 2141-V11 trial for Advanced Esophageal, Gastric or GEJ Cancer (NCT07818018). 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma. The purpose of this study is to find out whether adding the drug… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07818018.mp4 2026-10-20T00:53:48.428Z 74 yes no https://www.trianglehealth.com/es/phase-1/2141-v11-nct07818018 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07818018.jpg 2141-V11 trial for Advanced Esophageal, Gastric or GEJ Cancer (NCT07818018) 2141-V11 trial for Advanced Esophageal, Gastric or GEJ Cancer (NCT07818018). 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma. The purpose of this study is to find out whether adding the drug… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07818018.mp4 2026-10-20T00:53:48.428Z 74 yes no https://www.trianglehealth.com/phase-1/8-12-day-production-of-car-t-cells-nct04186520 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04186520.jpg 8/12-Day Production of Car-T Cells trial for Non Hodgkin Lymphoma (NHL) (NCT04186520) 8/12-Day Production of Car-T Cells trial for Non Hodgkin Lymphoma (NHL) (NCT04186520). CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies. This is a Phase I/II, interventional, single-arm, open-label, treatment study… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04186520.mp4 2026-09-12T20:44:28.776Z 77 yes no https://www.trianglehealth.com/es/phase-1/8-12-day-production-of-car-t-cells-nct04186520 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04186520.jpg 8/12-Day Production of Car-T Cells trial for Non Hodgkin Lymphoma (NHL) (NCT04186520) 8/12-Day Production of Car-T Cells trial for Non Hodgkin Lymphoma (NHL) (NCT04186520). CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies. This is a Phase I/II, interventional, single-arm, open-label, treatment study… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04186520.mp4 2026-09-12T20:44:28.776Z 77 yes no https://www.trianglehealth.com/phase-1/abcd-nk-nct06158828 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06158828.jpg ABCD-NK trial for Acute Myeloid Leukemia, Pediatric (NCT06158828) ABCD-NK trial for Acute Myeloid Leukemia, Pediatric (NCT06158828). Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML. This trial represents a single institution phase I/II… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06158828.mp4 2026-09-12T21:04:39.701Z 72 yes no https://www.trianglehealth.com/es/phase-1/abcd-nk-nct06158828 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06158828.jpg ABCD-NK trial for Acute Myeloid Leukemia, Pediatric (NCT06158828) ABCD-NK trial for Acute Myeloid Leukemia, Pediatric (NCT06158828). Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML. This trial represents a single institution phase I/II… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06158828.mp4 2026-09-12T21:04:39.701Z 72 yes no https://www.trianglehealth.com/phase-1/abemaciclib-nct04923542 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04923542.jpg Radiosurgery + Abemaciclib trial for HR+/HER2- Breast Cancer Brain Metastases (NCT04923542) Radiosurgery + Abemaciclib trial for HR+/HER2- Breast Cancer Brain Metastases (NCT04923542). SR & Abemaciclib With/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases. This is a single arm study of abemaciclib and endocrine… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04923542.mp4 2026-10-19T14:37:11.013Z 70 yes no https://www.trianglehealth.com/es/phase-1/abemaciclib-nct04923542 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04923542.jpg Radiosurgery + Abemaciclib trial for HR+/HER2- Breast Cancer Brain Metastases (NCT04923542) Radiosurgery + Abemaciclib trial for HR+/HER2- Breast Cancer Brain Metastases (NCT04923542). SR & Abemaciclib With/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases. This is a single arm study of abemaciclib and endocrine… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04923542.mp4 2026-10-19T14:37:11.013Z 70 yes no https://www.trianglehealth.com/phase-1/acalabrutinib-nct05256641 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05256641.jpg Acalabrutinib Maintenance trial for High-Risk Large B-Cell Lymphoma After Cellular… (NCT05256641) Acalabrutinib Maintenance trial for High-Risk Large B-Cell Lymphoma After Cellular Therapy (NCT05256641). Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma. This phase Ib/II trial studies the side effects and efficacy of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05256641.mp4 2026-10-20T05:51:48.930Z 64 yes no https://www.trianglehealth.com/es/phase-1/acalabrutinib-nct05256641 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05256641.jpg Acalabrutinib Maintenance trial for High-Risk Large B-Cell Lymphoma After Cellular… (NCT05256641) Acalabrutinib Maintenance trial for High-Risk Large B-Cell Lymphoma After Cellular Therapy (NCT05256641). Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma. This phase Ib/II trial studies the side effects and efficacy of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05256641.mp4 2026-10-20T05:51:48.930Z 64 yes no https://www.trianglehealth.com/phase-1/ad-hcmv-flt3l-nct06914479 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06914479.jpg Ad-hCMV-Flt3L trial for Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant (NCT06914479) Ad-hCMV-Flt3L trial for Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant (NCT06914479). Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06914479.mp4 2026-09-12T21:26:18.809Z 79 yes no https://www.trianglehealth.com/es/phase-1/ad-hcmv-flt3l-nct06914479 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06914479.jpg Ad-hCMV-Flt3L trial for Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant (NCT06914479) Ad-hCMV-Flt3L trial for Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant (NCT06914479). Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06914479.mp4 2026-09-12T21:26:18.809Z 79 yes no https://www.trianglehealth.com/phase-1/ad5-ycd-muttksr39rep-adp-adenovirus-nct05686798 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05686798.jpg Ad5-yCD/mutTKSR39rep-ADP adenovirus trial for Malignant Glioma of Brain (NCT05686798) Ad5-yCD/mutTKSR39rep-ADP adenovirus trial for Malignant Glioma of Brain (NCT05686798). Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. The primary goal of this Phase I study is to determine the maximum… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05686798.mp4 2026-09-12T20:18:10.958Z 75 yes no https://www.trianglehealth.com/es/phase-1/ad5-ycd-muttksr39rep-adp-adenovirus-nct05686798 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05686798.jpg Ad5-yCD/mutTKSR39rep-ADP adenovirus trial for Malignant Glioma of Brain (NCT05686798) Ad5-yCD/mutTKSR39rep-ADP adenovirus trial for Malignant Glioma of Brain (NCT05686798). Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. The primary goal of this Phase I study is to determine the maximum… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05686798.mp4 2026-09-12T20:18:10.958Z 75 yes no https://www.trianglehealth.com/phase-1/adaptive-stereotactic-body-radiation-nct05880667 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05880667.jpg Adaptive Stereotactic Body Radiation trial for Abdominopelvic Metastases (NCT05880667) Adaptive Stereotactic Body Radiation trial for Abdominopelvic Metastases (NCT05880667). Adaptive Radiation for Abdominopelvic Metastases. Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05880667.mp4 2026-10-19T01:21:41.880Z 59 yes no https://www.trianglehealth.com/es/phase-1/adaptive-stereotactic-body-radiation-nct05880667 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05880667.jpg Adaptive Stereotactic Body Radiation trial for Abdominopelvic Metastases (NCT05880667) Adaptive Stereotactic Body Radiation trial for Abdominopelvic Metastases (NCT05880667). Adaptive Radiation for Abdominopelvic Metastases. Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05880667.mp4 2026-10-19T01:21:41.880Z 59 yes no https://www.trianglehealth.com/phase-1/adclec-syn1-car-t-cells-nct05748197 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05748197.jpg ADCLEC.syn1 CAR T cells trial for Acute Myeloid Leukemia (NCT05748197) ADCLEC.syn1 CAR T cells trial for Acute Myeloid Leukemia (NCT05748197). ADCLEC.syn1 in People With Acute Myeloid Leukemia. The purpose of this study is to test the safety of ADCLEC.syn1 CAR T cells in people with relapsed or… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05748197.mp4 2026-09-12T21:14:11.987Z 78 yes no https://www.trianglehealth.com/es/phase-1/adclec-syn1-car-t-cells-nct05748197 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05748197.jpg ADCLEC.syn1 CAR T cells trial for Acute Myeloid Leukemia (NCT05748197) ADCLEC.syn1 CAR T cells trial for Acute Myeloid Leukemia (NCT05748197). ADCLEC.syn1 in People With Acute Myeloid Leukemia. The purpose of this study is to test the safety of ADCLEC.syn1 CAR T cells in people with relapsed or… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05748197.mp4 2026-09-12T21:14:11.987Z 78 yes no https://www.trianglehealth.com/phase-1/adenosine-a2b-receptor-antagonist-pbf-1129-nct05234307 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05234307.jpg Adenosine A2B Receptor Antagonist PBF-1129 trial for Metastatic Lung Non-Small Cell… (NCT05234307) Adenosine A2B Receptor Antagonist PBF-1129 trial for Metastatic Lung Non-Small Cell Carcinoma (NCT05234307). PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer. This phase I trial studies the side effects and best dose of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05234307.mp4 2026-10-18T22:14:26.908Z 78 yes no https://www.trianglehealth.com/es/phase-1/adenosine-a2b-receptor-antagonist-pbf-1129-nct05234307 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05234307.jpg Adenosine A2B Receptor Antagonist PBF-1129 trial for Metastatic Lung Non-Small Cell… (NCT05234307) Adenosine A2B Receptor Antagonist PBF-1129 trial for Metastatic Lung Non-Small Cell Carcinoma (NCT05234307). PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer. This phase I trial studies the side effects and best dose of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05234307.mp4 2026-10-18T22:14:26.908Z 78 yes no https://www.trianglehealth.com/phase-1/adept-nct07346144 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07346144.jpg ADePT trial for Glioblastoma (GBM) (NCT07346144) ADePT trial for Glioblastoma (GBM) (NCT07346144). An AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma. The goal of this clinical trial is to first define the Safety and Optimal… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07346144.mp4 2026-09-12T15:34:10.300Z 241 yes no https://www.trianglehealth.com/es/phase-1/adept-nct07346144 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07346144.jpg ADePT trial for Glioblastoma (GBM) (NCT07346144) ADePT trial for Glioblastoma (GBM) (NCT07346144). An AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma. The goal of this clinical trial is to first define the Safety and Optimal… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07346144.mp4 2026-09-12T15:34:10.300Z 241 yes no https://www.trianglehealth.com/phase-1/adv-hsv-tk-gene-therapy-nct03596086 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03596086.jpg ADV/HSV-tk (gene therapy) trial for Recurrent Glioblastoma or Grade III Astrocytoma (NCT03596086) ADV/HSV-tk (gene therapy) trial for Recurrent Glioblastoma or Grade III Astrocytoma (NCT03596086). HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM. Study to assess the safety and efficacy of HSV-tk (gene therapy), valacyclovir, radiotherapy… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03596086.mp4 2026-10-19T00:38:25.320Z 74 yes no https://www.trianglehealth.com/es/phase-1/adv-hsv-tk-gene-therapy-nct03596086 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03596086.jpg ADV/HSV-tk (gene therapy) trial for Recurrent Glioblastoma or Grade III Astrocytoma (NCT03596086) ADV/HSV-tk (gene therapy) trial for Recurrent Glioblastoma or Grade III Astrocytoma (NCT03596086). HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM. Study to assess the safety and efficacy of HSV-tk (gene therapy), valacyclovir, radiotherapy… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03596086.mp4 2026-10-19T00:38:25.320Z 74 yes no https://www.trianglehealth.com/phase-1/allogeneic-anti-ny-eso-1-tcr-il-15-transduced-cord-blood-nct06066359 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066359.jpg NY-ESO-1 TCR/IL-15 Cord Blood NK Cells trial for Relapsed/Refractory Myeloma (NCT06066359) NY-ESO-1 TCR/IL-15 Cord Blood NK Cells trial for Relapsed/Refractory Myeloma (NCT06066359). Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma. To find the recommended dose of NY-ESO-1 TCR/IL-15 NK cells that can be… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066359.mp4 2026-10-18T20:20:59.738Z 71 yes no https://www.trianglehealth.com/es/phase-1/allogeneic-anti-ny-eso-1-tcr-il-15-transduced-cord-blood-nct06066359 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066359.jpg NY-ESO-1 TCR/IL-15 Cord Blood NK Cells trial for Relapsed/Refractory Myeloma (NCT06066359) NY-ESO-1 TCR/IL-15 Cord Blood NK Cells trial for Relapsed/Refractory Myeloma (NCT06066359). Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma. To find the recommended dose of NY-ESO-1 TCR/IL-15 NK cells that can be… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06066359.mp4 2026-10-18T20:20:59.738Z 71 yes no https://www.trianglehealth.com/phase-1/anti-cd19-cd20-cd22-car-t-cells-nct05418088 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05418088.jpg Anti-CD19/CD20/CD22 CAR T-Cells trial for Recurrent Acute Lymphoblastic Leukemia (NCT05418088) Anti-CD19/CD20/CD22 CAR T-Cells trial for Recurrent Acute Lymphoblastic Leukemia (NCT05418088). Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies. This phase I trial tests the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05418088.mp4 2026-09-12T21:03:37.569Z 84 yes no https://www.trianglehealth.com/es/phase-1/anti-cd19-cd20-cd22-car-t-cells-nct05418088 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05418088.jpg Anti-CD19/CD20/CD22 CAR T-Cells trial for Recurrent Acute Lymphoblastic Leukemia (NCT05418088) Anti-CD19/CD20/CD22 CAR T-Cells trial for Recurrent Acute Lymphoblastic Leukemia (NCT05418088). Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies. This phase I trial tests the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05418088.mp4 2026-09-12T21:03:37.569Z 84 yes no https://www.trianglehealth.com/phase-1/anti-cd30-bispecific-antibody-armed-anti-cd3-activated-a-nct05544968 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05544968.jpg CD30-Armed T Cells trial for Relapsed or Refractory Hodgkin Lymphoma and CD30+… (NCT05544968) CD30-Armed T Cells trial for Relapsed or Refractory Hodgkin Lymphoma and CD30+ Lymphomas (NCT05544968). Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies. This first-in-human trial will assess the safety,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05544968.mp4 2026-10-20T02:24:17.450Z 67 yes no https://www.trianglehealth.com/es/phase-1/anti-cd30-bispecific-antibody-armed-anti-cd3-activated-a-nct05544968 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05544968.jpg CD30-Armed T Cells trial for Relapsed or Refractory Hodgkin Lymphoma and CD30+… (NCT05544968) CD30-Armed T Cells trial for Relapsed or Refractory Hodgkin Lymphoma and CD30+ Lymphomas (NCT05544968). Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies. This first-in-human trial will assess the safety,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05544968.mp4 2026-10-20T02:24:17.450Z 67 yes no https://www.trianglehealth.com/phase-1/anti-garp-chimeric-antigen-receptor-t-cells-nct06964737 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964737.jpg Anti-GARP Chimeric Antigen Receptor T Cel… trial for Recurrent Malignant Glioma (NCT06964737) Anti-GARP Chimeric Antigen Receptor T Cel… trial for Recurrent Malignant Glioma (NCT06964737). Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas. This phase I trial tests the safety, side effects,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964737.mp4 2026-09-12T20:14:47.450Z 63 yes no https://www.trianglehealth.com/es/phase-1/anti-garp-chimeric-antigen-receptor-t-cells-nct06964737 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964737.jpg Anti-GARP Chimeric Antigen Receptor T Cel… trial for Recurrent Malignant Glioma (NCT06964737) Anti-GARP Chimeric Antigen Receptor T Cel… trial for Recurrent Malignant Glioma (NCT06964737). Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas. This phase I trial tests the safety, side effects,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964737.mp4 2026-09-12T20:14:47.450Z 63 yes no https://www.trianglehealth.com/phase-1/archer-nct05950139 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05950139.jpg ARCHER trial for NSCLC Stage IV (NCT05950139) ARCHER trial for NSCLC Stage IV (NCT05950139). Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC. The purpose of this study is to evaluate the safety of a cancer peptide… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05950139.mp4 2026-09-12T21:16:22.405Z 80 yes no https://www.trianglehealth.com/es/phase-1/archer-nct05950139 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05950139.jpg ARCHER trial for NSCLC Stage IV (NCT05950139) ARCHER trial for NSCLC Stage IV (NCT05950139). Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC. The purpose of this study is to evaluate the safety of a cancer peptide… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05950139.mp4 2026-09-12T21:16:22.405Z 80 yes no https://www.trianglehealth.com/phase-1/astatine-at-211-anti-cd45-monoclonal-antibody-bc8-b10-nct03670966 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03670966.jpg 211At-BC8-B10 Before Stem Cell Transplant trial for High-Risk Acute Leukemia or… (NCT03670966) 211At-BC8-B10 Before Stem Cell Transplant trial for High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03670966). 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome.… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03670966.mp4 2026-10-18T22:54:56.345Z 71 yes no https://www.trianglehealth.com/es/phase-1/astatine-at-211-anti-cd45-monoclonal-antibody-bc8-b10-nct03670966 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03670966.jpg 211At-BC8-B10 Before Stem Cell Transplant trial for High-Risk Acute Leukemia or… (NCT03670966) 211At-BC8-B10 Before Stem Cell Transplant trial for High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03670966). 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome.… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03670966.mp4 2026-10-18T22:54:56.345Z 71 yes no https://www.trianglehealth.com/phase-1/astx727-nct03922555 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03922555.jpg ASTX727 trial for Recurrent/Progressive Non-Enhancing IDH-Mutant Glioma (NCT03922555) ASTX727 trial for Recurrent/Progressive Non-Enhancing IDH-Mutant Glioma (NCT03922555). ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas. this research study is evaluating the highest dose of ASTX727 that can be administered… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03922555.mp4 2026-10-19T14:27:47.951Z 67 yes no https://www.trianglehealth.com/es/phase-1/astx727-nct03922555 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03922555.jpg ASTX727 trial for Recurrent/Progressive Non-Enhancing IDH-Mutant Glioma (NCT03922555) ASTX727 trial for Recurrent/Progressive Non-Enhancing IDH-Mutant Glioma (NCT03922555). ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas. this research study is evaluating the highest dose of ASTX727 that can be administered… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03922555.mp4 2026-10-19T14:27:47.951Z 67 yes no https://www.trianglehealth.com/phase-1/atezolizumab-nct05096715 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05096715.jpg Atezolizumab + Bevacizumab + SBRT trial for Unresectable Hepatocellular Carcinoma (NCT05096715) Atezolizumab + Bevacizumab + SBRT trial for Unresectable Hepatocellular Carcinoma (NCT05096715). Atezolizumab+Bevacizumab+SBRT in Unresectable HCC. This research study is evaluating the safety and tolerability of the drugs atezolizumab and bevacizumab… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05096715.mp4 2026-10-20T03:53:25.515Z 63 yes no https://www.trianglehealth.com/es/phase-1/atezolizumab-nct05096715 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05096715.jpg Atezolizumab + Bevacizumab + SBRT trial for Unresectable Hepatocellular Carcinoma (NCT05096715) Atezolizumab + Bevacizumab + SBRT trial for Unresectable Hepatocellular Carcinoma (NCT05096715). Atezolizumab+Bevacizumab+SBRT in Unresectable HCC. This research study is evaluating the safety and tolerability of the drugs atezolizumab and bevacizumab… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05096715.mp4 2026-10-20T03:53:25.515Z 63 yes no https://www.trianglehealth.com/phase-1/atra-nct06536413 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536413.jpg ATRA trial for Relapsed/Refractory Multiple Myeloma (NCT06536413) ATRA trial for Relapsed/Refractory Multiple Myeloma (NCT06536413). ATRA and Carfilzomib in Plasma Cell Myeloma Patients. This is a Phase IB/II trial that will investigate the safety, tolerability and efficacy of combination… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536413.mp4 2026-10-19T02:30:56.587Z 76 yes no https://www.trianglehealth.com/es/phase-1/atra-nct06536413 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536413.jpg ATRA trial for Relapsed/Refractory Multiple Myeloma (NCT06536413) ATRA trial for Relapsed/Refractory Multiple Myeloma (NCT06536413). ATRA and Carfilzomib in Plasma Cell Myeloma Patients. This is a Phase IB/II trial that will investigate the safety, tolerability and efficacy of combination… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536413.mp4 2026-10-19T02:30:56.587Z 76 yes no https://www.trianglehealth.com/phase-1/autologous-anti-psca-car-4-1bb-tcrzeta-cd19t-expressing-nct05805371 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05805371.jpg PSCA-Targeting CAR-T Cells trial for Castration-Resistant Prostate Carcinoma (NCT05805371) PSCA-Targeting CAR-T Cells trial for Castration-Resistant Prostate Carcinoma (NCT05805371). PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer. This phase Ib… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05805371.mp4 2026-10-18T22:03:43.423Z 65 yes no https://www.trianglehealth.com/es/phase-1/autologous-anti-psca-car-4-1bb-tcrzeta-cd19t-expressing-nct05805371 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05805371.jpg PSCA-Targeting CAR-T Cells trial for Castration-Resistant Prostate Carcinoma (NCT05805371) PSCA-Targeting CAR-T Cells trial for Castration-Resistant Prostate Carcinoma (NCT05805371). PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer. This phase Ib… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05805371.mp4 2026-10-18T22:03:43.423Z 65 yes no https://www.trianglehealth.com/phase-1/avasopasem-nct07137871 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07137871.jpg Avasopasem trial for Metastatic Hormone Receptor-Positive Breast Cancer (NCT07137871) Avasopasem trial for Metastatic Hormone Receptor-Positive Breast Cancer (NCT07137871). Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy. This study aims… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07137871.mp4 2026-10-19T16:34:39.210Z 63 yes no https://www.trianglehealth.com/es/phase-1/avasopasem-nct07137871 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07137871.jpg Avasopasem trial for Metastatic Hormone Receptor-Positive Breast Cancer (NCT07137871) Avasopasem trial for Metastatic Hormone Receptor-Positive Breast Cancer (NCT07137871). Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy. This study aims… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07137871.mp4 2026-10-19T16:34:39.210Z 63 yes no https://www.trianglehealth.com/phase-1/axatilimab-nct06523556 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06523556.jpg Axatilimab trial for Advanced Myeloproliferative Neoplasms, MDS/MPN and High-Risk CMML (NCT06523556) Axatilimab trial for Advanced Myeloproliferative Neoplasms, MDS/MPN and High-Risk CMML (NCT06523556). Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06523556.mp4 2026-10-20T01:31:08.763Z 70 yes no https://www.trianglehealth.com/es/phase-1/axatilimab-nct06523556 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06523556.jpg Axatilimab trial for Advanced Myeloproliferative Neoplasms, MDS/MPN and High-Risk CMML (NCT06523556) Axatilimab trial for Advanced Myeloproliferative Neoplasms, MDS/MPN and High-Risk CMML (NCT06523556). Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06523556.mp4 2026-10-20T01:31:08.763Z 70 yes no https://www.trianglehealth.com/phase-1/b7-h3-cd28z-cart-nct07390539 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07390539.jpg B7-H3.CD28Z.CART trial for Central Nervous System Neoplasms (NCT07390539) B7-H3.CD28Z.CART trial for Central Nervous System Neoplasms (NCT07390539). B7-H3.CD28Z.CART in CNS Neoplasms. The purpose of this research study is to test the safety and effectiveness of a cell therapy at different doses for… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07390539.mp4 2026-09-12T20:48:02.130Z 73 yes no https://www.trianglehealth.com/es/phase-1/b7-h3-cd28z-cart-nct07390539 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07390539.jpg B7-H3.CD28Z.CART trial for Central Nervous System Neoplasms (NCT07390539) B7-H3.CD28Z.CART trial for Central Nervous System Neoplasms (NCT07390539). B7-H3.CD28Z.CART in CNS Neoplasms. The purpose of this research study is to test the safety and effectiveness of a cell therapy at different doses for… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07390539.mp4 2026-09-12T20:48:02.130Z 73 yes no https://www.trianglehealth.com/phase-1/bcma-tgf-car-t-cells-0-50-x-10-6-cells-kg-nct05976555 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05976555.jpg Phase I Trial of BCMA-TGF-BETA CAR-T Cell… trial for Multiple Myeloma (NCT05976555) Phase I Trial of BCMA-TGF-BETA CAR-T Cell… trial for Multiple Myeloma (NCT05976555). BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma. This is a phase I, interventional, single-arm, open-label, dose-finding treatment study designed to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05976555.mp4 2026-09-12T20:53:56.312Z 83 yes no https://www.trianglehealth.com/es/phase-1/bcma-tgf-car-t-cells-0-50-x-10-6-cells-kg-nct05976555 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05976555.jpg Phase I Trial of BCMA-TGF-BETA CAR-T Cell… trial for Multiple Myeloma (NCT05976555) Phase I Trial of BCMA-TGF-BETA CAR-T Cell… trial for Multiple Myeloma (NCT05976555). BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma. This is a phase I, interventional, single-arm, open-label, dose-finding treatment study designed to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05976555.mp4 2026-09-12T20:53:56.312Z 83 yes no https://www.trianglehealth.com/phase-1/bevacizumab-nct01269853 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01269853.jpg Bevacizumab trial for Glioblastoma Multiforme (NCT01269853) Bevacizumab trial for Glioblastoma Multiforme (NCT01269853). Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA. The high-grade malignant brain tumors,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01269853.mp4 2026-09-12T21:21:47.182Z 70 yes no https://www.trianglehealth.com/es/phase-1/bevacizumab-nct01269853 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01269853.jpg Bevacizumab trial for Glioblastoma Multiforme (NCT01269853) Bevacizumab trial for Glioblastoma Multiforme (NCT01269853). Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA. The high-grade malignant brain tumors,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01269853.mp4 2026-09-12T21:21:47.182Z 70 yes no https://www.trianglehealth.com/phase-1/brachytherapy-nct06543576 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06543576.jpg External Beam Radiation and Brachytherapy trial for Stage IVB Cervical Cancer (NCT06543576) External Beam Radiation and Brachytherapy trial for Stage IVB Cervical Cancer (NCT06543576). External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer. This phase I/II trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06543576.mp4 2026-10-18T22:36:35.000Z 65 yes no https://www.trianglehealth.com/es/phase-1/brachytherapy-nct06543576 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06543576.jpg External Beam Radiation and Brachytherapy trial for Stage IVB Cervical Cancer (NCT06543576) External Beam Radiation and Brachytherapy trial for Stage IVB Cervical Cancer (NCT06543576). External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer. This phase I/II trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06543576.mp4 2026-10-18T22:36:35.000Z 65 yes no https://www.trianglehealth.com/phase-1/brite-nct04903795 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903795.jpg BRiTE trial for Newly Diagnosed Glioblastoma (NCT04903795) BRiTE trial for Newly Diagnosed Glioblastoma (NCT04903795). BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma. This Phase 1 study will assess the safety of a novel brain Bispecific T cell engager (BRiTE)… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903795.mp4 2026-10-28T03:40:05.741Z 76 yes no https://www.trianglehealth.com/es/phase-1/brite-nct04903795 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903795.jpg BRiTE trial for Newly Diagnosed Glioblastoma (NCT04903795) BRiTE trial for Newly Diagnosed Glioblastoma (NCT04903795). BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma. This Phase 1 study will assess the safety of a novel brain Bispecific T cell engager (BRiTE)… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903795.mp4 2026-10-28T03:40:05.741Z 76 yes no https://www.trianglehealth.com/phase-1/c7r-gd2-cart-cells-iv-and-icv-infusion-nct04099797 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04099797.jpg C7R-GD2.CART cells (IV and ICV infusion) trial for Diffuse Intrinsic Pontine Glioma (NCT04099797) C7R-GD2.CART cells (IV and ICV infusion) trial for Diffuse Intrinsic Pontine Glioma (NCT04099797). C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B). In this study, there are two treatment groups called Cohort 1 and Cohort 2. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04099797.mp4 2026-09-12T20:26:10.154Z 74 yes no https://www.trianglehealth.com/es/phase-1/c7r-gd2-cart-cells-iv-and-icv-infusion-nct04099797 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04099797.jpg C7R-GD2.CART cells (IV and ICV infusion) trial for Diffuse Intrinsic Pontine Glioma (NCT04099797) C7R-GD2.CART cells (IV and ICV infusion) trial for Diffuse Intrinsic Pontine Glioma (NCT04099797). C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B). In this study, there are two treatment groups called Cohort 1 and Cohort 2. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04099797.mp4 2026-09-12T20:26:10.154Z 74 yes no https://www.trianglehealth.com/phase-1/car-70-il15-transduced-cb-nk-cells-nct05092451 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05092451.jpg CAR.70/IL15-transduced CB-NK cells trial for B-Cell Lymphoma (NCT05092451) CAR.70/IL15-transduced CB-NK cells trial for B-Cell Lymphoma (NCT05092451). CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05092451.mp4 2026-09-12T20:32:10.330Z 75 yes no https://www.trianglehealth.com/es/phase-1/car-70-il15-transduced-cb-nk-cells-nct05092451 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05092451.jpg CAR.70/IL15-transduced CB-NK cells trial for B-Cell Lymphoma (NCT05092451) CAR.70/IL15-transduced CB-NK cells trial for B-Cell Lymphoma (NCT05092451). CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05092451.mp4 2026-09-12T20:32:10.330Z 75 yes no https://www.trianglehealth.com/phase-1/car-t-cell-nct05003895 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05003895.jpg CAR-T cell trial for Hepatocellular Carcinoma (NCT05003895) CAR-T cell trial for Hepatocellular Carcinoma (NCT05003895). GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies. Background: A new cancer treatment takes a person s own T cells,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05003895.mp4 2026-09-12T21:02:25.642Z 78 yes no https://www.trianglehealth.com/es/phase-1/car-t-cell-nct05003895 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05003895.jpg CAR-T cell trial for Hepatocellular Carcinoma (NCT05003895) CAR-T cell trial for Hepatocellular Carcinoma (NCT05003895). GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies. Background: A new cancer treatment takes a person s own T cells,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05003895.mp4 2026-09-12T21:02:25.642Z 78 yes no https://www.trianglehealth.com/phase-1/car-t-cell-nct06768905 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06768905.jpg Iomab-B Followed by CAR-T Cell Therapy trial for Non Hodgkin Lymphoma (NCT06768905) Iomab-B Followed by CAR-T Cell Therapy trial for Non Hodgkin Lymphoma (NCT06768905). IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL. This study is being done to determine the safety, efficacy and tolerability of a single 50 mCi dose… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06768905.mp4 2026-10-18T19:51:51.422Z 65 yes no https://www.trianglehealth.com/es/phase-1/car-t-cell-nct06768905 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06768905.jpg Iomab-B Followed by CAR-T Cell Therapy trial for Non Hodgkin Lymphoma (NCT06768905) Iomab-B Followed by CAR-T Cell Therapy trial for Non Hodgkin Lymphoma (NCT06768905). IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL. This study is being done to determine the safety, efficacy and tolerability of a single 50 mCi dose… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06768905.mp4 2026-10-18T19:51:51.422Z 65 yes no https://www.trianglehealth.com/phase-1/care-t-cells-nct04715191 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04715191.jpg CARE T cells trial for Liver Cancer (NCT04715191) CARE T cells trial for Liver Cancer (NCT04715191). Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors. Patients may be considered if… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04715191.mp4 2026-09-12T21:00:56.585Z 85 yes no https://www.trianglehealth.com/es/phase-1/care-t-cells-nct04715191 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04715191.jpg CARE T cells trial for Liver Cancer (NCT04715191) CARE T cells trial for Liver Cancer (NCT04715191). Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors. Patients may be considered if… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04715191.mp4 2026-09-12T21:00:56.585Z 85 yes no https://www.trianglehealth.com/phase-1/carlotta01-nct05836896 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05836896.jpg CARLOTTA01 trial for Neoplasms (NCT05836896) CARLOTTA01 trial for Neoplasms (NCT05836896). Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05836896.mp4 2026-09-12T20:47:57.323Z 79 yes no https://www.trianglehealth.com/es/phase-1/carlotta01-nct05836896 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05836896.jpg CARLOTTA01 trial for Neoplasms (NCT05836896) CARLOTTA01 trial for Neoplasms (NCT05836896). Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05836896.mp4 2026-09-12T20:47:57.323Z 79 yes no https://www.trianglehealth.com/phase-1/cart-nct07319676 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07319676.jpg CART trial for B-cell Lymphoma Refractory (NCT07319676) CART trial for B-cell Lymphoma Refractory (NCT07319676). Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas. This is a single center, open label, phase 1 lead in to determine Recommended Phase… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07319676.mp4 2026-09-12T21:27:21.015Z 72 yes no https://www.trianglehealth.com/es/phase-1/cart-nct07319676 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07319676.jpg CART trial for B-cell Lymphoma Refractory (NCT07319676) CART trial for B-cell Lymphoma Refractory (NCT07319676). Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas. This is a single center, open label, phase 1 lead in to determine Recommended Phase… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07319676.mp4 2026-09-12T21:27:21.015Z 72 yes no https://www.trianglehealth.com/phase-1/carv3-team-e-t-cells-nct05660369 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05660369.jpg CARv3-TEAM-E T cells trial for Glioblastoma (NCT05660369) CARv3-TEAM-E T cells trial for Glioblastoma (NCT05660369). CARv3-TEAM-E T Cells in Glioblastoma. The goal of this research study is to determine the best dose of CARv3-TEAM-E T Cells for treating participants with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05660369.mp4 2026-09-12T20:18:12.097Z 65 yes no https://www.trianglehealth.com/es/phase-1/carv3-team-e-t-cells-nct05660369 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05660369.jpg CARv3-TEAM-E T cells trial for Glioblastoma (NCT05660369) CARv3-TEAM-E T cells trial for Glioblastoma (NCT05660369). CARv3-TEAM-E T Cells in Glioblastoma. The goal of this research study is to determine the best dose of CARv3-TEAM-E T Cells for treating participants with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05660369.mp4 2026-09-12T20:18:12.097Z 65 yes no https://www.trianglehealth.com/phase-1/cd123-car-t-nct04318678 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04318678.jpg CD123-CAR T trial for AML/MDS (NCT04318678) CD123-CAR T trial for AML/MDS (NCT04318678). CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML). The CD123-CAR T-cell therapy is a new treatment that is being investigated for… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04318678.mp4 2026-09-12T20:51:36.484Z 78 yes no https://www.trianglehealth.com/es/phase-1/cd123-car-t-nct04318678 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04318678.jpg CD123-CAR T trial for AML/MDS (NCT04318678) CD123-CAR T trial for AML/MDS (NCT04318678). CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML). The CD123-CAR T-cell therapy is a new treatment that is being investigated for… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04318678.mp4 2026-09-12T20:51:36.484Z 78 yes no https://www.trianglehealth.com/phase-1/cd19-car-t-cells-nct03676504 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03676504.jpg CD19.CAR T Cells trial for Acute Lymphoblastic Leukemia, Adult (NCT03676504) CD19.CAR T Cells trial for Acute Lymphoblastic Leukemia, Adult (NCT03676504). Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR. Adult patients with r/r acute… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03676504.mp4 2026-09-12T20:57:41.650Z 91 yes no https://www.trianglehealth.com/es/phase-1/cd19-car-t-cells-nct03676504 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03676504.jpg CD19.CAR T Cells trial for Acute Lymphoblastic Leukemia, Adult (NCT03676504) CD19.CAR T Cells trial for Acute Lymphoblastic Leukemia, Adult (NCT03676504). Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR. Adult patients with r/r acute… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03676504.mp4 2026-09-12T20:57:41.650Z 91 yes no https://www.trianglehealth.com/phase-1/cd19-cd22-car-transduced-t-cells-nct05442515 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05442515.jpg CD19/CD22-CAR-transduced T cells trial for B-Non Hodgkin Lymphoma (NCT05442515) CD19/CD22-CAR-transduced T cells trial for B-Non Hodgkin Lymphoma (NCT05442515). CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies. Background: Acute… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05442515.mp4 2026-09-12T20:41:12.518Z 76 yes no https://www.trianglehealth.com/es/phase-1/cd19-cd22-car-transduced-t-cells-nct05442515 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05442515.jpg CD19/CD22-CAR-transduced T cells trial for B-Non Hodgkin Lymphoma (NCT05442515) CD19/CD22-CAR-transduced T cells trial for B-Non Hodgkin Lymphoma (NCT05442515). CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies. Background: Acute… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05442515.mp4 2026-09-12T20:41:12.518Z 76 yes no https://www.trianglehealth.com/phase-1/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-t-lymphocyt-nct05625594 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05625594.jpg CD19-CAR T Cells for CNS Lymphoma trial for Central Nervous System Lymphoma (NCT05625594) CD19-CAR T Cells for CNS Lymphoma trial for Central Nervous System Lymphoma (NCT05625594). Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05625594.mp4 2026-10-18T18:51:05.646Z 60 yes no https://www.trianglehealth.com/es/phase-1/cd19car-cd28-cd3zeta-egfrt-expressing-tn-mem-t-lymphocyt-nct05625594 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05625594.jpg CD19-CAR T Cells for CNS Lymphoma trial for Central Nervous System Lymphoma (NCT05625594) CD19-CAR T Cells for CNS Lymphoma trial for Central Nervous System Lymphoma (NCT05625594). Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05625594.mp4 2026-10-18T18:51:05.646Z 60 yes no https://www.trianglehealth.com/phase-1/cd19x22-car-t-cells-nct05098613 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05098613.jpg CD19x22 CAR T Cells trial for Non-Hodgkin Lymphoma (NCT05098613) CD19x22 CAR T Cells trial for Non-Hodgkin Lymphoma (NCT05098613). Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients. This open-label, single arm phase 1 trial aims to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05098613.mp4 2026-09-12T20:38:05.923Z 77 yes no https://www.trianglehealth.com/es/phase-1/cd19x22-car-t-cells-nct05098613 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05098613.jpg CD19x22 CAR T Cells trial for Non-Hodgkin Lymphoma (NCT05098613) CD19x22 CAR T Cells trial for Non-Hodgkin Lymphoma (NCT05098613). Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients. This open-label, single arm phase 1 trial aims to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05098613.mp4 2026-09-12T20:38:05.923Z 77 yes no https://www.trianglehealth.com/phase-1/cd19x22-car-t-nct06559189 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06559189.jpg CD19x22 CAR T trial for B-cell Acute Lymphoblastic Leukemia (NCT06559189) CD19x22 CAR T trial for B-cell Acute Lymphoblastic Leukemia (NCT06559189). CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL. This study will evaluate the safety and tolerability of administering a novel… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06559189.mp4 2026-09-12T21:19:38.258Z 74 yes no https://www.trianglehealth.com/es/phase-1/cd19x22-car-t-nct06559189 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06559189.jpg CD19x22 CAR T trial for B-cell Acute Lymphoblastic Leukemia (NCT06559189) CD19x22 CAR T trial for B-cell Acute Lymphoblastic Leukemia (NCT06559189). CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL. This study will evaluate the safety and tolerability of administering a novel… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06559189.mp4 2026-09-12T21:19:38.258Z 74 yes no https://www.trianglehealth.com/phase-1/cd22cart-cell-nct04815356 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04815356.jpg CD22CART cell trial for Hairy Cell Leukemia (NCT04815356) CD22CART cell trial for Hairy Cell Leukemia (NCT04815356). Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant. Background: CAR (Chimeric Antigen Receptor) T cell… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04815356.mp4 2026-09-12T20:29:24.481Z 75 yes no https://www.trianglehealth.com/es/phase-1/cd22cart-cell-nct04815356 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04815356.jpg CD22CART cell trial for Hairy Cell Leukemia (NCT04815356) CD22CART cell trial for Hairy Cell Leukemia (NCT04815356). Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant. Background: CAR (Chimeric Antigen Receptor) T cell… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04815356.mp4 2026-09-12T20:29:24.481Z 75 yes no https://www.trianglehealth.com/phase-1/cd371-specific-ysnvz-i-18-car-t-cells-nct06017258 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06017258.jpg CD371-specific/YSNVz/I-18 CAR T cells trial for Refractory Acute Myeloid Leukemia (NCT06017258) CD371-specific/YSNVz/I-18 CAR T cells trial for Refractory Acute Myeloid Leukemia (NCT06017258). CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia. The purpose of this study is to find out whether CD371-YSNVZ-IL18 CAR T cells are safe,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06017258.mp4 2026-09-12T20:55:09.528Z 73 yes no https://www.trianglehealth.com/es/phase-1/cd371-specific-ysnvz-i-18-car-t-cells-nct06017258 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06017258.jpg CD371-specific/YSNVz/I-18 CAR T cells trial for Refractory Acute Myeloid Leukemia (NCT06017258) CD371-specific/YSNVz/I-18 CAR T cells trial for Refractory Acute Myeloid Leukemia (NCT06017258). CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia. The purpose of this study is to find out whether CD371-YSNVZ-IL18 CAR T cells are safe,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06017258.mp4 2026-09-12T20:55:09.528Z 73 yes no https://www.trianglehealth.com/phase-1/cd79b-19-car-t-cells-nct06026319 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06026319.jpg CD79b-19 CAR T cells trial for Non-hodgkin Lymphoma (NCT06026319) CD79b-19 CAR T cells trial for Non-hodgkin Lymphoma (NCT06026319). CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma. This research study involves the study of CD79b-19 CAR T cells for treating people with relapsed/refractory… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06026319.mp4 2026-10-18T22:34:23.611Z 73 yes no https://www.trianglehealth.com/es/phase-1/cd79b-19-car-t-cells-nct06026319 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06026319.jpg CD79b-19 CAR T cells trial for Non-hodgkin Lymphoma (NCT06026319) CD79b-19 CAR T cells trial for Non-hodgkin Lymphoma (NCT06026319). CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma. This research study involves the study of CD79b-19 CAR T cells for treating people with relapsed/refractory… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06026319.mp4 2026-10-18T22:34:23.611Z 73 yes no https://www.trianglehealth.com/phase-1/cdx-1140-nct05029999 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05029999.jpg CDX-1140 + CDX-301 + PLD trial for Metastatic HER2-Negative Breast Cancer (NCT05029999) CDX-1140 + CDX-301 + PLD trial for Metastatic HER2-Negative Breast Cancer (NCT05029999). CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer. This research study is being done to find out if the immunotherapy drugs called… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05029999.mp4 2026-10-19T14:46:47.250Z 73 yes no https://www.trianglehealth.com/es/phase-1/cdx-1140-nct05029999 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05029999.jpg CDX-1140 + CDX-301 + PLD trial for Metastatic HER2-Negative Breast Cancer (NCT05029999) CDX-1140 + CDX-301 + PLD trial for Metastatic HER2-Negative Breast Cancer (NCT05029999). CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer. This research study is being done to find out if the immunotherapy drugs called… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05029999.mp4 2026-10-19T14:46:47.250Z 73 yes no https://www.trianglehealth.com/phase-1/chimeric-antigen-receptor-t-cell-therapy-nct06815029 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815029.jpg Chimeric Antigen Receptor T-Cell Therapy trial for Recurrent Glioblastoma (NCT06815029) Chimeric Antigen Receptor T-Cell Therapy trial for Recurrent Glioblastoma (NCT06815029). Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815029.mp4 2026-09-12T21:09:19.890Z 72 yes no https://www.trianglehealth.com/es/phase-1/chimeric-antigen-receptor-t-cell-therapy-nct06815029 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815029.jpg Chimeric Antigen Receptor T-Cell Therapy trial for Recurrent Glioblastoma (NCT06815029) Chimeric Antigen Receptor T-Cell Therapy trial for Recurrent Glioblastoma (NCT06815029). Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06815029.mp4 2026-09-12T21:09:19.890Z 72 yes no https://www.trianglehealth.com/phase-1/chimeric-antigen-receptor-t-cells-nct05225363 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05225363.jpg Chimeric Antigen Receptor T-cells trial for Platinum-Resistant Ovarian Carcinoma (NCT05225363) Chimeric Antigen Receptor T-cells trial for Platinum-Resistant Ovarian Carcinoma (NCT05225363). Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer. This phase I trial tests the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05225363.mp4 2026-09-12T20:16:36.738Z 69 yes no https://www.trianglehealth.com/es/phase-1/chimeric-antigen-receptor-t-cells-nct05225363 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05225363.jpg Chimeric Antigen Receptor T-cells trial for Platinum-Resistant Ovarian Carcinoma (NCT05225363) Chimeric Antigen Receptor T-cells trial for Platinum-Resistant Ovarian Carcinoma (NCT05225363). Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer. This phase I trial tests the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05225363.mp4 2026-09-12T20:16:36.738Z 69 yes no https://www.trianglehealth.com/phase-1/ciml-nk-cells-nct05580601 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05580601.jpg CIML-NK Cells trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT05580601) CIML-NK Cells trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT05580601). Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML). The objective of this study is to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05580601.mp4 2026-10-19T00:44:37.918Z 67 yes no https://www.trianglehealth.com/es/phase-1/ciml-nk-cells-nct05580601 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05580601.jpg CIML-NK Cells trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT05580601) CIML-NK Cells trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT05580601). Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML). The objective of this study is to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05580601.mp4 2026-10-19T00:44:37.918Z 67 yes no https://www.trianglehealth.com/phase-1/ciml-nk-nct04024761 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04024761.jpg CIML NK trial for Acute Myeloid Leukemia (NCT04024761) CIML NK trial for Acute Myeloid Leukemia (NCT04024761). CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation. This research study is studying cytokine induced memory-like… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04024761.mp4 2026-09-12T20:26:00.391Z 72 yes no https://www.trianglehealth.com/es/phase-1/ciml-nk-nct04024761 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04024761.jpg CIML NK trial for Acute Myeloid Leukemia (NCT04024761) CIML NK trial for Acute Myeloid Leukemia (NCT04024761). CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation. This research study is studying cytokine induced memory-like… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04024761.mp4 2026-09-12T20:26:00.391Z 72 yes no https://www.trianglehealth.com/phase-1/cladribine-nct04375631 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04375631.jpg CLAG-M/FLAG-Ida + TBI trial for Relapsed or Refractory AML, MDS or CMML (NCT04375631) CLAG-M/FLAG-Ida + TBI trial for Relapsed or Refractory AML, MDS or CMML (NCT04375631). CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04375631.mp4 2026-10-20T01:15:48.988Z 66 yes no https://www.trianglehealth.com/es/phase-1/cladribine-nct04375631 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04375631.jpg CLAG-M/FLAG-Ida + TBI trial for Relapsed or Refractory AML, MDS or CMML (NCT04375631) CLAG-M/FLAG-Ida + TBI trial for Relapsed or Refractory AML, MDS or CMML (NCT04375631). CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04375631.mp4 2026-10-20T01:15:48.988Z 66 yes no https://www.trianglehealth.com/phase-1/cladribine-nct04797767 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04797767.jpg Venetoclax Plus CLAG-M trial for Acute Myeloid Leukemia and High-Grade Myeloid… (NCT04797767) Venetoclax Plus CLAG-M trial for Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms (NCT04797767). Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms. This phase I/II trial finds the best dose, side effects… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04797767.mp4 2026-10-18T22:13:31.199Z 65 yes no https://www.trianglehealth.com/es/phase-1/cladribine-nct04797767 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04797767.jpg Venetoclax Plus CLAG-M trial for Acute Myeloid Leukemia and High-Grade Myeloid… (NCT04797767) Venetoclax Plus CLAG-M trial for Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms (NCT04797767). Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms. This phase I/II trial finds the best dose, side effects… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04797767.mp4 2026-10-18T22:13:31.199Z 65 yes no https://www.trianglehealth.com/phase-1/combination-treatment-cxrpt-of-external-beam-radiation-x-nct04892303 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04892303.jpg Radiation + Radioactive Iodine trial for Recurrent Differentiated Thyroid Cancer (NCT04892303) Radiation + Radioactive Iodine trial for Recurrent Differentiated Thyroid Cancer (NCT04892303). Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer. The goal of this study is to evaluate combined radioactive… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04892303.mp4 2026-10-19T11:56:04.344Z 60 yes no https://www.trianglehealth.com/es/phase-1/combination-treatment-cxrpt-of-external-beam-radiation-x-nct04892303 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04892303.jpg Radiation + Radioactive Iodine trial for Recurrent Differentiated Thyroid Cancer (NCT04892303) Radiation + Radioactive Iodine trial for Recurrent Differentiated Thyroid Cancer (NCT04892303). Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer. The goal of this study is to evaluate combined radioactive… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04892303.mp4 2026-10-19T11:56:04.344Z 60 yes no https://www.trianglehealth.com/phase-1/cord-blood-derived-expanded-allogeneic-natural-killer-ce-nct04991870 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04991870.jpg Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM trial for Recurrent Gliosarcoma (NCT04991870) Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM trial for Recurrent Gliosarcoma (NCT04991870). Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM. This phase I trial is to find out the best dose, possible benefits and/or side effects of engineered natural killer… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04991870.mp4 2026-09-12T21:30:40.833Z 82 yes no https://www.trianglehealth.com/es/phase-1/cord-blood-derived-expanded-allogeneic-natural-killer-ce-nct04991870 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04991870.jpg Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM trial for Recurrent Gliosarcoma (NCT04991870) Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM trial for Recurrent Gliosarcoma (NCT04991870). Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM. This phase I trial is to find out the best dose, possible benefits and/or side effects of engineered natural killer… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04991870.mp4 2026-09-12T21:30:40.833Z 82 yes no https://www.trianglehealth.com/phase-1/crd3874-si-nct07661095 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07661095.jpg CRD3874-SI trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07661095) CRD3874-SI trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07661095). CRD3874-SI in People With Leukemia. The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07661095.mp4 2026-10-20T04:39:57.037Z 70 yes no https://www.trianglehealth.com/es/phase-1/crd3874-si-nct07661095 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07661095.jpg CRD3874-SI trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07661095) CRD3874-SI trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07661095). CRD3874-SI in People With Leukemia. The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07661095.mp4 2026-10-20T04:39:57.037Z 70 yes no https://www.trianglehealth.com/phase-1/cscc-nct05377905 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05377905.jpg MNA-D trial for Cutaneous Squamous Cell Carcinoma (NCT05377905) MNA-D trial for Cutaneous Squamous Cell Carcinoma (NCT05377905). Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC). The purpose of this study is to test a new method of experimental treatment for… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05377905.mp4 2026-10-19T16:20:02.316Z 55 yes no https://www.trianglehealth.com/es/phase-1/cscc-nct05377905 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05377905.jpg MNA-D trial for Cutaneous Squamous Cell Carcinoma (NCT05377905) MNA-D trial for Cutaneous Squamous Cell Carcinoma (NCT05377905). Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC). The purpose of this study is to test a new method of experimental treatment for… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05377905.mp4 2026-10-19T16:20:02.316Z 55 yes no https://www.trianglehealth.com/phase-1/cue-102-nct06917885 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06917885.jpg CUE-102 trial for Recurrent Glioblastoma (NCT06917885) CUE-102 trial for Recurrent Glioblastoma (NCT06917885). CUE-102 in Recurrent Glioblastoma. The goal of this study is to evaluate the safety of the experimental drug, CUE-102, and establish the recommended dose of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06917885.mp4 2026-10-20T01:00:30.896Z 66 yes no https://www.trianglehealth.com/es/phase-1/cue-102-nct06917885 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06917885.jpg CUE-102 trial for Recurrent Glioblastoma (NCT06917885) CUE-102 trial for Recurrent Glioblastoma (NCT06917885). CUE-102 in Recurrent Glioblastoma. The goal of this study is to evaluate the safety of the experimental drug, CUE-102, and establish the recommended dose of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06917885.mp4 2026-10-20T01:00:30.896Z 66 yes no https://www.trianglehealth.com/phase-1/cyclosporine-nct03128034 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03128034.jpg Cyclosporine trial for Acute Lymphoblastic Leukemia (NCT03128034) Cyclosporine trial for Acute Lymphoblastic Leukemia (NCT03128034). 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03128034.mp4 2026-09-12T21:22:44.004Z 77 yes no https://www.trianglehealth.com/es/phase-1/cyclosporine-nct03128034 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03128034.jpg Cyclosporine trial for Acute Lymphoblastic Leukemia (NCT03128034) Cyclosporine trial for Acute Lymphoblastic Leukemia (NCT03128034). 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03128034.mp4 2026-09-12T21:22:44.004Z 77 yes no https://www.trianglehealth.com/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06138587 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06138587.jpg Preemptive CIML NK Cell Therapy trial for Acute Myeloid Leukemia (NCT06138587) Preemptive CIML NK Cell Therapy trial for Acute Myeloid Leukemia (NCT06138587). Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation. The purpose of this research study is to test the safety and efficacy of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06138587.mp4 2026-10-18T19:07:27.932Z 63 yes no https://www.trianglehealth.com/es/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06138587 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06138587.jpg Preemptive CIML NK Cell Therapy trial for Acute Myeloid Leukemia (NCT06138587) Preemptive CIML NK Cell Therapy trial for Acute Myeloid Leukemia (NCT06138587). Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation. The purpose of this research study is to test the safety and efficacy of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06138587.mp4 2026-10-18T19:07:27.932Z 63 yes no https://www.trianglehealth.com/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06152809 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06152809.jpg CIML NK cells for AML trial for Acute Myeloid Leukemia (NCT06152809) CIML NK cells for AML trial for Acute Myeloid Leukemia (NCT06152809). CIML NK Cells With Venetoclax for AML. The purpose of this research study is to test the safety and to explore the effectiveness of infusing cytokine- induced… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06152809.mp4 2026-10-18T18:52:08.328Z 74 yes no https://www.trianglehealth.com/es/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06152809 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06152809.jpg CIML NK cells for AML trial for Acute Myeloid Leukemia (NCT06152809) CIML NK cells for AML trial for Acute Myeloid Leukemia (NCT06152809). CIML NK Cells With Venetoclax for AML. The purpose of this research study is to test the safety and to explore the effectiveness of infusing cytokine- induced… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06152809.mp4 2026-10-18T18:52:08.328Z 74 yes no https://www.trianglehealth.com/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06321484 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06321484.jpg CIML NK cells for ovarian cancer trial for Platinum-resistant Ovarian Cancer (NCT06321484) CIML NK cells for ovarian cancer trial for Platinum-resistant Ovarian Cancer (NCT06321484). Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer. The goal of this research study is to evaluate the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06321484.mp4 2026-09-12T21:18:12.439Z 76 yes no https://www.trianglehealth.com/es/phase-1/cytokine-induced-memory-like-natural-killer-cells-nct06321484 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06321484.jpg CIML NK cells for ovarian cancer trial for Platinum-resistant Ovarian Cancer (NCT06321484) CIML NK cells for ovarian cancer trial for Platinum-resistant Ovarian Cancer (NCT06321484). Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer. The goal of this research study is to evaluate the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06321484.mp4 2026-09-12T21:18:12.439Z 76 yes no https://www.trianglehealth.com/phase-1/danvatirsen-nct05986240 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05986240.jpg Danvatirsen trial for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic… (NCT05986240) Danvatirsen trial for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT05986240). Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML. This is a Phase 1 study investigating the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05986240.mp4 2026-10-19T01:28:14.263Z 70 yes no https://www.trianglehealth.com/es/phase-1/danvatirsen-nct05986240 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05986240.jpg Danvatirsen trial for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic… (NCT05986240) Danvatirsen trial for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT05986240). Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML. This is a Phase 1 study investigating the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05986240.mp4 2026-10-19T01:28:14.263Z 70 yes no https://www.trianglehealth.com/phase-1/db107-rrv-nct06504381 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06504381.jpg DB107-RRV trial for High Grade Glioma (NCT06504381) DB107-RRV trial for High Grade Glioma (NCT06504381). DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma. This is a multicenter, open-label study of DB107-RRV… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06504381.mp4 2026-10-19T00:21:10.556Z 80 yes no https://www.trianglehealth.com/es/phase-1/db107-rrv-nct06504381 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06504381.jpg DB107-RRV trial for High Grade Glioma (NCT06504381) DB107-RRV trial for High Grade Glioma (NCT06504381). DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma. This is a multicenter, open-label study of DB107-RRV… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06504381.mp4 2026-10-19T00:21:10.556Z 80 yes no https://www.trianglehealth.com/phase-1/dc-aml-fusion-vaccine-nct07374029 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07374029.jpg DC/AML Fusion Vaccine trial for Acute Myeloid Leukemia (NCT07374029) DC/AML Fusion Vaccine trial for Acute Myeloid Leukemia (NCT07374029). Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML. The goal of this research study is to test if the combination of a… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07374029.mp4 2026-10-18T23:50:25.080Z 63 yes no https://www.trianglehealth.com/es/phase-1/dc-aml-fusion-vaccine-nct07374029 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07374029.jpg DC/AML Fusion Vaccine trial for Acute Myeloid Leukemia (NCT07374029) DC/AML Fusion Vaccine trial for Acute Myeloid Leukemia (NCT07374029). Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML. The goal of this research study is to test if the combination of a… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07374029.mp4 2026-10-18T23:50:25.080Z 63 yes no https://www.trianglehealth.com/phase-1/dc-mm-fusion-vaccine-nct07377435 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07377435.jpg DC/MM Fusion Vaccine trial for Multiple Myeloma (NCT07377435) DC/MM Fusion Vaccine trial for Multiple Myeloma (NCT07377435). DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM. This study is to evaluate the safety and effectiveness of dendritic cell DC/MM fusion vaccine in combination… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07377435.mp4 2026-10-18T22:05:11.975Z 71 yes no https://www.trianglehealth.com/es/phase-1/dc-mm-fusion-vaccine-nct07377435 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07377435.jpg DC/MM Fusion Vaccine trial for Multiple Myeloma (NCT07377435) DC/MM Fusion Vaccine trial for Multiple Myeloma (NCT07377435). DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM. This study is to evaluate the safety and effectiveness of dendritic cell DC/MM fusion vaccine in combination… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07377435.mp4 2026-10-18T22:05:11.975Z 71 yes no https://www.trianglehealth.com/phase-1/decipher-nct05504707 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05504707.jpg DecipHER trial for Triple Negative Breast Cancer (NCT05504707) DecipHER trial for Triple Negative Breast Cancer (NCT05504707). DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer. The purpose of the study is to find out if an investigational vaccine called… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05504707.mp4 2026-10-18T18:50:15.187Z 68 yes no https://www.trianglehealth.com/es/phase-1/decipher-nct05504707 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05504707.jpg DecipHER trial for Triple Negative Breast Cancer (NCT05504707) DecipHER trial for Triple Negative Breast Cancer (NCT05504707). DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer. The purpose of the study is to find out if an investigational vaccine called… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05504707.mp4 2026-10-18T18:50:15.187Z 68 yes no https://www.trianglehealth.com/phase-1/dnajb1-prkaca-peptide-vaccine-nct04248569 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04248569.jpg DNAJB1-PRKACA peptide vaccine trial for Fibrolamellar Hepatocellular Carcinoma (FLC) (NCT04248569) DNAJB1-PRKACA peptide vaccine trial for Fibrolamellar Hepatocellular Carcinoma (FLC) (NCT04248569). DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma. The primary… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04248569.mp4 2026-09-12T15:26:30.203Z 233 yes no https://www.trianglehealth.com/es/phase-1/dnajb1-prkaca-peptide-vaccine-nct04248569 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04248569.jpg DNAJB1-PRKACA peptide vaccine trial for Fibrolamellar Hepatocellular Carcinoma (FLC) (NCT04248569) DNAJB1-PRKACA peptide vaccine trial for Fibrolamellar Hepatocellular Carcinoma (FLC) (NCT04248569). DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma. The primary… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04248569.mp4 2026-09-12T15:26:30.203Z 233 yes no https://www.trianglehealth.com/phase-1/dt2216-nct06964009 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964009.jpg DT2216 trial for Platinum-Resistant Ovarian Cancer (NCT06964009) DT2216 trial for Platinum-Resistant Ovarian Cancer (NCT06964009). DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer. The purpose of this research study is determining the highest dose of the study drug DT2216 in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964009.mp4 2026-10-19T01:34:09.298Z 69 yes no https://www.trianglehealth.com/es/phase-1/dt2216-nct06964009 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964009.jpg DT2216 trial for Platinum-Resistant Ovarian Cancer (NCT06964009) DT2216 trial for Platinum-Resistant Ovarian Cancer (NCT06964009). DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer. The purpose of this research study is determining the highest dose of the study drug DT2216 in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06964009.mp4 2026-10-19T01:34:09.298Z 69 yes no https://www.trianglehealth.com/phase-1/dupilumab-nct06088771 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06088771.jpg Dupilumab trial for Non-Small Cell Lung Cancer (NCT06088771) Dupilumab trial for Non-Small Cell Lung Cancer (NCT06088771). Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC. This is a phase 1/2 study of combined treatment with dupilumab… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06088771.mp4 2026-10-18T22:25:56.284Z 65 yes no https://www.trianglehealth.com/es/phase-1/dupilumab-nct06088771 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06088771.jpg Dupilumab trial for Non-Small Cell Lung Cancer (NCT06088771) Dupilumab trial for Non-Small Cell Lung Cancer (NCT06088771). Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC. This is a phase 1/2 study of combined treatment with dupilumab… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06088771.mp4 2026-10-18T22:25:56.284Z 65 yes no https://www.trianglehealth.com/phase-1/durable-nct05987644 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05987644.jpg Alectinib ± Radiosurgery trial for ALK-Positive Lung Cancer With Brain Metastases (NCT05987644) Alectinib ± Radiosurgery trial for ALK-Positive Lung Cancer With Brain Metastases (NCT05987644). Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05987644.mp4 2026-10-20T02:31:09.578Z 67 yes no https://www.trianglehealth.com/es/phase-1/durable-nct05987644 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05987644.jpg Alectinib ± Radiosurgery trial for ALK-Positive Lung Cancer With Brain Metastases (NCT05987644) Alectinib ± Radiosurgery trial for ALK-Positive Lung Cancer With Brain Metastases (NCT05987644). Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05987644.mp4 2026-10-20T02:31:09.578Z 67 yes no https://www.trianglehealth.com/phase-1/durvalumab-nct03011814 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03011814.jpg Durvalumab trial for Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT03011814) Durvalumab trial for Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT03011814). Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma. This randomized phase I/II… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03011814.mp4 2026-10-18T19:34:34.687Z 77 yes no https://www.trianglehealth.com/es/phase-1/durvalumab-nct03011814 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03011814.jpg Durvalumab trial for Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT03011814) Durvalumab trial for Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT03011814). Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma. This randomized phase I/II… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03011814.mp4 2026-10-18T19:34:34.687Z 77 yes no https://www.trianglehealth.com/phase-1/durvalumab-tremelimumab-nct05932199 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05932199.jpg Durvalumab + Tremelimumab trial for Resectable Pleural Mesothelioma (NCT05932199) Durvalumab + Tremelimumab trial for Resectable Pleural Mesothelioma (NCT05932199). Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma. Objectives: The investigators will test whether combination of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05932199.mp4 2026-10-20T01:23:27.851Z 64 yes no https://www.trianglehealth.com/es/phase-1/durvalumab-tremelimumab-nct05932199 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05932199.jpg Durvalumab + Tremelimumab trial for Resectable Pleural Mesothelioma (NCT05932199) Durvalumab + Tremelimumab trial for Resectable Pleural Mesothelioma (NCT05932199). Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma. Objectives: The investigators will test whether combination of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05932199.mp4 2026-10-20T01:23:27.851Z 64 yes no https://www.trianglehealth.com/phase-1/eagd-t-cell-nct03533816 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03533816.jpg EAGD T-cell trial for Acute Myeloid Leukemia (NCT03533816) EAGD T-cell trial for Acute Myeloid Leukemia (NCT03533816). Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide. Gamma delta T-cells are… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03533816.mp4 2026-09-12T20:21:45.403Z 71 yes no https://www.trianglehealth.com/es/phase-1/eagd-t-cell-nct03533816 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03533816.jpg EAGD T-cell trial for Acute Myeloid Leukemia (NCT03533816) EAGD T-cell trial for Acute Myeloid Leukemia (NCT03533816). Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide. Gamma delta T-cells are… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03533816.mp4 2026-09-12T20:21:45.403Z 71 yes no https://www.trianglehealth.com/phase-1/egfr-inhibitor-eras-801-nct07089641 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07089641.jpg ERAS-801 trial for EGFR-Altered IDH-Wildtype Glioblastoma or Gliosarcoma (NCT07089641) ERAS-801 trial for EGFR-Altered IDH-Wildtype Glioblastoma or Gliosarcoma (NCT07089641). ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07089641.mp4 2026-10-19T12:17:24.377Z 67 yes no https://www.trianglehealth.com/es/phase-1/egfr-inhibitor-eras-801-nct07089641 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07089641.jpg ERAS-801 trial for EGFR-Altered IDH-Wildtype Glioblastoma or Gliosarcoma (NCT07089641) ERAS-801 trial for EGFR-Altered IDH-Wildtype Glioblastoma or Gliosarcoma (NCT07089641). ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07089641.mp4 2026-10-19T12:17:24.377Z 67 yes no https://www.trianglehealth.com/phase-1/eli-002-7p-nct07671339 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07671339.jpg ELI-002 7P trial for KRAS-Mutant Pancreatic Cancer (NCT07671339) ELI-002 7P trial for KRAS-Mutant Pancreatic Cancer (NCT07671339). ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer. The researchers are doing this study to find out whether ELI-002 7P in combination… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07671339.mp4 2026-10-20T02:58:15.255Z 69 yes no https://www.trianglehealth.com/es/phase-1/eli-002-7p-nct07671339 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07671339.jpg ELI-002 7P trial for KRAS-Mutant Pancreatic Cancer (NCT07671339) ELI-002 7P trial for KRAS-Mutant Pancreatic Cancer (NCT07671339). ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer. The researchers are doing this study to find out whether ELI-002 7P in combination… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07671339.mp4 2026-10-20T02:58:15.255Z 69 yes no https://www.trianglehealth.com/phase-1/emapalumab-nct06996119 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06996119.jpg Emapalumab trial for AML or MDS Undergoing Reduced-Intensity Transplant (NCT06996119) Emapalumab trial for AML or MDS Undergoing Reduced-Intensity Transplant (NCT06996119). Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06996119.mp4 2026-10-20T01:55:22.743Z 70 yes no https://www.trianglehealth.com/es/phase-1/emapalumab-nct06996119 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06996119.jpg Emapalumab trial for AML or MDS Undergoing Reduced-Intensity Transplant (NCT06996119) Emapalumab trial for AML or MDS Undergoing Reduced-Intensity Transplant (NCT06996119). Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06996119.mp4 2026-10-20T01:55:22.743Z 70 yes no https://www.trianglehealth.com/phase-1/emavusertib-nct07107750 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07107750.jpg Emavusertib + Chemoimmunotherapy trial for Untreated Advanced Biliary Tract Cancer (NCT07107750) Emavusertib + Chemoimmunotherapy trial for Untreated Advanced Biliary Tract Cancer (NCT07107750). Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer. Based… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07107750.mp4 2026-10-20T00:45:55.581Z 72 yes no https://www.trianglehealth.com/es/phase-1/emavusertib-nct07107750 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07107750.jpg Emavusertib + Chemoimmunotherapy trial for Untreated Advanced Biliary Tract Cancer (NCT07107750) Emavusertib + Chemoimmunotherapy trial for Untreated Advanced Biliary Tract Cancer (NCT07107750). Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer. Based… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07107750.mp4 2026-10-20T00:45:55.581Z 72 yes no https://www.trianglehealth.com/phase-1/enfortumab-vedotin-nct04878029 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04878029.jpg Cabozantinib + Enfortumab Vedotin trial for Locally Advanced or Metastatic… (NCT04878029) Cabozantinib + Enfortumab Vedotin trial for Locally Advanced or Metastatic Urothelial Cancer (NCT04878029). Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer. This phase I/Ib trial seeks to find out the best… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04878029.mp4 2026-10-20T05:58:21.716Z 69 yes no https://www.trianglehealth.com/es/phase-1/enfortumab-vedotin-nct04878029 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04878029.jpg Cabozantinib + Enfortumab Vedotin trial for Locally Advanced or Metastatic… (NCT04878029) Cabozantinib + Enfortumab Vedotin trial for Locally Advanced or Metastatic Urothelial Cancer (NCT04878029). Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer. This phase I/Ib trial seeks to find out the best… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04878029.mp4 2026-10-20T05:58:21.716Z 69 yes no https://www.trianglehealth.com/phase-1/epcoritamab-nct06536049 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536049.jpg Epcoritamab + Ibrutinib trial for Relapsed or Refractory Aggressive B-Cell Lymphoma (NCT06536049) Epcoritamab + Ibrutinib trial for Relapsed or Refractory Aggressive B-Cell Lymphoma (NCT06536049). Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma. This phase Ib/II trial evaluates the safety,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536049.mp4 2026-10-20T01:43:27.652Z 76 yes no https://www.trianglehealth.com/es/phase-1/epcoritamab-nct06536049 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536049.jpg Epcoritamab + Ibrutinib trial for Relapsed or Refractory Aggressive B-Cell Lymphoma (NCT06536049) Epcoritamab + Ibrutinib trial for Relapsed or Refractory Aggressive B-Cell Lymphoma (NCT06536049). Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma. This phase Ib/II trial evaluates the safety,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06536049.mp4 2026-10-20T01:43:27.652Z 76 yes no https://www.trianglehealth.com/phase-1/epcoritamab-nct06672705 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06672705.jpg Epcoritamab trial for Relapsed or Refractory Post-Transplant Lymphoproliferative… (NCT06672705) Epcoritamab trial for Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder (NCT06672705). Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders. This phase Ib trial tests the safety and effectiveness… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06672705.mp4 2026-10-20T05:39:08.970Z 74 yes no https://www.trianglehealth.com/es/phase-1/epcoritamab-nct06672705 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06672705.jpg Epcoritamab trial for Relapsed or Refractory Post-Transplant Lymphoproliferative… (NCT06672705) Epcoritamab trial for Relapsed or Refractory Post-Transplant Lymphoproliferative Disorder (NCT06672705). Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders. This phase Ib trial tests the safety and effectiveness… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06672705.mp4 2026-10-20T05:39:08.970Z 74 yes no https://www.trianglehealth.com/phase-1/eradicate-nct07198724 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07198724.jpg Elacestrant + T-DXd trial for HR-Positive, HER2-Low or Ultralow Metastatic Breast… (NCT07198724) Elacestrant + T-DXd trial for HR-Positive, HER2-Low or Ultralow Metastatic Breast Cancer (NCT07198724). ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07198724.mp4 2026-10-20T01:09:33.284Z 77 yes no https://www.trianglehealth.com/es/phase-1/eradicate-nct07198724 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07198724.jpg Elacestrant + T-DXd trial for HR-Positive, HER2-Low or Ultralow Metastatic Breast… (NCT07198724) Elacestrant + T-DXd trial for HR-Positive, HER2-Low or Ultralow Metastatic Breast Cancer (NCT07198724). ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07198724.mp4 2026-10-20T01:09:33.284Z 77 yes no https://www.trianglehealth.com/phase-1/fenofibrate-nct06191133 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06191133.jpg Fenofibrate trial for Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer (NCT06191133) Fenofibrate trial for Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer (NCT06191133). Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma. Normally, p53 helps prevent tumors from forming in the body. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06191133.mp4 2026-10-19T12:33:53.681Z 73 yes no https://www.trianglehealth.com/es/phase-1/fenofibrate-nct06191133 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06191133.jpg Fenofibrate trial for Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer (NCT06191133) Fenofibrate trial for Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer (NCT06191133). Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma. Normally, p53 helps prevent tumors from forming in the body. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06191133.mp4 2026-10-19T12:33:53.681Z 73 yes no https://www.trianglehealth.com/phase-1/fgfr4-car-t-cells-nct06865664 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06865664.jpg FGFR4-CAR T Cells trial for Rhabdomyosarcoma (NCT06865664) FGFR4-CAR T Cells trial for Rhabdomyosarcoma (NCT06865664). FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma. Background: Rhabdomyosarcoma (RMS)… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06865664.mp4 2026-09-12T21:20:55.536Z 80 yes no https://www.trianglehealth.com/es/phase-1/fgfr4-car-t-cells-nct06865664 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06865664.jpg FGFR4-CAR T Cells trial for Rhabdomyosarcoma (NCT06865664) FGFR4-CAR T Cells trial for Rhabdomyosarcoma (NCT06865664). FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma. Background: Rhabdomyosarcoma (RMS)… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06865664.mp4 2026-09-12T21:20:55.536Z 80 yes no https://www.trianglehealth.com/phase-1/fhd-286-nct07283094 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07283094.jpg FHD-286 + Decitabine/Venetoclax trial for Acute Myeloid Leukemia and Myelodysplastic… (NCT07283094) FHD-286 + Decitabine/Venetoclax trial for Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT07283094). FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia. This is a Phase 1, uncontrolled, single-arm, open-label,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07283094.mp4 2026-10-19T02:45:17.350Z 70 yes no https://www.trianglehealth.com/es/phase-1/fhd-286-nct07283094 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07283094.jpg FHD-286 + Decitabine/Venetoclax trial for Acute Myeloid Leukemia and Myelodysplastic… (NCT07283094) FHD-286 + Decitabine/Venetoclax trial for Acute Myeloid Leukemia and Myelodysplastic Syndrome (NCT07283094). FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia. This is a Phase 1, uncontrolled, single-arm, open-label,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07283094.mp4 2026-10-19T02:45:17.350Z 70 yes no https://www.trianglehealth.com/phase-1/flinn-nct07355205 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07355205.jpg N-803 + Nivolumab/Ipilimumab trial for Untreated Stage IV or Recurrent Non-Small… (NCT07355205) N-803 + Nivolumab/Ipilimumab trial for Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT07355205). First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer. This is a… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07355205.mp4 2026-10-20T02:10:32.820Z 88 yes no https://www.trianglehealth.com/es/phase-1/flinn-nct07355205 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07355205.jpg N-803 + Nivolumab/Ipilimumab trial for Untreated Stage IV or Recurrent Non-Small… (NCT07355205) N-803 + Nivolumab/Ipilimumab trial for Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer (NCT07355205). First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer. This is a… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07355205.mp4 2026-10-20T02:10:32.820Z 88 yes no https://www.trianglehealth.com/phase-1/flt3-mertk-inhibitor-mrx-2843-nct04762199 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04762199.jpg MRX-2843 + Osimertinib trial for Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NCT04762199) MRX-2843 + Osimertinib trial for Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NCT04762199). MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer. This phase Ib trial evaluates the best dose and side effects of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04762199.mp4 2026-10-20T03:27:17.703Z 69 yes no https://www.trianglehealth.com/es/phase-1/flt3-mertk-inhibitor-mrx-2843-nct04762199 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04762199.jpg MRX-2843 + Osimertinib trial for Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NCT04762199) MRX-2843 + Osimertinib trial for Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NCT04762199). MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer. This phase Ib trial evaluates the best dose and side effects of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04762199.mp4 2026-10-20T03:27:17.703Z 69 yes no https://www.trianglehealth.com/phase-1/fluoxetine-nct06225011 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225011.jpg Fluoxetine trial for Colorectal Adenocarcinoma Planning Surgery (NCT06225011) Fluoxetine trial for Colorectal Adenocarcinoma Planning Surgery (NCT06225011). Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer. This phase I trial tests whether… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225011.mp4 2026-10-19T15:54:16.415Z 65 yes no https://www.trianglehealth.com/es/phase-1/fluoxetine-nct06225011 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225011.jpg Fluoxetine trial for Colorectal Adenocarcinoma Planning Surgery (NCT06225011) Fluoxetine trial for Colorectal Adenocarcinoma Planning Surgery (NCT06225011). Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer. This phase I trial tests whether… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225011.mp4 2026-10-19T15:54:16.415Z 65 yes no https://www.trianglehealth.com/phase-1/folfox-nct04808323 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04808323.jpg MRI-Guided Adaptive RT trial for Locally Advanced Rectal Adenocarcinoma (NCT04808323) MRI-Guided Adaptive RT trial for Locally Advanced Rectal Adenocarcinoma (NCT04808323). MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer. This study is a prospective, open-label, phase I design. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04808323.mp4 2026-10-20T05:28:59.496Z 69 yes no https://www.trianglehealth.com/es/phase-1/folfox-nct04808323 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04808323.jpg MRI-Guided Adaptive RT trial for Locally Advanced Rectal Adenocarcinoma (NCT04808323) MRI-Guided Adaptive RT trial for Locally Advanced Rectal Adenocarcinoma (NCT04808323). MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer. This study is a prospective, open-label, phase I design. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04808323.mp4 2026-10-20T05:28:59.496Z 69 yes no https://www.trianglehealth.com/phase-1/folr1-car-t-cells-nct06609928 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06609928.jpg FOLR1 CAR T-cells trial for Recurrent Childhood Acute Myeloid Leukemia (NCT06609928) FOLR1 CAR T-cells trial for Recurrent Childhood Acute Myeloid Leukemia (NCT06609928). FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia. This phase I trial tests… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06609928.mp4 2026-09-12T20:14:00.614Z 75 yes no https://www.trianglehealth.com/es/phase-1/folr1-car-t-cells-nct06609928 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06609928.jpg FOLR1 CAR T-cells trial for Recurrent Childhood Acute Myeloid Leukemia (NCT06609928) FOLR1 CAR T-cells trial for Recurrent Childhood Acute Myeloid Leukemia (NCT06609928). FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia. This phase I trial tests… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06609928.mp4 2026-09-12T20:14:00.614Z 75 yes no https://www.trianglehealth.com/phase-1/fostamatinib-nct06639724 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06639724.jpg Fostamatinib trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06639724) Fostamatinib trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06639724). Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer. This is a Phase 1b trial evaluating the combination of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06639724.mp4 2026-10-18T22:53:06.080Z 69 yes no https://www.trianglehealth.com/es/phase-1/fostamatinib-nct06639724 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06639724.jpg Fostamatinib trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06639724) Fostamatinib trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT06639724). Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer. This is a Phase 1b trial evaluating the combination of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06639724.mp4 2026-10-18T22:53:06.080Z 69 yes no https://www.trianglehealth.com/phase-1/g207-nct03911388 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03911388.jpg G207 trial for Neoplasms, Brain (NCT03911388) G207 trial for Neoplasms, Brain (NCT03911388). HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors. This study is a clinical trial to determine the safety of inoculating G207 (an… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03911388.mp4 2026-09-12T13:45:09.092Z 252 yes no https://www.trianglehealth.com/es/phase-1/g207-nct03911388 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03911388.jpg G207 trial for Neoplasms, Brain (NCT03911388) G207 trial for Neoplasms, Brain (NCT03911388). HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors. This study is a clinical trial to determine the safety of inoculating G207 (an… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03911388.mp4 2026-09-12T13:45:09.092Z 252 yes no https://www.trianglehealth.com/phase-1/gavel-nct07439211 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07439211.jpg GAVEL trial for Acute Myeloid Leukemia (NCT07439211) GAVEL trial for Acute Myeloid Leukemia (NCT07439211). Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia. This study is to evaluate the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07439211.mp4 2026-10-20T04:33:52.929Z 57 yes no https://www.trianglehealth.com/es/phase-1/gavel-nct07439211 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07439211.jpg GAVEL trial for Acute Myeloid Leukemia (NCT07439211) GAVEL trial for Acute Myeloid Leukemia (NCT07439211). Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia. This study is to evaluate the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07439211.mp4 2026-10-20T04:33:52.929Z 57 yes no https://www.trianglehealth.com/phase-1/gc511b-car-t-cell-nct07249879 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07249879.jpg GC511B CAR-T Cell trial for Relapsed/Refractory Small Cell Lung Cancer (NCT07249879) GC511B CAR-T Cell trial for Relapsed/Refractory Small Cell Lung Cancer (NCT07249879). This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07249879.mp4 2026-09-12T20:53:53.917Z 83 yes no https://www.trianglehealth.com/es/phase-1/gc511b-car-t-cell-nct07249879 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07249879.jpg GC511B CAR-T Cell trial for Relapsed/Refractory Small Cell Lung Cancer (NCT07249879) GC511B CAR-T Cell trial for Relapsed/Refractory Small Cell Lung Cancer (NCT07249879). This Study is an Open-lable, Early Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07249879.mp4 2026-09-12T20:53:53.917Z 83 yes no https://www.trianglehealth.com/phase-1/gd2-car-t-cells-nct04196413 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04196413.jpg GD2 CAR T cells trial for Glioma of Spinal Cord (NCT04196413) GD2 CAR T cells trial for Glioma of Spinal Cord (NCT04196413). GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG). The primary purpose of this study is to test whether CAR T… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04196413.mp4 2026-09-12T15:20:59.968Z 250 yes no https://www.trianglehealth.com/es/phase-1/gd2-car-t-cells-nct04196413 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04196413.jpg GD2 CAR T cells trial for Glioma of Spinal Cord (NCT04196413) GD2 CAR T cells trial for Glioma of Spinal Cord (NCT04196413). GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG). The primary purpose of this study is to test whether CAR T… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04196413.mp4 2026-09-12T15:20:59.968Z 250 yes no https://www.trianglehealth.com/phase-1/gemtuzumab-ozogamicin-nct05558124 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05558124.jpg CPX-351 + Gemtuzumab Ozogamicin trial for Newly Diagnosed Acute Myeloid Leukemia (NCT05558124) CPX-351 + Gemtuzumab Ozogamicin trial for Newly Diagnosed Acute Myeloid Leukemia (NCT05558124). CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML. The purpose of the study is to determine the safety of combining the drugs… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05558124.mp4 2026-10-20T04:48:37.487Z 69 yes no https://www.trianglehealth.com/es/phase-1/gemtuzumab-ozogamicin-nct05558124 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05558124.jpg CPX-351 + Gemtuzumab Ozogamicin trial for Newly Diagnosed Acute Myeloid Leukemia (NCT05558124) CPX-351 + Gemtuzumab Ozogamicin trial for Newly Diagnosed Acute Myeloid Leukemia (NCT05558124). CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML. The purpose of the study is to determine the safety of combining the drugs… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05558124.mp4 2026-10-20T04:48:37.487Z 69 yes no https://www.trianglehealth.com/phase-1/gilteritinib-nct06225427 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225427.jpg Gilteritinib trial for Lung Non-Small Cell Carcinoma (NCT06225427) Gilteritinib trial for Lung Non-Small Cell Carcinoma (NCT06225427). Gilteritinib for the Treatment of ALK NSCLC. This phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225427.mp4 2026-10-18T22:26:57.507Z 74 yes no https://www.trianglehealth.com/es/phase-1/gilteritinib-nct06225427 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225427.jpg Gilteritinib trial for Lung Non-Small Cell Carcinoma (NCT06225427) Gilteritinib trial for Lung Non-Small Cell Carcinoma (NCT06225427). Gilteritinib for the Treatment of ALK NSCLC. This phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06225427.mp4 2026-10-18T22:26:57.507Z 74 yes no https://www.trianglehealth.com/phase-1/ginakit2-nct03294954 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03294954.jpg GINAKIT2 trial for Neuroblastoma (NCT03294954) GINAKIT2 trial for Neuroblastoma (NCT03294954). GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma. This research study combines two different ways of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03294954.mp4 2026-09-12T20:42:11.104Z 74 yes no https://www.trianglehealth.com/es/phase-1/ginakit2-nct03294954 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03294954.jpg GINAKIT2 trial for Neuroblastoma (NCT03294954) GINAKIT2 trial for Neuroblastoma (NCT03294954). GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma. This research study combines two different ways of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03294954.mp4 2026-09-12T20:42:11.104Z 74 yes no https://www.trianglehealth.com/phase-1/grale-nct01555892 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01555892.jpg GRALE trial for EBV-Positive Hodgkin and Non-Hodgkin Lymphoma (NCT01555892) GRALE trial for EBV-Positive Hodgkin and Non-Hodgkin Lymphoma (NCT01555892). Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE. Subjects have a type of lymph gland disease called Hodgkin or non-Hodgkin Lymphoma or… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01555892.mp4 2026-10-19T00:55:50.468Z 55 yes no https://www.trianglehealth.com/es/phase-1/grale-nct01555892 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01555892.jpg GRALE trial for EBV-Positive Hodgkin and Non-Hodgkin Lymphoma (NCT01555892) GRALE trial for EBV-Positive Hodgkin and Non-Hodgkin Lymphoma (NCT01555892). Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE. Subjects have a type of lymph gland disease called Hodgkin or non-Hodgkin Lymphoma or… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01555892.mp4 2026-10-19T00:55:50.468Z 55 yes no https://www.trianglehealth.com/phase-1/high-dose-ascorbate-nct07177079 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07177079.jpg High-Dose Ascorbate + Aza/Ven trial for Newly Diagnosed Acute Myeloid Leukemia (NCT07177079) High-Dose Ascorbate + Aza/Ven trial for Newly Diagnosed Acute Myeloid Leukemia (NCT07177079). High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML). This is a randomized, open-label,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07177079.mp4 2026-10-19T15:14:05.718Z 66 yes no https://www.trianglehealth.com/es/phase-1/high-dose-ascorbate-nct07177079 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07177079.jpg High-Dose Ascorbate + Aza/Ven trial for Newly Diagnosed Acute Myeloid Leukemia (NCT07177079) High-Dose Ascorbate + Aza/Ven trial for Newly Diagnosed Acute Myeloid Leukemia (NCT07177079). High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML). This is a randomized, open-label,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07177079.mp4 2026-10-19T15:14:05.718Z 66 yes no https://www.trianglehealth.com/phase-1/honokiol-nct06566443 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06566443.jpg Honokiol trial for Early-Stage Resectable Non-Small Cell Lung Cancer (NCT06566443) Honokiol trial for Early-Stage Resectable Non-Small Cell Lung Cancer (NCT06566443). Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer. This is a Phase I Trial evaluating the safety of the dietary supplement honokiol for lung… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06566443.mp4 2026-10-19T00:26:16.599Z 62 yes no https://www.trianglehealth.com/es/phase-1/honokiol-nct06566443 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06566443.jpg Honokiol trial for Early-Stage Resectable Non-Small Cell Lung Cancer (NCT06566443) Honokiol trial for Early-Stage Resectable Non-Small Cell Lung Cancer (NCT06566443). Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer. This is a Phase I Trial evaluating the safety of the dietary supplement honokiol for lung… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06566443.mp4 2026-10-19T00:26:16.599Z 62 yes no https://www.trianglehealth.com/phase-1/ig-imrt-nct01659203 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01659203.jpg Proton or Photon RT trial for Retroperitoneal Sarcoma (NCT01659203) Proton or Photon RT trial for Retroperitoneal Sarcoma (NCT01659203). Proton or Photon RT for Retroperitoneal Sarcomas. This research study is a Phase I clinical trial. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01659203.mp4 2026-10-20T05:46:24.370Z 72 yes no https://www.trianglehealth.com/es/phase-1/ig-imrt-nct01659203 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01659203.jpg Proton or Photon RT trial for Retroperitoneal Sarcoma (NCT01659203) Proton or Photon RT trial for Retroperitoneal Sarcoma (NCT01659203). Proton or Photon RT for Retroperitoneal Sarcomas. This research study is a Phase I clinical trial. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01659203.mp4 2026-10-20T05:46:24.370Z 72 yes no https://www.trianglehealth.com/phase-1/il13ralpha2-specific-hinge-optimized-41bb-co-stimulatory-nct04510051 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04510051.jpg CAR T Cells After Lymphodepletion for the… trial for Malignant Brain Neoplasm (NCT04510051) CAR T Cells After Lymphodepletion for the… trial for Malignant Brain Neoplasm (NCT04510051). CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children. This phase I trial investigates the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04510051.mp4 2026-09-12T20:29:13.976Z 65 yes no https://www.trianglehealth.com/es/phase-1/il13ralpha2-specific-hinge-optimized-41bb-co-stimulatory-nct04510051 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04510051.jpg CAR T Cells After Lymphodepletion for the… trial for Malignant Brain Neoplasm (NCT04510051) CAR T Cells After Lymphodepletion for the… trial for Malignant Brain Neoplasm (NCT04510051). CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children. This phase I trial investigates the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04510051.mp4 2026-09-12T20:29:13.976Z 65 yes no https://www.trianglehealth.com/phase-1/impact-nct06193759 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06193759.jpg IMPACT trial for Medulloblastoma, Childhood (NCT06193759) IMPACT trial for Medulloblastoma, Childhood (NCT06193759). Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT). This is an open-label phase 1 safety and feasibility study… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06193759.mp4 2026-09-12T20:46:13.677Z 70 yes no https://www.trianglehealth.com/es/phase-1/impact-nct06193759 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06193759.jpg IMPACT trial for Medulloblastoma, Childhood (NCT06193759) IMPACT trial for Medulloblastoma, Childhood (NCT06193759). Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT). This is an open-label phase 1 safety and feasibility study… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06193759.mp4 2026-09-12T20:46:13.677Z 70 yes no https://www.trianglehealth.com/phase-1/impact-nct07148050 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07148050.jpg IMPACT trial for Solid Tumor (Excluding CNS) (NCT07148050) IMPACT trial for Solid Tumor (Excluding CNS) (NCT07148050). Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells. This… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07148050.mp4 2026-09-12T20:51:35.445Z 79 yes no https://www.trianglehealth.com/es/phase-1/impact-nct07148050 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07148050.jpg IMPACT trial for Solid Tumor (Excluding CNS) (NCT07148050) IMPACT trial for Solid Tumor (Excluding CNS) (NCT07148050). Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells. This… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07148050.mp4 2026-09-12T20:51:35.445Z 79 yes no https://www.trianglehealth.com/phase-1/implantable-microdevice-imd-nct05700461 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05700461.jpg Implantable Microdevice trial for Metastatic Renal Cell Carcinoma (NCT05700461) Implantable Microdevice trial for Metastatic Renal Cell Carcinoma (NCT05700461). Drug Screening Using Novel IMD in Renal Cell Carcinoma. This research is being done to study the safety and feasibility of implanting and retrieving a… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05700461.mp4 2026-10-20T03:41:09.500Z 65 yes no https://www.trianglehealth.com/es/phase-1/implantable-microdevice-imd-nct05700461 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05700461.jpg Implantable Microdevice trial for Metastatic Renal Cell Carcinoma (NCT05700461) Implantable Microdevice trial for Metastatic Renal Cell Carcinoma (NCT05700461). Drug Screening Using Novel IMD in Renal Cell Carcinoma. This research is being done to study the safety and feasibility of implanting and retrieving a… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05700461.mp4 2026-10-20T03:41:09.500Z 65 yes no https://www.trianglehealth.com/phase-1/indoximod-nct05106296 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05106296.jpg Ibrutinib + Indoximod trial for Pediatric Brain Cancer (NCT05106296) Ibrutinib + Indoximod trial for Pediatric Brain Cancer (NCT05106296). Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer. Recent lab-based discoveries suggest that IDO (indoleamine… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05106296.mp4 2026-10-19T01:48:51.137Z 72 yes no https://www.trianglehealth.com/es/phase-1/indoximod-nct05106296 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05106296.jpg Ibrutinib + Indoximod trial for Pediatric Brain Cancer (NCT05106296) Ibrutinib + Indoximod trial for Pediatric Brain Cancer (NCT05106296). Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer. Recent lab-based discoveries suggest that IDO (indoleamine… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05106296.mp4 2026-10-19T01:48:51.137Z 72 yes no https://www.trianglehealth.com/phase-1/inm176-nct06600698 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06600698.jpg INM176 trial for Prostate Cancer With Rising PSA (NCT06600698) INM176 trial for Prostate Cancer With Rising PSA (NCT06600698). AGN-INM176 in Prostate Patients With Rising PSA. This Phase I/II open-label trial aims to evaluate the safety and efficacy of the herbal supplement INM176 in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06600698.mp4 2026-10-19T15:01:26.887Z 59 yes no https://www.trianglehealth.com/es/phase-1/inm176-nct06600698 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06600698.jpg INM176 trial for Prostate Cancer With Rising PSA (NCT06600698) INM176 trial for Prostate Cancer With Rising PSA (NCT06600698). AGN-INM176 in Prostate Patients With Rising PSA. This Phase I/II open-label trial aims to evaluate the safety and efficacy of the herbal supplement INM176 in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06600698.mp4 2026-10-19T15:01:26.887Z 59 yes no https://www.trianglehealth.com/phase-1/inotuzumab-ozogamicin-nct01371630 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01371630.jpg Inotuzumab Ozogamicin trial for B Acute Lymphoblastic Leukemia With… (NCT01371630) Inotuzumab Ozogamicin trial for B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 (NCT01371630). Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia. This phase I/II trial studies the side effects and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01371630.mp4 2026-09-12T21:28:14.945Z 78 yes no https://www.trianglehealth.com/es/phase-1/inotuzumab-ozogamicin-nct01371630 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01371630.jpg Inotuzumab Ozogamicin trial for B Acute Lymphoblastic Leukemia With… (NCT01371630) Inotuzumab Ozogamicin trial for B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 (NCT01371630). Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia. This phase I/II trial studies the side effects and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT01371630.mp4 2026-09-12T21:28:14.945Z 78 yes no https://www.trianglehealth.com/phase-1/intradermal-injection-of-cadi-05-nct07455032 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07455032.jpg CADI-05 + Pembrolizumab trial for Resectable Locally Advanced Head and Neck Squamous… (NCT07455032) CADI-05 + Pembrolizumab trial for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07455032). Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas. The goal of this… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07455032.mp4 2026-10-19T12:53:43.522Z 58 yes no https://www.trianglehealth.com/es/phase-1/intradermal-injection-of-cadi-05-nct07455032 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07455032.jpg CADI-05 + Pembrolizumab trial for Resectable Locally Advanced Head and Neck Squamous… (NCT07455032) CADI-05 + Pembrolizumab trial for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07455032). Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas. The goal of this… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07455032.mp4 2026-10-19T12:53:43.522Z 58 yes no https://www.trianglehealth.com/phase-1/ipilimumab-and-nivolumab-nct07075120 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07075120.jpg Ipilimumab and Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07075120) Ipilimumab and Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07075120). Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer. Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07075120.mp4 2026-10-19T01:01:49.545Z 64 yes no https://www.trianglehealth.com/es/phase-1/ipilimumab-and-nivolumab-nct07075120 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07075120.jpg Ipilimumab and Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07075120) Ipilimumab and Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07075120). Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer. Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07075120.mp4 2026-10-19T01:01:49.545Z 64 yes no https://www.trianglehealth.com/phase-1/ipilimumab-nct07128680 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07128680.jpg EXL01 + Nivolumab/Ipilimumab trial for Metastatic Clear Cell or Sarcomatoid Renal… (NCT07128680) EXL01 + Nivolumab/Ipilimumab trial for Metastatic Clear Cell or Sarcomatoid Renal Cell Carcinoma (NCT07128680). Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer. This phase… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07128680.mp4 2026-10-20T03:06:44.812Z 64 yes no https://www.trianglehealth.com/es/phase-1/ipilimumab-nct07128680 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07128680.jpg EXL01 + Nivolumab/Ipilimumab trial for Metastatic Clear Cell or Sarcomatoid Renal… (NCT07128680) EXL01 + Nivolumab/Ipilimumab trial for Metastatic Clear Cell or Sarcomatoid Renal Cell Carcinoma (NCT07128680). Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer. This phase… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07128680.mp4 2026-10-20T03:06:44.812Z 64 yes no https://www.trianglehealth.com/phase-1/ivonescimab-nct07535463 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07535463.jpg Ivonescimab + Radiosurgery trial for Non-Small Cell Lung Cancer With Brain Metastases (NCT07535463) Ivonescimab + Radiosurgery trial for Non-Small Cell Lung Cancer With Brain Metastases (NCT07535463). Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer. The researchers are doing this study to test the safety… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07535463.mp4 2026-10-20T02:45:30.160Z 64 yes no https://www.trianglehealth.com/es/phase-1/ivonescimab-nct07535463 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07535463.jpg Ivonescimab + Radiosurgery trial for Non-Small Cell Lung Cancer With Brain Metastases (NCT07535463) Ivonescimab + Radiosurgery trial for Non-Small Cell Lung Cancer With Brain Metastases (NCT07535463). Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer. The researchers are doing this study to test the safety… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07535463.mp4 2026-10-20T02:45:30.160Z 64 yes no https://www.trianglehealth.com/phase-1/leflunomide-nct04997993 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04997993.jpg Leflunomide trial for PTEN-Altered Advanced Solid Tumors and HER2-Negative Breast… (NCT04997993) Leflunomide trial for PTEN-Altered Advanced Solid Tumors and HER2-Negative Breast Cancer (NCT04997993). Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer. Leflunomide in patients with PTEN-Altered advanced… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04997993.mp4 2026-10-19T15:41:57.522Z 62 yes no https://www.trianglehealth.com/es/phase-1/leflunomide-nct04997993 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04997993.jpg Leflunomide trial for PTEN-Altered Advanced Solid Tumors and HER2-Negative Breast… (NCT04997993) Leflunomide trial for PTEN-Altered Advanced Solid Tumors and HER2-Negative Breast Cancer (NCT04997993). Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer. Leflunomide in patients with PTEN-Altered advanced… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04997993.mp4 2026-10-19T15:41:57.522Z 62 yes no https://www.trianglehealth.com/phase-1/lenvatinib-nct05603910 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05603910.jpg Lenvatinib + Pembrolizumab + RT trial for Recurrent or Unresectable pMMR Endometrial… (NCT05603910) Lenvatinib + Pembrolizumab + RT trial for Recurrent or Unresectable pMMR Endometrial (Uterine) Cancer (NCT05603910). Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma. The purpose of this research… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05603910.mp4 2026-10-20T03:32:40.160Z 69 yes no https://www.trianglehealth.com/es/phase-1/lenvatinib-nct05603910 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05603910.jpg Lenvatinib + Pembrolizumab + RT trial for Recurrent or Unresectable pMMR Endometrial… (NCT05603910) Lenvatinib + Pembrolizumab + RT trial for Recurrent or Unresectable pMMR Endometrial (Uterine) Cancer (NCT05603910). Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma. The purpose of this research… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05603910.mp4 2026-10-20T03:32:40.160Z 69 yes no https://www.trianglehealth.com/phase-1/lifileucel-ln-144-ln-145-nct05607095 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05607095.jpg Lifileucel (LN-144/LN-145) trial for Uveal Melanoma (NCT05607095) Lifileucel (LN-144/LN-145) trial for Uveal Melanoma (NCT05607095). LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma. This is an open… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05607095.mp4 2026-10-18T22:21:54.523Z 67 yes no https://www.trianglehealth.com/es/phase-1/lifileucel-ln-144-ln-145-nct05607095 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05607095.jpg Lifileucel (LN-144/LN-145) trial for Uveal Melanoma (NCT05607095) Lifileucel (LN-144/LN-145) trial for Uveal Melanoma (NCT05607095). LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma. This is an open… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05607095.mp4 2026-10-18T22:21:54.523Z 67 yes no https://www.trianglehealth.com/phase-1/lm-gucy2c-vaccine-nct07417488 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07417488.jpg Lm-GUCY2C vaccine trial for Colorectal Cancer and Small Bowel Adenocarcinoma (NCT07417488) Lm-GUCY2C vaccine trial for Colorectal Cancer and Small Bowel Adenocarcinoma (NCT07417488). GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas. This is an open-label, non-randomized, single-center, dose-escalation… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07417488.mp4 2026-10-18T22:50:09.080Z 76 yes no https://www.trianglehealth.com/es/phase-1/lm-gucy2c-vaccine-nct07417488 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07417488.jpg Lm-GUCY2C vaccine trial for Colorectal Cancer and Small Bowel Adenocarcinoma (NCT07417488) Lm-GUCY2C vaccine trial for Colorectal Cancer and Small Bowel Adenocarcinoma (NCT07417488). GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas. This is an open-label, non-randomized, single-center, dose-escalation… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07417488.mp4 2026-10-18T22:50:09.080Z 76 yes no https://www.trianglehealth.com/phase-1/lnk001-nct07564232 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07564232.jpg LNK001 trial for Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232) LNK001 trial for Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232). LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma. There are 2 parts to this clinical research study: Part 1 (Dose Escalation) and Part 2 (Dose… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07564232.mp4 2026-10-20T06:06:17.595Z 70 yes no https://www.trianglehealth.com/es/phase-1/lnk001-nct07564232 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07564232.jpg LNK001 trial for Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232) LNK001 trial for Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT07564232). LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma. There are 2 parts to this clinical research study: Part 1 (Dose Escalation) and Part 2 (Dose… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07564232.mp4 2026-10-20T06:06:17.595Z 70 yes no https://www.trianglehealth.com/phase-1/lomustine-nct07145112 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07145112.jpg LITT + Lomustine trial for Recurrent Glioblastoma (NCT07145112) LITT + Lomustine trial for Recurrent Glioblastoma (NCT07145112). Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma. This is a phase 1 study evaluating the safety and feasibility of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07145112.mp4 2026-10-19T13:18:26.663Z 56 yes no https://www.trianglehealth.com/es/phase-1/lomustine-nct07145112 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07145112.jpg LITT + Lomustine trial for Recurrent Glioblastoma (NCT07145112) LITT + Lomustine trial for Recurrent Glioblastoma (NCT07145112). Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma. This is a phase 1 study evaluating the safety and feasibility of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07145112.mp4 2026-10-19T13:18:26.663Z 56 yes no https://www.trianglehealth.com/phase-1/lu-177-dotatate-nct04086485 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04086485.jpg Lu-177-DOTATATE trial for Inoperable Gastroenteropancreatic Neuroendocrine Tumors… (NCT04086485) Lu-177-DOTATATE trial for Inoperable Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) (NCT04086485). Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET). Background: A neuroendocrine… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04086485.mp4 2026-10-18T22:12:00.601Z 74 yes no https://www.trianglehealth.com/es/phase-1/lu-177-dotatate-nct04086485 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04086485.jpg Lu-177-DOTATATE trial for Inoperable Gastroenteropancreatic Neuroendocrine Tumors… (NCT04086485) Lu-177-DOTATATE trial for Inoperable Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) (NCT04086485). Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET). Background: A neuroendocrine… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04086485.mp4 2026-10-18T22:12:00.601Z 74 yes no https://www.trianglehealth.com/phase-1/lutathera-lutetium-lu-177-dotatate-nct05278208 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05278208.jpg LUTATHERA (Lutetium Lu 177 dotatate) trial for High Grade Glioma (NCT05278208) LUTATHERA (Lutetium Lu 177 dotatate) trial for High Grade Glioma (NCT05278208). Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors. This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05278208.mp4 2026-09-12T20:35:38.632Z 81 yes no https://www.trianglehealth.com/es/phase-1/lutathera-lutetium-lu-177-dotatate-nct05278208 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05278208.jpg LUTATHERA (Lutetium Lu 177 dotatate) trial for High Grade Glioma (NCT05278208) LUTATHERA (Lutetium Lu 177 dotatate) trial for High Grade Glioma (NCT05278208). Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors. This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05278208.mp4 2026-09-12T20:35:38.632Z 81 yes no https://www.trianglehealth.com/phase-1/m032-nct05084430 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05084430.jpg M032 + Pembrolizumab trial for Malignant Glioma (NCT05084430) M032 + Pembrolizumab trial for Malignant Glioma (NCT05084430). Pembrolizumab and M032 (NSC 733972). This Phase I (Cohort I and Cohort II) and Phase II trial is designed to confirm the safety and tolerability of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05084430.mp4 2026-10-19T13:07:48.662Z 68 yes no https://www.trianglehealth.com/es/phase-1/m032-nct05084430 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05084430.jpg M032 + Pembrolizumab trial for Malignant Glioma (NCT05084430) M032 + Pembrolizumab trial for Malignant Glioma (NCT05084430). Pembrolizumab and M032 (NSC 733972). This Phase I (Cohort I and Cohort II) and Phase II trial is designed to confirm the safety and tolerability of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05084430.mp4 2026-10-19T13:07:48.662Z 68 yes no https://www.trianglehealth.com/phase-1/m28z1xxpd1dnr-car-nct06623396 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06623396.jpg M28z1XXPD1DNR CAR trial for Mesothelin-Expressing Tumors (NCT06623396) M28z1XXPD1DNR CAR trial for Mesothelin-Expressing Tumors (NCT06623396). Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer. Participants will have a sample of their white blood cells, called T cells,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06623396.mp4 2026-09-12T21:25:14.270Z 81 yes no https://www.trianglehealth.com/es/phase-1/m28z1xxpd1dnr-car-nct06623396 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06623396.jpg M28z1XXPD1DNR CAR trial for Mesothelin-Expressing Tumors (NCT06623396) M28z1XXPD1DNR CAR trial for Mesothelin-Expressing Tumors (NCT06623396). Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer. Participants will have a sample of their white blood cells, called T cells,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06623396.mp4 2026-09-12T21:25:14.270Z 81 yes no https://www.trianglehealth.com/phase-1/magenta-nct03081910 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03081910.jpg MAGENTA trial for T-cell Acute Lymphoblastic Lymphoma (NCT03081910) MAGENTA trial for T-cell Acute Lymphoblastic Lymphoma (NCT03081910). Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen. Patients eligible for this study have a… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03081910.mp4 2026-09-12T20:19:58.614Z 79 yes no https://www.trianglehealth.com/es/phase-1/magenta-nct03081910 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03081910.jpg MAGENTA trial for T-cell Acute Lymphoblastic Lymphoma (NCT03081910) MAGENTA trial for T-cell Acute Lymphoblastic Lymphoma (NCT03081910). Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen. Patients eligible for this study have a… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03081910.mp4 2026-09-12T20:19:58.614Z 79 yes no https://www.trianglehealth.com/phase-1/magenta-nct07032714 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07032714.jpg MAGENTA trial for Relapsed or Refractory Multiple Myeloma (NCT07032714) MAGENTA trial for Relapsed or Refractory Multiple Myeloma (NCT07032714). Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma. This is a phase 1 study to find the recommended dose and schedule of mezigdomide and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07032714.mp4 2026-10-20T05:21:19.174Z 70 yes no https://www.trianglehealth.com/es/phase-1/magenta-nct07032714 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07032714.jpg MAGENTA trial for Relapsed or Refractory Multiple Myeloma (NCT07032714) MAGENTA trial for Relapsed or Refractory Multiple Myeloma (NCT07032714). Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma. This is a phase 1 study to find the recommended dose and schedule of mezigdomide and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07032714.mp4 2026-10-20T05:21:19.174Z 70 yes no https://www.trianglehealth.com/phase-1/melphalan-nct04483206 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04483206.jpg PK-Directed Melphalan trial for Multiple Myeloma (NCT04483206) PK-Directed Melphalan trial for Multiple Myeloma (NCT04483206). Personalized Autologous Transplant for Multiple Myeloma. This phase I trial studies the best dose and side effects of mephalan in treating patients with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04483206.mp4 2026-10-19T11:49:23.712Z 62 yes no https://www.trianglehealth.com/es/phase-1/melphalan-nct04483206 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04483206.jpg PK-Directed Melphalan trial for Multiple Myeloma (NCT04483206) PK-Directed Melphalan trial for Multiple Myeloma (NCT04483206). Personalized Autologous Transplant for Multiple Myeloma. This phase I trial studies the best dose and side effects of mephalan in treating patients with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04483206.mp4 2026-10-19T11:49:23.712Z 62 yes no https://www.trianglehealth.com/phase-1/mesenchymal-stromal-cells-derived-exosomes-with-kras-g12-nct03608631 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03608631.jpg iExosomes in Treating Participants With M… trial for Metastatic Pancreatic… (NCT03608631) iExosomes in Treating Participants With M… trial for Metastatic Pancreatic Adenocarcinoma (NCT03608631). IExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation. This phase I trial studies the best dose and side effects of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03608631.mp4 2026-09-12T20:15:44.188Z 73 yes no https://www.trianglehealth.com/es/phase-1/mesenchymal-stromal-cells-derived-exosomes-with-kras-g12-nct03608631 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03608631.jpg iExosomes in Treating Participants With M… trial for Metastatic Pancreatic… (NCT03608631) iExosomes in Treating Participants With M… trial for Metastatic Pancreatic Adenocarcinoma (NCT03608631). IExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation. This phase I trial studies the best dose and side effects of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03608631.mp4 2026-09-12T20:15:44.188Z 73 yes no https://www.trianglehealth.com/phase-1/mir-126-inhibitor-miristen-nct07025564 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07025564.jpg miRisten trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07025564) miRisten trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07025564). MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia. This phase I trial tests the safety, side effects, and best dose of miRisten in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07025564.mp4 2026-10-20T02:38:30.698Z 66 yes no https://www.trianglehealth.com/es/phase-1/mir-126-inhibitor-miristen-nct07025564 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07025564.jpg miRisten trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07025564) miRisten trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT07025564). MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia. This phase I trial tests the safety, side effects, and best dose of miRisten in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07025564.mp4 2026-10-20T02:38:30.698Z 66 yes no https://www.trianglehealth.com/phase-1/mirda-nct06159166 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06159166.jpg Mirdametinib trial for Neurofibromatosis Type 1 With Cutaneous Neurofibromas (NCT06159166) Mirdametinib trial for Neurofibromatosis Type 1 With Cutaneous Neurofibromas (NCT06159166). Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). This is a Phase 1/2a, open-label, non-randomized,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06159166.mp4 2026-10-20T06:12:50.258Z 58 yes no https://www.trianglehealth.com/es/phase-1/mirda-nct06159166 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06159166.jpg Mirdametinib trial for Neurofibromatosis Type 1 With Cutaneous Neurofibromas (NCT06159166) Mirdametinib trial for Neurofibromatosis Type 1 With Cutaneous Neurofibromas (NCT06159166). Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). This is a Phase 1/2a, open-label, non-randomized,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06159166.mp4 2026-10-20T06:12:50.258Z 58 yes no https://www.trianglehealth.com/phase-1/mosunetuzumab-nct06249191 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06249191.jpg Mosunetuzumab + Chemotherapy trial for C-Myc Rearranged High-Grade B-Cell Lymphoma… (NCT06249191) Mosunetuzumab + Chemotherapy trial for C-Myc Rearranged High-Grade B-Cell Lymphoma or DLBCL (NCT06249191). Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06249191.mp4 2026-10-19T01:59:18.528Z 75 yes no https://www.trianglehealth.com/es/phase-1/mosunetuzumab-nct06249191 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06249191.jpg Mosunetuzumab + Chemotherapy trial for C-Myc Rearranged High-Grade B-Cell Lymphoma… (NCT06249191) Mosunetuzumab + Chemotherapy trial for C-Myc Rearranged High-Grade B-Cell Lymphoma or DLBCL (NCT06249191). Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06249191.mp4 2026-10-19T01:59:18.528Z 75 yes no https://www.trianglehealth.com/phase-1/natural-killer-cell-therapy-nct05588453 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05588453.jpg Donor NK Cells + Temozolomide trial for Stage IV Melanoma With Brain Metastases (NCT05588453) Donor NK Cells + Temozolomide trial for Stage IV Melanoma With Brain Metastases (NCT05588453). Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain. This phase I/II trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05588453.mp4 2026-10-20T00:37:45.548Z 76 yes no https://www.trianglehealth.com/es/phase-1/natural-killer-cell-therapy-nct05588453 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05588453.jpg Donor NK Cells + Temozolomide trial for Stage IV Melanoma With Brain Metastases (NCT05588453) Donor NK Cells + Temozolomide trial for Stage IV Melanoma With Brain Metastases (NCT05588453). Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain. This phase I/II trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05588453.mp4 2026-10-20T00:37:45.548Z 76 yes no https://www.trianglehealth.com/phase-1/navlimetostat-nct07579221 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579221.jpg Navlimetostat + Pumitamig trial for MTAP-Deleted Advanced Non-Small Cell Lung Cancer (NCT07579221) Navlimetostat + Pumitamig trial for MTAP-Deleted Advanced Non-Small Cell Lung Cancer (NCT07579221). Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer. The goal of this clinical research study is to find a safe… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579221.mp4 2026-10-20T02:51:52.037Z 62 yes no https://www.trianglehealth.com/es/phase-1/navlimetostat-nct07579221 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579221.jpg Navlimetostat + Pumitamig trial for MTAP-Deleted Advanced Non-Small Cell Lung Cancer (NCT07579221) Navlimetostat + Pumitamig trial for MTAP-Deleted Advanced Non-Small Cell Lung Cancer (NCT07579221). Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer. The goal of this clinical research study is to find a safe… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579221.mp4 2026-10-20T02:51:52.037Z 62 yes no https://www.trianglehealth.com/phase-1/neo-combatxl-nct06902376 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06902376.jpg NEO-COMBATXL trial for BRAF V600E Wild-Type Anaplastic Thyroid Cancer (NCT06902376) NEO-COMBATXL trial for BRAF V600E Wild-Type Anaplastic Thyroid Cancer (NCT06902376). XL092 and Cemiplimab in BRAF WT Thyroid Cancer. This multicenter study examines the safety and feasibility of the combination of neoadjuvant XL092 and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06902376.mp4 2026-10-19T13:13:43.759Z 65 yes no https://www.trianglehealth.com/es/phase-1/neo-combatxl-nct06902376 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06902376.jpg NEO-COMBATXL trial for BRAF V600E Wild-Type Anaplastic Thyroid Cancer (NCT06902376) NEO-COMBATXL trial for BRAF V600E Wild-Type Anaplastic Thyroid Cancer (NCT06902376). XL092 and Cemiplimab in BRAF WT Thyroid Cancer. This multicenter study examines the safety and feasibility of the combination of neoadjuvant XL092 and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06902376.mp4 2026-10-19T13:13:43.759Z 65 yes no https://www.trianglehealth.com/phase-1/neratinib-pill-nct05274048 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05274048.jpg Neratinib + Trastuzumab Deruxtecan trial for HER2-Positive Advanced… (NCT05274048) Neratinib + Trastuzumab Deruxtecan trial for HER2-Positive Advanced Gastro-Esophageal and GI Cancers (NCT05274048). Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients. This is Phase 1 dose finding trial with potential dose expansion to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05274048.mp4 2026-10-19T12:39:38.410Z 68 yes no https://www.trianglehealth.com/es/phase-1/neratinib-pill-nct05274048 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05274048.jpg Neratinib + Trastuzumab Deruxtecan trial for HER2-Positive Advanced… (NCT05274048) Neratinib + Trastuzumab Deruxtecan trial for HER2-Positive Advanced Gastro-Esophageal and GI Cancers (NCT05274048). Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients. This is Phase 1 dose finding trial with potential dose expansion to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05274048.mp4 2026-10-19T12:39:38.410Z 68 yes no https://www.trianglehealth.com/phase-1/neural-stem-cells-expressing-crad-s-pk7-nct05139056 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05139056.jpg Neural Stem Cells-expressing CRAd-S-pk7 trial for Currently Only Enrolling… (NCT05139056) Neural Stem Cells-expressing CRAd-S-pk7 trial for Currently Only Enrolling Glioblastoma Patients at First Recurrence (NCT05139056). Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas. This phase I trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05139056.mp4 2026-09-12T21:23:42.134Z 73 yes no https://www.trianglehealth.com/es/phase-1/neural-stem-cells-expressing-crad-s-pk7-nct05139056 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05139056.jpg Neural Stem Cells-expressing CRAd-S-pk7 trial for Currently Only Enrolling… (NCT05139056) Neural Stem Cells-expressing CRAd-S-pk7 trial for Currently Only Enrolling Glioblastoma Patients at First Recurrence (NCT05139056). Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas. This phase I trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05139056.mp4 2026-09-12T21:23:42.134Z 73 yes no https://www.trianglehealth.com/phase-1/nilotinib-nct04903119 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903119.jpg Nilotinib trial for BRAF V600 Metastatic or Unresectable Melanoma (NCT04903119) Nilotinib trial for BRAF V600 Metastatic or Unresectable Melanoma (NCT04903119). Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma. This is a phase 1 dose-escalation study of nilotinib in combination… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903119.mp4 2026-10-19T16:13:18.166Z 61 yes no https://www.trianglehealth.com/es/phase-1/nilotinib-nct04903119 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903119.jpg Nilotinib trial for BRAF V600 Metastatic or Unresectable Melanoma (NCT04903119) Nilotinib trial for BRAF V600 Metastatic or Unresectable Melanoma (NCT04903119). Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma. This is a phase 1 dose-escalation study of nilotinib in combination… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04903119.mp4 2026-10-19T16:13:18.166Z 61 yes no https://www.trianglehealth.com/phase-1/nk-cells-nct07411599 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07411599.jpg TROP2-Directed CAR-NK trial for Colorectal Cancer (NCT07411599) TROP2-Directed CAR-NK trial for Colorectal Cancer (NCT07411599). Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07411599.mp4 2026-10-18T18:57:42.825Z 66 yes no https://www.trianglehealth.com/es/phase-1/nk-cells-nct07411599 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07411599.jpg TROP2-Directed CAR-NK trial for Colorectal Cancer (NCT07411599) TROP2-Directed CAR-NK trial for Colorectal Cancer (NCT07411599). Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07411599.mp4 2026-10-18T18:57:42.825Z 66 yes no https://www.trianglehealth.com/phase-1/nk-cells-nct07579208 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579208.jpg NK Cells trial for Recurrent Glioblastoma (NCT07579208) NK Cells trial for Recurrent Glioblastoma (NCT07579208). Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579208.mp4 2026-09-12T21:12:12.662Z 78 yes no https://www.trianglehealth.com/es/phase-1/nk-cells-nct07579208 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579208.jpg NK Cells trial for Recurrent Glioblastoma (NCT07579208) NK Cells trial for Recurrent Glioblastoma (NCT07579208). Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07579208.mp4 2026-09-12T21:12:12.662Z 78 yes no https://www.trianglehealth.com/phase-1/nt-i7-nct07052305 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07052305.jpg NT-I7 for large B-cell lymphoma trial for Large B-cell Lymphoma (NCT07052305) NT-I7 for large B-cell lymphoma trial for Large B-cell Lymphoma (NCT07052305). NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07052305.mp4 2026-10-18T18:55:42.288Z 67 yes no https://www.trianglehealth.com/es/phase-1/nt-i7-nct07052305 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07052305.jpg NT-I7 for large B-cell lymphoma trial for Large B-cell Lymphoma (NCT07052305) NT-I7 for large B-cell lymphoma trial for Large B-cell Lymphoma (NCT07052305). NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07052305.mp4 2026-10-18T18:55:42.288Z 67 yes no https://www.trianglehealth.com/phase-1/nt-i7-nct07200089 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200089.jpg NT-I7 for multiple myeloma trial for Multiple Myeloma (NCT07200089) NT-I7 for multiple myeloma trial for Multiple Myeloma (NCT07200089). Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel). CAR-T cell therapy is an emerging treatment… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200089.mp4 2026-10-18T19:50:53.082Z 79 yes no https://www.trianglehealth.com/es/phase-1/nt-i7-nct07200089 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200089.jpg NT-I7 for multiple myeloma trial for Multiple Myeloma (NCT07200089) NT-I7 for multiple myeloma trial for Multiple Myeloma (NCT07200089). Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel). CAR-T cell therapy is an emerging treatment… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200089.mp4 2026-10-18T19:50:53.082Z 79 yes no https://www.trianglehealth.com/phase-1/oncolytic-adenovirus-ad5-dnx-2401-nct03896568 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03896568.jpg Oncolytic Adenovirus Ad5-DNX-2401 trial for Recurrent Glioblastoma (NCT03896568) Oncolytic Adenovirus Ad5-DNX-2401 trial for Recurrent Glioblastoma (NCT03896568). MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma. This phase I trial studies best dose and side effects of oncolytic adenovirus DNX-2401 in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03896568.mp4 2026-09-12T20:23:42.652Z 76 yes no https://www.trianglehealth.com/es/phase-1/oncolytic-adenovirus-ad5-dnx-2401-nct03896568 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03896568.jpg Oncolytic Adenovirus Ad5-DNX-2401 trial for Recurrent Glioblastoma (NCT03896568) Oncolytic Adenovirus Ad5-DNX-2401 trial for Recurrent Glioblastoma (NCT03896568). MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma. This phase I trial studies best dose and side effects of oncolytic adenovirus DNX-2401 in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03896568.mp4 2026-09-12T20:23:42.652Z 76 yes no https://www.trianglehealth.com/phase-1/ont01-nct06904378 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06904378.jpg ONT01 + Gem/Nab-Paclitaxel trial for Metastatic Pancreatic Ductal Adenocarcinoma… (NCT06904378) ONT01 + Gem/Nab-Paclitaxel trial for Metastatic Pancreatic Ductal Adenocarcinoma (Second Line) (NCT06904378). ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma. The investigators hypothesize that CD11b agonism… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06904378.mp4 2026-10-20T06:22:06.226Z 72 yes no https://www.trianglehealth.com/es/phase-1/ont01-nct06904378 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06904378.jpg ONT01 + Gem/Nab-Paclitaxel trial for Metastatic Pancreatic Ductal Adenocarcinoma… (NCT06904378) ONT01 + Gem/Nab-Paclitaxel trial for Metastatic Pancreatic Ductal Adenocarcinoma (Second Line) (NCT06904378). ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma. The investigators hypothesize that CD11b agonism… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06904378.mp4 2026-10-20T06:22:06.226Z 72 yes no https://www.trianglehealth.com/phase-1/papaverine-nct05136846 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05136846.jpg Papaverine trial for Locally Advanced Lung Non-Small Cell Carcinoma (NCT05136846) Papaverine trial for Locally Advanced Lung Non-Small Cell Carcinoma (NCT05136846). Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer. This phase I trial finds out the best dose,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05136846.mp4 2026-10-18T22:02:38.704Z 70 yes no https://www.trianglehealth.com/es/phase-1/papaverine-nct05136846 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05136846.jpg Papaverine trial for Locally Advanced Lung Non-Small Cell Carcinoma (NCT05136846) Papaverine trial for Locally Advanced Lung Non-Small Cell Carcinoma (NCT05136846). Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer. This phase I trial finds out the best dose,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05136846.mp4 2026-10-18T22:02:38.704Z 70 yes no https://www.trianglehealth.com/phase-1/pembrolizumab-nct03760575 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03760575.jpg Pembrolizumab + Image-Guided Surgery trial for Malignant Pleural Mesothelioma (NCT03760575) Pembrolizumab + Image-Guided Surgery trial for Malignant Pleural Mesothelioma (NCT03760575). Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM). The study is a single-arm phase I trial to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03760575.mp4 2026-10-19T11:43:41.202Z 62 yes no https://www.trianglehealth.com/es/phase-1/pembrolizumab-nct03760575 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03760575.jpg Pembrolizumab + Image-Guided Surgery trial for Malignant Pleural Mesothelioma (NCT03760575) Pembrolizumab + Image-Guided Surgery trial for Malignant Pleural Mesothelioma (NCT03760575). Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM). The study is a single-arm phase I trial to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03760575.mp4 2026-10-19T11:43:41.202Z 62 yes no https://www.trianglehealth.com/phase-1/pembrolizumab-nct04297605 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04297605.jpg Pembrolizumab + Single-Agent Chemotherapy trial for Locally Advanced or Metastatic… (NCT04297605) Pembrolizumab + Single-Agent Chemotherapy trial for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (ECOG 2) (NCT04297605). Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04297605.mp4 2026-10-19T11:20:56.783Z 63 yes no https://www.trianglehealth.com/es/phase-1/pembrolizumab-nct04297605 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04297605.jpg Pembrolizumab + Single-Agent Chemotherapy trial for Locally Advanced or Metastatic… (NCT04297605) Pembrolizumab + Single-Agent Chemotherapy trial for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (ECOG 2) (NCT04297605). Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04297605.mp4 2026-10-19T11:20:56.783Z 63 yes no https://www.trianglehealth.com/phase-1/pembrolizumab-nct06868433 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06868433.jpg TMV Vaccine With Pembrolizumab trial for Recurrent or Metastatic Head and Neck… (NCT06868433) TMV Vaccine With Pembrolizumab trial for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT06868433). TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer. This phase Ib trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06868433.mp4 2026-10-19T02:39:37.475Z 60 yes no https://www.trianglehealth.com/es/phase-1/pembrolizumab-nct06868433 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06868433.jpg TMV Vaccine With Pembrolizumab trial for Recurrent or Metastatic Head and Neck… (NCT06868433) TMV Vaccine With Pembrolizumab trial for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT06868433). TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer. This phase Ib trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06868433.mp4 2026-10-19T02:39:37.475Z 60 yes no https://www.trianglehealth.com/phase-1/pemigatinib-nct04659616 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04659616.jpg Pemigatinib After Chemotherapy trial for Newly Diagnosed Acute Myeloid Leukemia (NCT04659616) Pemigatinib After Chemotherapy trial for Newly Diagnosed Acute Myeloid Leukemia (NCT04659616). Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia. This phase I trial identifies the best dose and clinical benefit… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04659616.mp4 2026-10-19T11:27:50.719Z 69 yes no https://www.trianglehealth.com/es/phase-1/pemigatinib-nct04659616 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04659616.jpg Pemigatinib After Chemotherapy trial for Newly Diagnosed Acute Myeloid Leukemia (NCT04659616) Pemigatinib After Chemotherapy trial for Newly Diagnosed Acute Myeloid Leukemia (NCT04659616). Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia. This phase I trial identifies the best dose and clinical benefit… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04659616.mp4 2026-10-19T11:27:50.719Z 69 yes no https://www.trianglehealth.com/phase-1/personalized-neoantigen-dna-vaccine-nct03988283 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03988283.jpg Personalized neoantigen DNA vaccine trial for Pediatric Recurrent Central Nervous… (NCT03988283) Personalized neoantigen DNA vaccine trial for Pediatric Recurrent Central Nervous System Tumors (NCT03988283). Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors. The purpose of this research study is… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03988283.mp4 2026-09-12T21:07:58.512Z 73 yes no https://www.trianglehealth.com/es/phase-1/personalized-neoantigen-dna-vaccine-nct03988283 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03988283.jpg Personalized neoantigen DNA vaccine trial for Pediatric Recurrent Central Nervous… (NCT03988283) Personalized neoantigen DNA vaccine trial for Pediatric Recurrent Central Nervous System Tumors (NCT03988283). Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors. The purpose of this research study is… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03988283.mp4 2026-09-12T21:07:58.512Z 73 yes no https://www.trianglehealth.com/phase-1/phoebe-nct05900895 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05900895.jpg PHOEBE trial for Advanced ER-Positive HER2-Negative Breast Cancer (NCT05900895) PHOEBE trial for Advanced ER-Positive HER2-Negative Breast Cancer (NCT05900895). Estradiol Plus Olaparib for Breast Cancer (PHOEBE). Determine the safety and recommended Phase II dose of olaparib in combination with 17b-estradiol in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05900895.mp4 2026-10-19T15:47:30.156Z 58 yes no https://www.trianglehealth.com/es/phase-1/phoebe-nct05900895 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05900895.jpg PHOEBE trial for Advanced ER-Positive HER2-Negative Breast Cancer (NCT05900895) PHOEBE trial for Advanced ER-Positive HER2-Negative Breast Cancer (NCT05900895). Estradiol Plus Olaparib for Breast Cancer (PHOEBE). Determine the safety and recommended Phase II dose of olaparib in combination with 17b-estradiol in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05900895.mp4 2026-10-19T15:47:30.156Z 58 yes no https://www.trianglehealth.com/phase-1/photodynamic-therapy-nct06307548 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06307548.jpg Photodynamic Therapy trial for Locally Advanced or Recurrent Colorectal Cancer (NCT06307548) Photodynamic Therapy trial for Locally Advanced or Recurrent Colorectal Cancer (NCT06307548). Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06307548.mp4 2026-10-19T14:54:10.110Z 60 yes no https://www.trianglehealth.com/es/phase-1/photodynamic-therapy-nct06307548 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06307548.jpg Photodynamic Therapy trial for Locally Advanced or Recurrent Colorectal Cancer (NCT06307548) Photodynamic Therapy trial for Locally Advanced or Recurrent Colorectal Cancer (NCT06307548). Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06307548.mp4 2026-10-19T14:54:10.110Z 60 yes no https://www.trianglehealth.com/phase-1/pmd-026-nct07379125 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07379125.jpg PMD-026 trial for Myelofibrosis (NCT07379125) PMD-026 trial for Myelofibrosis (NCT07379125). Therapeutic RSK1 Targeting in Myelofibrosis. This is a phase Ib study evaluating PMD-026, an oral inhibitor of ribosomal protein S6 kinase A1 (RSK1), in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07379125.mp4 2026-10-20T04:20:35.000Z 63 yes no https://www.trianglehealth.com/es/phase-1/pmd-026-nct07379125 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07379125.jpg PMD-026 trial for Myelofibrosis (NCT07379125) PMD-026 trial for Myelofibrosis (NCT07379125). Therapeutic RSK1 Targeting in Myelofibrosis. This is a phase Ib study evaluating PMD-026, an oral inhibitor of ribosomal protein S6 kinase A1 (RSK1), in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07379125.mp4 2026-10-20T04:20:35.000Z 63 yes no https://www.trianglehealth.com/phase-1/pnoc020-nct04573140 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04573140.jpg PNOC020 trial for Adult Glioblastoma (NCT04573140) PNOC020 trial for Adult Glioblastoma (NCT04573140). RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM). The primary objective will be to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04573140.mp4 2026-09-12T20:23:45.097Z 78 yes no https://www.trianglehealth.com/es/phase-1/pnoc020-nct04573140 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04573140.jpg PNOC020 trial for Adult Glioblastoma (NCT04573140) PNOC020 trial for Adult Glioblastoma (NCT04573140). RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM). The primary objective will be to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04573140.mp4 2026-09-12T20:23:45.097Z 78 yes no https://www.trianglehealth.com/phase-1/pomalidomide-nct05389423 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05389423.jpg Pomalidomide for HIV-associated lymphoma trial for HIV-Associated Lymphoma (NCT05389423) Pomalidomide for HIV-associated lymphoma trial for HIV-Associated Lymphoma (NCT05389423). Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas. Background: Non-Hodgkin lymphoma (NHL) is the most common cancer among people… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05389423.mp4 2026-10-18T22:21:13.005Z 65 yes no https://www.trianglehealth.com/es/phase-1/pomalidomide-nct05389423 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05389423.jpg Pomalidomide for HIV-associated lymphoma trial for HIV-Associated Lymphoma (NCT05389423) Pomalidomide for HIV-associated lymphoma trial for HIV-Associated Lymphoma (NCT05389423). Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas. Background: Non-Hodgkin lymphoma (NHL) is the most common cancer among people… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05389423.mp4 2026-10-18T22:21:13.005Z 65 yes no https://www.trianglehealth.com/phase-1/pomalidomide-nct07532525 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07532525.jpg Pomalidomide after CAR T trial for Recurrent B Acute Lymphoblastic Leukemia (NCT07532525) Pomalidomide after CAR T trial for Recurrent B Acute Lymphoblastic Leukemia (NCT07532525). Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma. This phase I trial tests the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07532525.mp4 2026-10-18T19:36:46.786Z 69 yes no https://www.trianglehealth.com/es/phase-1/pomalidomide-nct07532525 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07532525.jpg Pomalidomide after CAR T trial for Recurrent B Acute Lymphoblastic Leukemia (NCT07532525) Pomalidomide after CAR T trial for Recurrent B Acute Lymphoblastic Leukemia (NCT07532525). Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma. This phase I trial tests the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07532525.mp4 2026-10-18T19:36:46.786Z 69 yes no https://www.trianglehealth.com/phase-1/pralatrexate-nct07225985 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225985.jpg Pralatrexate Conditioning trial for Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma (NCT07225985) Pralatrexate Conditioning trial for Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma (NCT07225985). Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225985.mp4 2026-10-20T04:15:12.807Z 66 yes no https://www.trianglehealth.com/es/phase-1/pralatrexate-nct07225985 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225985.jpg Pralatrexate Conditioning trial for Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma (NCT07225985) Pralatrexate Conditioning trial for Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma (NCT07225985). Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225985.mp4 2026-10-20T04:15:12.807Z 66 yes no https://www.trianglehealth.com/phase-1/prism-nct07139990 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07139990.jpg PRISM trial for Extensive-Stage SCLC, Brain Metastases, Soft Tissue Sarcoma and Head… (NCT07139990) PRISM trial for Extensive-Stage SCLC, Brain Metastases, Soft Tissue Sarcoma and Head and Neck Cancer (NCT07139990). Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM). To characterize feasibility, safety, and/or preliminary efficacy of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07139990.mp4 2026-10-19T13:57:44.541Z 74 yes no https://www.trianglehealth.com/es/phase-1/prism-nct07139990 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07139990.jpg PRISM trial for Extensive-Stage SCLC, Brain Metastases, Soft Tissue Sarcoma and Head… (NCT07139990) PRISM trial for Extensive-Stage SCLC, Brain Metastases, Soft Tissue Sarcoma and Head and Neck Cancer (NCT07139990). Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM). To characterize feasibility, safety, and/or preliminary efficacy of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07139990.mp4 2026-10-19T13:57:44.541Z 74 yes no https://www.trianglehealth.com/phase-1/prmt5-inhibitor-bms-986504-nct07594626 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07594626.jpg BMS-986504 + Pemetrexed trial for Metastatic MTAP-Deleted Solid Tumors (NCT07594626) BMS-986504 + Pemetrexed trial for Metastatic MTAP-Deleted Solid Tumors (NCT07594626). BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion. This phase Ib/II trial tests the safety and side… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07594626.mp4 2026-10-19T13:48:49.834Z 76 yes no https://www.trianglehealth.com/es/phase-1/prmt5-inhibitor-bms-986504-nct07594626 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07594626.jpg BMS-986504 + Pemetrexed trial for Metastatic MTAP-Deleted Solid Tumors (NCT07594626) BMS-986504 + Pemetrexed trial for Metastatic MTAP-Deleted Solid Tumors (NCT07594626). BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion. This phase Ib/II trial tests the safety and side… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07594626.mp4 2026-10-19T13:48:49.834Z 76 yes no https://www.trianglehealth.com/phase-1/rabbit-nct06814496 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06814496.jpg RABBIT trial for Relapsed/Refractory DLL3-Expressing Tumors (NCT06814496) RABBIT trial for Relapsed/Refractory DLL3-Expressing Tumors (NCT06814496). Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors. Phase I study to examine safety of the addition of concurrent tarlatamab with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06814496.mp4 2026-10-19T12:07:51.190Z 64 yes no https://www.trianglehealth.com/es/phase-1/rabbit-nct06814496 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06814496.jpg RABBIT trial for Relapsed/Refractory DLL3-Expressing Tumors (NCT06814496) RABBIT trial for Relapsed/Refractory DLL3-Expressing Tumors (NCT06814496). Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors. Phase I study to examine safety of the addition of concurrent tarlatamab with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06814496.mp4 2026-10-19T12:07:51.190Z 64 yes no https://www.trianglehealth.com/phase-1/ramucirumab-nct06675136 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06675136.jpg PIPAC Nab-Paclitaxel trial for Gastric Cancer With Peritoneal Metastases (NCT06675136) PIPAC Nab-Paclitaxel trial for Gastric Cancer With Peritoneal Metastases (NCT06675136). Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases. This phase I trial tests… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06675136.mp4 2026-10-20T01:49:38.602Z 69 yes no https://www.trianglehealth.com/es/phase-1/ramucirumab-nct06675136 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06675136.jpg PIPAC Nab-Paclitaxel trial for Gastric Cancer With Peritoneal Metastases (NCT06675136) PIPAC Nab-Paclitaxel trial for Gastric Cancer With Peritoneal Metastases (NCT06675136). Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases. This phase I trial tests… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06675136.mp4 2026-10-20T01:49:38.602Z 69 yes no https://www.trianglehealth.com/phase-1/recombinant-interferon-alpha-2b-like-protein-nct04380545 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04380545.jpg Nivolumab, Fluorouracil, and Interferon Alpha 2B trial for Unresectable… (NCT04380545) Nivolumab, Fluorouracil, and Interferon Alpha 2B trial for Unresectable Fibrolamellar Carcinoma (NCT04380545). Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer. This phase I/II trial studies the side effects and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04380545.mp4 2026-10-18T18:46:59.020Z 69 yes no https://www.trianglehealth.com/es/phase-1/recombinant-interferon-alpha-2b-like-protein-nct04380545 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04380545.jpg Nivolumab, Fluorouracil, and Interferon Alpha 2B trial for Unresectable… (NCT04380545) Nivolumab, Fluorouracil, and Interferon Alpha 2B trial for Unresectable Fibrolamellar Carcinoma (NCT04380545). Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer. This phase I/II trial studies the side effects and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04380545.mp4 2026-10-18T18:46:59.020Z 69 yes no https://www.trianglehealth.com/phase-1/rely-30-nct02917083 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT02917083.jpg RELY-30 trial for Hodgkin's Lymphoma (NCT02917083) RELY-30 trial for Hodgkin's Lymphoma (NCT02917083). CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30). The subject has a type of lymph gland cancer called Lymphoma. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT02917083.mp4 2026-09-12T20:30:21.899Z 73 yes no https://www.trianglehealth.com/es/phase-1/rely-30-nct02917083 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT02917083.jpg RELY-30 trial for Hodgkin's Lymphoma (NCT02917083) RELY-30 trial for Hodgkin's Lymphoma (NCT02917083). CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30). The subject has a type of lymph gland cancer called Lymphoma. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT02917083.mp4 2026-09-12T20:30:21.899Z 73 yes no https://www.trianglehealth.com/phase-1/replay-nct07237594 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07237594.jpg REPLAY trial for Metastatic Melanoma After Immune-Related Toxicity (NCT07237594) REPLAY trial for Metastatic Melanoma After Immune-Related Toxicity (NCT07237594). IL-17 Blockade to Decrease irAEs (REPLAY). The primary objective of this study is to determine the safety and feasibility of administering an IL-17A (human… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07237594.mp4 2026-10-19T16:26:21.467Z 62 yes no https://www.trianglehealth.com/es/phase-1/replay-nct07237594 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07237594.jpg REPLAY trial for Metastatic Melanoma After Immune-Related Toxicity (NCT07237594) REPLAY trial for Metastatic Melanoma After Immune-Related Toxicity (NCT07237594). IL-17 Blockade to Decrease irAEs (REPLAY). The primary objective of this study is to determine the safety and feasibility of administering an IL-17A (human… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07237594.mp4 2026-10-19T16:26:21.467Z 62 yes no https://www.trianglehealth.com/phase-1/revlimid-lenalidomide-nct03223610 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03223610.jpg ViPOR Combination trial for Relapsed/Refractory B-Cell Lymphoma (NCT03223610) ViPOR Combination trial for Relapsed/Refractory B-Cell Lymphoma (NCT03223610). Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma. Background: B-cell lymphoma is a cancer of white… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03223610.mp4 2026-10-18T22:12:52.157Z 63 yes no https://www.trianglehealth.com/es/phase-1/revlimid-lenalidomide-nct03223610 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03223610.jpg ViPOR Combination trial for Relapsed/Refractory B-Cell Lymphoma (NCT03223610) ViPOR Combination trial for Relapsed/Refractory B-Cell Lymphoma (NCT03223610). Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma. Background: B-cell lymphoma is a cancer of white… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03223610.mp4 2026-10-18T22:12:52.157Z 63 yes no https://www.trianglehealth.com/phase-1/revumenib-nct06313437 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06313437.jpg Revumenib + 7+3 + Midostaurin trial for Newly Diagnosed NPM1- and FLT3-Mutated AML (NCT06313437) Revumenib + 7+3 + Midostaurin trial for Newly Diagnosed NPM1- and FLT3-Mutated AML (NCT06313437). Revumenib in Combination With 7+3 + Midostaurin in AML. This research is being conducted to determine a safe and effective dose of revumenib that can be given… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06313437.mp4 2026-10-20T05:01:48.550Z 66 yes no https://www.trianglehealth.com/es/phase-1/revumenib-nct06313437 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06313437.jpg Revumenib + 7+3 + Midostaurin trial for Newly Diagnosed NPM1- and FLT3-Mutated AML (NCT06313437) Revumenib + 7+3 + Midostaurin trial for Newly Diagnosed NPM1- and FLT3-Mutated AML (NCT06313437). Revumenib in Combination With 7+3 + Midostaurin in AML. This research is being conducted to determine a safe and effective dose of revumenib that can be given… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06313437.mp4 2026-10-20T05:01:48.550Z 66 yes no https://www.trianglehealth.com/phase-1/rhdnase-i-nct07361224 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07361224.jpg RhDNase I trial for Large B-Cell Lymphoma (LBCL) (NCT07361224) RhDNase I trial for Large B-Cell Lymphoma (LBCL) (NCT07361224). Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion. This is a Phase 1,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07361224.mp4 2026-09-12T21:05:38.316Z 71 yes no https://www.trianglehealth.com/es/phase-1/rhdnase-i-nct07361224 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07361224.jpg RhDNase I trial for Large B-Cell Lymphoma (LBCL) (NCT07361224) RhDNase I trial for Large B-Cell Lymphoma (LBCL) (NCT07361224). Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion. This is a Phase 1,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07361224.mp4 2026-09-12T21:05:38.316Z 71 yes no https://www.trianglehealth.com/phase-1/riot-4a-nct07192900 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07192900.jpg (RIOT 4A) trial for Malignant Pleural Effusion (NCT07192900) (RIOT 4A) trial for Malignant Pleural Effusion (NCT07192900). Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease. This research study aims to evaluate the safety and effectiveness of a novel… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07192900.mp4 2026-09-12T20:56:07.710Z 67 yes no https://www.trianglehealth.com/es/phase-1/riot-4a-nct07192900 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07192900.jpg (RIOT 4A) trial for Malignant Pleural Effusion (NCT07192900) (RIOT 4A) trial for Malignant Pleural Effusion (NCT07192900). Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease. This research study aims to evaluate the safety and effectiveness of a novel… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07192900.mp4 2026-09-12T20:56:07.710Z 67 yes no https://www.trianglehealth.com/phase-1/riot-4b-nct07443020 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07443020.jpg RIOT 4B trial for Malignant Pleural Effusion (NCT07443020) RIOT 4B trial for Malignant Pleural Effusion (NCT07443020). Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors. This research study aims to evaluate the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07443020.mp4 2026-09-12T20:45:42.418Z 69 yes no https://www.trianglehealth.com/es/phase-1/riot-4b-nct07443020 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07443020.jpg RIOT 4B trial for Malignant Pleural Effusion (NCT07443020) RIOT 4B trial for Malignant Pleural Effusion (NCT07443020). Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors. This research study aims to evaluate the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07443020.mp4 2026-09-12T20:45:42.418Z 69 yes no https://www.trianglehealth.com/phase-1/rituximab-nct06209619 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06209619.jpg CC-99282 + Rituximab trial for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT06209619) CC-99282 + Rituximab trial for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT06209619). CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma. This phase I trial tests the safety, side effects and best dose of CC-99282 with rituximab… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06209619.mp4 2026-10-19T01:08:29.681Z 66 yes no https://www.trianglehealth.com/es/phase-1/rituximab-nct06209619 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06209619.jpg CC-99282 + Rituximab trial for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT06209619) CC-99282 + Rituximab trial for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT06209619). CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma. This phase I trial tests the safety, side effects and best dose of CC-99282 with rituximab… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06209619.mp4 2026-10-19T01:08:29.681Z 66 yes no https://www.trianglehealth.com/phase-1/roginolisib-nct06644183 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06644183.jpg Roginolisib + Venetoclax + Rituximab trial for Relapsed or Refractory Chronic… (NCT06644183) Roginolisib + Venetoclax + Rituximab trial for Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT06644183). Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL). This research study will test the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06644183.mp4 2026-10-20T05:15:17.471Z 68 yes no https://www.trianglehealth.com/es/phase-1/roginolisib-nct06644183 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06644183.jpg Roginolisib + Venetoclax + Rituximab trial for Relapsed or Refractory Chronic… (NCT06644183) Roginolisib + Venetoclax + Rituximab trial for Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT06644183). Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL). This research study will test the safety and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06644183.mp4 2026-10-20T05:15:17.471Z 68 yes no https://www.trianglehealth.com/phase-1/ruxolitinib-nct03874052 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03874052.jpg Ruxolitinib + Venetoclax trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT03874052) Ruxolitinib + Venetoclax trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT03874052). Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia. This phase I… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03874052.mp4 2026-10-19T02:54:37.648Z 73 yes no https://www.trianglehealth.com/es/phase-1/ruxolitinib-nct03874052 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03874052.jpg Ruxolitinib + Venetoclax trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT03874052) Ruxolitinib + Venetoclax trial for Relapsed/Refractory Acute Myeloid Leukemia (NCT03874052). Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia. This phase I… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03874052.mp4 2026-10-19T02:54:37.648Z 73 yes no https://www.trianglehealth.com/phase-1/ruxolitinib-phosphate-nct07278856 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07278856.jpg Ruxolitinib + CHOP trial for Untreated Nodal T Follicular Helper Cell Lymphoma (NCT07278856) Ruxolitinib + CHOP trial for Untreated Nodal T Follicular Helper Cell Lymphoma (NCT07278856). Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas. This phase I trial tests the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07278856.mp4 2026-10-20T02:02:32.921Z 62 yes no https://www.trianglehealth.com/es/phase-1/ruxolitinib-phosphate-nct07278856 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07278856.jpg Ruxolitinib + CHOP trial for Untreated Nodal T Follicular Helper Cell Lymphoma (NCT07278856) Ruxolitinib + CHOP trial for Untreated Nodal T Follicular Helper Cell Lymphoma (NCT07278856). Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas. This phase I trial tests the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07278856.mp4 2026-10-20T02:02:32.921Z 62 yes no https://www.trianglehealth.com/phase-1/sabre-nct07172958 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07172958.jpg SABRE trial for Relapsed/Refractory Embryonal Tumors (NCT07172958) SABRE trial for Relapsed/Refractory Embryonal Tumors (NCT07172958). Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE). This is a phase I dose-escalation study to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07172958.mp4 2026-10-19T01:15:04.890Z 69 yes no https://www.trianglehealth.com/es/phase-1/sabre-nct07172958 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07172958.jpg SABRE trial for Relapsed/Refractory Embryonal Tumors (NCT07172958) SABRE trial for Relapsed/Refractory Embryonal Tumors (NCT07172958). Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE). This is a phase I dose-escalation study to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07172958.mp4 2026-10-19T01:15:04.890Z 69 yes no https://www.trianglehealth.com/phase-1/sacituzumab-nct06040970 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06040970.jpg Sacituzumab Govitecan + Cisplatin trial for Platinum-Sensitive Recurrent Ovarian and… (NCT06040970) Sacituzumab Govitecan + Cisplatin trial for Platinum-Sensitive Recurrent Ovarian and Endometrial Cancer (NCT06040970). Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer. This is an open-label, Phase 1 study with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06040970.mp4 2026-10-19T12:24:46.983Z 60 yes no https://www.trianglehealth.com/es/phase-1/sacituzumab-nct06040970 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06040970.jpg Sacituzumab Govitecan + Cisplatin trial for Platinum-Sensitive Recurrent Ovarian and… (NCT06040970) Sacituzumab Govitecan + Cisplatin trial for Platinum-Sensitive Recurrent Ovarian and Endometrial Cancer (NCT06040970). Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer. This is an open-label, Phase 1 study with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06040970.mp4 2026-10-19T12:24:46.983Z 60 yes no https://www.trianglehealth.com/phase-1/sbrt-atezolizumab-and-bevacizumab-nct05488522 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05488522.jpg SBRT + atezolizumab and bevacizumab trial for Unresectable Hepatocellular Carcinoma (NCT05488522) SBRT + atezolizumab and bevacizumab trial for Unresectable Hepatocellular Carcinoma (NCT05488522). SBRT With Atezo/Bev for HCC. A phase I dose escalation and pharmacodynamic study of repeated dose stereotactic body radiotherapy (SBRT) administered with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05488522.mp4 2026-10-19T11:38:06.321Z 71 yes no https://www.trianglehealth.com/es/phase-1/sbrt-atezolizumab-and-bevacizumab-nct05488522 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05488522.jpg SBRT + atezolizumab and bevacizumab trial for Unresectable Hepatocellular Carcinoma (NCT05488522) SBRT + atezolizumab and bevacizumab trial for Unresectable Hepatocellular Carcinoma (NCT05488522). SBRT With Atezo/Bev for HCC. A phase I dose escalation and pharmacodynamic study of repeated dose stereotactic body radiotherapy (SBRT) administered with… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05488522.mp4 2026-10-19T11:38:06.321Z 71 yes no https://www.trianglehealth.com/phase-1/scri-carb7h3-s-b7h3-specific-chimeric-antigen-receptor-c-nct04185038 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04185038.jpg Study of B7-H3-Specific CAR T Cell Locore… trial for Central Nervous System Tumor (NCT04185038) Study of B7-H3-Specific CAR T Cell Locore… trial for Central Nervous System Tumor (NCT04185038). B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04185038.mp4 2026-09-12T19:58:00.472Z 77 yes no https://www.trianglehealth.com/es/phase-1/scri-carb7h3-s-b7h3-specific-chimeric-antigen-receptor-c-nct04185038 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04185038.jpg Study of B7-H3-Specific CAR T Cell Locore… trial for Central Nervous System Tumor (NCT04185038) Study of B7-H3-Specific CAR T Cell Locore… trial for Central Nervous System Tumor (NCT04185038). B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT04185038.mp4 2026-09-12T19:58:00.472Z 77 yes no https://www.trianglehealth.com/phase-1/selinexor-nct07200102 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200102.jpg Selinexor Maintenance trial for Relapsed Multiple Myeloma After CAR T-Cell Therapy (NCT07200102) Selinexor Maintenance trial for Relapsed Multiple Myeloma After CAR T-Cell Therapy (NCT07200102). Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma. The outcomes in patients with relapsed multiple myeloma refractory to triple-therapy… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200102.mp4 2026-10-20T00:30:14.036Z 66 yes no https://www.trianglehealth.com/es/phase-1/selinexor-nct07200102 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200102.jpg Selinexor Maintenance trial for Relapsed Multiple Myeloma After CAR T-Cell Therapy (NCT07200102) Selinexor Maintenance trial for Relapsed Multiple Myeloma After CAR T-Cell Therapy (NCT07200102). Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma. The outcomes in patients with relapsed multiple myeloma refractory to triple-therapy… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07200102.mp4 2026-10-20T00:30:14.036Z 66 yes no https://www.trianglehealth.com/phase-1/seneca-valley-virus-001-svv-001-nct06889493 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06889493.jpg Seneca Valley Virus-001 (SVV-001) trial for Neuroendocrine Carcinoma (NCT06889493) Seneca Valley Virus-001 (SVV-001) trial for Neuroendocrine Carcinoma (NCT06889493). SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06889493.mp4 2026-10-18T22:39:38.147Z 68 yes no https://www.trianglehealth.com/es/phase-1/seneca-valley-virus-001-svv-001-nct06889493 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06889493.jpg Seneca Valley Virus-001 (SVV-001) trial for Neuroendocrine Carcinoma (NCT06889493) Seneca Valley Virus-001 (SVV-001) trial for Neuroendocrine Carcinoma (NCT06889493). SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06889493.mp4 2026-10-18T22:39:38.147Z 68 yes no https://www.trianglehealth.com/phase-1/siaci-of-cetuximab-and-bevacizumab-nct05956821 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05956821.jpg SIACI of cetuximab and bevacizumab trial for Relapsed/Refractory Intracranial Glioma (NCT05956821) SIACI of cetuximab and bevacizumab trial for Relapsed/Refractory Intracranial Glioma (NCT05956821). Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age. This study assesses the safety and efficacy of repeat monthly dosing… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05956821.mp4 2026-10-19T01:41:42.249Z 61 yes no https://www.trianglehealth.com/es/phase-1/siaci-of-cetuximab-and-bevacizumab-nct05956821 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05956821.jpg SIACI of cetuximab and bevacizumab trial for Relapsed/Refractory Intracranial Glioma (NCT05956821) SIACI of cetuximab and bevacizumab trial for Relapsed/Refractory Intracranial Glioma (NCT05956821). Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age. This study assesses the safety and efficacy of repeat monthly dosing… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05956821.mp4 2026-10-19T01:41:42.249Z 61 yes no https://www.trianglehealth.com/phase-1/sirolimus-nct07581704 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07581704.jpg Sirolimus trial for Multiple Myeloma (NCT07581704) Sirolimus trial for Multiple Myeloma (NCT07581704). Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma. This is a single center, single arm Phase… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07581704.mp4 2026-10-18T22:52:18.717Z 65 yes no https://www.trianglehealth.com/es/phase-1/sirolimus-nct07581704 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07581704.jpg Sirolimus trial for Multiple Myeloma (NCT07581704) Sirolimus trial for Multiple Myeloma (NCT07581704). Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma. This is a single center, single arm Phase… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07581704.mp4 2026-10-18T22:52:18.717Z 65 yes no https://www.trianglehealth.com/phase-1/sitagliptin-nct07541781 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07541781.jpg Sitagliptin trial for Glioma (NCT07541781) Sitagliptin trial for Glioma (NCT07541781). Sitagliptin in Recurrent/Progressive Grade 4 Glioma. Sitagliptin, when combined with standard-of-care drug bevacizumab, is being tested to 1) find out if it… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07541781.mp4 2026-10-18T22:50:46.819Z 64 yes no https://www.trianglehealth.com/es/phase-1/sitagliptin-nct07541781 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07541781.jpg Sitagliptin trial for Glioma (NCT07541781) Sitagliptin trial for Glioma (NCT07541781). Sitagliptin in Recurrent/Progressive Grade 4 Glioma. Sitagliptin, when combined with standard-of-care drug bevacizumab, is being tested to 1) find out if it… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07541781.mp4 2026-10-18T22:50:46.819Z 64 yes no https://www.trianglehealth.com/phase-1/sl-401-nct03113643 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03113643.jpg SL-401 trial for Acute Myeloid Leukemia (NCT03113643) SL-401 trial for Acute Myeloid Leukemia (NCT03113643). SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03113643.mp4 2026-09-12T20:40:15.055Z 83 yes no https://www.trianglehealth.com/es/phase-1/sl-401-nct03113643 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03113643.jpg SL-401 trial for Acute Myeloid Leukemia (NCT03113643) SL-401 trial for Acute Myeloid Leukemia (NCT03113643). SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03113643.mp4 2026-09-12T20:40:15.055Z 83 yes no https://www.trianglehealth.com/phase-1/solar-nct06607549 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06607549.jpg SOLAR trial for Central Nervous System Lymphoma (NCT06607549) SOLAR trial for Central Nervous System Lymphoma (NCT06607549). Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR). The purpose of this… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06607549.mp4 2026-10-19T15:07:06.006Z 65 yes no https://www.trianglehealth.com/es/phase-1/solar-nct06607549 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06607549.jpg SOLAR trial for Central Nervous System Lymphoma (NCT06607549) SOLAR trial for Central Nervous System Lymphoma (NCT06607549). Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR). The purpose of this… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06607549.mp4 2026-10-19T15:07:06.006Z 65 yes no https://www.trianglehealth.com/phase-1/sorafenib-nct05468359 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05468359.jpg Sorafenib, Bevacizumab and Atezolizumab trial for Refractory Pediatric Solid Tumors (NCT05468359) Sorafenib, Bevacizumab and Atezolizumab trial for Refractory Pediatric Solid Tumors (NCT05468359). Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients. This is a phase I/II study to evaluate the safety of combining… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05468359.mp4 2026-10-19T02:23:12.050Z 61 yes no https://www.trianglehealth.com/es/phase-1/sorafenib-nct05468359 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05468359.jpg Sorafenib, Bevacizumab and Atezolizumab trial for Refractory Pediatric Solid Tumors (NCT05468359) Sorafenib, Bevacizumab and Atezolizumab trial for Refractory Pediatric Solid Tumors (NCT05468359). Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients. This is a phase I/II study to evaluate the safety of combining… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05468359.mp4 2026-10-19T02:23:12.050Z 61 yes no https://www.trianglehealth.com/phase-1/sotorasib-nct05815173 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05815173.jpg Ladarixin + Sotorasib trial for Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer (NCT05815173) Ladarixin + Sotorasib trial for Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer (NCT05815173). Ladarixin With Sotorasib in Advanced NSCLC. This is a phase I/II, open-label, study of twice-daily oral ladarixin with sotorasib in participants with advanced… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05815173.mp4 2026-10-19T12:01:06.298Z 62 yes no https://www.trianglehealth.com/es/phase-1/sotorasib-nct05815173 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05815173.jpg Ladarixin + Sotorasib trial for Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer (NCT05815173) Ladarixin + Sotorasib trial for Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer (NCT05815173). Ladarixin With Sotorasib in Advanced NSCLC. This is a phase I/II, open-label, study of twice-daily oral ladarixin with sotorasib in participants with advanced… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05815173.mp4 2026-10-19T12:01:06.298Z 62 yes no https://www.trianglehealth.com/phase-1/spatially-fractionated-rt-nct06546969 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06546969.jpg Chemoimmunotherapy + SFRT and Hyperthermia trial for Advanced Biliary Tract Cancer (NCT06546969) Chemoimmunotherapy + SFRT and Hyperthermia trial for Advanced Biliary Tract Cancer (NCT06546969). Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer. This study is being done to see if the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06546969.mp4 2026-10-19T12:47:22.054Z 63 yes no https://www.trianglehealth.com/es/phase-1/spatially-fractionated-rt-nct06546969 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06546969.jpg Chemoimmunotherapy + SFRT and Hyperthermia trial for Advanced Biliary Tract Cancer (NCT06546969) Chemoimmunotherapy + SFRT and Hyperthermia trial for Advanced Biliary Tract Cancer (NCT06546969). Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer. This study is being done to see if the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06546969.mp4 2026-10-19T12:47:22.054Z 63 yes no https://www.trianglehealth.com/phase-1/starlite-nct06428045 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06428045.jpg STARLITE trial for High Grade Glioma (NCT06428045) STARLITE trial for High Grade Glioma (NCT06428045). STARLITE for Unresectable High-Grade Gliomas. The purpose of this study is to determine whether newly diagnosed high-grade glioma(s) that cannot be removed… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06428045.mp4 2026-10-18T22:38:43.467Z 67 yes no https://www.trianglehealth.com/es/phase-1/starlite-nct06428045 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06428045.jpg STARLITE trial for High Grade Glioma (NCT06428045) STARLITE trial for High Grade Glioma (NCT06428045). STARLITE for Unresectable High-Grade Gliomas. The purpose of this study is to determine whether newly diagnosed high-grade glioma(s) that cannot be removed… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06428045.mp4 2026-10-18T22:38:43.467Z 67 yes no https://www.trianglehealth.com/phase-1/sx-682-nct07814352 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07814352.jpg SX-682 + Proton CSI trial for Leptomeningeal Disease From Melanoma or NSCLC (NCT07814352) SX-682 + Proton CSI trial for Leptomeningeal Disease From Melanoma or NSCLC (NCT07814352). SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease. The researchers are doing this study to find out… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07814352.mp4 2026-10-20T03:19:39.464Z 69 yes no https://www.trianglehealth.com/es/phase-1/sx-682-nct07814352 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07814352.jpg SX-682 + Proton CSI trial for Leptomeningeal Disease From Melanoma or NSCLC (NCT07814352) SX-682 + Proton CSI trial for Leptomeningeal Disease From Melanoma or NSCLC (NCT07814352). SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal Disease. The researchers are doing this study to find out… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07814352.mp4 2026-10-20T03:19:39.464Z 69 yes no https://www.trianglehealth.com/phase-1/tafasitamab-nct07225439 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225439.jpg Tafasitamab trial for Non Hodgkin Lymphoma (NCT07225439) Tafasitamab trial for Non Hodgkin Lymphoma (NCT07225439). Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL). This… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225439.mp4 2026-09-12T20:21:47.247Z 68 yes no https://www.trianglehealth.com/es/phase-1/tafasitamab-nct07225439 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225439.jpg Tafasitamab trial for Non Hodgkin Lymphoma (NCT07225439) Tafasitamab trial for Non Hodgkin Lymphoma (NCT07225439). Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL). This… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07225439.mp4 2026-09-12T20:21:47.247Z 68 yes no https://www.trianglehealth.com/phase-1/talquetamab-nct07093554 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07093554.jpg Talquetamab trial for Relapsed/Refractory Multiple Myeloma (NCT07093554) Talquetamab trial for Relapsed/Refractory Multiple Myeloma (NCT07093554). Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07093554.mp4 2026-10-18T22:04:25.727Z 59 yes no https://www.trianglehealth.com/es/phase-1/talquetamab-nct07093554 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07093554.jpg Talquetamab trial for Relapsed/Refractory Multiple Myeloma (NCT07093554) Talquetamab trial for Relapsed/Refractory Multiple Myeloma (NCT07093554). Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07093554.mp4 2026-10-18T22:04:25.727Z 59 yes no https://www.trianglehealth.com/phase-1/tazemetostat-nct05627232 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05627232.jpg Tazemetostat trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT05627232) Tazemetostat trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT05627232). Tazemetostat and Palbociclib With CPX-351for R/R AML. This is a two-part phase Ib dose escalation study to evaluate the safety and preliminary efficacy of the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05627232.mp4 2026-10-19T15:31:09.507Z 65 yes no https://www.trianglehealth.com/es/phase-1/tazemetostat-nct05627232 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05627232.jpg Tazemetostat trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT05627232) Tazemetostat trial for Relapsed or Refractory Acute Myeloid Leukemia (NCT05627232). Tazemetostat and Palbociclib With CPX-351for R/R AML. This is a two-part phase Ib dose escalation study to evaluate the safety and preliminary efficacy of the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05627232.mp4 2026-10-19T15:31:09.507Z 65 yes no https://www.trianglehealth.com/phase-1/tegavivint-nct05755087 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05755087.jpg Tegavivint trial for Relapsed or Refractory Large B-Cell Lymphoma (NCT05755087) Tegavivint trial for Relapsed or Refractory Large B-Cell Lymphoma (NCT05755087). Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma. This phase I trial tests the safety, side effects, and best dose of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05755087.mp4 2026-10-20T04:55:27.219Z 58 yes no https://www.trianglehealth.com/es/phase-1/tegavivint-nct05755087 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05755087.jpg Tegavivint trial for Relapsed or Refractory Large B-Cell Lymphoma (NCT05755087) Tegavivint trial for Relapsed or Refractory Large B-Cell Lymphoma (NCT05755087). Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma. This phase I trial tests the safety, side effects, and best dose of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05755087.mp4 2026-10-20T04:55:27.219Z 58 yes no https://www.trianglehealth.com/phase-1/tepotinib-nct07619339 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07619339.jpg Tepotinib + Ivonescimab trial for MET Exon 14 Skipping Non-Small Cell Lung Cancer (NCT07619339) Tepotinib + Ivonescimab trial for MET Exon 14 Skipping Non-Small Cell Lung Cancer (NCT07619339). Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer. The researchers are doing this study to find out whether the combination of tepotinib and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07619339.mp4 2026-10-20T02:18:32.125Z 63 yes no https://www.trianglehealth.com/es/phase-1/tepotinib-nct07619339 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07619339.jpg Tepotinib + Ivonescimab trial for MET Exon 14 Skipping Non-Small Cell Lung Cancer (NCT07619339) Tepotinib + Ivonescimab trial for MET Exon 14 Skipping Non-Small Cell Lung Cancer (NCT07619339). Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer. The researchers are doing this study to find out whether the combination of tepotinib and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07619339.mp4 2026-10-20T02:18:32.125Z 63 yes no https://www.trianglehealth.com/phase-1/tgfbr2-ko-car27-il-15-nk-cells-nct07444632 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07444632.jpg CAR.70 NK Cells trial for Relapsed or Refractory Lymphomas and B-ALL (NCT07444632) CAR.70 NK Cells trial for Relapsed or Refractory Lymphomas and B-ALL (NCT07444632). CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies. This is a phase 1 basket… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07444632.mp4 2026-10-20T03:47:53.059Z 66 yes no https://www.trianglehealth.com/es/phase-1/tgfbr2-ko-car27-il-15-nk-cells-nct07444632 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07444632.jpg CAR.70 NK Cells trial for Relapsed or Refractory Lymphomas and B-ALL (NCT07444632) CAR.70 NK Cells trial for Relapsed or Refractory Lymphomas and B-ALL (NCT07444632). CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies. This is a phase 1 basket… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07444632.mp4 2026-10-20T03:47:53.059Z 66 yes no https://www.trianglehealth.com/phase-1/tgfbr2-ko-car27-il-15-nk-cells-nct07509008 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07509008.jpg TROP2 CAR/IL-15 TGFBR2 KO NK Cells trial for Gastric Cancer, Metastatic (NCT07509008) TROP2 CAR/IL-15 TGFBR2 KO NK Cells trial for Gastric Cancer, Metastatic (NCT07509008). TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum. The goal of this clinical… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07509008.mp4 2026-10-18T18:46:13.500Z 67 yes no https://www.trianglehealth.com/es/phase-1/tgfbr2-ko-car27-il-15-nk-cells-nct07509008 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07509008.jpg TROP2 CAR/IL-15 TGFBR2 KO NK Cells trial for Gastric Cancer, Metastatic (NCT07509008) TROP2 CAR/IL-15 TGFBR2 KO NK Cells trial for Gastric Cancer, Metastatic (NCT07509008). TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum. The goal of this clinical… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07509008.mp4 2026-10-18T18:46:13.500Z 67 yes no https://www.trianglehealth.com/phase-1/tinks-nct05634369 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05634369.jpg TINKS trial for Relapsed/Refractory Pediatric Sarcoma (NCT05634369) TINKS trial for Relapsed/Refractory Pediatric Sarcoma (NCT05634369). A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05634369.mp4 2026-10-19T00:50:34.757Z 63 yes no https://www.trianglehealth.com/es/phase-1/tinks-nct05634369 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05634369.jpg TINKS trial for Relapsed/Refractory Pediatric Sarcoma (NCT05634369) TINKS trial for Relapsed/Refractory Pediatric Sarcoma (NCT05634369). A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05634369.mp4 2026-10-19T00:50:34.757Z 63 yes no https://www.trianglehealth.com/phase-1/tnhyp218-car-t-cells-nct06885697 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06885697.jpg TNhYP218 CAR T Cells trial for Mesothelioma (NCT06885697) TNhYP218 CAR T Cells trial for Mesothelioma (NCT06885697). Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma. Background:… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06885697.mp4 2026-09-12T20:43:33.857Z 78 yes no https://www.trianglehealth.com/es/phase-1/tnhyp218-car-t-cells-nct06885697 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06885697.jpg TNhYP218 CAR T Cells trial for Mesothelioma (NCT06885697) TNhYP218 CAR T Cells trial for Mesothelioma (NCT06885697). Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma. Background:… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06885697.mp4 2026-09-12T20:43:33.857Z 78 yes no https://www.trianglehealth.com/phase-1/total-body-irradiation-nct06928662 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06928662.jpg Decitabine + FLAG-Ida and Total-Body Irradiation trial for Acute Myeloid Leukemia… (NCT06928662) Decitabine + FLAG-Ida and Total-Body Irradiation trial for Acute Myeloid Leukemia and Other Myeloid Malignancies (NCT06928662). Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06928662.mp4 2026-10-19T02:16:47.708Z 70 yes no https://www.trianglehealth.com/es/phase-1/total-body-irradiation-nct06928662 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06928662.jpg Decitabine + FLAG-Ida and Total-Body Irradiation trial for Acute Myeloid Leukemia… (NCT06928662) Decitabine + FLAG-Ida and Total-Body Irradiation trial for Acute Myeloid Leukemia and Other Myeloid Malignancies (NCT06928662). Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06928662.mp4 2026-10-19T02:16:47.708Z 70 yes no https://www.trianglehealth.com/phase-1/tpt-ced-rhgg-nct06666712 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06666712.jpg TPT CED rHGG trial for Brain Tumor, Recurrent (NCT06666712) TPT CED rHGG trial for Brain Tumor, Recurrent (NCT06666712). Chronic CED of TPT for Recurrent Malignant Glioma. The primary goal of this study is to establish the safety of chronic Convection Enhanced Delivery (CED) of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06666712.mp4 2026-09-12T15:30:58.168Z 259 yes no https://www.trianglehealth.com/es/phase-1/tpt-ced-rhgg-nct06666712 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06666712.jpg TPT CED rHGG trial for Brain Tumor, Recurrent (NCT06666712) TPT CED rHGG trial for Brain Tumor, Recurrent (NCT06666712). Chronic CED of TPT for Recurrent Malignant Glioma. The primary goal of this study is to establish the safety of chronic Convection Enhanced Delivery (CED) of… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06666712.mp4 2026-09-12T15:30:58.168Z 259 yes no https://www.trianglehealth.com/phase-1/trabedersen-nct06579196 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06579196.jpg Trabedersen trial for Non-small Cell Lung Cancer (NCT06579196) Trabedersen trial for Non-small Cell Lung Cancer (NCT06579196). Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1. The goal of this clinical trial is to: 1) evaluate the safety… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06579196.mp4 2026-09-12T20:19:58.663Z 77 yes no https://www.trianglehealth.com/es/phase-1/trabedersen-nct06579196 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06579196.jpg Trabedersen trial for Non-small Cell Lung Cancer (NCT06579196) Trabedersen trial for Non-small Cell Lung Cancer (NCT06579196). Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1. The goal of this clinical trial is to: 1) evaluate the safety… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06579196.mp4 2026-09-12T20:19:58.663Z 77 yes no https://www.trianglehealth.com/phase-1/tumor-infiltrating-lymphocytes-til-nct05681780 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05681780.jpg Tumor-infiltrating Lymphocytes (TIL) trial for Non Small Cell Lung Cancer (NCT05681780) Tumor-infiltrating Lymphocytes (TIL) trial for Non Small Cell Lung Cancer (NCT05681780). CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC. To determine the effect of a special preparation of cells, called… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05681780.mp4 2026-09-12T20:13:05.644Z 79 yes no https://www.trianglehealth.com/es/phase-1/tumor-infiltrating-lymphocytes-til-nct05681780 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05681780.jpg Tumor-infiltrating Lymphocytes (TIL) trial for Non Small Cell Lung Cancer (NCT05681780) Tumor-infiltrating Lymphocytes (TIL) trial for Non Small Cell Lung Cancer (NCT05681780). CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC. To determine the effect of a special preparation of cells, called… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05681780.mp4 2026-09-12T20:13:05.644Z 79 yes no https://www.trianglehealth.com/phase-1/ultrasound-induced-microbubble-cavitation-nct07501650 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07501650.jpg Ultrasound Microbubble Cavitation trial for Recurrent or Metastatic Head and Neck… (NCT07501650) Ultrasound Microbubble Cavitation trial for Recurrent or Metastatic Head and Neck Cancer (NCT07501650). Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer. This is a feasibility trial studying anti-PD-1 therapy (Pembrolizumab)… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07501650.mp4 2026-10-19T16:08:36.195Z 62 yes no https://www.trianglehealth.com/es/phase-1/ultrasound-induced-microbubble-cavitation-nct07501650 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07501650.jpg Ultrasound Microbubble Cavitation trial for Recurrent or Metastatic Head and Neck… (NCT07501650) Ultrasound Microbubble Cavitation trial for Recurrent or Metastatic Head and Neck Cancer (NCT07501650). Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer. This is a feasibility trial studying anti-PD-1 therapy (Pembrolizumab)… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT07501650.mp4 2026-10-19T16:08:36.195Z 62 yes no https://www.trianglehealth.com/phase-1/vaccine-therapy-nct06324240 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06324240.jpg Personalized TMV Tumor Vaccine trial for Triple-Negative Breast Cancer (NCT06324240) Personalized TMV Tumor Vaccine trial for Triple-Negative Breast Cancer (NCT06324240). Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer. This phase I trial tests the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06324240.mp4 2026-10-18T22:37:34.639Z 64 yes no https://www.trianglehealth.com/es/phase-1/vaccine-therapy-nct06324240 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06324240.jpg Personalized TMV Tumor Vaccine trial for Triple-Negative Breast Cancer (NCT06324240) Personalized TMV Tumor Vaccine trial for Triple-Negative Breast Cancer (NCT06324240). Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer. This phase I trial tests the… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06324240.mp4 2026-10-18T22:37:34.639Z 64 yes no https://www.trianglehealth.com/phase-1/valemetostat-nct06807632 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06807632.jpg Valemetostat trial for Extensive-stage Small-cell Lung Cancer (NCT06807632) Valemetostat trial for Extensive-stage Small-cell Lung Cancer (NCT06807632). Valemetostat in Combination With Atezolizumab in People With Lung Cancer. This study will test whether valemetostat in combination with atezolizumab is a safe… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06807632.mp4 2026-10-18T22:27:50.200Z 68 yes no https://www.trianglehealth.com/es/phase-1/valemetostat-nct06807632 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06807632.jpg Valemetostat trial for Extensive-stage Small-cell Lung Cancer (NCT06807632) Valemetostat trial for Extensive-stage Small-cell Lung Cancer (NCT06807632). Valemetostat in Combination With Atezolizumab in People With Lung Cancer. This study will test whether valemetostat in combination with atezolizumab is a safe… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06807632.mp4 2026-10-18T22:27:50.200Z 68 yes no https://www.trianglehealth.com/phase-1/venetoclax-nct03214562 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03214562.jpg Venetoclax trial for Acute Myeloid Leukemia (NCT03214562) Venetoclax trial for Acute Myeloid Leukemia (NCT03214562). Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia. This phase Ib/II trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03214562.mp4 2026-10-18T18:48:23.484Z 64 yes no https://www.trianglehealth.com/es/phase-1/venetoclax-nct03214562 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03214562.jpg Venetoclax trial for Acute Myeloid Leukemia (NCT03214562) Venetoclax trial for Acute Myeloid Leukemia (NCT03214562). Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia. This phase Ib/II trial… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03214562.mp4 2026-10-18T18:48:23.484Z 64 yes no https://www.trianglehealth.com/phase-1/venetoclax-nct06129734 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06129734.jpg Decitabine + Venetoclax Maintenance trial for Acute Myeloid Leukemia and… (NCT06129734) Decitabine + Venetoclax Maintenance trial for Acute Myeloid Leukemia and Myelodysplastic Syndromes After Allogeneic Transplant (NCT06129734). Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant. The goal of this interventional clinical trial is… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06129734.mp4 2026-10-19T14:06:34.675Z 63 yes no https://www.trianglehealth.com/es/phase-1/venetoclax-nct06129734 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06129734.jpg Decitabine + Venetoclax Maintenance trial for Acute Myeloid Leukemia and… (NCT06129734) Decitabine + Venetoclax Maintenance trial for Acute Myeloid Leukemia and Myelodysplastic Syndromes After Allogeneic Transplant (NCT06129734). Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant. The goal of this interventional clinical trial is… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06129734.mp4 2026-10-19T14:06:34.675Z 63 yes no https://www.trianglehealth.com/phase-1/victory-nct05609994 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05609994.jpg ViCToRy trial for Low Grade Glioma of Brain (NCT05609994) ViCToRy trial for Low Grade Glioma of Brain (NCT05609994). ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas. The purpose of this study is to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05609994.mp4 2026-10-18T22:00:02.588Z 61 yes no https://www.trianglehealth.com/es/phase-1/victory-nct05609994 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05609994.jpg ViCToRy trial for Low Grade Glioma of Brain (NCT05609994) ViCToRy trial for Low Grade Glioma of Brain (NCT05609994). ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas. The purpose of this study is to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05609994.mp4 2026-10-18T22:00:02.588Z 61 yes no https://www.trianglehealth.com/phase-1/vista-nct03740256 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03740256.jpg VISTA trial for Bladder Cancer (NCT03740256) VISTA trial for Bladder Cancer (NCT03740256). Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors. This study is a first in human Phase 1… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03740256.mp4 2026-09-12T21:06:49.473Z 88 yes no https://www.trianglehealth.com/es/phase-1/vista-nct03740256 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03740256.jpg VISTA trial for Bladder Cancer (NCT03740256) VISTA trial for Bladder Cancer (NCT03740256). Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors. This study is a first in human Phase 1… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT03740256.mp4 2026-09-12T21:06:49.473Z 88 yes no https://www.trianglehealth.com/phase-1/withaferin-a-nct05610735 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05610735.jpg Ashwagandha + Liposomal Doxorubicin trial for Recurrent Ovarian Cancer (NCT05610735) Ashwagandha + Liposomal Doxorubicin trial for Recurrent Ovarian Cancer (NCT05610735). Combination Therapy for Recurrent Ovarian Cancer. The proposed study "combination therapy with liposomal doxorubicin and withaferin A (Ashwagandha, ASWD) in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05610735.mp4 2026-10-19T13:47:11.465Z 71 yes no https://www.trianglehealth.com/es/phase-1/withaferin-a-nct05610735 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05610735.jpg Ashwagandha + Liposomal Doxorubicin trial for Recurrent Ovarian Cancer (NCT05610735) Ashwagandha + Liposomal Doxorubicin trial for Recurrent Ovarian Cancer (NCT05610735). Combination Therapy for Recurrent Ovarian Cancer. The proposed study "combination therapy with liposomal doxorubicin and withaferin A (Ashwagandha, ASWD) in… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT05610735.mp4 2026-10-19T13:47:11.465Z 71 yes no https://www.trianglehealth.com/phase-1/ws-cart-cs1-nct06185751 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06185751.jpg WS-CART-CS1 trial for Multiple Myeloma (NCT06185751) WS-CART-CS1 trial for Multiple Myeloma (NCT06185751). CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma. Despite recent therapeutic advances, multiple myeloma (MM) remains an incurable disease. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06185751.mp4 2026-10-18T18:54:51.976Z 61 yes no https://www.trianglehealth.com/es/phase-1/ws-cart-cs1-nct06185751 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06185751.jpg WS-CART-CS1 trial for Multiple Myeloma (NCT06185751) WS-CART-CS1 trial for Multiple Myeloma (NCT06185751). CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma. Despite recent therapeutic advances, multiple myeloma (MM) remains an incurable disease. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06185751.mp4 2026-10-18T18:54:51.976Z 61 yes no https://www.trianglehealth.com/phase-1/zanu-tafa-nct06029309 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06029309.jpg Zanubrutinib + Tafasitamab trial for Mantle Cell Lymphoma (NCT06029309) Zanubrutinib + Tafasitamab trial for Mantle Cell Lymphoma (NCT06029309). Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma. The main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06029309.mp4 2026-10-20T03:59:00.526Z 51 yes no https://www.trianglehealth.com/es/phase-1/zanu-tafa-nct06029309 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06029309.jpg Zanubrutinib + Tafasitamab trial for Mantle Cell Lymphoma (NCT06029309) Zanubrutinib + Tafasitamab trial for Mantle Cell Lymphoma (NCT06029309). Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma. The main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06029309.mp4 2026-10-20T03:59:00.526Z 51 yes no https://www.trianglehealth.com/phase-1/zanubrutinib-nct06730542 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06730542.jpg Zanubrutinib + Pola-R-CHP trial for Secondary CNS Lymphoma (NCT06730542) Zanubrutinib + Pola-R-CHP trial for Secondary CNS Lymphoma (NCT06730542). Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma. The purpose of this study is to is to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06730542.mp4 2026-10-20T04:05:26.635Z 65 yes no https://www.trianglehealth.com/es/phase-1/zanubrutinib-nct06730542 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06730542.jpg Zanubrutinib + Pola-R-CHP trial for Secondary CNS Lymphoma (NCT06730542) Zanubrutinib + Pola-R-CHP trial for Secondary CNS Lymphoma (NCT06730542). Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma. The purpose of this study is to is to… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06730542.mp4 2026-10-20T04:05:26.635Z 65 yes no https://www.trianglehealth.com/phase-1/ziftomenib-nct06440135 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06440135.jpg Ziftomenib Maintenance trial for NPM1-Mutated AML in Remission After Allogeneic… (NCT06440135) Ziftomenib Maintenance trial for NPM1-Mutated AML in Remission After Allogeneic Transplant (NCT06440135). Ziftomenib Maintenance Post Allo-HCT. The purpose of this study is to test the safety, effects, and recommended dose of an investigational drug, ziftomenib,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06440135.mp4 2026-10-20T05:07:08.263Z 64 yes no https://www.trianglehealth.com/es/phase-1/ziftomenib-nct06440135 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06440135.jpg Ziftomenib Maintenance trial for NPM1-Mutated AML in Remission After Allogeneic… (NCT06440135) Ziftomenib Maintenance trial for NPM1-Mutated AML in Remission After Allogeneic Transplant (NCT06440135). Ziftomenib Maintenance Post Allo-HCT. The purpose of this study is to test the safety, effects, and recommended dose of an investigational drug, ziftomenib,… https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-1/films/NCT06440135.mp4 2026-10-20T05:07:08.263Z 64 yes no https://www.trianglehealth.com/phase-2/24bro681-alternating-gnp-and-mfolfirinox-for-br-pdac-nct07043270 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07043270.jpg Nab-paclitaxel + Gemcitabine trial for Pancreas Adenocarcinoma (NCT07043270) Nab-paclitaxel + Gemcitabine trial for Pancreas Adenocarcinoma (NCT07043270). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07043270. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07043270.mp4 2026-10-31T20:16:43.025Z 87 yes no https://www.trianglehealth.com/phase-2/3-5-fraction-stereotactic-body-radiation-therapy-for-palliation-nct05674396 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05674396.jpg Stereotactic body radiotherapy trial for Head and Neck Squamous Cell Carcinoma (NCT05674396) Stereotactic body radiotherapy trial for Head and Neck Squamous Cell Carcinoma (NCT05674396). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05674396. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05674396.mp4 2026-10-31T20:11:41.058Z 98 yes no https://www.trianglehealth.com/phase-2/5-azacytidine-and-or-nivolumab-in-resectable-hpv-associated-hnsc-nct05317000 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05317000.jpg Combination 5-azacytidine and nivolumab trial for Squamous Cell Carcinoma of Head… (NCT05317000) Combination 5-azacytidine and nivolumab trial for Squamous Cell Carcinoma of Head and Neck (NCT05317000). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05317000. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05317000.mp4 2026-11-01T00:07:58.978Z 84 yes no https://www.trianglehealth.com/phase-2/5-day-preoperative-radiation-for-soft-tissue-sarcoma-nct06087861 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06087861.jpg External Beam Radiotherapy trial for Soft Tissue Sarcoma (NCT06087861) External Beam Radiotherapy trial for Soft Tissue Sarcoma (NCT06087861). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06087861. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06087861.mp4 2026-11-01T00:05:35.745Z 77 yes no https://www.trianglehealth.com/phase-2/5-fluorouracil-leucovorin-5fu-lv-in-combination-with-regorafenib-nct06887218 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06887218.jpg Regorafenib (BAY 73-4506) trial for Metastatic Colorectal Cancer (CRC) (NCT06887218) Regorafenib (BAY 73-4506) trial for Metastatic Colorectal Cancer (CRC) (NCT06887218). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06887218. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06887218.mp4 2026-10-31T06:39:56.651Z 84 yes no https://www.trianglehealth.com/phase-2/a-cancer-vaccine-stemvac-in-combination-with-chemotherapy-for-th-nct07078604 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07078604.jpg CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine trial for Anatomic Stage… (NCT07078604) CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT07078604). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07078604. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07078604.mp4 2026-10-31T20:29:29.257Z 82 yes no https://www.trianglehealth.com/phase-2/a-clinical-study-of-calderasib-mk-1084-in-people-with-advanced-s-nct07209111 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07209111.jpg Calderasib trial for Neoplasm Malignant (NCT07209111) Calderasib trial for Neoplasm Malignant (NCT07209111). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07209111. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07209111.mp4 2026-10-31T07:51:23.029Z 72 yes no https://www.trianglehealth.com/phase-2/a-clinical-study-of-intismeran-autogene-v940-and-pembrolizumab-m-nct06961006 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06961006.jpg Intismeran autogene trial for Malignant Melanoma (NCT06961006) Intismeran autogene trial for Malignant Melanoma (NCT06961006). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06961006. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06961006.mp4 2026-10-31T14:56:25.670Z 83 yes no https://www.trianglehealth.com/phase-2/a-clinical-study-of-zilovertamab-vedotin-mk-2140-plus-rituximab-nct06890884 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06890884.jpg Zilovertamab vedotin trial for Lymphoma, Large B-Cell, Diffuse (NCT06890884) Zilovertamab vedotin trial for Lymphoma, Large B-Cell, Diffuse (NCT06890884). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06890884. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06890884.mp4 2026-10-31T15:06:02.504Z 93 yes no https://www.trianglehealth.com/phase-2/a-long-term-treatment-extension-study-of-niraparib-in-participan-nct04641247 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04641247.jpg Niraparib trial for Ovarian Neoplasms (NCT04641247) Niraparib trial for Ovarian Neoplasms (NCT04641247). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04641247. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04641247.mp4 2026-10-31T22:55:09.848Z 85 yes no https://www.trianglehealth.com/phase-2/a-multicenter-trial-to-identify-optimal-atezolizumab-biomarkers-nct06069726 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06069726.jpg Atezolizumab trial for Recurrent Glioblastoma (NCT06069726) Atezolizumab trial for Recurrent Glioblastoma (NCT06069726). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06069726. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06069726.mp4 2026-10-31T20:44:12.723Z 89 yes no https://www.trianglehealth.com/phase-2/a-multiple-antigen-vaccine-stemvac-for-the-treatment-of-patients-nct05242965 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05242965.jpg CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine trial for Lung Non-Small… (NCT05242965) CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine trial for Lung Non-Small Cell Carcinoma (NCT05242965). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05242965. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05242965.mp4 2026-10-31T21:07:38.788Z 74 yes no https://www.trianglehealth.com/phase-2/a-neoadjuvant-study-of-tislelizumab-and-sx-682-for-resectable-pa-nct05604560 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05604560.jpg Tislelizumab trial for Pancreatic Cancer (NCT05604560) Tislelizumab trial for Pancreatic Cancer (NCT05604560). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05604560. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05604560.mp4 2026-10-31T16:34:24.429Z 85 yes no https://www.trianglehealth.com/phase-2/a-phase-2-and-pharmacodynamic-study-of-sitagliptin-in-patients-w-nct07003542 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07003542.jpg Sitagliptin trial for Glioblastoma (NCT07003542) Sitagliptin trial for Glioblastoma (NCT07003542). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07003542. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07003542.mp4 2026-10-31T20:16:40.902Z 74 yes no https://www.trianglehealth.com/phase-2/a-phase-2-neoadjuvant-study-of-zanidatamab-in-combination-with-c-nct07102381 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07102381.jpg Zanidatamab trial for HER2-positive Breast Cancer (NCT07102381) Zanidatamab trial for HER2-positive Breast Cancer (NCT07102381). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07102381. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07102381.mp4 2026-10-31T05:25:35.534Z 73 yes no https://www.trianglehealth.com/phase-2/a-phase-2-open-label-single-arm-study-of-autologous-m-cenk-adopt-nct06710288 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06710288.jpg Gemcitabine trial for Platinum-resistant Ovarian Cancer (NCT06710288) Gemcitabine trial for Platinum-resistant Ovarian Cancer (NCT06710288). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06710288. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06710288.mp4 2026-10-31T22:33:18.378Z 91 yes no https://www.trianglehealth.com/phase-2/a-phase-2-platform-study-of-immunomodulatory-compounds-in-ici-re-nct07133425 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07133425.jpg SAR445877 trial for Non-Small Cell Lung Cancer (NCT07133425) SAR445877 trial for Non-Small Cell Lung Cancer (NCT07133425). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07133425. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07133425.mp4 2026-10-31T21:46:22.037Z 76 yes no https://www.trianglehealth.com/phase-2/a-phase-2-single-arm-open-label-pilot-trial-evaluating-zanidatam-nct05035836 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05035836.jpg Zanidatamab trial for Breast Cancer (NCT05035836) Zanidatamab trial for Breast Cancer (NCT05035836). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05035836. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05035836.mp4 2026-10-31T22:44:05.053Z 76 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-evaluating-olutasidenib-in-patients-with-idh1-mu-nct06566742 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06566742.jpg Olutasidenib trial for Myelodysplastic Syndromes (NCT06566742) Olutasidenib trial for Myelodysplastic Syndromes (NCT06566742). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06566742. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06566742.mp4 2026-10-31T15:13:10.078Z 72 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-of-acr-368-in-endometrial-adenocarcinoma-nct05548296 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05548296.jpg ACR-368 trial for Endometrial Adenocarcinoma (NCT05548296) ACR-368 trial for Endometrial Adenocarcinoma (NCT05548296). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05548296. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05548296.mp4 2026-10-31T22:50:03.762Z 83 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-of-ptx-100-in-patients-with-relapsed-refractory-nct06854653 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06854653.jpg PTX-100 trial for CTCL (NCT06854653) PTX-100 trial for CTCL (NCT06854653). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06854653. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06854653.mp4 2026-10-31T17:42:14.302Z 71 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-of-the-ketogenic-diet-vs-standard-anti-cancer-di-nct05708352 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05708352.jpg Keto Diet trial for Glioblastoma Multiforme (NCT05708352) Keto Diet trial for Glioblastoma Multiforme (NCT05708352). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05708352. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05708352.mp4 2026-10-31T20:24:46.998Z 80 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-co-nct07659795 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07659795.jpg VS-7375 trial for Colorectal Cancer (NCT07659795) VS-7375 trial for Colorectal Cancer (NCT07659795). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07659795. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07659795.mp4 2026-10-31T06:32:01.199Z 80 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-of-vs-7375-in-patients-with-kras-g12d-mutated-pa-nct07644559 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07644559.jpg VS-7375 trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT07644559) VS-7375 trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT07644559). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07644559. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07644559.mp4 2026-10-31T21:53:41.198Z 87 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-of-wu-cart-007-an-anti-cd7-allogeneic-car-t-cell-nct06514794 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06514794.jpg WU-CART-007 trial for T-cell Acute Lymphoblastic Leukemia (NCT06514794) WU-CART-007 trial for T-cell Acute Lymphoblastic Leukemia (NCT06514794). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06514794. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06514794.mp4 2026-10-31T06:40:12.392Z 87 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-of-zanidatamab-in-patients-with-her2-expressing-nct06695845 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06695845.jpg Zanidatamab trial for Breast Cancer (NCT06695845) Zanidatamab trial for Breast Cancer (NCT06695845). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06695845. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06695845.mp4 2026-10-31T22:23:52.637Z 85 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-to-evaluate-efficacy-of-calaspargase-pegol-mknl-nct06561074 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06561074.jpg Decitabine trial for T-cell Acute Lymphoblastic Leukemia (NCT06561074) Decitabine trial for T-cell Acute Lymphoblastic Leukemia (NCT06561074). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06561074. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06561074.mp4 2026-10-31T22:27:53.756Z 81 yes no https://www.trianglehealth.com/phase-2/a-phase-2-study-to-evaluate-the-effects-of-asp5541-in-participan-nct07005154 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07005154.jpg ASP5541 trial for Prostate Cancer (NCT07005154) ASP5541 trial for Prostate Cancer (NCT07005154). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07005154. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07005154.mp4 2026-10-31T19:47:30.728Z 83 yes no https://www.trianglehealth.com/phase-2/a-phase-2-trial-for-metastatic-melanoma-using-adoptive-cell-ther-nct02621021 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02621021.jpg young TIL trial for Melanoma (NCT02621021) young TIL trial for Melanoma (NCT02621021). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02621021. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02621021.mp4 2026-10-31T21:48:46.285Z 87 yes no https://www.trianglehealth.com/phase-2/a-phase-2-trial-of-ivonescimab-for-patients-with-advanced-metast-nct06805617 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06805617.jpg Ivonescimab trial for Salivary Gland Cancer (NCT06805617) Ivonescimab trial for Salivary Gland Cancer (NCT06805617). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06805617. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06805617.mp4 2026-10-31T15:06:12.459Z 77 yes no https://www.trianglehealth.com/phase-2/a-phase-2-trial-of-mosunetuzumab-and-zanubrutinib-for-patients-w-nct06563505 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06563505.jpg Mosunetuzumab trial for Lymphoma (NCT06563505) Mosunetuzumab trial for Lymphoma (NCT06563505). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06563505. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06563505.mp4 2026-10-31T06:42:16.250Z 75 yes no https://www.trianglehealth.com/phase-2/a-phase-2-trial-of-the-bruton-tyrosine-kinase-degrader-bgb-16673-nct07508995 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07508995.jpg BGB-16673 trial for Chronic Lymphocytic Leukemia (CLL) (NCT07508995) BGB-16673 trial for Chronic Lymphocytic Leukemia (CLL) (NCT07508995). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07508995. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07508995.mp4 2026-10-31T05:19:08.079Z 81 yes no https://www.trianglehealth.com/phase-2/a-phase-2-trial-of-zanzalintinib-in-advanced-metastatic-bone-sar-nct07193550 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07193550.jpg Zanzalintinib trial for Bone Sarcomas (NCT07193550) Zanzalintinib trial for Bone Sarcomas (NCT07193550). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07193550. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07193550.mp4 2026-10-31T06:57:35.833Z 84 yes no https://www.trianglehealth.com/phase-2/a-phase-2-trial-to-assess-safety-and-efficacy-of-tofacitinib-2-c-nct06698822 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06698822.jpg tofacitinib 2% cream trial for Cutaneous T-Cell Lymphoma (NCT06698822) tofacitinib 2% cream trial for Cutaneous T-Cell Lymphoma (NCT06698822). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06698822. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06698822.mp4 2026-10-31T22:13:44.628Z 79 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-clinical-study-to-evaluate-hlx43-in-subjects-with-adv-nct06907615 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06907615.jpg HLX43 DOSE 1 (2.0 mg/kg) trial for Non Small Cell Lung Cancer (NCT06907615) HLX43 DOSE 1 (2.0 mg/kg) trial for Non Small Cell Lung Cancer (NCT06907615). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06907615. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06907615.mp4 2026-10-31T07:07:45.365Z 76 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-evaluation-of-afatinib-in-patients-with-persistent-or-nct02491099 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02491099.jpg Afatinib trial for HER2/Neu+ Uterine Serous Carcinoma (NCT02491099) Afatinib trial for HER2/Neu+ Uterine Serous Carcinoma (NCT02491099). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02491099. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02491099.mp4 2026-10-31T23:44:20.316Z 83 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-open-label-study-of-olutasidenib-post-transplant-main-nct06668584 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06668584.jpg Olutasidenib trial for Myeloid Malignancies (NCT06668584) Olutasidenib trial for Myeloid Malignancies (NCT06668584). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06668584. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06668584.mp4 2026-10-31T16:15:33.322Z 82 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-single-center-single-arm-study-evaluating-the-safety-nct06630091 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06630091.jpg Golidocitinib trial for Peripheral T Cell Lymphoma (NCT06630091) Golidocitinib trial for Peripheral T Cell Lymphoma (NCT06630091). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06630091. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06630091.mp4 2026-10-31T07:15:48.780Z 79 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-study-evaluating-t-cell-clonality-after-stereotactic-nct05361798 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05361798.jpg PDS01ADC trial for Cancer Of Prostate (NCT05361798) PDS01ADC trial for Cancer Of Prostate (NCT05361798). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05361798. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05361798.mp4 2026-10-31T22:06:51.336Z 73 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-axicabtagene-ciloleucel-an-anti-cd19-chimeri-nct06043323 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06043323.jpg Axicabtagene Ciloleucel trial for Follicular Lymphoma (NCT06043323) Axicabtagene Ciloleucel trial for Follicular Lymphoma (NCT06043323). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06043323. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06043323.mp4 2026-10-31T19:45:13.501Z 70 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-loncastuximab-tesirine-as-consolidation-stra-nct05464719 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05464719.jpg Loncastuximab Tesirine trial for Large B-cell Lymphoma (NCT05464719) Loncastuximab Tesirine trial for Large B-cell Lymphoma (NCT05464719). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05464719. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05464719.mp4 2026-10-31T22:00:33.935Z 86 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-pemigatinib-plus-durvalumab-in-previously-tr-nct06728410 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06728410.jpg Pemigatinib trial for Intrahepatic Cholangiocarcinoma (NCT06728410) Pemigatinib trial for Intrahepatic Cholangiocarcinoma (NCT06728410). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06728410. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06728410.mp4 2026-10-31T07:33:00.999Z 79 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-the-menin-inhibitor-revumenib-in-leukemia-as-nct06229912 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06229912.jpg Revumenib trial for Leukemia (NCT06229912) Revumenib trial for Leukemia (NCT06229912). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06229912. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06229912.mp4 2026-10-31T20:48:37.801Z 82 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-study-of-tucatinib-and-ado-trastuzumab-emtansine-t-dm-nct05673928 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05673928.jpg Trastuzumab emtansine trial for Metastatic Solid Tumor (NCT05673928) Trastuzumab emtansine trial for Metastatic Solid Tumor (NCT05673928). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05673928. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05673928.mp4 2026-10-31T21:51:21.971Z 94 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-study-with-a-safety-run-in-of-the-addition-of-n-803-t-nct07085338 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07085338.jpg Temozolomide trial for Neuroblastoma Recurrent (NCT07085338) Temozolomide trial for Neuroblastoma Recurrent (NCT07085338). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07085338. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07085338.mp4 2026-10-31T20:16:15.671Z 83 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-trial-of-mosunetuzumab-polatuzumab-tafasitamab-and-le-nct05615636 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05615636.jpg Mosunetuzumab trial for Hodgkin Lymphoma (NCT05615636) Mosunetuzumab trial for Hodgkin Lymphoma (NCT05615636). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05615636. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05615636.mp4 2026-10-31T15:49:32.581Z 73 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-trial-of-sacituzumab-govitecan-in-patients-with-advan-nct06248515 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06248515.jpg Sacituzumab govitecan-hziy trial for Thymoma (NCT06248515) Sacituzumab govitecan-hziy trial for Thymoma (NCT06248515). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06248515. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06248515.mp4 2026-10-31T15:17:09.454Z 79 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-trial-of-tebentafusp-in-hla-a-02-01-positive-patients-nct06942442 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06942442.jpg Physician's Choice trial for HLA-A*0201 Positive Cells Present (NCT06942442) Physician's Choice trial for HLA-A*0201 Positive Cells Present (NCT06942442). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06942442. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06942442.mp4 2026-10-31T06:21:53.813Z 86 yes no https://www.trianglehealth.com/phase-2/a-phase-ii-trial-to-evaluate-the-effect-of-itraconazole-on-patho-nct05563766 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05563766.jpg Itraconazole trial for Esophageal Adenocarcinoma (NCT05563766) Itraconazole trial for Esophageal Adenocarcinoma (NCT05563766). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05563766. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05563766.mp4 2026-10-31T07:39:20.646Z 79 yes no https://www.trianglehealth.com/phase-2/a-pivotal-phase-ii-clinical-trial-of-utidelone-injection-plus-ca-nct06764940 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06764940.jpg Utidelone trial for HER2-negative Breast Cancer Patients With Brain Metastases (NCT06764940) Utidelone trial for HER2-negative Breast Cancer Patients With Brain Metastases (NCT06764940). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06764940. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06764940.mp4 2026-10-31T22:48:14.915Z 81 yes no https://www.trianglehealth.com/phase-2/a-randomized-phase-2-trial-of-fruquintinib-and-tas-102-as-compar-nct06992258 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06992258.jpg Fruquintinib+ Lonsurf (trifluridine and tipiracil) trial for Colorectal Cancer (NCT06992258) Fruquintinib+ Lonsurf (trifluridine and tipiracil) trial for Colorectal Cancer (NCT06992258). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06992258. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06992258.mp4 2026-10-31T21:20:41.161Z 91 yes no https://www.trianglehealth.com/phase-2/a-randomized-study-of-astx727-with-or-without-iadademstat-in-adv-nct06661915 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06661915.jpg Biospecimen Collection trial for Accelerated Phase Myeloproliferative Neoplasm (NCT06661915) Biospecimen Collection trial for Accelerated Phase Myeloproliferative Neoplasm (NCT06661915). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06661915. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06661915.mp4 2026-10-31T05:35:06.073Z 81 yes no https://www.trianglehealth.com/phase-2/a-randomized-trial-of-fianlimab-and-cemiplimab-ipilimumab-or-ipi-nct07188896 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07188896.jpg Fianlimab trial for Advanced Renal Cell Carcinoma (aRCC) (NCT07188896) Fianlimab trial for Advanced Renal Cell Carcinoma (aRCC) (NCT07188896). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07188896. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07188896.mp4 2026-10-31T19:07:37.468Z 74 yes no https://www.trianglehealth.com/phase-2/a-randomized-trial-of-maintenance-systemic-therapy-after-radiati-nct06004336 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06004336.jpg Pembrolizumab trial for Oligometastatic Renal Cell Carcinoma (NCT06004336) Pembrolizumab trial for Oligometastatic Renal Cell Carcinoma (NCT06004336). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06004336. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06004336.mp4 2026-10-31T21:40:05.500Z 79 yes no https://www.trianglehealth.com/phase-2/a-single-arm-phase-ii-study-of-neoadjuvant-intensified-androgen-nct05593497 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05593497.jpg Capivasertib trial for High-Risk Prostate Cancer (NCT05593497) Capivasertib trial for High-Risk Prostate Cancer (NCT05593497). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05593497. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05593497.mp4 2026-10-31T16:11:48.878Z 69 yes no https://www.trianglehealth.com/phase-2/a-single-arm-study-of-pembrolizumab-with-gemcitabine-and-cisplat-nct05967182 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05967182.jpg Pembrolizumab trial for Cholangiocarcinoma (NCT05967182) Pembrolizumab trial for Cholangiocarcinoma (NCT05967182). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05967182. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05967182.mp4 2026-10-31T16:24:36.080Z 69 yes no https://www.trianglehealth.com/phase-2/a-study-comparing-two-immunotherapy-options-for-human-papillomav-nct07179315 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07179315.jpg cemiplimab+fianlimab trial for Head and Neck Cancer (NCT07179315) cemiplimab+fianlimab trial for Head and Neck Cancer (NCT07179315). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07179315. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07179315.mp4 2026-10-31T21:37:24.761Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-evaluating-ficerafusp-alfa-bca101-qw-in-combination-with-nct07807163 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07807163.jpg Ficerafusp alfa trial for Metastatic Head and Neck Squamous Cell Carcinoma (NCT07807163) Ficerafusp alfa trial for Metastatic Head and Neck Squamous Cell Carcinoma (NCT07807163). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07807163. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07807163.mp4 2026-10-31T22:19:40.599Z 88 yes no https://www.trianglehealth.com/phase-2/a-study-evaluating-the-combination-of-immunotherapy-with-radioth-nct07603856 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07603856.jpg Investigator Choice Immunotherapy (for example: pembrolizumab, cemiplimab,… (NCT07603856) Investigator Choice Immunotherapy (for example: pembrolizumab, cemiplimab, durvalumab, ipilimumab plus nivolumab) trial for Non-Small Cell Lung Cancer (NCT07603856). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07603856. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07603856.mp4 2026-10-31T23:54:52.145Z 88 yes no https://www.trianglehealth.com/phase-2/a-study-evaluating-the-safety-of-inavolisib-and-fulvestrant-with-nct07748208 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07748208.jpg Inavolisib trial for Breast Cancer (NCT07748208) Inavolisib trial for Breast Cancer (NCT07748208). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07748208. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07748208.mp4 2026-10-31T21:19:10.905Z 95 yes no https://www.trianglehealth.com/phase-2/a-study-of-a-new-way-to-treat-children-and-young-adults-with-a-b-nct04684368 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04684368.jpg Biospecimen Collection trial for Central Nervous System Nongerminomatous Germ Cell… (NCT04684368) Biospecimen Collection trial for Central Nervous System Nongerminomatous Germ Cell Tumor (NCT04684368). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04684368. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04684368.mp4 2026-10-31T21:04:39.079Z 79 yes no https://www.trianglehealth.com/phase-2/a-study-of-a-vaccine-in-combination-with-beta-glucan-in-people-w-nct06057948 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06057948.jpg OPT-821 (QS-21) trial for Neuroblastoma (NCT06057948) OPT-821 (QS-21) trial for Neuroblastoma (NCT06057948). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06057948. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06057948.mp4 2026-10-31T21:24:36.380Z 78 yes no https://www.trianglehealth.com/phase-2/a-study-of-alisertib-in-patients-with-extensive-stage-small-cell-nct06095505 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06095505.jpg Alisertib trial for Small Cell Lung Cancer (NCT06095505) Alisertib trial for Small Cell Lung Cancer (NCT06095505). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06095505. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06095505.mp4 2026-10-31T22:59:16.457Z 77 yes no https://www.trianglehealth.com/phase-2/a-study-of-amivantamab-in-combination-with-lazertinib-or-amivant-nct06667076 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06667076.jpg Amivantamab trial for Carcinoma, Non-Small-Cell Lung (NCT06667076) Amivantamab trial for Carcinoma, Non-Small-Cell Lung (NCT06667076). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06667076. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06667076.mp4 2026-10-31T16:07:30.710Z 80 yes no https://www.trianglehealth.com/phase-2/a-study-of-amivantamab-in-participants-with-advanced-or-metastat-nct05498428 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05498428.jpg Amivantamab trial for Carcinoma, Non-small-Cell Lung (NCT05498428) Amivantamab trial for Carcinoma, Non-small-Cell Lung (NCT05498428). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05498428. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05498428.mp4 2026-10-31T06:49:41.196Z 83 yes no https://www.trianglehealth.com/phase-2/a-study-of-avutometinib-and-defactinib-in-people-with-thyroid-ca-nct06007924 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06007924.jpg Avutometinib trial for Thyroid Cancer (NCT06007924) Avutometinib trial for Thyroid Cancer (NCT06007924). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06007924. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06007924.mp4 2026-10-31T21:21:33.579Z 87 yes no https://www.trianglehealth.com/phase-2/a-study-of-avutometinib-defactinib-and-letrozole-in-people-with-nct06394804 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06394804.jpg Avutometinib trial for Low-Grade Serous Ovarian Cancer (NCT06394804) Avutometinib trial for Low-Grade Serous Ovarian Cancer (NCT06394804). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06394804. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06394804.mp4 2026-10-31T21:56:17.116Z 78 yes no https://www.trianglehealth.com/phase-2/a-study-of-axicabtagene-ciloleucel-and-glofitamab-as-second-line-nct06213311 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06213311.jpg Glofitamab trial for B Cell Lymphoma (NCT06213311) Glofitamab trial for B Cell Lymphoma (NCT06213311). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06213311. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06213311.mp4 2026-10-31T21:00:58.118Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-of-azenosertib-zn-c3-in-subjects-with-platinum-resistant-nct05128825 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05128825.jpg azenosertib trial for High-Grade Serous Ovarian, Fallopian Tube or Primary… (NCT05128825) azenosertib trial for High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT05128825). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05128825. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05128825.mp4 2026-10-31T14:54:15.700Z 87 yes no https://www.trianglehealth.com/phase-2/a-study-of-belzutifan-in-adolescent-participants-with-solid-tumo-nct07700758 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07700758.jpg Belzutifan trial for Malignant Neoplasm (NCT07700758) Belzutifan trial for Malignant Neoplasm (NCT07700758). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07700758. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07700758.mp4 2026-10-31T21:52:50.647Z 69 yes no https://www.trianglehealth.com/phase-2/a-study-of-botensilimab-and-balstilimab-for-colorectal-cancer-wi-nct07227636 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227636.jpg Botensilimab trial for Colorectal Cancer (NCT07227636) Botensilimab trial for Colorectal Cancer (NCT07227636). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227636. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227636.mp4 2026-10-31T21:04:57.268Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-of-botensilimab-and-balstilimab-for-rectal-adenocarcinom-nct06843434 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06843434.jpg Balstilimab trial for Microsatellite Stable Rectal Carcinoma (NCT06843434) Balstilimab trial for Microsatellite Stable Rectal Carcinoma (NCT06843434). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06843434. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06843434.mp4 2026-10-31T23:59:52.102Z 95 yes no https://www.trianglehealth.com/phase-2/a-study-of-cadonilimab-combined-with-chemotherapy-in-people-with-nct07631000 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07631000.jpg Cadonilimab trial for Gastric Cancer (NCT07631000) Cadonilimab trial for Gastric Cancer (NCT07631000). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07631000. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07631000.mp4 2026-10-31T07:30:52.182Z 83 yes no https://www.trianglehealth.com/phase-2/a-study-of-combination-chemotherapy-for-patients-with-newly-diag-nct04322318 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04322318.jpg Biopsy Procedure trial for Anaplastic Kidney Wilms Tumor (NCT04322318) Biopsy Procedure trial for Anaplastic Kidney Wilms Tumor (NCT04322318). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04322318. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04322318.mp4 2026-10-31T21:42:49.055Z 82 yes no https://www.trianglehealth.com/phase-2/a-study-of-cybord-cyclophosphamide-bortezomib-dexamethasone-plus-nct06083922 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06083922.jpg Cyclophosphamide trial for Multiple Myeloma (NCT06083922) Cyclophosphamide trial for Multiple Myeloma (NCT06083922). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06083922. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06083922.mp4 2026-10-31T22:29:48.947Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-of-disitamab-vedotin-alone-or-with-pembrolizumab-in-urot-nct04879329 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04879329.jpg disitamab vedotin trial for Urothelial Carcinoma (NCT04879329) disitamab vedotin trial for Urothelial Carcinoma (NCT04879329). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04879329. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04879329.mp4 2026-10-31T21:23:44.595Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-of-emavusertib-an-approved-bruton-tyrosine-kinase-inhibi-nct07271667 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07271667.jpg Emavusertib trial for Chronic Lymphocytic Leukemia (NCT07271667) Emavusertib trial for Chronic Lymphocytic Leukemia (NCT07271667). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07271667. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07271667.mp4 2026-11-01T00:00:14.636Z 75 yes no https://www.trianglehealth.com/phase-2/a-study-of-enzalutamide-plus-the-glucocorticoid-receptor-antagon-nct05726292 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05726292.jpg Relacorilant trial for Prostate Cancer (NCT05726292) Relacorilant trial for Prostate Cancer (NCT05726292). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05726292. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05726292.mp4 2026-10-31T15:37:43.726Z 81 yes no https://www.trianglehealth.com/phase-2/a-study-of-fg-3246-in-participants-with-metastatic-castration-re-nct06842498 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06842498.jpg FG-3246 trial for Metastatic Castration-Resistant Prostate Cancer (NCT06842498) FG-3246 trial for Metastatic Castration-Resistant Prostate Cancer (NCT06842498). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06842498. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06842498.mp4 2026-10-31T22:58:19.655Z 88 yes no https://www.trianglehealth.com/phase-2/a-study-of-fianlimab-cemiplimab-and-ipilimumab-in-people-with-me-nct06594991 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06594991.jpg Fianlimab trial for Advanced Melanoma (NCT06594991) Fianlimab trial for Advanced Melanoma (NCT06594991). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06594991. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06594991.mp4 2026-10-31T16:17:27.996Z 79 yes no https://www.trianglehealth.com/phase-2/a-study-of-imlunestrant-ly3484356-in-premenopausal-women-with-es-nct07287098 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07287098.jpg Imlunestrant trial for Breast Neoplasms (NCT07287098) Imlunestrant trial for Breast Neoplasms (NCT07287098). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07287098. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07287098.mp4 2026-10-31T15:52:09.949Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-of-incb123667-in-participants-with-platinum-resistant-ov-nct07023627 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07023627.jpg INCB123667 trial for Ovarian Cancer (NCT07023627) INCB123667 trial for Ovarian Cancer (NCT07023627). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07023627. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07023627.mp4 2026-10-31T16:18:11.227Z 90 yes no https://www.trianglehealth.com/phase-2/a-study-of-investigational-agents-in-participants-with-previousl-nct06780085 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780085.jpg Raludotatug Deruxtecan trial for Carcinoma, Non-Small-Cell Lung (NCT06780085) Raludotatug Deruxtecan trial for Carcinoma, Non-Small-Cell Lung (NCT06780085). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06780085. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780085.mp4 2026-10-31T05:22:45.192Z 76 yes no https://www.trianglehealth.com/phase-2/a-study-of-ivonescimab-in-people-with-endometrial-and-cervical-c-nct06925724 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06925724.jpg Ivonescimab trial for Endometrial Cancer (NCT06925724) Ivonescimab trial for Endometrial Cancer (NCT06925724). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06925724. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06925724.mp4 2026-10-31T15:19:52.902Z 68 yes no https://www.trianglehealth.com/phase-2/a-study-of-ivonescimab-in-people-with-leiomyosarcoma-nct07516925 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07516925.jpg Ivonescimab trial for Leiomyosarcoma (NCT07516925) Ivonescimab trial for Leiomyosarcoma (NCT07516925). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07516925. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07516925.mp4 2026-10-31T06:19:54.246Z 88 yes no https://www.trianglehealth.com/phase-2/a-study-of-jnj-101556143-in-participants-with-metastatic-prostat-nct07832292 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07832292.jpg JNJ-101556143 trial for Prostatic Neoplasms (NCT07832292) JNJ-101556143 trial for Prostatic Neoplasms (NCT07832292). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07832292. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07832292.mp4 2026-10-31T06:41:23.746Z 85 yes no https://www.trianglehealth.com/phase-2/a-study-of-jnj-90301900-in-combination-with-chemoradiation-follo-nct06667908 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06667908.jpg JNJ-90301900 trial for Carcinoma, Non-Small-Cell Lung (NCT06667908) JNJ-90301900 trial for Carcinoma, Non-Small-Cell Lung (NCT06667908). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06667908. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06667908.mp4 2026-10-31T06:42:25.870Z 90 yes no https://www.trianglehealth.com/phase-2/a-study-of-jzp3507-onc206-in-recurrent-grade-2-or-3-meningioma-nct07533942 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07533942.jpg JZP3507 trial for Meningioma (NCT07533942) JZP3507 trial for Meningioma (NCT07533942). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07533942. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07533942.mp4 2026-10-31T05:24:05.571Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-of-lifileucel-tumor-infiltrating-lymphocytes-in-adults-w-nct07741877 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07741877.jpg Lifileucel trial for Sarcoma (NCT07741877) Lifileucel trial for Sarcoma (NCT07741877). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07741877. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07741877.mp4 2026-10-31T07:28:06.888Z 82 yes no https://www.trianglehealth.com/phase-2/a-study-of-lower-dose-radiation-therapy-for-people-with-prostate-nct07635238 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07635238.jpg MR-guided Stereotactic Body Radiation Therapy trial for Prostate Cancer (NCT07635238) MR-guided Stereotactic Body Radiation Therapy trial for Prostate Cancer (NCT07635238). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07635238. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07635238.mp4 2026-10-31T23:47:14.748Z 79 yes no https://www.trianglehealth.com/phase-2/a-study-of-lower-radiotherapy-dose-to-treat-children-with-cns-ge-nct06368817 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06368817.jpg 3-Dimensional Conformal Proton Radiation Therapy trial for Basal Ganglia Germinoma (NCT06368817) 3-Dimensional Conformal Proton Radiation Therapy trial for Basal Ganglia Germinoma (NCT06368817). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06368817. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06368817.mp4 2026-10-31T21:40:27.824Z 79 yes no https://www.trianglehealth.com/phase-2/a-study-of-lurbinectedin-in-combination-with-durvalumab-for-the-nct07459634 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07459634.jpg Lurbinectedin trial for Extensive-stage Small-cell Lung Cancer (NCT07459634) Lurbinectedin trial for Extensive-stage Small-cell Lung Cancer (NCT07459634). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07459634. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07459634.mp4 2026-10-31T15:57:52.674Z 72 yes no https://www.trianglehealth.com/phase-2/a-study-of-mosunetuzumab-alone-or-with-zanubrutinib-in-people-wi-nct05389293 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05389293.jpg Mosunetuzumab trial for Follicular Lymphoma (NCT05389293) Mosunetuzumab trial for Follicular Lymphoma (NCT05389293). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05389293. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05389293.mp4 2026-10-31T20:11:16.709Z 73 yes no https://www.trianglehealth.com/phase-2/a-study-of-multiple-therapies-in-biomarker-selected-participants-nct04302025 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04302025.jpg Alectinib trial for Non-small Cell Lung Cancer (NCT04302025) Alectinib trial for Non-small Cell Lung Cancer (NCT04302025). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04302025. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04302025.mp4 2026-10-31T07:10:07.019Z 96 yes no https://www.trianglehealth.com/phase-2/a-study-of-nalirifox-in-combination-with-radiation-therapy-in-pe-nct05851924 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05851924.jpg NALIRIFOX trial for Pancreatic Ductal Adenocarcinoma (NCT05851924) NALIRIFOX trial for Pancreatic Ductal Adenocarcinoma (NCT05851924). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05851924. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05851924.mp4 2026-10-31T22:30:47.344Z 85 yes no https://www.trianglehealth.com/phase-2/a-study-of-navlimetostat-bms-986504-alone-or-in-combination-with-nct06855771 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06855771.jpg BMS-986504 trial for Carcinoma, Non-Small-Cell Lung (NCT06855771) BMS-986504 trial for Carcinoma, Non-Small-Cell Lung (NCT06855771). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06855771. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06855771.mp4 2026-10-31T22:27:26.751Z 77 yes no https://www.trianglehealth.com/phase-2/a-study-of-neoadjuvant-amivantamab-with-either-lazertinib-or-che-nct07586202 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07586202.jpg Amivantamab trial for Carcinoma, Non-Small-Cell Lung (NCT07586202) Amivantamab trial for Carcinoma, Non-Small-Cell Lung (NCT07586202). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07586202. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07586202.mp4 2026-10-31T14:58:33.359Z 77 yes no https://www.trianglehealth.com/phase-2/a-study-of-novel-agents-or-combinations-as-perioperative-treatme-nct07069712 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07069712.jpg Sonesitatug Vedotin trial for Gastroesophageal Adenocarcinoma (NCT07069712) Sonesitatug Vedotin trial for Gastroesophageal Adenocarcinoma (NCT07069712). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07069712. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07069712.mp4 2026-10-31T06:21:23.841Z 91 yes no https://www.trianglehealth.com/phase-2/a-study-of-nuzefatide-pevedotin-bt5528-in-patients-with-metastat-nct07450859 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07450859.jpg nuzefatide pevedotin (BT5528) trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT07450859) nuzefatide pevedotin (BT5528) trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT07450859). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07450859. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07450859.mp4 2026-10-31T21:35:04.018Z 74 yes no https://www.trianglehealth.com/phase-2/a-study-of-nx-5948-in-adults-with-cll-sll-previously-treated-wit-nct07221500 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07221500.jpg NX-5948 trial for Chronic Lymphocytic Leukemia (CLL) (NCT07221500) NX-5948 trial for Chronic Lymphocytic Leukemia (CLL) (NCT07221500). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07221500. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07221500.mp4 2026-10-31T22:29:55.673Z 72 yes no https://www.trianglehealth.com/phase-2/a-study-of-obecabtagene-autoleucel-in-people-with-b-cell-acute-l-nct07400029 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07400029.jpg Obecabtagene Autoleucel trial for Acute Lymphoblastic Leukemia (NCT07400029) Obecabtagene Autoleucel trial for Acute Lymphoblastic Leukemia (NCT07400029). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07400029. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07400029.mp4 2026-10-31T15:16:38.889Z 80 yes no https://www.trianglehealth.com/phase-2/a-study-of-pembrolizumab-in-people-with-ultra-rare-sarcomas-nct07089992 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07089992.jpg Pembrolizumab trial for Sarcoma (NCT07089992) Pembrolizumab trial for Sarcoma (NCT07089992). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07089992. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07089992.mp4 2026-10-31T20:51:36.019Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-of-pembrolizumab-with-or-without-chemotherapy-in-combina-nct06731907 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06731907.jpg Pembrolizumab trial for Non-small Cell Lung Cancer (NCT06731907) Pembrolizumab trial for Non-small Cell Lung Cancer (NCT06731907). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06731907. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06731907.mp4 2026-10-31T06:33:39.952Z 78 yes no https://www.trianglehealth.com/phase-2/a-study-of-pembrolizumab-with-trastuzumab-and-chemotherapy-in-pe-nct06123338 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06123338.jpg Pembrolizumab trial for Esophageal Cancer (NCT06123338) Pembrolizumab trial for Esophageal Cancer (NCT06123338). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06123338. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06123338.mp4 2026-10-31T07:05:01.503Z 85 yes no https://www.trianglehealth.com/phase-2/a-study-of-pirtobrutinib-venetoclax-and-rituximab-in-people-with-nct07231952 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07231952.jpg Pirtobrutinib trial for Waldenstrom Macroglobulinemia (NCT07231952) Pirtobrutinib trial for Waldenstrom Macroglobulinemia (NCT07231952). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07231952. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07231952.mp4 2026-10-31T20:58:44.809Z 89 yes no https://www.trianglehealth.com/phase-2/a-study-of-response-adapted-ultra-low-dose-4-gy-radiation-for-de-nct05929612 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05929612.jpg Ultra Low Dose 4 Gy Radiation trial for Lymphoma (NCT05929612) Ultra Low Dose 4 Gy Radiation trial for Lymphoma (NCT05929612). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05929612. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05929612.mp4 2026-10-31T21:42:48.022Z 78 yes no https://www.trianglehealth.com/phase-2/a-study-of-sacituzumab-govitecan-immu-132-in-patients-with-recur-nct05838521 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05838521.jpg Sacituzumab govitecan trial for Cervical Cancer (NCT05838521) Sacituzumab govitecan trial for Cervical Cancer (NCT05838521). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05838521. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05838521.mp4 2026-10-31T21:07:08.614Z 77 yes no https://www.trianglehealth.com/phase-2/a-study-of-sasanlimab-palbociclib-and-axitinib-in-metastatic-ren-nct07123090 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07123090.jpg Sasanlimab trial for Metastatic Renal Cell Carcinoma (NCT07123090) Sasanlimab trial for Metastatic Renal Cell Carcinoma (NCT07123090). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07123090. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07123090.mp4 2026-10-31T21:46:58.805Z 80 yes no https://www.trianglehealth.com/phase-2/a-study-of-sdx-7320-in-combination-with-eribulin-for-people-with-nct05570253 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05570253.jpg Eribulin trial for Breast Cancer (NCT05570253) Eribulin trial for Breast Cancer (NCT05570253). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05570253. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05570253.mp4 2026-10-31T18:14:07.651Z 85 yes no https://www.trianglehealth.com/phase-2/a-study-of-selinexor-in-combination-with-carfilzomib-daratumumab-nct04661137 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04661137.jpg Selinexor 60 MG trial for Multiple Myeloma (NCT04661137) Selinexor 60 MG trial for Multiple Myeloma (NCT04661137). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04661137. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04661137.mp4 2026-10-31T21:33:57.619Z 75 yes no https://www.trianglehealth.com/phase-2/a-study-of-selinexor-in-people-with-wilms-tumors-and-other-solid-nct05985161 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05985161.jpg Selinexor trial for Wilms Tumor (NCT05985161) Selinexor trial for Wilms Tumor (NCT05985161). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05985161. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05985161.mp4 2026-10-31T21:56:39.974Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-of-sotorasib-in-people-with-non-small-cell-lung-cancer-nct06582771 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06582771.jpg Sotorasib trial for Non Small Lung Cancer (NCT06582771) Sotorasib trial for Non Small Lung Cancer (NCT06582771). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06582771. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06582771.mp4 2026-10-31T22:41:37.625Z 80 yes no https://www.trianglehealth.com/phase-2/a-study-of-stereotactic-radiosurgery-srs-and-standard-treatment-nct06741085 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06741085.jpg osimertinib trial for Non Small Cell Lung Cancer Metastatic (NCT06741085) osimertinib trial for Non Small Cell Lung Cancer Metastatic (NCT06741085). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06741085. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06741085.mp4 2026-10-31T05:20:09.318Z 78 yes no https://www.trianglehealth.com/phase-2/a-study-of-stereotactic-radiosurgery-srs-for-people-with-lung-ca-nct05419076 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05419076.jpg Stereotactic Radiosurgery trial for Lung Cancer (NCT05419076) Stereotactic Radiosurgery trial for Lung Cancer (NCT05419076). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05419076. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05419076.mp4 2026-11-01T00:08:15.854Z 81 yes no https://www.trianglehealth.com/phase-2/a-study-of-sync-t-therapy-sv-102-in-participants-with-metastatic-nct06533644 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533644.jpg Partial Oncolysis trial for Metastatic Castration-resistant Prostate Cancer (NCT06533644) Partial Oncolysis trial for Metastatic Castration-resistant Prostate Cancer (NCT06533644). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06533644. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533644.mp4 2026-10-31T22:57:09.771Z 76 yes no https://www.trianglehealth.com/phase-2/a-study-of-t3011-in-patients-with-bcg-unresponsive-nmibc-or-bcg-nct06971614 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06971614.jpg T3011 trial for Nonmuscle-invasive Bladder Cancer (NCT06971614) T3011 trial for Nonmuscle-invasive Bladder Cancer (NCT06971614). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06971614. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06971614.mp4 2026-10-31T22:54:02.157Z 79 yes no https://www.trianglehealth.com/phase-2/a-study-of-talazoparib-with-or-without-enzalutamide-in-people-wi-nct06844383 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06844383.jpg Talazoparib with enzalutamide trial for Prostate Cancer (Adenocarcinoma) (NCT06844383) Talazoparib with enzalutamide trial for Prostate Cancer (Adenocarcinoma) (NCT06844383). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06844383. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06844383.mp4 2026-10-31T22:44:29.566Z 86 yes no https://www.trianglehealth.com/phase-2/a-study-of-talquetamab-in-participants-with-relapsed-or-refracto-nct04634552 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04634552.jpg Talquetamab trial for Hematological Malignancies (NCT04634552) Talquetamab trial for Hematological Malignancies (NCT04634552). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04634552. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04634552.mp4 2026-10-31T15:48:44.618Z 78 yes no https://www.trianglehealth.com/phase-2/a-study-of-targeted-post-surgery-radiation-therapy-for-non-small-nct07293247 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07293247.jpg Chemotherapy trial for Lung Non-Small Cell Carcinoma (NCT07293247) Chemotherapy trial for Lung Non-Small Cell Carcinoma (NCT07293247). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07293247. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07293247.mp4 2026-10-31T22:09:57.117Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-of-tarlatamab-for-people-with-prostate-cancer-nct07111507 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07111507.jpg Tarlatamab trial for Metastatic Prostate Cancer (NCT07111507) Tarlatamab trial for Metastatic Prostate Cancer (NCT07111507). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07111507. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07111507.mp4 2026-10-31T15:21:04.395Z 72 yes no https://www.trianglehealth.com/phase-2/a-study-of-trk-950-when-used-in-combination-with-ramucirumab-and-nct06038578 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06038578.jpg TRK-950 trial for Gastric Adenocarcinoma (NCT06038578) TRK-950 trial for Gastric Adenocarcinoma (NCT06038578). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06038578. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06038578.mp4 2026-10-31T07:43:29.907Z 89 yes no https://www.trianglehealth.com/phase-2/a-study-of-venetoclax-in-combination-with-conventional-chemother-nct05955261 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05955261.jpg Venetoclax trial for Acute Myeloid Leukemia (NCT05955261) Venetoclax trial for Acute Myeloid Leukemia (NCT05955261). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05955261. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05955261.mp4 2026-10-31T22:30:24.336Z 87 yes no https://www.trianglehealth.com/phase-2/a-study-of-zanzalintinib-in-participants-with-recurrent-or-progr-nct07428616 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07428616.jpg Zanzalintinib trial for Meningioma (NCT07428616) Zanzalintinib trial for Meningioma (NCT07428616). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07428616. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07428616.mp4 2026-10-31T05:27:49.609Z 60 yes no https://www.trianglehealth.com/phase-2/a-study-of-zen003694-in-people-with-squamous-cell-lung-cancer-nct05607108 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05607108.jpg ZEN003694 trial for Squamous Cell Lung Cancer (NCT05607108) ZEN003694 trial for Squamous Cell Lung Cancer (NCT05607108). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05607108. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05607108.mp4 2026-10-31T21:03:24.253Z 83 yes no https://www.trianglehealth.com/phase-2/a-study-testing-the-combination-of-dasatinib-or-imatinib-to-chem-nct06124157 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06124157.jpg Biospecimen Collection trial for B Acute Lymphoblastic Leukemia (NCT06124157) Biospecimen Collection trial for B Acute Lymphoblastic Leukemia (NCT06124157). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06124157. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06124157.mp4 2026-10-31T15:53:26.391Z 89 yes no https://www.trianglehealth.com/phase-2/a-study-to-assess-adverse-events-and-change-in-disease-activity-nct07023289 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07023289.jpg Telisotuzumab Adizutecan trial for Colorectal Cancer (NCT07023289) Telisotuzumab Adizutecan trial for Colorectal Cancer (NCT07023289). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07023289. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07023289.mp4 2026-10-31T06:41:45.185Z 75 yes no https://www.trianglehealth.com/phase-2/a-study-to-assess-adverse-events-and-change-in-disease-activity-nct07059845 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07059845.jpg Mirvetuximab Soravtansine trial for Ovarian Cancer (NCT07059845) Mirvetuximab Soravtansine trial for Ovarian Cancer (NCT07059845). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07059845. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07059845.mp4 2026-10-31T15:03:02.959Z 95 yes no https://www.trianglehealth.com/phase-2/a-study-to-assess-adverse-events-and-how-intravenously-iv-infuse-nct06568939 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06568939.jpg Telisotuzumab Vedotin trial for Non-Small Cell Lung Cancer (NCT06568939) Telisotuzumab Vedotin trial for Non-Small Cell Lung Cancer (NCT06568939). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06568939. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06568939.mp4 2026-10-31T06:29:23.651Z 81 yes no https://www.trianglehealth.com/phase-2/a-study-to-assess-adverse-events-change-in-disease-activity-and-nct07744126 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07744126.jpg Telisotuzumab Adizutecan trial for Head and Neck Squamous Cell Carcinoma (NCT07744126) Telisotuzumab Adizutecan trial for Head and Neck Squamous Cell Carcinoma (NCT07744126). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07744126. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07744126.mp4 2026-10-31T05:32:05.058Z 76 yes no https://www.trianglehealth.com/phase-2/a-study-to-assess-anti-tumor-activity-of-intravenously-iv-infuse-nct06890338 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06890338.jpg Carboplatin trial for Epithelial Ovarian Cancer (NCT06890338) Carboplatin trial for Epithelial Ovarian Cancer (NCT06890338). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06890338. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06890338.mp4 2026-10-31T22:04:16.575Z 82 yes no https://www.trianglehealth.com/phase-2/a-study-to-assess-the-efficacy-and-safety-of-fore8394-in-partici-nct05503797 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05503797.jpg Plixorafenib trial for Cancer Harboring BRAF Alterations (NCT05503797) Plixorafenib trial for Cancer Harboring BRAF Alterations (NCT05503797). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05503797. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05503797.mp4 2026-10-31T21:07:41.462Z 82 yes no https://www.trianglehealth.com/phase-2/a-study-to-compare-the-administration-of-encorafenib-binimetinib-nct04511013 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04511013.jpg Binimetinib trial for Acral Lentiginous Melanoma (NCT04511013) Binimetinib trial for Acral Lentiginous Melanoma (NCT04511013). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04511013. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04511013.mp4 2026-10-31T16:42:00.880Z 87 yes no https://www.trianglehealth.com/phase-2/a-study-to-estimate-early-clinical-efficacy-signals-of-glp-1-ago-nct07107334 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07107334.jpg Glucagon-like peptide 1 receptor agonist trial for Endometrioid Endometrial… (NCT07107334) Glucagon-like peptide 1 receptor agonist trial for Endometrioid Endometrial Adenocarcinoma (NCT07107334). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07107334. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07107334.mp4 2026-10-31T21:16:33.335Z 74 yes no https://www.trianglehealth.com/phase-2/a-study-to-evaluate-efficacy-and-safety-of-ciltacabtagene-autole-nct07149857 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07149857.jpg Cilta-cel trial for Multiple Myeloma (NCT07149857) Cilta-cel trial for Multiple Myeloma (NCT07149857). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07149857. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07149857.mp4 2026-10-31T07:06:43.835Z 83 yes no https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-adverse-events-and-efficacy-of-intraveno-nct06820463 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06820463.jpg Telisotuzumab Adizutecan trial for Metastatic Colorectal Cancer (NCT06820463) Telisotuzumab Adizutecan trial for Metastatic Colorectal Cancer (NCT06820463). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06820463. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06820463.mp4 2026-10-31T05:22:23.406Z 76 yes no https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-efficacy-and-safety-of-belantamab-mafodo-nct07227311 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227311.jpg Belantamab mafodotin trial for Multiple Myeloma (NCT07227311) Belantamab mafodotin trial for Multiple Myeloma (NCT07227311). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227311. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227311.mp4 2026-10-31T21:38:02.357Z 78 yes no https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-efficacy-and-safety-of-tl118-in-solid-tu-nct06010342 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06010342.jpg TL118 Capsule trial for Solid Tumor (NCT06010342) TL118 Capsule trial for Solid Tumor (NCT06010342). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06010342. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06010342.mp4 2026-10-31T05:23:14.629Z 82 yes no https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-efficacy-of-cemsidomide-dexamethasone-in-nct07284758 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07284758.jpg Cemsidomide trial for Multiple Myeloma (NCT07284758) Cemsidomide trial for Multiple Myeloma (NCT07284758). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07284758. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07284758.mp4 2026-10-31T20:15:37.256Z 83 yes no https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-optimal-dose-adverse-events-and-change-i-nct07155174 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07155174.jpg ABBV-706 trial for Small Cell Lung Cancer (NCT07155174) ABBV-706 trial for Small Cell Lung Cancer (NCT07155174). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07155174. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07155174.mp4 2026-10-31T05:34:00.004Z 80 yes no https://www.trianglehealth.com/phase-2/a-study-to-evaluate-the-safety-and-efficacy-of-two-dose-levels-o-nct06948448 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06948448.jpg ONO-4578 trial for Colorectal Cancer (NCT06948448) ONO-4578 trial for Colorectal Cancer (NCT06948448). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06948448. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06948448.mp4 2026-10-31T21:38:49.829Z 96 yes no https://www.trianglehealth.com/phase-2/a-study-to-find-out-if-enfortumab-vedotin-given-with-pembrolizum-nct07475806 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07475806.jpg Enfortumab Vedotin trial for Muscle-invasive Bladder Cancer (NCT07475806) Enfortumab Vedotin trial for Muscle-invasive Bladder Cancer (NCT07475806). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07475806. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07475806.mp4 2026-10-31T06:27:57.618Z 83 yes no https://www.trianglehealth.com/phase-2/a-study-to-give-treatment-inside-the-eye-to-treat-retinoblastoma-nct05504291 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05504291.jpg Biospecimen Collection trial for Bilateral Retinoblastoma (NCT05504291) Biospecimen Collection trial for Bilateral Retinoblastoma (NCT05504291). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05504291. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05504291.mp4 2026-10-31T21:40:59.283Z 77 yes no https://www.trianglehealth.com/phase-2/a-study-to-investigate-ubamatamab-with-and-without-marlotamig-re-nct07154290 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07154290.jpg Ubamatamab trial for Non Small Cell Lung Cancer (NCT07154290) Ubamatamab trial for Non Small Cell Lung Cancer (NCT07154290). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07154290. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07154290.mp4 2026-10-31T06:21:11.456Z 77 yes no https://www.trianglehealth.com/phase-2/a-study-to-learn-more-about-how-well-treatment-with-sevabertinib-nct06760819 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06760819.jpg BAY2927088 trial for Advanced Solid Tumors (NCT06760819) BAY2927088 trial for Advanced Solid Tumors (NCT06760819). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06760819. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06760819.mp4 2026-10-31T15:48:41.932Z 73 yes no https://www.trianglehealth.com/phase-2/a-study-to-see-if-giving-fianlimab-and-cemiplimab-together-is-be-nct06769698 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06769698.jpg FDC fianlimab+cemiplimab trial for Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT06769698) FDC fianlimab+cemiplimab trial for Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT06769698). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06769698. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06769698.mp4 2026-10-31T06:22:21.323Z 91 yes no https://www.trianglehealth.com/phase-2/a-study-to-test-dsp107-in-combination-with-atezolizumab-in-compa-nct07235293 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07235293.jpg DSP107 + Atezolizumab trial for Colorectal Cancer (NCT07235293) DSP107 + Atezolizumab trial for Colorectal Cancer (NCT07235293). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07235293. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07235293.mp4 2026-10-31T15:21:31.312Z 84 yes no https://www.trianglehealth.com/phase-2/a-study-to-test-inavolisib-treatments-in-participants-with-early-nct07054190 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07054190.jpg Inavolisib trial for Breast Cancer (NCT07054190) Inavolisib trial for Breast Cancer (NCT07054190). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07054190. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07054190.mp4 2026-10-31T06:28:43.562Z 72 yes no https://www.trianglehealth.com/phase-2/a-study-using-nivolumab-in-combination-with-chemotherapy-drugs-t-nct06064097 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06064097.jpg Biopsy Procedure trial for Stage II Nasopharyngeal Carcinoma AJCC v8 (NCT06064097) Biopsy Procedure trial for Stage II Nasopharyngeal Carcinoma AJCC v8 (NCT06064097). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06064097. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06064097.mp4 2026-10-31T22:18:24.653Z 87 yes no https://www.trianglehealth.com/phase-2/a-trial-evaluating-the-efficacy-of-ivonescimab-in-metastatic-end-nct07229417 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07229417.jpg Ivonescimab trial for Metastatic Endocrine Refractory (NCT07229417) Ivonescimab trial for Metastatic Endocrine Refractory (NCT07229417). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07229417. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07229417.mp4 2026-10-31T20:49:34.341Z 90 yes no https://www.trianglehealth.com/phase-2/a-trial-of-durvalumab-medi4736-plus-monalizumab-in-non-muscle-in-nct06503614 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06503614.jpg Durvalumab trial for Non-muscle Invasive Bladder Cancer (NCT06503614) Durvalumab trial for Non-muscle Invasive Bladder Cancer (NCT06503614). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06503614. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06503614.mp4 2026-10-31T06:45:45.736Z 80 yes no https://www.trianglehealth.com/phase-2/a-ugt1a1-genotype-directed-study-of-belinostat-pharmacokinetics-nct06406465 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06406465.jpg Belinostat trial for Carcinoma, Neuroendocrine (NCT06406465) Belinostat trial for Carcinoma, Neuroendocrine (NCT06406465). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06406465. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06406465.mp4 2026-10-31T05:26:22.983Z 73 yes no https://www.trianglehealth.com/phase-2/abemaciclib-for-bone-and-soft-tissue-sarcoma-with-cyclin-depende-nct04040205 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04040205.jpg Abemaciclib trial for Chondrosarcoma (NCT04040205) Abemaciclib trial for Chondrosarcoma (NCT04040205). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04040205. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04040205.mp4 2026-10-31T21:02:13.255Z 89 yes no https://www.trianglehealth.com/phase-2/abemaciclib-for-the-treatment-of-recurrent-ovarian-or-endometria-nct04469764 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04469764.jpg Abemaciclib trial for Recurrent Endometrial Carcinoma (NCT04469764) Abemaciclib trial for Recurrent Endometrial Carcinoma (NCT04469764). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04469764. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04469764.mp4 2026-10-31T21:34:37.404Z 87 yes no https://www.trianglehealth.com/phase-2/abi-pred-adt-vs-adt-in-psma-positive-conventionally-node-negativ-nct07237269 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07237269.jpg Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT07237269) Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT07237269). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07237269. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07237269.mp4 2026-10-31T22:10:29.225Z 76 yes no https://www.trianglehealth.com/phase-2/abiraterone-enzalutamide-or-apalutamide-in-castrate-sensitive-pr-nct05422911 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05422911.jpg Abiraterone acetate trial for Metastatic Cancer (NCT05422911) Abiraterone acetate trial for Metastatic Cancer (NCT05422911). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05422911. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05422911.mp4 2026-11-01T00:00:24.359Z 79 yes no https://www.trianglehealth.com/phase-2/acalabrutinib-in-combination-with-venetoclax-for-the-treatment-o-nct04941716 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04941716.jpg Acalabrutinib trial for Recurrent Chronic Lymphocytic Leukemia (NCT04941716) Acalabrutinib trial for Recurrent Chronic Lymphocytic Leukemia (NCT04941716). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04941716. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04941716.mp4 2026-10-31T21:59:12.631Z 83 yes no https://www.trianglehealth.com/phase-2/acalabrutinib-lenalidomide-and-rituximab-for-the-treatment-of-cd-nct04404088 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04404088.jpg Acalabrutinib trial for Ann Arbor Stage III Grade 1 Follicular Lymphoma (NCT04404088) Acalabrutinib trial for Ann Arbor Stage III Grade 1 Follicular Lymphoma (NCT04404088). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04404088. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04404088.mp4 2026-10-31T06:41:06.582Z 78 yes no https://www.trianglehealth.com/phase-2/acalabrutinib-with-da-epoch-r-or-r-chop-for-people-with-untreate-nct04002947 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04002947.jpg DA-EPOCH trial for Non-Hodgkin's Lymphoma (NCT04002947) DA-EPOCH trial for Non-Hodgkin's Lymphoma (NCT04002947). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04002947. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04002947.mp4 2026-10-31T21:14:44.321Z 77 yes no https://www.trianglehealth.com/phase-2/acalabrutinib-with-or-without-obinutuzumab-in-treating-patients-nct03516617 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03516617.jpg Acalabrutinib trial for Chronic Lymphocytic Leukemia (NCT03516617) Acalabrutinib trial for Chronic Lymphocytic Leukemia (NCT03516617). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03516617. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03516617.mp4 2026-10-31T21:15:05.770Z 70 yes no https://www.trianglehealth.com/phase-2/acoustic-cluster-therapy-act-with-chemotherapy-for-the-treatment-nct06850623 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06850623.jpg Acoustic Cluster Therapy trial for Locally Advanced Pancreatic Adenocarcinoma (NCT06850623) Acoustic Cluster Therapy trial for Locally Advanced Pancreatic Adenocarcinoma (NCT06850623). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06850623. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06850623.mp4 2026-10-31T06:47:32.111Z 75 yes no https://www.trianglehealth.com/phase-2/act001-for-the-treatment-of-diffuse-intrinsic-pontine-gliomas-an-nct06838676 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06838676.jpg ACT001 trial for Diffuse Intrinsic Pontine Gliomas (DIPG) (NCT06838676) ACT001 trial for Diffuse Intrinsic Pontine Gliomas (DIPG) (NCT06838676). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06838676. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06838676.mp4 2026-10-31T21:55:19.540Z 79 yes no https://www.trianglehealth.com/phase-2/ad-hoc-trial-artificial-intelligence-based-drug-dosing-in-hepato-nct05669339 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05669339.jpg Irinotecan trial for Hepatocellular Carcinoma (NCT05669339) Irinotecan trial for Hepatocellular Carcinoma (NCT05669339). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05669339. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05669339.mp4 2026-10-31T22:04:49.249Z 73 yes no https://www.trianglehealth.com/phase-2/adaptive-dosing-of-immune-checkpoint-inhibitors-for-hepatocellul-nct07689175 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07689175.jpg Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07689175) Nivolumab trial for Hepatocellular Carcinoma (HCC) (NCT07689175). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07689175. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07689175.mp4 2026-10-31T21:10:12.634Z 79 yes no https://www.trianglehealth.com/phase-2/adaptive-therapy-with-capecitabine-for-treatment-of-metastatic-e-nct06525766 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06525766.jpg Biospecimen Collection trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT06525766) Biospecimen Collection trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT06525766). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06525766. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06525766.mp4 2026-10-31T23:01:50.837Z 77 yes no https://www.trianglehealth.com/phase-2/adding-a-live-biotherapeutic-product-cbm588-to-pembrolizumab-for-nct07037004 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07037004.jpg Biospecimen Collection trial for Clear Cell Renal Cell Carcinoma (NCT07037004) Biospecimen Collection trial for Clear Cell Renal Cell Carcinoma (NCT07037004). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07037004. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07037004.mp4 2026-10-31T22:11:43.045Z 80 yes no https://www.trianglehealth.com/phase-2/adding-dasatinib-or-venetoclax-to-improve-responses-in-children-nct06390319 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06390319.jpg Dexamethasone trial for T-cell Acute Lymphoblastic Leukemia (NCT06390319) Dexamethasone trial for T-cell Acute Lymphoblastic Leukemia (NCT06390319). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06390319. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06390319.mp4 2026-10-31T20:08:51.443Z 79 yes no https://www.trianglehealth.com/phase-2/addition-of-antibiotics-to-upfront-treatment-regimen-for-colorec-nct06728072 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06728072.jpg Standard of Care Chemotherapy + Metronidazole, ciprofloxacin, aspirin trial for… (NCT06728072) Standard of Care Chemotherapy + Metronidazole, ciprofloxacin, aspirin trial for Colorectal Cancer (NCT06728072). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06728072. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06728072.mp4 2026-10-31T22:54:48.293Z 78 yes no https://www.trianglehealth.com/phase-2/adjuvant-chemotherapy-and-immunotherapy-for-completely-resected-nct07149363 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07149363.jpg Durvalumab 50 MG/ML trial for Small Cell Lung Cancer (SCLC) (NCT07149363) Durvalumab 50 MG/ML trial for Small Cell Lung Cancer (SCLC) (NCT07149363). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07149363. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07149363.mp4 2026-10-31T16:45:51.027Z 86 yes no https://www.trianglehealth.com/phase-2/adjuvant-ip-001-treatment-for-hcc-patients-following-surgical-re-nct06526338 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526338.jpg 1.0% IP-001 for injection trial for Hepatocellular Carcinoma (NCT06526338) 1.0% IP-001 for injection trial for Hepatocellular Carcinoma (NCT06526338). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06526338. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526338.mp4 2026-10-31T19:38:34.290Z 71 yes no https://www.trianglehealth.com/phase-2/adjuvant-quisinostat-in-high-risk-uveal-melanoma-nct06932757 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06932757.jpg Quisinostat trial for Uveal Melanoma (NCT06932757) Quisinostat trial for Uveal Melanoma (NCT06932757). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06932757. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06932757.mp4 2026-10-31T23:47:06.423Z 72 yes no https://www.trianglehealth.com/phase-2/administration-of-autologous-t-cells-genetically-engineered-to-e-nct03412877 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03412877.jpg Cyclophosphamide trial for Endocrine Tumors (NCT03412877) Cyclophosphamide trial for Endocrine Tumors (NCT03412877). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03412877. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03412877.mp4 2026-10-31T16:01:27.469Z 83 yes no https://www.trianglehealth.com/phase-2/all-backbone-in-ayas-nct07227584 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227584.jpg Blinatumomab trial for Acute Lymphoblastic Leukemia (NCT07227584) Blinatumomab trial for Acute Lymphoblastic Leukemia (NCT07227584). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227584. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227584.mp4 2026-10-31T22:57:28.109Z 87 yes no https://www.trianglehealth.com/phase-2/allo-hsct-using-ric-and-ptcy-for-hematological-diseases-nct05805605 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05805605.jpg Peripheral Blood Stem Cell Transplant trial for Acute Myelogenous Leukemia (NCT05805605) Peripheral Blood Stem Cell Transplant trial for Acute Myelogenous Leukemia (NCT05805605). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05805605. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05805605.mp4 2026-10-31T22:26:23.145Z 92 yes no https://www.trianglehealth.com/phase-2/allosct-for-malignant-and-non-malignant-hematologic-diseases-uti-nct04099966 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04099966.jpg alpha beta depletion trial for Acute Leukemia (NCT04099966) alpha beta depletion trial for Acute Leukemia (NCT04099966). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04099966. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04099966.mp4 2026-10-31T22:01:30.606Z 74 yes no https://www.trianglehealth.com/phase-2/alternate-doses-and-dosing-schedules-of-belantamab-mafodotin-for-nct05847569 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05847569.jpg Belantamab Mafodotin trial for Recurrent Multiple Myeloma (NCT05847569) Belantamab Mafodotin trial for Recurrent Multiple Myeloma (NCT05847569). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05847569. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05847569.mp4 2026-10-31T22:06:52.112Z 77 yes no https://www.trianglehealth.com/phase-2/alternating-chemo-immunotherapy-and-fgfr-inhibitor-for-fgfr-posi-nct07780838 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07780838.jpg Biospecimen Collection trial for Locally Advanced Ampulla of Vater Carcinoma (NCT07780838) Biospecimen Collection trial for Locally Advanced Ampulla of Vater Carcinoma (NCT07780838). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07780838. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07780838.mp4 2026-10-31T15:29:16.305Z 88 yes no https://www.trianglehealth.com/phase-2/an-adjuvant-study-to-evaluate-sms001-paclitaxel-in-non-small-cel-nct06693336 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06693336.jpg SMS001 trial for Carcinoma, Non-Small-Cell Lung Cancer (NSCLC) (NCT06693336) SMS001 trial for Carcinoma, Non-Small-Cell Lung Cancer (NSCLC) (NCT06693336). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06693336. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06693336.mp4 2026-10-31T21:00:35.455Z 79 yes no https://www.trianglehealth.com/phase-2/an-evaluation-of-maintenance-therapy-combination-mirvetuximab-so-nct05887609 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05887609.jpg Mirvetuximab Soravtansine-gynx trial for Ovary Cancer (NCT05887609) Mirvetuximab Soravtansine-gynx trial for Ovary Cancer (NCT05887609). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05887609. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05887609.mp4 2026-10-31T22:14:58.419Z 82 yes no https://www.trianglehealth.com/phase-2/androgen-ablation-therapy-with-or-without-niraparib-after-radiat-nct04947254 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04947254.jpg Abiraterone Acetate trial for Prostate Carcinoma (NCT04947254) Abiraterone Acetate trial for Prostate Carcinoma (NCT04947254). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04947254. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04947254.mp4 2026-10-31T23:02:19.057Z 86 yes no https://www.trianglehealth.com/phase-2/anti-pd-1-mab-plus-metabolic-modulator-in-solid-tumor-malignanci-nct04114136 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04114136.jpg Nivolumab or Pembrolizumab (dependent upon approved indication) trial for Melanoma (NCT04114136) Nivolumab or Pembrolizumab (dependent upon approved indication) trial for Melanoma (NCT04114136). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04114136. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04114136.mp4 2026-10-31T23:02:55.305Z 76 yes no https://www.trianglehealth.com/phase-2/apollo-a-randomized-phase-ii-double-blind-study-of-olaparib-vers-nct04858334 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04858334.jpg Biospecimen Collection trial for Pancreatic Acinar Cell Carcinoma (NCT04858334) Biospecimen Collection trial for Pancreatic Acinar Cell Carcinoma (NCT04858334). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04858334. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04858334.mp4 2026-10-31T20:50:35.027Z 85 yes no https://www.trianglehealth.com/phase-2/asparaginase-erwinia-chrysanthemi-with-chemotherapy-for-the-trea-nct06918431 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06918431.jpg Asparaginase Erwinia chrysanthemi trial for B Acute Lymphoblastic Leukemia,… (NCT06918431) Asparaginase Erwinia chrysanthemi trial for B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative (NCT06918431). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06918431. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06918431.mp4 2026-10-31T06:46:22.147Z 79 yes no https://www.trianglehealth.com/phase-2/aspen-09-03-a-study-of-evorpacept-in-combination-with-trastuzuma-nct07007559 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07007559.jpg Evorpacept (ALX148) trial for Breast Cancer, Metastatic (NCT07007559) Evorpacept (ALX148) trial for Breast Cancer, Metastatic (NCT07007559). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07007559. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07007559.mp4 2026-10-31T07:11:14.680Z 81 yes no https://www.trianglehealth.com/phase-2/assessment-of-decision-tool-to-select-women-for-gynecologic-spar-nct06184516 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06184516.jpg Reproductive organ sparing radical cystectomy trial for Urothelial Carcinoma Bladder (NCT06184516) Reproductive organ sparing radical cystectomy trial for Urothelial Carcinoma Bladder (NCT06184516). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06184516. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06184516.mp4 2026-10-31T17:57:11.414Z 72 yes no https://www.trianglehealth.com/phase-2/atempt-2-0-adjuvant-t-dm1-vs-th-nct04893109 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04893109.jpg trastuzumab-emtansine trial for Breast Cancer (NCT04893109) trastuzumab-emtansine trial for Breast Cancer (NCT04893109). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04893109. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04893109.mp4 2026-10-31T22:50:51.820Z 82 yes no https://www.trianglehealth.com/phase-2/atezolizumab-and-cabozantinib-for-the-treatment-of-adolescents-a-nct05019703 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05019703.jpg Atezolizumab trial for Locally Advanced Osteosarcoma (NCT05019703) Atezolizumab trial for Locally Advanced Osteosarcoma (NCT05019703). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05019703. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05019703.mp4 2026-10-31T06:43:35.593Z 87 yes no https://www.trianglehealth.com/phase-2/atezolizumab-in-combination-with-a-multi-kinase-inhibitor-for-th-nct05168163 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05168163.jpg Atezolizumab trial for Locally Advanced Hepatocellular Carcinoma (NCT05168163) Atezolizumab trial for Locally Advanced Hepatocellular Carcinoma (NCT05168163). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05168163. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05168163.mp4 2026-10-31T20:37:20.192Z 83 yes no https://www.trianglehealth.com/phase-2/atezolizumab-plus-etoposide-and-platinum-in-small-cell-bladder-c-nct05312671 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05312671.jpg Atezolizumab trial for Small Cell Neuroendocrine Carcinoma of Bladder (NCT05312671) Atezolizumab trial for Small Cell Neuroendocrine Carcinoma of Bladder (NCT05312671). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05312671. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05312671.mp4 2026-10-31T22:49:23.425Z 82 yes no https://www.trianglehealth.com/phase-2/autologous-ln-145-in-patients-with-metastatic-non-small-cell-lun-nct04614103 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04614103.jpg LN-145 trial for Metastatic Non Small Cell Lung Cancer (NCT04614103) LN-145 trial for Metastatic Non Small Cell Lung Cancer (NCT04614103). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04614103. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04614103.mp4 2026-10-31T22:48:14.401Z 88 yes no https://www.trianglehealth.com/phase-2/azacitidine-and-enasidenib-in-treating-patients-with-idh2-mutant-nct03383575 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03383575.jpg Azacitidine trial for Acute Myeloid Leukemia (NCT03383575) Azacitidine trial for Acute Myeloid Leukemia (NCT03383575). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03383575. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03383575.mp4 2026-10-31T19:47:10.318Z 82 yes no https://www.trianglehealth.com/phase-2/azd0901-in-participants-with-advanced-solid-tumours-expressing-c-nct06219941 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06219941.jpg AZD0901 trial for Gastric Cancer (NCT06219941) AZD0901 trial for Gastric Cancer (NCT06219941). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06219941. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06219941.mp4 2026-10-31T21:30:37.508Z 88 yes no https://www.trianglehealth.com/phase-2/bal-bot-agent-797-in-pmmr-crc-with-liver-metastases-nct07550088 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07550088.jpg Balstilimab (BAL) trial for Colorectal Cancer Metastatic (NCT07550088) Balstilimab (BAL) trial for Colorectal Cancer Metastatic (NCT07550088). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07550088. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07550088.mp4 2026-10-31T20:05:34.541Z 83 yes no https://www.trianglehealth.com/phase-2/belantamab-mafodotin-pomalidomide-and-dexamethasone-for-the-trea-nct05208307 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05208307.jpg Belantamab Mafodotin trial for Plasma Cell Myeloma (NCT05208307) Belantamab Mafodotin trial for Plasma Cell Myeloma (NCT05208307). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05208307. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05208307.mp4 2026-10-31T19:55:09.455Z 75 yes no https://www.trianglehealth.com/phase-2/belzutifan-mk-6482-for-the-treatment-of-advanced-pheochromocytom-nct04924075 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04924075.jpg Belzutifan trial for Pheochromocytoma/Paraganglioma (NCT04924075) Belzutifan trial for Pheochromocytoma/Paraganglioma (NCT04924075). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04924075. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04924075.mp4 2026-10-31T15:55:32.999Z 89 yes no https://www.trianglehealth.com/phase-2/bicazo-a-study-combining-two-immunotherapies-cabozantinib-and-ni-nct05136196 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05136196.jpg Biopsy Procedure trial for Clinical Stage III Cutaneous Melanoma AJCC v8 (NCT05136196) Biopsy Procedure trial for Clinical Stage III Cutaneous Melanoma AJCC v8 (NCT05136196). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05136196. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05136196.mp4 2026-10-31T05:27:10.043Z 84 yes no https://www.trianglehealth.com/phase-2/binimetinib-and-imatinib-for-unresectable-stage-iii-iv-kit-mutan-nct04598009 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04598009.jpg Binimetinib trial for Melanoma Stage III (NCT04598009) Binimetinib trial for Melanoma Stage III (NCT04598009). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04598009. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04598009.mp4 2026-10-31T16:35:49.336Z 79 yes no https://www.trianglehealth.com/phase-2/binimetinib-for-people-with-relapsed-refractory-braf-wild-type-h-nct04322383 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04322383.jpg binimetinib trial for Hairy Cell Leukemia (NCT04322383) binimetinib trial for Hairy Cell Leukemia (NCT04322383). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04322383. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04322383.mp4 2026-10-31T15:04:33.178Z 72 yes no https://www.trianglehealth.com/phase-2/biologically-guided-radiation-therapy-bgrt-and-stereotactic-body-nct06014827 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06014827.jpg Biospecimen Collection trial for Lung Non-Small Cell Carcinoma (NCT06014827) Biospecimen Collection trial for Lung Non-Small Cell Carcinoma (NCT06014827). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06014827. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06014827.mp4 2026-10-31T05:29:01.289Z 80 yes no https://www.trianglehealth.com/phase-2/bladder-preservation-for-patients-with-muscle-invasive-bladder-c-nct06417190 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06417190.jpg Trimodal therapy (TMT) within 45 days of neoadjuvant chemotherapy (NAC) trial for… (NCT06417190) Trimodal therapy (TMT) within 45 days of neoadjuvant chemotherapy (NAC) trial for Muscle-Invasive Bladder Carcinoma (NCT06417190). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06417190. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06417190.mp4 2026-10-31T20:19:17.655Z 88 yes no https://www.trianglehealth.com/phase-2/bms-986340-in-combination-with-nivolumab-gemcitabine-and-nab-pac-nct07226856 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226856.jpg Biopsy Procedure trial for Metastatic Pancreatic Adenocarcinoma (NCT07226856) Biopsy Procedure trial for Metastatic Pancreatic Adenocarcinoma (NCT07226856). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07226856. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226856.mp4 2026-10-31T16:23:59.738Z 86 yes no https://www.trianglehealth.com/phase-2/brain-metastases-in-greater-size-hypofractionated-options-trial-nct07227610 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227610.jpg Staged Stereotactic Radiosurgery (SSRS) trial for Brain Metastases (NCT07227610) Staged Stereotactic Radiosurgery (SSRS) trial for Brain Metastases (NCT07227610). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227610. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227610.mp4 2026-10-31T22:26:50.602Z 70 yes no https://www.trianglehealth.com/phase-2/bre-10-biomarker-optimization-of-neoadjuvant-therapy-in-breast-c-nct06441890 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06441890.jpg Paclitaxel trial for Breast Cancer (NCT06441890) Paclitaxel trial for Breast Cancer (NCT06441890). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06441890. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06441890.mp4 2026-10-31T22:49:06.540Z 84 yes no https://www.trianglehealth.com/phase-2/brentuximab-vedotin-and-bendamustine-for-the-treatment-of-relaps-nct04587687 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04587687.jpg Bendamustine Hydrochloride trial for Recurrent Follicular Lymphoma (NCT04587687) Bendamustine Hydrochloride trial for Recurrent Follicular Lymphoma (NCT04587687). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04587687. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04587687.mp4 2026-10-31T22:42:15.122Z 81 yes no https://www.trianglehealth.com/phase-2/brentuximab-vedotin-and-nivolumab-for-the-treatment-of-patients-nct04561206 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04561206.jpg Brentuximab Vedotin trial for Relapsed Classic Hodgkin Lymphoma (NCT04561206) Brentuximab Vedotin trial for Relapsed Classic Hodgkin Lymphoma (NCT04561206). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04561206. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04561206.mp4 2026-10-31T21:05:51.422Z 82 yes no https://www.trianglehealth.com/phase-2/brentuximab-vedotin-and-nivolumab-for-the-treatment-of-relapsed-nct05039073 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05039073.jpg Brentuximab Vedotin trial for Recurrent Classic Hodgkin Lymphoma (NCT05039073) Brentuximab Vedotin trial for Recurrent Classic Hodgkin Lymphoma (NCT05039073). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05039073. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05039073.mp4 2026-10-31T18:41:11.709Z 81 yes no https://www.trianglehealth.com/phase-2/cabazitaxel-carboplatin-vs-177lu-psma-617-in-metastatic-castrate-nct06738303 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06738303.jpg Cabazitaxel and carboplatin trial for Metastatic Prostate Cancer (NCT06738303) Cabazitaxel and carboplatin trial for Metastatic Prostate Cancer (NCT06738303). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06738303. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06738303.mp4 2026-10-31T20:56:44.033Z 81 yes no https://www.trianglehealth.com/phase-2/cabozantinib-combined-with-ipilimumab-nivolumab-and-tace-in-pati-nct04472767 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04472767.jpg Nivolumab trial for Hepatocellular Carcinoma (NCT04472767) Nivolumab trial for Hepatocellular Carcinoma (NCT04472767). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04472767. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04472767.mp4 2026-10-31T21:13:50.612Z 74 yes no https://www.trianglehealth.com/phase-2/cabozantinib-in-patients-with-ret-fusion-positive-advanced-non-s-nct01639508 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01639508.jpg Cabozantinib trial for Non-Small Cell Lung Cancer (NCT01639508) Cabozantinib trial for Non-Small Cell Lung Cancer (NCT01639508). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT01639508. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01639508.mp4 2026-10-31T07:23:47.059Z 90 yes no https://www.trianglehealth.com/phase-2/candida-therapeutic-vaccine-in-head-and-neck-cancer-patients-to-nct05952934 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05952934.jpg 0.5 mL Candin®/injection trial for Squamous Cell Carcinoma of Head and Neck (NCT05952934) 0.5 mL Candin®/injection trial for Squamous Cell Carcinoma of Head and Neck (NCT05952934). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05952934. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05952934.mp4 2026-10-31T21:22:12.837Z 78 yes no https://www.trianglehealth.com/phase-2/captemy90-for-grade-2-3-net-liver-metastases-nct04339036 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04339036.jpg Capecitabine Oral Product trial for Neuroendocrine Tumor Grade 2 (NCT04339036) Capecitabine Oral Product trial for Neuroendocrine Tumor Grade 2 (NCT04339036). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04339036. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04339036.mp4 2026-10-31T07:49:36.447Z 77 yes no https://www.trianglehealth.com/phase-2/car-t-cell-therapy-in-patients-with-renal-dysfunction-nct05909059 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05909059.jpg Fludarabine trial for Non-hodgkin Lymphoma,B Cell (NCT05909059) Fludarabine trial for Non-hodgkin Lymphoma,B Cell (NCT05909059). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05909059. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05909059.mp4 2026-10-31T22:18:51.835Z 86 yes no https://www.trianglehealth.com/phase-2/carboplatin-taxane-and-ramucirumab-for-patients-with-nsclc-after-nct04332367 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04332367.jpg Carboplatin trial for Non-small Cell Lung Cancer (NCT04332367) Carboplatin trial for Non-small Cell Lung Cancer (NCT04332367). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04332367. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04332367.mp4 2026-11-01T00:09:22.133Z 77 yes no https://www.trianglehealth.com/phase-2/cd22-car-t-cells-to-extend-remission-following-commercial-cd19-c-nct07328503 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07328503.jpg CD22 CAR-transduced T cells trial for Acute Lymphoblastic Leukemia (NCT07328503) CD22 CAR-transduced T cells trial for Acute Lymphoblastic Leukemia (NCT07328503). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07328503. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07328503.mp4 2026-10-31T06:24:43.670Z 67 yes no https://www.trianglehealth.com/phase-2/cemiplimab-and-cetuximab-prior-salvage-surgery-in-patients-with-nct06448026 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06448026.jpg Cemiplimab trial for Locally Recurrent Oral Cavity Squamous Cell Carcinoma (NCT06448026) Cemiplimab trial for Locally Recurrent Oral Cavity Squamous Cell Carcinoma (NCT06448026). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06448026. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06448026.mp4 2026-10-31T20:43:38.775Z 79 yes no https://www.trianglehealth.com/phase-2/cemiplimab-for-the-treatment-of-incurable-metastatic-or-unresect-nct07050186 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07050186.jpg Biopsy Procedure trial for Metastatic NUT Carcinoma (NCT07050186) Biopsy Procedure trial for Metastatic NUT Carcinoma (NCT07050186). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07050186. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07050186.mp4 2026-10-31T22:52:52.354Z 84 yes no https://www.trianglehealth.com/phase-2/cemiplimab-plus-gemcitabine-in-patients-with-metastatic-pancreat-nct06790602 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06790602.jpg Cemiplimab Plus Gemcitabine trial for Pancreatic Ductal Adenocarcinoma (mPDAC) (NCT06790602) Cemiplimab Plus Gemcitabine trial for Pancreatic Ductal Adenocarcinoma (mPDAC) (NCT06790602). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06790602. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06790602.mp4 2026-11-01T00:09:27.796Z 75 yes no https://www.trianglehealth.com/phase-2/cetuximab-after-immunotherapy-for-the-treatment-of-head-and-neck-nct04375384 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04375384.jpg Cetuximab trial for Head and Neck Squamous Cell Carcinoma (NCT04375384) Cetuximab trial for Head and Neck Squamous Cell Carcinoma (NCT04375384). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04375384. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04375384.mp4 2026-10-31T21:35:08.231Z 82 yes no https://www.trianglehealth.com/phase-2/chemotherapy-anakinra-in-patients-with-pancreatic-adenocarcinoma-nct04926467 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04926467.jpg Anakinra trial for Pancreatic Adenocarcinoma (NCT04926467) Anakinra trial for Pancreatic Adenocarcinoma (NCT04926467). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04926467. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04926467.mp4 2026-10-31T16:50:39.815Z 88 yes no https://www.trianglehealth.com/phase-2/chemotherapy-and-radiation-therapy-for-the-treatment-of-idh-wild-nct04623931 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04623931.jpg Quality-of-Life Assessment trial for Anaplastic Astrocytoma, IDH-Wildtype (NCT04623931) Quality-of-Life Assessment trial for Anaplastic Astrocytoma, IDH-Wildtype (NCT04623931). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04623931. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04623931.mp4 2026-10-31T21:58:55.794Z 82 yes no https://www.trianglehealth.com/phase-2/chemotherapy-with-or-without-immunotherapy-for-peritoneal-mesoth-nct05001880 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05001880.jpg Atezolizumab trial for Peritoneal Malignant Mesothelioma (NCT05001880) Atezolizumab trial for Peritoneal Malignant Mesothelioma (NCT05001880). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05001880. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05001880.mp4 2026-10-31T21:13:15.346Z 81 yes no https://www.trianglehealth.com/phase-2/chemotherapy-with-or-without-radiation-or-surgery-in-treating-pa-nct03161522 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03161522.jpg Capecitabine trial for Gastric Adenocarcinoma (NCT03161522) Capecitabine trial for Gastric Adenocarcinoma (NCT03161522). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03161522. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03161522.mp4 2026-10-31T07:21:19.505Z 74 yes no https://www.trianglehealth.com/phase-2/circulating-tumor-dna-nct06923527 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06923527.jpg Elacestrant trial for ER+ Breast Cancer (NCT06923527) Elacestrant trial for ER+ Breast Cancer (NCT06923527). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06923527. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06923527.mp4 2026-10-31T15:21:49.412Z 71 yes no https://www.trianglehealth.com/phase-2/circulating-tumor-dna-to-guide-changes-in-standard-of-care-chemo-nct05770531 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05770531.jpg Biospecimen Collection trial for Metastatic HER2-Negative Breast Carcinoma (NCT05770531) Biospecimen Collection trial for Metastatic HER2-Negative Breast Carcinoma (NCT05770531). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05770531. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05770531.mp4 2026-10-31T22:48:33.530Z 74 yes no https://www.trianglehealth.com/phase-2/cladribine-and-rituximab-in-treating-patients-with-hairy-cell-le-nct00412594 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT00412594.jpg Cladribine trial for Hairy Cell Leukemia (NCT00412594) Cladribine trial for Hairy Cell Leukemia (NCT00412594). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT00412594. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT00412594.mp4 2026-11-01T00:04:53.671Z 78 yes no https://www.trianglehealth.com/phase-2/clag-go-for-patients-with-persistent-relapsed-or-refractory-aml-nct04050280 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04050280.jpg Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated… (NCT04050280) Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO) trial for Acute Myeloid Leukemia, Adult (NCT04050280). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04050280. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04050280.mp4 2026-10-31T22:37:46.986Z 79 yes no https://www.trianglehealth.com/phase-2/cobimetinib-in-refractory-langerhans-cell-histiocytosis-lch-and-nct04079179 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04079179.jpg Cobimetinib trial for Langerhan's Cell Histiocytosis (NCT04079179) Cobimetinib trial for Langerhan's Cell Histiocytosis (NCT04079179). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04079179. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04079179.mp4 2026-10-31T21:14:06.933Z 63 yes no https://www.trianglehealth.com/phase-2/combination-chemotherapy-in-treating-patients-with-relapsed-or-r-nct03136146 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03136146.jpg Bortezomib trial for Recurrent Acute Lymphoblastic Leukemia (NCT03136146) Bortezomib trial for Recurrent Acute Lymphoblastic Leukemia (NCT03136146). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03136146. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03136146.mp4 2026-10-31T20:13:08.111Z 68 yes no https://www.trianglehealth.com/phase-2/combination-therapy-for-the-treatment-of-diffuse-midline-gliomas-nct05009992 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05009992.jpg ONC201 trial for Diffuse Intrinsic Pontine Glioma (NCT05009992) ONC201 trial for Diffuse Intrinsic Pontine Glioma (NCT05009992). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05009992. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05009992.mp4 2026-10-31T22:45:40.212Z 80 yes no https://www.trianglehealth.com/phase-2/combination-therapy-using-durvalumab-and-histotripsy-for-treatme-nct07766187 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07766187.jpg Histotripsy trial for Intrahepatic Cholangiocarcinoma (NCT07766187) Histotripsy trial for Intrahepatic Cholangiocarcinoma (NCT07766187). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07766187. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07766187.mp4 2026-10-31T22:20:21.888Z 72 yes no https://www.trianglehealth.com/phase-2/combined-systemic-and-intraperitoneal-chemotherapy-for-synchrono-nct07475286 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07475286.jpg Cisplatin trial for Synchronous Gastric Peritoneal Carcinomatosis (NCT07475286) Cisplatin trial for Synchronous Gastric Peritoneal Carcinomatosis (NCT07475286). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07475286. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07475286.mp4 2026-10-31T06:17:31.454Z 91 yes no https://www.trianglehealth.com/phase-2/comparing-cytarabine-daunorubicin-therapy-versus-cytarabine-daun-nct05554393 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05554393.jpg Azacitidine trial for Acute Myeloid Leukemia (NCT05554393) Azacitidine trial for Acute Myeloid Leukemia (NCT05554393). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05554393. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05554393.mp4 2026-10-31T05:30:13.977Z 91 yes no https://www.trianglehealth.com/phase-2/comparing-different-treatment-lengths-for-venetoclax-in-older-pe-nct07437950 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07437950.jpg Biospecimen Collection trial for Acute Myeloid Leukemia (NCT07437950) Biospecimen Collection trial for Acute Myeloid Leukemia (NCT07437950). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07437950. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07437950.mp4 2026-10-31T05:24:28.360Z 74 yes no https://www.trianglehealth.com/phase-2/comparing-new-treatments-for-people-with-newly-diagnosed-acute-m-nct06672146 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06672146.jpg Biospecimen Collection trial for Acute Myeloid Leukemia (NCT06672146) Biospecimen Collection trial for Acute Myeloid Leukemia (NCT06672146). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06672146. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06672146.mp4 2026-10-31T05:34:43.112Z 74 yes no https://www.trianglehealth.com/phase-2/comparing-the-effectiveness-of-the-immunotherapy-agents-rituxima-nct05886036 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05886036.jpg Biopsy Procedure trial for Nodular Lymphocyte Predominant B-Cell Lymphoma (NCT05886036) Biopsy Procedure trial for Nodular Lymphocyte Predominant B-Cell Lymphoma (NCT05886036). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05886036. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05886036.mp4 2026-10-31T22:19:16.706Z 82 yes no https://www.trianglehealth.com/phase-2/comparing-the-radiopharmaceutical-drug-177lu-lu-dotatate-to-stan-nct06955169 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06955169.jpg [177Lu]Lu-DOTATATE trial for Intracranial Meningioma (NCT06955169) [177Lu]Lu-DOTATATE trial for Intracranial Meningioma (NCT06955169). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06955169. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06955169.mp4 2026-10-31T06:48:50.291Z 85 yes no https://www.trianglehealth.com/phase-2/concurrent-immunotherapy-and-systemic-therapy-with-stereotactic-nct07770100 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07770100.jpg Stereotactic Body Radiation Therapy (SBRT) trial for Head and Neck Cancer (NCT07770100) Stereotactic Body Radiation Therapy (SBRT) trial for Head and Neck Cancer (NCT07770100). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07770100. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07770100.mp4 2026-10-31T21:23:51.227Z 79 yes no https://www.trianglehealth.com/phase-2/consolidation-of-first-line-mrd-remission-with-cema-cel-in-patie-nct06500273 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06500273.jpg cemacabtagene ansegedleucel trial for Large B-cell Lymphoma (NCT06500273) cemacabtagene ansegedleucel trial for Large B-cell Lymphoma (NCT06500273). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06500273. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06500273.mp4 2026-10-31T21:28:23.228Z 77 yes no https://www.trianglehealth.com/phase-2/consolidative-local-therapy-clt-in-oligo-metastatic-urothelial-c-nct07048457 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07048457.jpg Radical cystectomy trial for Locally Advanced Urothelial Carcinoma (NCT07048457) Radical cystectomy trial for Locally Advanced Urothelial Carcinoma (NCT07048457). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07048457. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07048457.mp4 2026-10-31T07:53:40.346Z 84 yes no https://www.trianglehealth.com/phase-2/cord-blood-transplant-cyclophosphamide-fludarabine-and-total-bod-nct06013423 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06013423.jpg Biospecimen Collection trial for Acute Leukemia of Ambiguous Lineage (NCT06013423) Biospecimen Collection trial for Acute Leukemia of Ambiguous Lineage (NCT06013423). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06013423. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06013423.mp4 2026-10-31T15:09:14.734Z 88 yes no https://www.trianglehealth.com/phase-2/cpx-351-and-ivosidenib-for-the-treatment-of-idh1-mutated-acute-m-nct04493164 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04493164.jpg Ivosidenib trial for Acute Myeloid Leukemia With Gene Mutations (NCT04493164) Ivosidenib trial for Acute Myeloid Leukemia With Gene Mutations (NCT04493164). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04493164. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04493164.mp4 2026-10-31T21:41:57.500Z 85 yes no https://www.trianglehealth.com/phase-2/cryoablation-ipilimumab-nivolumab-in-melanoma-nct05779423 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05779423.jpg Ipilimumab trial for Metastatic Melanoma (NCT05779423) Ipilimumab trial for Metastatic Melanoma (NCT05779423). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05779423. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05779423.mp4 2026-10-31T16:55:14.084Z 78 yes no https://www.trianglehealth.com/phase-2/ctdna-guided-addition-of-ipilimumab-to-patients-receiving-nivolu-nct07504796 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07504796.jpg Nivolumab trial for Metastatic Melanoma (NCT07504796) Nivolumab trial for Metastatic Melanoma (NCT07504796). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07504796. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07504796.mp4 2026-10-31T21:43:39.368Z 76 yes no https://www.trianglehealth.com/phase-2/ctdna-guided-sunitinib-and-regorafenib-therapy-for-gist-nct05366816 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05366816.jpg Sunitinib trial for Gastrointestinal Stromal Tumors (NCT05366816) Sunitinib trial for Gastrointestinal Stromal Tumors (NCT05366816). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05366816. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05366816.mp4 2026-10-31T21:57:49.263Z 74 yes no https://www.trianglehealth.com/phase-2/ctdna-guided-therapy-for-relapsed-refractory-hodgkin-lymphoma-nct07021989 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07021989.jpg Pembrolizumab trial for Hodgkin Lymphoma, Adult (NCT07021989) Pembrolizumab trial for Hodgkin Lymphoma, Adult (NCT07021989). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07021989. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07021989.mp4 2026-10-31T22:03:26.742Z 82 yes no https://www.trianglehealth.com/phase-2/cthpvdna-response-adapted-chemoradiation-retifanlimab-treatment-nct07425054 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07425054.jpg HPV ctDNA Response based radiation trial for Anal Cancer (NCT07425054) HPV ctDNA Response based radiation trial for Anal Cancer (NCT07425054). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07425054. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07425054.mp4 2026-10-31T16:40:45.408Z 78 yes no https://www.trianglehealth.com/phase-2/cyclophosphamide-and-sirolimus-for-the-treatment-of-metastatic-r-nct03099356 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03099356.jpg Cyclophosphamide trial for Metastatic Thyroid Cancer (NCT03099356) Cyclophosphamide trial for Metastatic Thyroid Cancer (NCT03099356). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03099356. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03099356.mp4 2026-10-31T20:43:12.529Z 76 yes no https://www.trianglehealth.com/phase-2/dabrafenib-and-trametinib-for-braf-v600-mutant-low-grade-gliomas-nct07110246 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07110246.jpg Dabrafenib trial for BRAF V600 Mutation (NCT07110246) Dabrafenib trial for BRAF V600 Mutation (NCT07110246). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07110246. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07110246.mp4 2026-10-31T06:27:27.432Z 86 yes no https://www.trianglehealth.com/phase-2/daly-ii-usa-mb-cart2019-1-for-dlbcl-nct04792489 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04792489.jpg zamtocabtagene autoleucel (MB-CART2019.1) trial for Refractory Diffuse Large B Cell… (NCT04792489) zamtocabtagene autoleucel (MB-CART2019.1) trial for Refractory Diffuse Large B Cell Lymphoma (DLBCL) (NCT04792489). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04792489. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04792489.mp4 2026-10-31T22:18:29.614Z 86 yes no https://www.trianglehealth.com/phase-2/daratumumab-for-chemotherapy-refractory-minimal-residual-disease-nct05289687 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05289687.jpg Daratumumab / Hyaluronidase Injection trial for T-cell Acute Lymphoblastic Leukemia (NCT05289687) Daratumumab / Hyaluronidase Injection trial for T-cell Acute Lymphoblastic Leukemia (NCT05289687). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05289687. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05289687.mp4 2026-10-31T16:36:36.236Z 90 yes no https://www.trianglehealth.com/phase-2/daratumumab-for-relapsed-refractory-primary-effusion-lymphoma-pl-nct05907759 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05907759.jpg Daratumumab SC trial for Lymphoma, Primary Effusion (NCT05907759) Daratumumab SC trial for Lymphoma, Primary Effusion (NCT05907759). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05907759. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05907759.mp4 2026-10-31T06:30:03.988Z 83 yes no https://www.trianglehealth.com/phase-2/dareontm-5-a-study-to-test-whether-different-doses-of-bi-764532-nct05882058 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05882058.jpg BI 764532, dose 1 trial for Small Cell Lung Carcinoma (NCT05882058) BI 764532, dose 1 trial for Small Cell Lung Carcinoma (NCT05882058). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05882058. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05882058.mp4 2026-10-31T21:16:27.263Z 87 yes no https://www.trianglehealth.com/phase-2/dasatinib-and-quercetin-with-car-t-therapy-for-the-treatment-of-nct06940297 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06940297.jpg Biopsy Procedure trial for Recurrent Multiple Myeloma (NCT06940297) Biopsy Procedure trial for Recurrent Multiple Myeloma (NCT06940297). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06940297. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06940297.mp4 2026-10-31T21:09:12.373Z 80 yes no https://www.trianglehealth.com/phase-2/dato-base-datopotamab-deruxtecan-for-breast-cancer-brain-metasta-nct06176261 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06176261.jpg Datopotamab Deruxtecan trial for Breast Cancer (NCT06176261) Datopotamab Deruxtecan trial for Breast Cancer (NCT06176261). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06176261. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06176261.mp4 2026-10-31T20:18:40.869Z 79 yes no https://www.trianglehealth.com/phase-2/dcis-recast-trial-ductal-carcinoma-in-situ-re-evaluating-conditi-nct06075953 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06075953.jpg Tamoxifen trial for Ductal Carcinoma in Situ (NCT06075953) Tamoxifen trial for Ductal Carcinoma in Situ (NCT06075953). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06075953. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06075953.mp4 2026-10-31T06:29:51.976Z 79 yes no https://www.trianglehealth.com/phase-2/decitabine-cedazuridine-inqovi-an-oral-dna-demethylating-agent-i-nct05960773 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05960773.jpg Decitabine/cedazuridine trial for Mesothelioma (NCT05960773) Decitabine/cedazuridine trial for Mesothelioma (NCT05960773). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05960773. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05960773.mp4 2026-10-31T06:28:58.826Z 77 yes no https://www.trianglehealth.com/phase-2/decitabine-with-ruxolitinib-fedratinib-or-pacritinib-for-the-tre-nct04282187 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04282187.jpg Decitabine trial for Acute Myeloid Leukemia (NCT04282187) Decitabine trial for Acute Myeloid Leukemia (NCT04282187). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04282187. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04282187.mp4 2026-10-31T22:32:26.376Z 71 yes no https://www.trianglehealth.com/phase-2/defining-the-ablative-dose-for-y-90-tare-nct07586046 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07586046.jpg Yttrium-90 Radiation Segmentectomy (Y90 RS) using glass microspheres trial for HCC -… (NCT07586046) Yttrium-90 Radiation Segmentectomy (Y90 RS) using glass microspheres trial for HCC - Hepatocellular Carcinoma (NCT07586046). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07586046. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07586046.mp4 2026-10-31T22:36:29.849Z 73 yes no https://www.trianglehealth.com/phase-2/dfmo-as-maintenance-therapy-for-molecular-high-very-high-risk-an-nct04696029 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04696029.jpg Difluoromethylornithine trial for Medulloblastoma (NCT04696029) Difluoromethylornithine trial for Medulloblastoma (NCT04696029). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04696029. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04696029.mp4 2026-10-31T17:01:00.751Z 79 yes no https://www.trianglehealth.com/phase-2/digoxin-medulloblastoma-study-nct06701812 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06701812.jpg Digoxin trial for Medulloblastoma (NCT06701812) Digoxin trial for Medulloblastoma (NCT06701812). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06701812. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06701812.mp4 2026-10-31T21:09:28.825Z 76 yes no https://www.trianglehealth.com/phase-2/discern-dual-versus-single-icb-in-pdl-1-negative-nsclc-nct06364917 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06364917.jpg Pembrolizumab trial for Non Small Cell Lung Cancer (NCT06364917) Pembrolizumab trial for Non Small Cell Lung Cancer (NCT06364917). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06364917. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06364917.mp4 2026-10-31T23:59:45.646Z 83 yes no https://www.trianglehealth.com/phase-2/doc1021-dendritic-cell-immunotherapy-for-treatment-of-newly-diag-nct06805305 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06805305.jpg DOC1021 trial for Glioblastoma (GBM) (NCT06805305) DOC1021 trial for Glioblastoma (GBM) (NCT06805305). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06805305. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06805305.mp4 2026-10-31T22:29:57.049Z 89 yes no https://www.trianglehealth.com/phase-2/dose-adjusted-epoch-with-or-without-rituximab-plus-ponatinib-for-nct07224100 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07224100.jpg Cyclophosphamide trial for B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2);… (NCT07224100) Cyclophosphamide trial for B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 (NCT07224100). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07224100. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07224100.mp4 2026-10-31T23:00:19.502Z 87 yes no https://www.trianglehealth.com/phase-2/durvalumab-in-combination-with-chemotherapy-in-treating-patients-nct03907475 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03907475.jpg Biopsy Procedure trial for Locally Advanced Malignant Solid Neoplasm (NCT03907475) Biopsy Procedure trial for Locally Advanced Malignant Solid Neoplasm (NCT03907475). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03907475. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03907475.mp4 2026-10-31T21:18:21.990Z 78 yes no https://www.trianglehealth.com/phase-2/duvelisib-maintenance-for-the-treatment-of-peripheral-t-cell-lym-nct07293403 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07293403.jpg Biospecimen Collection trial for Follicular Helper T-Cell Lymphoma (NCT07293403) Biospecimen Collection trial for Follicular Helper T-Cell Lymphoma (NCT07293403). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07293403. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07293403.mp4 2026-10-31T22:09:20.161Z 77 yes no https://www.trianglehealth.com/phase-2/e7-tcr-t-cell-immunotherapy-for-human-papillomavirus-hpv-associa-nct05686226 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05686226.jpg E7 TCR-T cells trial for Cervical Cancer (NCT05686226) E7 TCR-T cells trial for Cervical Cancer (NCT05686226). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05686226. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05686226.mp4 2026-10-31T05:29:48.571Z 87 yes no https://www.trianglehealth.com/phase-2/effects-of-infusion-timing-on-treatment-response-in-solid-tumors-nct07630168 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07630168.jpg PD-1/PD-L1 inhibitor monotherapy - 4 cycles before 12:00PM trial for Lung Cancer (NCT07630168) PD-1/PD-L1 inhibitor monotherapy - 4 cycles before 12:00PM trial for Lung Cancer (NCT07630168). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07630168. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07630168.mp4 2026-10-31T16:06:18.277Z 81 yes no https://www.trianglehealth.com/phase-2/efficacy-and-safety-of-nemtabrutinib-mk-1026-in-participants-wit-nct04728893 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04728893.jpg Nemtabrutinib trial for Hematologic Malignancies (NCT04728893) Nemtabrutinib trial for Hematologic Malignancies (NCT04728893). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04728893. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04728893.mp4 2026-10-31T06:18:34.078Z 85 yes no https://www.trianglehealth.com/phase-2/efficacy-and-safety-of-tyra-300-in-participants-with-fgfr3-alter-nct06995677 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06995677.jpg TYRA-300 60mg trial for Low-grade NMIBC (NCT06995677) TYRA-300 60mg trial for Low-grade NMIBC (NCT06995677). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06995677. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06995677.mp4 2026-10-31T05:34:21.827Z 73 yes no https://www.trianglehealth.com/phase-2/efficacy-of-hypomethylating-agents-vs-intensive-chemotherapy-in-nct07060001 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07060001.jpg 5hmC Biomarker trial for Acute Myeloid Leukemia (AML) (NCT07060001) 5hmC Biomarker trial for Acute Myeloid Leukemia (AML) (NCT07060001). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07060001. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07060001.mp4 2026-10-31T16:00:21.663Z 80 yes no https://www.trianglehealth.com/phase-2/elranatamab-in-r-r-multiple-myeloma-nct06138275 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06138275.jpg Elranatamab trial for Refractory Multiple Myeloma (NCT06138275) Elranatamab trial for Refractory Multiple Myeloma (NCT06138275). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06138275. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06138275.mp4 2026-10-31T15:32:16.606Z 88 yes no https://www.trianglehealth.com/phase-2/enasidenib-and-azacitidine-in-treating-patients-with-recurrent-o-nct03683433 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03683433.jpg Azacitidine trial for Acute Bilineal Leukemia (NCT03683433) Azacitidine trial for Acute Bilineal Leukemia (NCT03683433). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03683433. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03683433.mp4 2026-10-31T22:40:51.272Z 73 yes no https://www.trianglehealth.com/phase-2/enasidenib-in-idh2-mutated-malignant-sinonasal-and-skull-base-tu-nct06176989 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06176989.jpg Enasidenib trial for Metastatic Chondrosarcoma (NCT06176989) Enasidenib trial for Metastatic Chondrosarcoma (NCT06176989). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06176989. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06176989.mp4 2026-10-31T06:24:47.590Z 91 yes no https://www.trianglehealth.com/phase-2/endocrine-treatment-alone-for-elderly-patients-with-estrogen-rec-nct02476786 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02476786.jpg FACT-B trial for Breast Cancer (NCT02476786) FACT-B trial for Breast Cancer (NCT02476786). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02476786. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02476786.mp4 2026-10-31T21:12:10.740Z 84 yes no https://www.trianglehealth.com/phase-2/enfortumab-vedotin-with-or-without-pembrolizumab-in-rare-genitou-nct06041503 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06041503.jpg Pembrolizumab trial for Adenocarcinoma of the Bladder (NCT06041503) Pembrolizumab trial for Adenocarcinoma of the Bladder (NCT06041503). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06041503. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06041503.mp4 2026-10-31T23:00:41.798Z 83 yes no https://www.trianglehealth.com/phase-2/enzalutamide-and-pds01adc-in-pet-positive-recurrent-prostate-can-nct06096870 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06096870.jpg Enzalutamide trial for Prostate Cancer (NCT06096870) Enzalutamide trial for Prostate Cancer (NCT06096870). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06096870. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06096870.mp4 2026-10-31T06:27:38.223Z 96 yes no https://www.trianglehealth.com/phase-2/epco-zanu-ritux-for-r-r-fl-or-mzl-nct06563596 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06563596.jpg Zanubrutinib trial for Follicular Lymphoma (NCT06563596) Zanubrutinib trial for Follicular Lymphoma (NCT06563596). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06563596. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06563596.mp4 2026-10-31T16:17:37.738Z 88 yes no https://www.trianglehealth.com/phase-2/epcoritamab-and-lenalidomide-in-treating-patients-with-refractor-nct06723457 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06723457.jpg Biospecimen Collection trial for Recurrent B-Cell Non-Hodgkin Lymphoma (NCT06723457) Biospecimen Collection trial for Recurrent B-Cell Non-Hodgkin Lymphoma (NCT06723457). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06723457. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06723457.mp4 2026-10-31T22:21:36.541Z 74 yes no https://www.trianglehealth.com/phase-2/epcoritamab-in-combination-with-loncastuximab-tesirine-in-relaps-nct06919939 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06919939.jpg Epcoritamab trial for Large B-cell Lymphoma (NCT06919939) Epcoritamab trial for Large B-cell Lymphoma (NCT06919939). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06919939. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06919939.mp4 2026-10-31T21:21:06.847Z 96 yes no https://www.trianglehealth.com/phase-2/epcoritamab-rituximab-gemcitabine-and-oxaliplatin-r-gemox-as-sal-nct07365306 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07365306.jpg Autologous Hematopoietic Stem Cell Transplantation trial for Recurrent Diffuse Large… (NCT07365306) Autologous Hematopoietic Stem Cell Transplantation trial for Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (NCT07365306). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07365306. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07365306.mp4 2026-10-31T15:48:17.554Z 80 yes no https://www.trianglehealth.com/phase-2/epcoritamab-with-dose-adjusted-etoposide-cyclophosphamide-vincri-nct07097363 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07097363.jpg Biospecimen Collection trial for B-Cell Non-Hodgkin Lymphoma (NCT07097363) Biospecimen Collection trial for B-Cell Non-Hodgkin Lymphoma (NCT07097363). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07097363. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07097363.mp4 2026-10-31T06:24:44.979Z 76 yes no https://www.trianglehealth.com/phase-2/estrogen-to-improve-quality-of-life-for-men-with-newly-diagnosed-nct07466498 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07466498.jpg Androgen Receptor Pathway Inhibitor trial for Castration-Sensitive Prostate… (NCT07466498) Androgen Receptor Pathway Inhibitor trial for Castration-Sensitive Prostate Adenocarcinoma (NCT07466498). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07466498. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07466498.mp4 2026-10-31T22:16:10.249Z 79 yes no https://www.trianglehealth.com/phase-2/ethan-et-for-male-bc-nct05501704 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05501704.jpg Tamoxifen trial for Male Breast Cancer (NCT05501704) Tamoxifen trial for Male Breast Cancer (NCT05501704). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05501704. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05501704.mp4 2026-10-31T22:42:24.917Z 93 yes no https://www.trianglehealth.com/phase-2/eus-rfa-pancardinal-1-trial-nct04990609 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04990609.jpg Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA) trial for… (NCT04990609) Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA) trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT04990609). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04990609. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04990609.mp4 2026-10-31T20:50:51.123Z 77 yes no https://www.trianglehealth.com/phase-2/evaluate-optimization-of-crs-profile-for-glofit-monotherapy-and-nct06806033 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06806033.jpg Obinutuzumab trial for Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NCT06806033) Obinutuzumab trial for Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NCT06806033). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06806033. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06806033.mp4 2026-10-31T07:35:14.817Z 78 yes no https://www.trianglehealth.com/phase-2/evaluating-a-decreased-dose-of-radiation-therapy-to-the-elective-nct07178301 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07178301.jpg Computed Tomography trial for Clinical Stage I HPV-Mediated (p16-Positive)… (NCT07178301) Computed Tomography trial for Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (NCT07178301). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07178301. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07178301.mp4 2026-10-31T22:03:48.463Z 84 yes no https://www.trianglehealth.com/phase-2/evaluating-efficacy-of-b7-h3-car-t-cells-administered-at-the-end-nct07428993 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07428993.jpg Cyclophosphamide trial for Pediatric Osteosarcoma (NCT07428993) Cyclophosphamide trial for Pediatric Osteosarcoma (NCT07428993). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07428993. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07428993.mp4 2026-10-31T20:02:03.478Z 77 yes no https://www.trianglehealth.com/phase-2/evaluation-of-alternative-site-goserelin-acetate-injection-for-o-nct07460752 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07460752.jpg Biospecimen Collection trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07460752) Biospecimen Collection trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07460752). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07460752. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07460752.mp4 2026-10-31T07:03:36.670Z 73 yes no https://www.trianglehealth.com/phase-2/evaluation-of-mirvetuximab-soravtansine-imgn853-in-women-with-fo-nct03832361 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03832361.jpg IMGN853 trial for Endometrial Cancer (NCT03832361) IMGN853 trial for Endometrial Cancer (NCT03832361). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03832361. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03832361.mp4 2026-10-31T22:47:44.450Z 82 yes no https://www.trianglehealth.com/phase-2/evaluation-of-the-safety-and-efficacy-of-treatment-w-high-dose-m-nct06607458 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06607458.jpg Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus… (NCT06607458) Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab trial for Refractory Metastatic Colorectal Cancer (NCT06607458). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06607458. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06607458.mp4 2026-10-31T22:05:19.926Z 75 yes no https://www.trianglehealth.com/phase-2/evaluation-of-the-safety-and-efficacy-of-treatment-w-high-dose-m-nct06875128 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06875128.jpg Melphalan/HDS followed by Physician's choice of SOC (eribulin, vinorelbine, or… (NCT06875128) Melphalan/HDS followed by Physician's choice of SOC (eribulin, vinorelbine, or capecitabine) trial for Metastatic Breast Cancer in the Liver (NCT06875128). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06875128. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06875128.mp4 2026-10-31T22:12:19.550Z 80 yes no https://www.trianglehealth.com/phase-2/evaluation-of-two-dose-levels-of-quizartinib-as-maintenance-in-f-nct06824168 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06824168.jpg Quizartinib High Dose trial for Acute Myeloid Leukemia (NCT06824168) Quizartinib High Dose trial for Acute Myeloid Leukemia (NCT06824168). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06824168. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06824168.mp4 2026-10-31T22:33:12.097Z 69 yes no https://www.trianglehealth.com/phase-2/exclaim-exploring-combined-local-and-systemic-approaches-in-brai-nct06649058 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06649058.jpg Systemic Therapy trial for Brain Metastases (NCT06649058) Systemic Therapy trial for Brain Metastases (NCT06649058). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06649058. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06649058.mp4 2026-10-31T06:37:05.538Z 80 yes no https://www.trianglehealth.com/phase-2/extracorporeal-photopheresis-and-mogamulizumab-for-the-treatment-nct04930653 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04930653.jpg Extracorporeal Photopheresis trial for Folliculotropic Mycosis Fungoides (NCT04930653) Extracorporeal Photopheresis trial for Folliculotropic Mycosis Fungoides (NCT04930653). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04930653. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04930653.mp4 2026-10-31T20:00:28.534Z 75 yes no https://www.trianglehealth.com/phase-2/fdg-pet-guided-metastasis-directed-radiation-therapy-for-the-tre-nct06244004 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06244004.jpg Antiandrogen Therapy trial for Castration-Sensitive Prostate Carcinoma (NCT06244004) Antiandrogen Therapy trial for Castration-Sensitive Prostate Carcinoma (NCT06244004). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06244004. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06244004.mp4 2026-10-31T07:41:10.674Z 72 yes no https://www.trianglehealth.com/phase-2/feasibility-study-to-treat-lung-cancer-with-the-permanently-impl-nct03290534 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03290534.jpg CivaSheet trial for Lung Cancer (NCT03290534) CivaSheet trial for Lung Cancer (NCT03290534). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03290534. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03290534.mp4 2026-10-31T21:18:43.289Z 74 yes no https://www.trianglehealth.com/phase-2/fludarabine-phosphate-cytarabine-filgrastim-sndz-gemtuzumab-ozog-nct00801489 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT00801489.jpg Cytarabine trial for Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 (NCT00801489) Cytarabine trial for Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 (NCT00801489). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT00801489. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT00801489.mp4 2026-10-31T21:27:00.703Z 92 yes no https://www.trianglehealth.com/phase-2/fluorescence-guided-surgical-resection-for-reducing-unexpected-p-nct07650656 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07650656.jpg Electronic Health Record Review trial for High Grade Sarcoma (NCT07650656) Electronic Health Record Review trial for High Grade Sarcoma (NCT07650656). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07650656. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07650656.mp4 2026-10-31T22:15:44.219Z 80 yes no https://www.trianglehealth.com/phase-2/focal-therapy-with-stereotactic-body-radiation-therapy-sbrt-for-nct05616650 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05616650.jpg 18F-DCFPyL trial for Prostatic Neoplasms (NCT05616650) 18F-DCFPyL trial for Prostatic Neoplasms (NCT05616650). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05616650. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05616650.mp4 2026-10-31T06:30:56.750Z 77 yes no https://www.trianglehealth.com/phase-2/folate-receptor-alpha-dendritic-cells-fr-dcs-or-placebo-for-the-nct06639074 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06639074.jpg Biopsy trial for Advanced Fallopian Tube Carcinoma (NCT06639074) Biopsy trial for Advanced Fallopian Tube Carcinoma (NCT06639074). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06639074. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06639074.mp4 2026-10-31T15:57:59.549Z 82 yes no https://www.trianglehealth.com/phase-2/folfiri-and-bevacizumab-with-or-without-pelareorep-for-second-li-nct07446322 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07446322.jpg Bevacizumab trial for Ras-mutated Metastatic Colorectal Cancer (NCT07446322) Bevacizumab trial for Ras-mutated Metastatic Colorectal Cancer (NCT07446322). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07446322. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07446322.mp4 2026-10-31T05:21:55.658Z 87 yes no https://www.trianglehealth.com/phase-2/folfox-botensilimab-and-balstilimab-for-the-treatment-of-localiz-nct06780787 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780787.jpg Balstilimab trial for Rectal Adenocarcinoma (NCT06780787) Balstilimab trial for Rectal Adenocarcinoma (NCT06780787). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06780787. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780787.mp4 2026-10-31T22:39:31.467Z 79 yes no https://www.trianglehealth.com/phase-2/fractionated-gemtuzumab-ozogamicin-in-treating-measurable-residu-nct03737955 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03737955.jpg Gemtuzumab Ozogamicin trial for Acute Myeloid Leukemia (NCT03737955) Gemtuzumab Ozogamicin trial for Acute Myeloid Leukemia (NCT03737955). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03737955. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03737955.mp4 2026-10-31T23:01:08.654Z 81 yes no https://www.trianglehealth.com/phase-2/frameless-stereotactic-radiosurgery-for-intact-brain-metastases-nct02747303 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02747303.jpg Stereotactic Radiosurgery trial for Brain Metastases (NCT02747303) Stereotactic Radiosurgery trial for Brain Metastases (NCT02747303). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02747303. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02747303.mp4 2026-10-31T17:00:20.324Z 73 yes no https://www.trianglehealth.com/phase-2/functional-precision-oncology-to-predict-prevent-and-treat-early-nct05464082 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05464082.jpg Functional Precision Oncology trial for Breast Cancer Recurrent (NCT05464082) Functional Precision Oncology trial for Breast Cancer Recurrent (NCT05464082). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05464082. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05464082.mp4 2026-10-31T22:43:02.341Z 84 yes no https://www.trianglehealth.com/phase-2/futibatinib-in-combination-with-durvalumab-prior-to-cystectomy-f-nct06263153 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06263153.jpg Biospecimen Collection trial for Bladder Urothelial Carcinoma (NCT06263153) Biospecimen Collection trial for Bladder Urothelial Carcinoma (NCT06263153). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06263153. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06263153.mp4 2026-10-31T21:28:52.765Z 90 yes no https://www.trianglehealth.com/phase-2/gemcitabine-and-oxaliplatin-chemotherapy-with-or-without-a-floxu-nct04891289 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04891289.jpg Gemcitabine trial for Intrahepatic Cholangiocarcinoma (NCT04891289) Gemcitabine trial for Intrahepatic Cholangiocarcinoma (NCT04891289). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04891289. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04891289.mp4 2026-10-31T16:04:16.421Z 82 yes no https://www.trianglehealth.com/phase-2/gemcitabine-cisplatin-and-nab-paclitaxel-as-neoadjuvant-treatmen-nct06423326 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06423326.jpg Biopsy trial for Borderline Resectable Pancreatic Ductal Adenocarcinoma (NCT06423326) Biopsy trial for Borderline Resectable Pancreatic Ductal Adenocarcinoma (NCT06423326). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06423326. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06423326.mp4 2026-10-31T21:29:33.831Z 83 yes no https://www.trianglehealth.com/phase-2/gemcitabine-docetaxel-toripalimab-induction-in-epstein-barr-viru-nct06592599 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06592599.jpg Toripalimab trial for Nasopharyngeal Carcinoma (NCT06592599) Toripalimab trial for Nasopharyngeal Carcinoma (NCT06592599). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06592599. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06592599.mp4 2026-10-31T22:53:28.823Z 84 yes no https://www.trianglehealth.com/phase-2/gemcitabine-nab-paclitaxel-plus-the-therabionic-p1-an-amplitude-nct06576115 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06576115.jpg Nab paclitaxel trial for Metastatic Pancreatic Adenocarcinoma (NCT06576115) Nab paclitaxel trial for Metastatic Pancreatic Adenocarcinoma (NCT06576115). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06576115. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06576115.mp4 2026-10-31T20:07:04.019Z 86 yes no https://www.trianglehealth.com/phase-2/genetic-testing-to-select-therapy-for-the-treatment-of-advanced-nct05361720 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05361720.jpg Cabozantinib trial for Advanced Clear Cell Renal Cell Carcinoma (NCT05361720) Cabozantinib trial for Advanced Clear Cell Renal Cell Carcinoma (NCT05361720). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05361720. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05361720.mp4 2026-10-31T16:17:14.203Z 80 yes no https://www.trianglehealth.com/phase-2/genomic-biomarker-selected-umbrella-neoadjuvant-study-for-high-r-nct04812366 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04812366.jpg Apalutamide 60mg Tab trial for Prostate Cancer (NCT04812366) Apalutamide 60mg Tab trial for Prostate Cancer (NCT04812366). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04812366. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04812366.mp4 2026-10-31T22:59:55.732Z 76 yes no https://www.trianglehealth.com/phase-2/genomically-guided-radiation-therapy-in-the-management-of-triple-nct05528133 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05528133.jpg Genomically Guided Radiation Therapy trial for Triple Negative Breast Cancer (NCT05528133) Genomically Guided Radiation Therapy trial for Triple Negative Breast Cancer (NCT05528133). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05528133. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05528133.mp4 2026-10-31T06:44:58.555Z 71 yes no https://www.trianglehealth.com/phase-2/gi-102-alone-or-with-pembrolizumab-before-surgery-for-treatment-nct07301268 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07301268.jpg Biospecimen Collection trial for Glioblastoma, IDH-Wildtype (NCT07301268) Biospecimen Collection trial for Glioblastoma, IDH-Wildtype (NCT07301268). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07301268. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07301268.mp4 2026-10-31T20:57:16.031Z 94 yes no https://www.trianglehealth.com/phase-2/glioblastoma-temozolomide-with-or-without-wsd0922-fu-nct07708961 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07708961.jpg Archive Sample Retrieval trial for Glioblastoma, IDH-Wildtype (NCT07708961) Archive Sample Retrieval trial for Glioblastoma, IDH-Wildtype (NCT07708961). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07708961. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07708961.mp4 2026-10-31T05:17:53.369Z 82 yes no https://www.trianglehealth.com/phase-2/glofitamab-with-pirtobrutinib-for-relapsed-or-refractory-mantle-nct06252675 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06252675.jpg Obinutuzumab trial for Mantle Cell Lymphoma (NCT06252675) Obinutuzumab trial for Mantle Cell Lymphoma (NCT06252675). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06252675. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06252675.mp4 2026-10-31T20:57:41.395Z 90 yes no https://www.trianglehealth.com/phase-2/glory-glofit-gemox-with-liso-cel-for-lymphoma-nct07711483 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07711483.jpg Obinutuzumab trial for Lymphoma (NCT07711483) Obinutuzumab trial for Lymphoma (NCT07711483). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07711483. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07711483.mp4 2026-10-31T06:26:32.418Z 80 yes no https://www.trianglehealth.com/phase-2/golcadomide-and-rituximab-as-bridging-therapy-for-relapsed-or-re-nct06834373 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06834373.jpg Biospecimen Collection trial for Large B-Cell Lymphoma With IRF4 Rearrangement (NCT06834373) Biospecimen Collection trial for Large B-Cell Lymphoma With IRF4 Rearrangement (NCT06834373). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06834373. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06834373.mp4 2026-10-31T22:04:58.828Z 78 yes no https://www.trianglehealth.com/phase-2/graft-versus-host-disease-reduction-strategies-for-donor-blood-s-nct03970096 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03970096.jpg Total-Body Irradiation trial for Acute Leukemia (NCT03970096) Total-Body Irradiation trial for Acute Leukemia (NCT03970096). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03970096. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03970096.mp4 2026-10-31T22:07:25.688Z 80 yes no https://www.trianglehealth.com/phase-2/gt103-in-combination-with-pembrolizumab-for-the-treatment-of-adv-nct07017829 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07017829.jpg Anti-CFH Monoclonal Antibody GT103 trial for Advanced Lung Non-Small Cell Carcinoma (NCT07017829) Anti-CFH Monoclonal Antibody GT103 trial for Advanced Lung Non-Small Cell Carcinoma (NCT07017829). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07017829. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07017829.mp4 2026-10-31T21:49:47.041Z 79 yes no https://www.trianglehealth.com/phase-2/haplo-identical-transplantation-for-severe-aplastic-anemia-hypo-nct03520647 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03520647.jpg Cyclophosphamide trial for Severe Aplastic Anemia (SAA) (NCT03520647) Cyclophosphamide trial for Severe Aplastic Anemia (SAA) (NCT03520647). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03520647. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03520647.mp4 2026-10-31T19:00:46.210Z 89 yes no https://www.trianglehealth.com/phase-2/haploidentical-donor-cytokine-induced-memory-like-natural-killer-nct07635056 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07635056.jpg CIML-NK Cells trial for Neuroblastoma (NCT07635056) CIML-NK Cells trial for Neuroblastoma (NCT07635056). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07635056. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07635056.mp4 2026-10-31T21:43:17.412Z 68 yes no https://www.trianglehealth.com/phase-2/hcmt-mm2401-ph2-study-of-selinexor-bispecific-antibody-for-rrmm-nct06822972 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06822972.jpg Selinexor 40 mg trial for Multiple Myeloma in Relapse (NCT06822972) Selinexor 40 mg trial for Multiple Myeloma in Relapse (NCT06822972). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06822972. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06822972.mp4 2026-10-31T19:54:45.062Z 81 yes no https://www.trianglehealth.com/phase-2/herizon-breast-a-ctdna-guided-adaptive-study-of-sequential-anti-nct07459673 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07459673.jpg Personalis NeXT Personal trial for Breast Cancer (NCT07459673) Personalis NeXT Personal trial for Breast Cancer (NCT07459673). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07459673. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07459673.mp4 2026-10-31T15:23:42.488Z 82 yes no https://www.trianglehealth.com/phase-2/high-dose-ruxolitinib-and-allogeneic-stem-cell-transplantation-i-nct06345495 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06345495.jpg Ruxolitinib trial for Splenomegaly (NCT06345495) Ruxolitinib trial for Splenomegaly (NCT06345495). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06345495. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06345495.mp4 2026-10-31T22:35:10.004Z 80 yes no https://www.trianglehealth.com/phase-2/high-dose-testosterone-for-atm-cdk12-or-chek2-altered-prostate-c-nct05011383 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05011383.jpg High dose testosterone trial for Metastatic Prostate Cancer (NCT05011383) High dose testosterone trial for Metastatic Prostate Cancer (NCT05011383). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05011383. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05011383.mp4 2026-10-31T22:31:56.277Z 73 yes no https://www.trianglehealth.com/phase-2/hippocampal-avoidance-in-craniospinal-irradiation-for-the-treatm-nct06518057 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06518057.jpg Biospecimen Collection trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT06518057) Biospecimen Collection trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT06518057). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06518057. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06518057.mp4 2026-10-31T22:59:35.091Z 67 yes no https://www.trianglehealth.com/phase-2/hormone-therapy-apalutamide-and-image-guided-stereotactic-body-r-nct06067269 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06067269.jpg Apalutamide trial for Prostate Adenocarcinoma (NCT06067269) Apalutamide trial for Prostate Adenocarcinoma (NCT06067269). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06067269. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06067269.mp4 2026-10-31T21:34:59.166Z 86 yes no https://www.trianglehealth.com/phase-2/hotspot-stereotactic-ablative-radiotherapy-versus-traditional-st-nct07718672 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07718672.jpg Biospecimen Collection trial for Early Stage Lung Non-Small Cell Carcinoma (NCT07718672) Biospecimen Collection trial for Early Stage Lung Non-Small Cell Carcinoma (NCT07718672). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07718672. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07718672.mp4 2026-10-31T17:01:11.790Z 80 yes no https://www.trianglehealth.com/phase-2/hypofractionated-radiation-therapy-for-merkel-cell-carcinoma-nct05100095 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05100095.jpg Radiation therapy trial for Merkel Cell Carcinoma (NCT05100095) Radiation therapy trial for Merkel Cell Carcinoma (NCT05100095). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05100095. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05100095.mp4 2026-10-31T21:49:19.652Z 69 yes no https://www.trianglehealth.com/phase-2/hypofractionated-radiochemotherapy-nct06331468 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06331468.jpg Cisplatin trial for Uterine Cervix Cancer (NCT06331468) Cisplatin trial for Uterine Cervix Cancer (NCT06331468). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06331468. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06331468.mp4 2026-10-31T20:48:07.633Z 84 yes no https://www.trianglehealth.com/phase-2/iberdomide-and-daratumumab-as-maintenance-therapy-after-an-autol-nct06107738 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06107738.jpg Iberdomide trial for Multiple Myeloma (NCT06107738) Iberdomide trial for Multiple Myeloma (NCT06107738). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06107738. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06107738.mp4 2026-10-31T22:47:47.873Z 72 yes no https://www.trianglehealth.com/phase-2/identifying-effective-and-cost-conscious-maintenance-daratumumab-nct07485647 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07485647.jpg Daratumumab and Recombinant Human Hyaluronidase trial for Multiple Myeloma (NCT07485647) Daratumumab and Recombinant Human Hyaluronidase trial for Multiple Myeloma (NCT07485647). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07485647. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07485647.mp4 2026-10-31T21:49:24.124Z 77 yes no https://www.trianglehealth.com/phase-2/idh-targeted-non-targeted-vs-non-targeted-idh-targeted-approache-nct05401097 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05401097.jpg Azacitidine trial for Acute Myeloid Leukemia (NCT05401097) Azacitidine trial for Acute Myeloid Leukemia (NCT05401097). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05401097. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05401097.mp4 2026-10-31T22:57:41.354Z 77 yes no https://www.trianglehealth.com/phase-2/igfbp-2-vaccine-to-prevent-ovarian-cancer-progression-in-patient-nct07495124 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07495124.jpg pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine trial for Fallopian Tube Carcinoma (NCT07495124) pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine trial for Fallopian Tube Carcinoma (NCT07495124). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07495124. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07495124.mp4 2026-10-31T15:24:01.170Z 83 yes no https://www.trianglehealth.com/phase-2/iit2023-09-chung-upfronttad-upfront-tad-snb-in-patients-with-bre-nct06092892 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06092892.jpg Breast Surgery (BCS or mastectomy) with TAD/SNB trial for Breast Cancer (NCT06092892) Breast Surgery (BCS or mastectomy) with TAD/SNB trial for Breast Cancer (NCT06092892). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06092892. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06092892.mp4 2026-10-31T20:09:00.638Z 77 yes no https://www.trianglehealth.com/phase-2/ilkn421h-plus-pembrolizumab-in-advanced-non-small-cell-lung-canc-nct07452224 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07452224.jpg ILKN421H trial for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT07452224) ILKN421H trial for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT07452224). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07452224. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07452224.mp4 2026-10-31T22:18:24.939Z 87 yes no https://www.trianglehealth.com/phase-2/illuminate-a-clinical-study-evaluating-car-t-immune-cell-therapy-nct07680439 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07680439.jpg BCB-276 trial for Diffuse Intrinsic Pontine Glioma (NCT07680439) BCB-276 trial for Diffuse Intrinsic Pontine Glioma (NCT07680439). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07680439. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07680439.mp4 2026-10-31T05:27:32.367Z 80 yes no https://www.trianglehealth.com/phase-2/imlunestrant-and-abemaciclib-for-the-treatment-of-estrogen-recep-nct07191717 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07191717.jpg Abemaciclib trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07191717) Abemaciclib trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07191717). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07191717. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07191717.mp4 2026-10-31T21:46:04.250Z 81 yes no https://www.trianglehealth.com/phase-2/immunoplant-for-newly-diagnosed-multiple-myeloma-nct06376526 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06376526.jpg Linvoseltamab trial for Multiple Myeloma (NCT06376526) Linvoseltamab trial for Multiple Myeloma (NCT06376526). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06376526. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06376526.mp4 2026-10-31T22:56:13.303Z 81 yes no https://www.trianglehealth.com/phase-2/immunotherapy-and-nodal-sparing-irradiation-for-t-cell-induction-nct07773987 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07773987.jpg Pembrolizumab trial for Head and Neck Cancer Squamous Cell Carcinoma (NCT07773987) Pembrolizumab trial for Head and Neck Cancer Squamous Cell Carcinoma (NCT07773987). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07773987. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07773987.mp4 2026-10-31T22:08:27.315Z 95 yes no https://www.trianglehealth.com/phase-2/immunotherapy-biomarkers-to-predict-first-line-pd-l-1-based-immu-nct07288034 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07288034.jpg Adagrasib trial for Lung Non-Small Cell Carcinoma (NCT07288034) Adagrasib trial for Lung Non-Small Cell Carcinoma (NCT07288034). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07288034. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07288034.mp4 2026-10-31T06:16:08.247Z 86 yes no https://www.trianglehealth.com/phase-2/immunotherapy-platform-study-in-platinum-resistant-high-grade-se-nct04918186 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04918186.jpg Durvalumab trial for Ovarian Cancer (NCT04918186) Durvalumab trial for Ovarian Cancer (NCT04918186). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04918186. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04918186.mp4 2026-10-31T21:28:11.374Z 72 yes no https://www.trianglehealth.com/phase-2/immunotherapy-toripalimab-for-reducing-recurrence-risk-after-sur-nct07140679 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07140679.jpg Biopsy Procedure trial for Localized Colon Carcinoma (NCT07140679) Biopsy Procedure trial for Localized Colon Carcinoma (NCT07140679). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07140679. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07140679.mp4 2026-10-31T16:32:31.885Z 73 yes no https://www.trianglehealth.com/phase-2/immunotherapy-using-tumor-infiltrating-lymphocytes-for-patients-nct01174121 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01174121.jpg Pembrolizumab (Keytruda) trial for Metastatic Colorectal Cancer (NCT01174121) Pembrolizumab (Keytruda) trial for Metastatic Colorectal Cancer (NCT01174121). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT01174121. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01174121.mp4 2026-10-31T23:04:53.406Z 73 yes no https://www.trianglehealth.com/phase-2/impact-of-vitamin-d-supplementation-on-the-rate-of-pathologic-co-nct04677816 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04677816.jpg Standard of Care Neoadjuvant Chemotherapy (NAC) trial for Triple Negative Breast… (NCT04677816) Standard of Care Neoadjuvant Chemotherapy (NAC) trial for Triple Negative Breast Cancer (NCT04677816). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04677816. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04677816.mp4 2026-10-31T16:38:51.480Z 76 yes no https://www.trianglehealth.com/phase-2/individualized-screening-trial-of-innovative-glioblastoma-therap-nct02977780 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02977780.jpg Temozolomide trial for Glioblastoma (NCT02977780) Temozolomide trial for Glioblastoma (NCT02977780). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02977780. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02977780.mp4 2026-10-31T16:26:49.433Z 95 yes no https://www.trianglehealth.com/phase-2/innovative-trial-for-understanding-the-impact-of-targeted-therap-nct04374305 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04374305.jpg Brigatinib trial for Neurofibromatosis Type 2 (NCT04374305) Brigatinib trial for Neurofibromatosis Type 2 (NCT04374305). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04374305. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04374305.mp4 2026-10-31T05:20:55.579Z 75 yes no https://www.trianglehealth.com/phase-2/inobrodib-pomalidomide-and-dexamethasone-in-relapsed-or-refracto-nct07096778 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07096778.jpg Inobrodib trial for Multiple Myeloma Refractory (NCT07096778) Inobrodib trial for Multiple Myeloma Refractory (NCT07096778). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07096778. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07096778.mp4 2026-10-31T15:18:00.819Z 83 yes no https://www.trianglehealth.com/phase-2/inotuzumab-ozogamicin-and-blinatumomab-with-or-without-ponatinib-nct03739814 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03739814.jpg Biospecimen Collection trial for B Acute Lymphoblastic Leukemia, Philadelphia… (NCT03739814) Biospecimen Collection trial for B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative (NCT03739814). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03739814. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03739814.mp4 2026-10-31T05:31:43.233Z 81 yes no https://www.trianglehealth.com/phase-2/intensity-modulated-total-marrow-irradiation-in-fully-human-leuk-nct06802315 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06802315.jpg Intensity modulated total marrow irradiation trial for Acute Myeloid Leukemia,… (NCT06802315) Intensity modulated total marrow irradiation trial for Acute Myeloid Leukemia, Relapsed, Adult (NCT06802315). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06802315. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06802315.mp4 2026-10-31T22:46:59.564Z 82 yes no https://www.trianglehealth.com/phase-2/interleukin-6-receptor-inhibitor-sarilumab-in-combination-with-i-nct05428007 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05428007.jpg Sarilumab trial for Melanoma (NCT05428007) Sarilumab trial for Melanoma (NCT05428007). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05428007. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05428007.mp4 2026-10-31T05:30:36.842Z 81 yes no https://www.trianglehealth.com/phase-2/intermittent-fasting-using-a-fasting-mimicking-diet-to-improve-p-nct05832086 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05832086.jpg Fasting Mimicking Diet (FMD) trial for Prostate Adenocarcinoma (NCT05832086) Fasting Mimicking Diet (FMD) trial for Prostate Adenocarcinoma (NCT05832086). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05832086. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05832086.mp4 2026-10-31T20:09:57.567Z 77 yes no https://www.trianglehealth.com/phase-2/intralesional-chemotherapy-ic-cisplatin-epinephrine-nct07392580 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07392580.jpg Cisplatin trial for Laryngeal Squamous Cell Carcinoma (NCT07392580) Cisplatin trial for Laryngeal Squamous Cell Carcinoma (NCT07392580). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07392580. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07392580.mp4 2026-10-31T17:02:54.144Z 67 yes no https://www.trianglehealth.com/phase-2/investigation-of-ubamatamab-combination-therapy-in-adult-partici-nct06787612 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06787612.jpg Ubamatamab trial for Ovarian Cancer (NCT06787612) Ubamatamab trial for Ovarian Cancer (NCT06787612). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06787612. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06787612.mp4 2026-10-31T22:39:57.735Z 77 yes no https://www.trianglehealth.com/phase-2/ivonescimab-alone-and-with-carboplatin-pemetrexed-for-nsclc-nct07405190 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07405190.jpg Ivonescimab trial for Lung Cancer (NSCLC) (NCT07405190) Ivonescimab trial for Lung Cancer (NSCLC) (NCT07405190). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07405190. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07405190.mp4 2026-10-31T22:01:24.801Z 101 yes no https://www.trianglehealth.com/phase-2/ivonescimab-before-surgery-for-the-treatment-of-resectable-stage-nct07094685 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07094685.jpg Biopsy Procedure trial for Advanced Head and Neck Squamous Cell Carcinoma (NCT07094685) Biopsy Procedure trial for Advanced Head and Neck Squamous Cell Carcinoma (NCT07094685). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07094685. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07094685.mp4 2026-10-31T22:41:22.625Z 72 yes no https://www.trianglehealth.com/phase-2/ivonescimab-for-the-treatment-of-thymic-cancer-nct06980077 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06980077.jpg Biopsy Procedure trial for Thymus Carcinoma (NCT06980077) Biopsy Procedure trial for Thymus Carcinoma (NCT06980077). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06980077. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06980077.mp4 2026-10-31T07:29:47.231Z 82 yes no https://www.trianglehealth.com/phase-2/ivonescimab-in-comb-with-folfox-in-advanced-her2-neg-gea-nct07070466 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07070466.jpg Ivonescimab trial for Stomach Cancer Stage IV (NCT07070466) Ivonescimab trial for Stomach Cancer Stage IV (NCT07070466). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07070466. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07070466.mp4 2026-10-31T16:06:58.278Z 88 yes no https://www.trianglehealth.com/phase-2/ivonescimab-prior-to-surgery-for-the-treatment-of-high-risk-loca-nct07226544 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226544.jpg Biopsy Procedure trial for Localized Clear Cell Renal Cell Carcinoma (NCT07226544) Biopsy Procedure trial for Localized Clear Cell Renal Cell Carcinoma (NCT07226544). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07226544. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226544.mp4 2026-10-31T21:54:28.971Z 68 yes no https://www.trianglehealth.com/phase-2/ivosidenib-as-post-hsct-maintenance-for-aml-nct06707493 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06707493.jpg Ivosidenib trial for IDH1 Mutation (NCT06707493) Ivosidenib trial for IDH1 Mutation (NCT06707493). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06707493. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06707493.mp4 2026-10-31T07:36:22.545Z 85 yes no https://www.trianglehealth.com/phase-2/keymaker-u01-substudy-01j-a-study-of-pembrolizumab-plus-mk-1084-nct07252739 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07252739.jpg MK-1084 trial for Malignant Neoplasm (NCT07252739) MK-1084 trial for Malignant Neoplasm (NCT07252739). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07252739. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07252739.mp4 2026-10-31T19:59:02.613Z 77 yes no https://www.trianglehealth.com/phase-2/kqb198-in-combination-with-imatinib-in-participants-with-advance-nct07406633 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07406633.jpg KQB198 trial for GIST - Gastrointestinal Stromal Tumor (NCT07406633) KQB198 trial for GIST - Gastrointestinal Stromal Tumor (NCT07406633). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07406633. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07406633.mp4 2026-10-31T20:08:17.264Z 77 yes no https://www.trianglehealth.com/phase-2/l19il2-l19tnf-in-patients-with-cutaneous-squamous-cell-carcinoma-nct07228442 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07228442.jpg L19IL2/L19TNF trial for Locally Advanced Cutaneous Squamous Cell Carcinoma (NCT07228442) L19IL2/L19TNF trial for Locally Advanced Cutaneous Squamous Cell Carcinoma (NCT07228442). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07228442. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07228442.mp4 2026-10-31T21:08:30.458Z 84 yes no https://www.trianglehealth.com/phase-2/l19il2-tnf-in-patients-with-basal-cell-carcinoma-nct07227870 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227870.jpg L19IL2/L19TNF trial for Locally Advanced Basal Cell Carcinoma (NCT07227870) L19IL2/L19TNF trial for Locally Advanced Basal Cell Carcinoma (NCT07227870). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07227870. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07227870.mp4 2026-10-31T21:27:06.419Z 81 yes no https://www.trianglehealth.com/phase-2/lerapolturev-pvsripo-in-gbm-nct06177964 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06177964.jpg Lerapolturev trial for Recurrent Supratentorial Glioblastoma (NCT06177964) Lerapolturev trial for Recurrent Supratentorial Glioblastoma (NCT06177964). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06177964. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06177964.mp4 2026-10-31T21:30:47.527Z 87 yes no https://www.trianglehealth.com/phase-2/letrozole-in-uterine-leiomyosarcoma-nct05649956 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05649956.jpg Letrozole trial for Uterine Leiomyosarcoma (NCT05649956) Letrozole trial for Uterine Leiomyosarcoma (NCT05649956). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05649956. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05649956.mp4 2026-10-31T20:47:47.824Z 86 yes no https://www.trianglehealth.com/phase-2/leuprolide-and-goserelin-for-ovarian-function-suppression-in-pre-nct07158021 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07158021.jpg Biospecimen Collection trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07158021) Biospecimen Collection trial for Anatomic Stage I Breast Cancer AJCC v8 (NCT07158021). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07158021. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07158021.mp4 2026-10-31T22:58:27.968Z 80 yes no https://www.trianglehealth.com/phase-2/liposomal-irinotecan-with-tas102-and-bevacizumab-for-patients-wi-nct05854498 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05854498.jpg Liposomal irinotecan trial for Metastatic Colorectal Cancer (NCT05854498) Liposomal irinotecan trial for Metastatic Colorectal Cancer (NCT05854498). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05854498. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05854498.mp4 2026-10-31T16:27:22.494Z 91 yes no https://www.trianglehealth.com/phase-2/liposome-encapsulated-daunorubicin-cytarabine-and-venetoclax-in-nct03629171 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03629171.jpg Liposome-encapsulated Daunorubicin-Cytarabine trial for Recurrent Acute Myeloid… (NCT03629171) Liposome-encapsulated Daunorubicin-Cytarabine trial for Recurrent Acute Myeloid Leukemia (NCT03629171). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03629171. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03629171.mp4 2026-10-31T07:25:36.955Z 83 yes no https://www.trianglehealth.com/phase-2/liquid-nitrogen-spray-cryotherapy-prior-to-neoadjuvant-systemic-nct07222657 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07222657.jpg Standard of care chemotherapy trial for Esophageal Adenocarcinoma (NCT07222657) Standard of care chemotherapy trial for Esophageal Adenocarcinoma (NCT07222657). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07222657. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07222657.mp4 2026-10-31T22:52:08.484Z 80 yes no https://www.trianglehealth.com/phase-2/local-consolidative-therapy-and-durvalumab-for-oligoprogressive-nct04892953 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04892953.jpg Carboplatin trial for Stage III Lung Cancer AJCC v8 (NCT04892953) Carboplatin trial for Stage III Lung Cancer AJCC v8 (NCT04892953). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04892953. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04892953.mp4 2026-10-31T19:56:43.218Z 83 yes no https://www.trianglehealth.com/phase-2/loncastuximab-tesirine-and-mosunetuzumab-for-the-treatment-of-re-nct05672251 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05672251.jpg Biopsy trial for Recurrent Diffuse Large B-Cell Lymphoma (NCT05672251) Biopsy trial for Recurrent Diffuse Large B-Cell Lymphoma (NCT05672251). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05672251. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05672251.mp4 2026-10-31T07:45:33.273Z 79 yes no https://www.trianglehealth.com/phase-2/loncastuximab-tesirine-and-rituximab-as-bridging-therapy-before-nct06788964 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06788964.jpg Loncastuximab Tesirine trial for Relapsed or Refractory Large B-cell Lymphoma (NCT06788964) Loncastuximab Tesirine trial for Relapsed or Refractory Large B-cell Lymphoma (NCT06788964). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06788964. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06788964.mp4 2026-10-31T06:33:14.946Z 78 yes no https://www.trianglehealth.com/phase-2/low-dose-mosunetuzumab-for-the-treatment-of-patients-with-indole-nct06442475 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06442475.jpg Biospecimen Collection trial for Ann Arbor Stage II Follicular Lymphoma (NCT06442475) Biospecimen Collection trial for Ann Arbor Stage II Follicular Lymphoma (NCT06442475). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06442475. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06442475.mp4 2026-10-31T16:51:50.745Z 82 yes no https://www.trianglehealth.com/phase-2/low-psma-suv-boost-lps-boost-intensified-177lu-psma-617-treatmen-nct06526299 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526299.jpg Biospecimen Collection trial for Metastatic Castration-Resistant Prostate Carcinoma (NCT06526299) Biospecimen Collection trial for Metastatic Castration-Resistant Prostate Carcinoma (NCT06526299). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06526299. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526299.mp4 2026-10-31T22:23:33.513Z 84 yes no https://www.trianglehealth.com/phase-2/lu-177-dotatate-lutathera-in-therapy-of-inoperable-pheochromocyt-nct03206060 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03206060.jpg Lu-177-DOTATATE trial for Pheochromocytoma (NCT03206060) Lu-177-DOTATATE trial for Pheochromocytoma (NCT03206060). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03206060. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03206060.mp4 2026-10-31T21:52:22.658Z 81 yes no https://www.trianglehealth.com/phase-2/luminal-bladder-cancer-effective-response-to-neoadjuvant-chemoth-nct07762586 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07762586.jpg Neoadjuvant Therapy trial for Bladder Cancer (NCT07762586) Neoadjuvant Therapy trial for Bladder Cancer (NCT07762586). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07762586. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07762586.mp4 2026-10-31T15:46:16.846Z 70 yes no https://www.trianglehealth.com/phase-2/lurbinectedin-with-or-without-avelumab-in-small-cell-carcinoma-o-nct06228066 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06228066.jpg Lurbinectedin trial for Small Cell Carcinoma of the Bladder (NCT06228066) Lurbinectedin trial for Small Cell Carcinoma of the Bladder (NCT06228066). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06228066. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06228066.mp4 2026-10-31T06:23:33.352Z 78 yes no https://www.trianglehealth.com/phase-2/lutathera-for-the-treatment-of-inoperable-progressive-meningioma-nct04082520 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04082520.jpg Gallium Ga 68-DOTATATE trial for Grade 1 Meningioma (NCT04082520) Gallium Ga 68-DOTATATE trial for Grade 1 Meningioma (NCT04082520). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04082520. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04082520.mp4 2026-10-31T07:14:32.325Z 83 yes no https://www.trianglehealth.com/phase-2/maintenance-combinatorial-myeloid-immunotherapy-for-unresectable-nct07199764 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07199764.jpg Odetiglucan trial for Pancreatic Ductal Adenocarcinoma (NCT07199764) Odetiglucan trial for Pancreatic Ductal Adenocarcinoma (NCT07199764). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07199764. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07199764.mp4 2026-11-01T00:06:33.793Z 78 yes no https://www.trianglehealth.com/phase-2/maintenance-niraparib-plus-ipilimumab-in-patients-with-metastati-nct06747845 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06747845.jpg Niraparib trial for Pancreatic Adenocarcinoma Metastatic (NCT06747845) Niraparib trial for Pancreatic Adenocarcinoma Metastatic (NCT06747845). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06747845. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06747845.mp4 2026-10-31T06:49:05.294Z 91 yes no https://www.trianglehealth.com/phase-2/maintenance-obinutuzumab-in-treating-patients-with-central-nervo-nct06175000 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06175000.jpg Cognitive Assessment trial for Primary Central Nervous System Lymphoma (NCT06175000) Cognitive Assessment trial for Primary Central Nervous System Lymphoma (NCT06175000). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06175000. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06175000.mp4 2026-10-31T21:01:37.585Z 75 yes no https://www.trianglehealth.com/phase-2/marginal-zone-lymphoma-nemtabrutinib-and-rituximab-nct07583810 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07583810.jpg Biopsy Procedure trial for Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma (NCT07583810) Biopsy Procedure trial for Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma (NCT07583810). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07583810. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07583810.mp4 2026-10-31T05:16:33.740Z 77 yes no https://www.trianglehealth.com/phase-2/mavric-studies-2l-treatment-with-av-in-patients-with-cll-sll-who-nct07024706 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07024706.jpg Acalabrutinib trial for Chronic Lymphocytic Leukemia (CLL) (NCT07024706) Acalabrutinib trial for Chronic Lymphocytic Leukemia (CLL) (NCT07024706). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07024706. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07024706.mp4 2026-10-31T21:54:53.309Z 85 yes no https://www.trianglehealth.com/phase-2/mdrt-in-prostate-cancer-treated-with-long-term-androgen-deprivat-nct06150417 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06150417.jpg Androgen deprivation therapy (ADT) trial for Prostate Cancer (NCT06150417) Androgen deprivation therapy (ADT) trial for Prostate Cancer (NCT06150417). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06150417. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06150417.mp4 2026-10-31T22:37:19.705Z 82 yes no https://www.trianglehealth.com/phase-2/measurable-residual-disease-guided-post-transplant-elranatamab-m-nct06483100 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06483100.jpg Elrantamab trial for Multiple Myeloma (NCT06483100) Elrantamab trial for Multiple Myeloma (NCT06483100). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06483100. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06483100.mp4 2026-10-31T20:16:07.153Z 74 yes no https://www.trianglehealth.com/phase-2/metformin-hydrochloride-in-combination-with-standard-of-care-sys-nct07291297 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07291297.jpg Metformin Hydrochloride ER trial for Sarcoma Metastatic (NCT07291297) Metformin Hydrochloride ER trial for Sarcoma Metastatic (NCT07291297). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07291297. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07291297.mp4 2026-10-31T21:14:44.501Z 72 yes no https://www.trianglehealth.com/phase-2/metformin-in-pseudomyxoma-peritonei-secondary-to-appendiceal-muc-nct07693452 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07693452.jpg Metformin trial for Appendiceal Mucinous Neoplasm (NCT07693452) Metformin trial for Appendiceal Mucinous Neoplasm (NCT07693452). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07693452. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07693452.mp4 2026-10-31T22:13:12.129Z 75 yes no https://www.trianglehealth.com/phase-2/methylprednisolone-horse-anti-thymocyte-globulin-cyclosporine-fi-nct01624805 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01624805.jpg Anti-Thymocyte Globulin trial for Aplastic Anemia (NCT01624805) Anti-Thymocyte Globulin trial for Aplastic Anemia (NCT01624805). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT01624805. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01624805.mp4 2026-10-31T23:43:07.074Z 77 yes no https://www.trianglehealth.com/phase-2/metronomic-decitabine-cedazuridine-and-venetoclax-in-r-r-aml-hr-nct07710534 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07710534.jpg Decitabine-cedazuridine plus venetoclax (DEC-C+VEN) trial for Relapsed / Refractory… (NCT07710534) Decitabine-cedazuridine plus venetoclax (DEC-C+VEN) trial for Relapsed / Refractory AML (NCT07710534). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07710534. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07710534.mp4 2026-10-31T15:09:40.058Z 92 yes no https://www.trianglehealth.com/phase-2/metronomic-gemcitabine-mitomycin-c-and-thalidomide-for-advanced-nct07671534 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07671534.jpg Gemcitabine trial for Solid Tumor Cancer (NCT07671534) Gemcitabine trial for Solid Tumor Cancer (NCT07671534). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07671534. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07671534.mp4 2026-10-31T22:41:28.725Z 73 yes no https://www.trianglehealth.com/phase-2/mezigdomide-carfilzomib-and-dexamethasone-for-the-treatment-of-r-nct06627751 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06627751.jpg Mezigdomide trial for Extramedullary Disease in Multiple Myeloma (NCT06627751) Mezigdomide trial for Extramedullary Disease in Multiple Myeloma (NCT06627751). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06627751. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06627751.mp4 2026-10-31T22:55:32.038Z 81 yes no https://www.trianglehealth.com/phase-2/mogamulizumab-low-dose-total-skin-electron-beam-tx-in-mycosis-fu-nct04256018 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04256018.jpg Mogamulizumab trial for Sezary Syndrome (NCT04256018) Mogamulizumab trial for Sezary Syndrome (NCT04256018). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04256018. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04256018.mp4 2026-10-31T22:34:43.038Z 73 yes no https://www.trianglehealth.com/phase-2/molecular-analyses-to-predict-pathways-of-endocrine-resistance-f-nct06361940 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06361940.jpg Aromatase inhibitors or tamoxifen trial for Breast Cancer (NCT06361940) Aromatase inhibitors or tamoxifen trial for Breast Cancer (NCT06361940). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06361940. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06361940.mp4 2026-10-31T22:05:44.324Z 83 yes no https://www.trianglehealth.com/phase-2/molecular-and-clinical-risk-directed-therapy-for-infants-and-you-nct05535166 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05535166.jpg Surgical resection trial for Medulloblastoma (NCT05535166) Surgical resection trial for Medulloblastoma (NCT05535166). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05535166. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05535166.mp4 2026-10-31T22:38:22.360Z 95 yes no https://www.trianglehealth.com/phase-2/monthly-alternating-nalirifox-and-gnp-in-the-first-line-setting-nct07163273 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07163273.jpg NALIRIFOX trial for Pancreatic Ductal Adenocarcinoma (NCT07163273) NALIRIFOX trial for Pancreatic Ductal Adenocarcinoma (NCT07163273). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07163273. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07163273.mp4 2026-10-31T07:02:18.256Z 89 yes no https://www.trianglehealth.com/phase-2/mosunetuzumab-and-polatuzumab-vedotin-for-the-treatment-of-patie-nct06453044 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06453044.jpg Biospecimen Collection trial for Recurrent Grade 1 Follicular Lymphoma (NCT06453044) Biospecimen Collection trial for Recurrent Grade 1 Follicular Lymphoma (NCT06453044). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06453044. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06453044.mp4 2026-10-31T21:05:20.739Z 89 yes no https://www.trianglehealth.com/phase-2/mosunetuzumab-and-polatuzumab-vedotin-with-split-dose-chp-chemot-nct06594939 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06594939.jpg Polatuzumab Vedotin trial for Diffuse Large B Cell Lymphoma (DLBCL) (NCT06594939) Polatuzumab Vedotin trial for Diffuse Large B Cell Lymphoma (DLBCL) (NCT06594939). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06594939. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06594939.mp4 2026-10-31T21:40:04.361Z 84 yes no https://www.trianglehealth.com/phase-2/mosunetuzumab-with-lenalidomide-augmentation-as-first-line-thera-nct04792502 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04792502.jpg Mosunetuzumab trial for Follicular Lymphoma (NCT04792502) Mosunetuzumab trial for Follicular Lymphoma (NCT04792502). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04792502. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04792502.mp4 2026-10-31T21:48:12.540Z 76 yes no https://www.trianglehealth.com/phase-2/mri-based-focal-intraprostatic-simultaneous-integrated-boost-sib-nct07644598 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07644598.jpg Microboost SBRT trial for Prostate Cancer (NCT07644598) Microboost SBRT trial for Prostate Cancer (NCT07644598). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07644598. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07644598.mp4 2026-10-31T22:50:26.562Z 80 yes no https://www.trianglehealth.com/phase-2/mt2022-60-ph-2-study-of-pembro-beam-with-asct-for-relapsed-hodgk-nct06377540 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06377540.jpg Pembrolizumab trial for Autologous Stem Cell Transplant (NCT06377540) Pembrolizumab trial for Autologous Stem Cell Transplant (NCT06377540). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06377540. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06377540.mp4 2026-10-31T06:39:37.282Z 75 yes no https://www.trianglehealth.com/phase-2/myeloablative-consolidation-therapy-and-tandem-autologous-stem-c-nct02605421 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02605421.jpg Thiotepa trial for Neuroblastoma (NCT02605421) Thiotepa trial for Neuroblastoma (NCT02605421). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02605421. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02605421.mp4 2026-10-31T06:16:38.539Z 73 yes no https://www.trianglehealth.com/phase-2/nalirifox-before-surgery-for-the-treatment-of-borderline-resecta-nct06821997 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06821997.jpg Biospecimen Collection trial for Borderline Resectable Pancreatic Ductal… (NCT06821997) Biospecimen Collection trial for Borderline Resectable Pancreatic Ductal Adenocarcinoma (NCT06821997). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06821997. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06821997.mp4 2026-10-31T21:32:00.069Z 76 yes no https://www.trianglehealth.com/phase-2/nant-2021-01-phase-ii-sting-sequential-temozolomide-irinotecan-n-nct06450041 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06450041.jpg Universal Donor (UD) TGFβi NK Cells trial for Neuroblastoma (NCT06450041) Universal Donor (UD) TGFβi NK Cells trial for Neuroblastoma (NCT06450041). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06450041. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06450041.mp4 2026-10-31T21:28:25.965Z 83 yes no https://www.trianglehealth.com/phase-2/naxitamab-added-to-induction-for-newly-diagnosed-high-risk-neuro-nct05489887 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05489887.jpg Naxitamab trial for Neuroblastoma (NCT05489887) Naxitamab trial for Neuroblastoma (NCT05489887). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05489887. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05489887.mp4 2026-10-31T23:02:37.791Z 77 yes no https://www.trianglehealth.com/phase-2/nemtabrutinib-and-lisocabtagene-maraleucel-for-the-treatment-of-nct07194980 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07194980.jpg Nemtabrutinib trial for Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic… (NCT07194980) Nemtabrutinib trial for Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT07194980). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07194980. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07194980.mp4 2026-10-31T05:25:14.638Z 83 yes no https://www.trianglehealth.com/phase-2/nemtabrutinib-and-pembrolizumab-for-the-treatment-of-richter-tra-nct06863402 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06863402.jpg Biospecimen Collection trial for Richter Syndrome (NCT06863402) Biospecimen Collection trial for Richter Syndrome (NCT06863402). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06863402. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06863402.mp4 2026-10-31T06:50:35.410Z 86 yes no https://www.trianglehealth.com/phase-2/nemtabrutinib-and-venetoclax-for-the-treatment-of-patients-with-nct07557056 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07557056.jpg Biospecimen Collection trial for Chronic Lymphocytic Leukemia (NCT07557056) Biospecimen Collection trial for Chronic Lymphocytic Leukemia (NCT07557056). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07557056. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07557056.mp4 2026-10-31T16:35:46.070Z 80 yes no https://www.trianglehealth.com/phase-2/nemtabrutinib-with-car-t-therapy-in-relapsed-refractory-mantle-c-nct07673367 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07673367.jpg Nemtabrutinib trial for Recurrent Mantle Cell Lymphoma (NCT07673367) Nemtabrutinib trial for Recurrent Mantle Cell Lymphoma (NCT07673367). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07673367. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07673367.mp4 2026-10-31T22:56:39.621Z 70 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-and-adjuvant-treatment-in-resectable-non-small-cell-nct05061550 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05061550.jpg Durvalumab trial for Non-small Cell Lung Cancer (NCT05061550) Durvalumab trial for Non-small Cell Lung Cancer (NCT05061550). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05061550. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05061550.mp4 2026-10-31T21:17:26.357Z 89 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-botensilimab-and-balstilimab-for-the-treatment-of-ad-nct07595874 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07595874.jpg Balstilimab trial for Advanced Colon Adenocarcinoma (NCT07595874) Balstilimab trial for Advanced Colon Adenocarcinoma (NCT07595874). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07595874. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07595874.mp4 2026-10-31T22:08:51.211Z 84 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-chemo-immunotherapy-and-surgical-resection-in-locall-nct06449313 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06449313.jpg Cemiplimab-Rwlc trial for Non-small Cell Lung Cancer Stage III (NCT06449313) Cemiplimab-Rwlc trial for Non-small Cell Lung Cancer Stage III (NCT06449313). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06449313. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06449313.mp4 2026-10-31T07:17:18.156Z 84 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-chemotherapy-for-borderline-resectable-and-locally-a-nct05825066 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05825066.jpg Nab paclitaxel trial for Pancreas Adenocarcinoma (NCT05825066) Nab paclitaxel trial for Pancreas Adenocarcinoma (NCT05825066). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05825066. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05825066.mp4 2026-10-31T14:57:37.136Z 88 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-folfirinox-combined-with-pembrolizumab-followed-by-s-nct05132504 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05132504.jpg Pembrolizumab trial for Pancreatic Ductal Adenocarcinoma (NCT05132504) Pembrolizumab trial for Pancreatic Ductal Adenocarcinoma (NCT05132504). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05132504. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05132504.mp4 2026-10-31T20:42:56.032Z 83 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-inbrx-106-in-combination-with-pembrolizumab-for-stag-nct06353997 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06353997.jpg Pembrolizumab trial for Triple Negative Breast Cancer (NCT06353997) Pembrolizumab trial for Triple Negative Breast Cancer (NCT06353997). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06353997. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06353997.mp4 2026-10-31T22:34:36.220Z 72 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-lenvatinib-and-pembrolizumab-for-ivc-tumor-thrombus-nct05319015 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05319015.jpg Neoadjuvant Lenvatinib trial for Renal Cell Carcinoma (NCT05319015) Neoadjuvant Lenvatinib trial for Renal Cell Carcinoma (NCT05319015). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05319015. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05319015.mp4 2026-10-31T22:36:09.039Z 80 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-neratinib-in-stage-i-iii-her2-mutated-lobular-breast-nct05919108 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05919108.jpg Endocrine Therapy trial for Anatomic Stage I Breast Cancer (NCT05919108) Endocrine Therapy trial for Anatomic Stage I Breast Cancer (NCT05919108). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05919108. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05919108.mp4 2026-10-31T21:50:07.387Z 74 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-pembrolizumab-and-porustobart-in-resectable-pmmr-mss-nct07808151 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07808151.jpg Pembrolizumab trial for Colon Cancer (NCT07808151) Pembrolizumab trial for Colon Cancer (NCT07808151). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07808151. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07808151.mp4 2026-10-31T05:21:18.584Z 78 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-spare-adjuvant-nasa-in-stage-iiib-iv-m1a-melanoma-nct07740941 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07740941.jpg Pembrolizumab trial for Melanoma (Skin Cancer) (NCT07740941) Pembrolizumab trial for Melanoma (Skin Cancer) (NCT07740941). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07740941. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07740941.mp4 2026-10-31T20:58:26.060Z 71 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-tebentafusp-for-uveal-melanoma-nct06414590 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06414590.jpg Tebentafusp-Tebn trial for Locally Advanced Unresectable Uveal Melanoma (NCT06414590) Tebentafusp-Tebn trial for Locally Advanced Unresectable Uveal Melanoma (NCT06414590). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06414590. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06414590.mp4 2026-11-01T00:02:58.166Z 76 yes no https://www.trianglehealth.com/phase-2/neoadjuvant-zanzalintinib-plus-nivolumab-in-patients-with-locall-nct06794229 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06794229.jpg Zanzalintinib trial for Locally Advanced Renal Cell Carcinoma (NCT06794229) Zanzalintinib trial for Locally Advanced Renal Cell Carcinoma (NCT06794229). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06794229. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06794229.mp4 2026-10-31T19:21:02.239Z 71 yes no https://www.trianglehealth.com/phase-2/newly-diagnosed-stage-iii-iv-ovarian-cancer-neoadjuvant-carbo-ta-nct05952453 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05952453.jpg Carboplatin trial for Ovarian Cancer (NCT05952453) Carboplatin trial for Ovarian Cancer (NCT05952453). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05952453. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05952453.mp4 2026-10-31T22:40:25.397Z 82 yes no https://www.trianglehealth.com/phase-2/nirogacestat-in-patients-with-kaposi-sarcoma-nct07539454 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07539454.jpg Biospecimen Collection trial for AIDS-Related Kaposi Sarcoma (NCT07539454) Biospecimen Collection trial for AIDS-Related Kaposi Sarcoma (NCT07539454). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07539454. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07539454.mp4 2026-10-31T22:02:32.528Z 73 yes no https://www.trianglehealth.com/phase-2/nivolumab-in-epstein-barr-virus-ebv-positive-lymphoproliferative-nct03258567 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03258567.jpg Nivolumab trial for Epstein-Barr Virus Infections (NCT03258567) Nivolumab trial for Epstein-Barr Virus Infections (NCT03258567). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03258567. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03258567.mp4 2026-10-31T16:10:19.919Z 84 yes no https://www.trianglehealth.com/phase-2/nodal-radiation-therapy-for-sentinel-lymph-node-positive-melanom-nct04594187 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04594187.jpg Immunotherapy trial for Melanoma (NCT04594187) Immunotherapy trial for Melanoma (NCT04594187). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04594187. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04594187.mp4 2026-10-31T20:13:11.046Z 63 yes no https://www.trianglehealth.com/phase-2/obinutuzumab-and-ice-chemotherapy-in-refractory-recurrent-cd20-m-nct02393157 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02393157.jpg Obinutuzumab trial for Non-Hodgkin Lymphoma (NCT02393157) Obinutuzumab trial for Non-Hodgkin Lymphoma (NCT02393157). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02393157. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02393157.mp4 2026-10-31T23:04:21.288Z 79 yes no https://www.trianglehealth.com/phase-2/odronextamab-for-relapsed-and-refractory-large-b-cell-lymphomas-nct06784726 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06784726.jpg Odronextamab trial for Recurrent Diffuse Large B-Cell Lymphoma (NCT06784726) Odronextamab trial for Recurrent Diffuse Large B-Cell Lymphoma (NCT06784726). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06784726. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06784726.mp4 2026-10-31T16:25:09.402Z 83 yes no https://www.trianglehealth.com/phase-2/olaparib-with-cediranib-or-azd6738-for-the-treatment-of-advanced-nct04090567 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04090567.jpg Cediranib trial for Advanced Breast Carcinoma (NCT04090567) Cediranib trial for Advanced Breast Carcinoma (NCT04090567). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04090567. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04090567.mp4 2026-10-31T16:57:21.493Z 81 yes no https://www.trianglehealth.com/phase-2/olutasidenib-in-relapsed-idh1-mutated-aml-patients-who-have-prev-nct07471841 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07471841.jpg Olutasidenib trial for IDH1 Mutation (NCT07471841) Olutasidenib trial for IDH1 Mutation (NCT07471841). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07471841. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07471841.mp4 2026-10-31T19:59:56.227Z 74 yes no https://www.trianglehealth.com/phase-2/olutasidenib-with-azacitidine-followed-by-olutasidenib-maintenan-nct07304011 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07304011.jpg Azacitidine trial for Acute Myeloid Leukemia (NCT07304011) Azacitidine trial for Acute Myeloid Leukemia (NCT07304011). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07304011. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07304011.mp4 2026-10-31T05:33:17.273Z 89 yes no https://www.trianglehealth.com/phase-2/open-label-of-loncastuximab-tesirine-adct-402-in-relapsed-refrac-nct05296070 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05296070.jpg Loncastuximab tesirine 150 µg/Kg trial for Marginal Zone Lymphoma (NCT05296070) Loncastuximab tesirine 150 µg/Kg trial for Marginal Zone Lymphoma (NCT05296070). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05296070. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05296070.mp4 2026-10-31T21:33:06.918Z 70 yes no https://www.trianglehealth.com/phase-2/open-label-phase-2-study-of-avutometinib-raf-mek-clamp-in-combin-nct06369259 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06369259.jpg Defactinib trial for Advanced Colorectal Cancer (NCT06369259) Defactinib trial for Advanced Colorectal Cancer (NCT06369259). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06369259. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06369259.mp4 2026-10-31T16:26:48.768Z 87 yes no https://www.trianglehealth.com/phase-2/optimal-psa-triggered-individual-management-of-androgen-sensitiv-nct07216248 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07216248.jpg relugolix + ARPI trial for Metastatic Hormone-sensitive Prostate Cancer (mHSPC) (NCT07216248) relugolix + ARPI trial for Metastatic Hormone-sensitive Prostate Cancer (mHSPC) (NCT07216248). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07216248. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07216248.mp4 2026-10-31T22:52:37.298Z 77 yes no https://www.trianglehealth.com/phase-2/optimizing-neurocognition-with-whole-brain-radiation-therapy-wbr-nct05045950 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05045950.jpg Memantine -Twice Daily or Extended Release trial for Brain Metastases (NCT05045950) Memantine -Twice Daily or Extended Release trial for Brain Metastases (NCT05045950). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05045950. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05045950.mp4 2026-10-31T20:55:32.302Z 71 yes no https://www.trianglehealth.com/phase-2/oral-tgf-beta-receptor-i-inhibitor-vactosertib-in-soc-chemoradio-nct06044311 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06044311.jpg Vactosertib trial for Adenocarcinoma Esophagus (NCT06044311) Vactosertib trial for Adenocarcinoma Esophagus (NCT06044311). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06044311. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06044311.mp4 2026-10-31T06:39:01.257Z 78 yes no https://www.trianglehealth.com/phase-2/osimertinib-alone-or-with-chemotherapy-for-egfr-mutant-lung-canc-nct04410796 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04410796.jpg Osimertinib trial for Metastatic Non-small Cell Lung Cancer (NCT04410796) Osimertinib trial for Metastatic Non-small Cell Lung Cancer (NCT04410796). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04410796. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04410796.mp4 2026-10-31T15:28:28.835Z 83 yes no https://www.trianglehealth.com/phase-2/osimertinib-and-cyclosporine-a-to-enhance-antitumor-efficacy-in-nct07874490 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07874490.jpg Osimertinib trial for Non-Small Cell Lung Cancer With Mutation in Epidermal Growth… (NCT07874490) Osimertinib trial for Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (NCT07874490). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07874490. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07874490.mp4 2026-10-31T16:18:59.106Z 79 yes no https://www.trianglehealth.com/phase-2/oxaliplatin-and-liposomal-irinotecan-plus-trastuzumab-for-her2-p-nct04150640 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04150640.jpg Nal-IRI trial for Esophageal Adenocarcinoma (NCT04150640) Nal-IRI trial for Esophageal Adenocarcinoma (NCT04150640). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04150640. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04150640.mp4 2026-10-31T23:03:18.319Z 79 yes no https://www.trianglehealth.com/phase-2/pacritinib-in-participants-with-metastatic-castrate-resistant-pr-nct07226713 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226713.jpg Pacritinib trial for Prostate Cancer (NCT07226713) Pacritinib trial for Prostate Cancer (NCT07226713). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07226713. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07226713.mp4 2026-10-31T17:28:15.896Z 80 yes no https://www.trianglehealth.com/phase-2/pacritinib-vs-hydroxyurea-in-advanced-proliferative-chronic-myel-nct07033598 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07033598.jpg Pacritinib trial for Leukemia, Myelomonocytic, Chronic (NCT07033598) Pacritinib trial for Leukemia, Myelomonocytic, Chronic (NCT07033598). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07033598. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07033598.mp4 2026-10-31T22:53:34.643Z 76 yes no https://www.trianglehealth.com/phase-2/palbociclib-and-pembrolizumab-in-central-nervous-system-metastas-nct02896335 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02896335.jpg Palbociclib trial for Metastatic Malignant Neoplasm to Brain (NCT02896335) Palbociclib trial for Metastatic Malignant Neoplasm to Brain (NCT02896335). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02896335. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02896335.mp4 2026-10-31T21:26:30.413Z 84 yes no https://www.trianglehealth.com/phase-2/pancreatic-cancer-choose-preoperative-chemotherapy-by-smad4-stat-nct07748611 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07748611.jpg Biospecimen Collection trial for Borderline Resectable Pancreatic Ductal… (NCT07748611) Biospecimen Collection trial for Borderline Resectable Pancreatic Ductal Adenocarcinoma (NCT07748611). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07748611. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07748611.mp4 2026-10-31T05:18:50.066Z 80 yes no https://www.trianglehealth.com/phase-2/paxalisib-gdc-0084-in-recurrent-or-refractory-pcnsl-nct04906096 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04906096.jpg PAXALISIB trial for Primary Central Nervous System Lymphoma (NCT04906096) PAXALISIB trial for Primary Central Nervous System Lymphoma (NCT04906096). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04906096. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04906096.mp4 2026-10-31T20:24:43.252Z 70 yes no https://www.trianglehealth.com/phase-2/pbi-11-ta-hpv-with-pembrolizumab-as-treatment-for-patients-w-adv-nct05799144 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05799144.jpg DNA Vaccine trial for Metastatic Oropharyngeal Carcinoma (NCT05799144) DNA Vaccine trial for Metastatic Oropharyngeal Carcinoma (NCT05799144). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05799144. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05799144.mp4 2026-10-31T22:00:59.182Z 80 yes no https://www.trianglehealth.com/phase-2/pd-l1-t-hank-nai-il-15sa-and-cetuximab-for-recurrent-metastatic-nct06239220 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06239220.jpg PD-L1 t-haNK trial for Head and Neck Cancer (NCT06239220) PD-L1 t-haNK trial for Head and Neck Cancer (NCT06239220). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06239220. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06239220.mp4 2026-10-31T20:48:17.705Z 83 yes no https://www.trianglehealth.com/phase-2/pds01adc-in-combination-with-hepatic-artery-infusion-pump-haip-a-nct05286814 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05286814.jpg Dexamethasone trial for Metastatic Colorectal Cancer (Mcrc) (NCT05286814) Dexamethasone trial for Metastatic Colorectal Cancer (Mcrc) (NCT05286814). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05286814. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05286814.mp4 2026-10-31T15:43:37.869Z 83 yes no https://www.trianglehealth.com/phase-2/pembro-with-radiation-with-or-without-olaparib-nct05568550 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05568550.jpg Pembrolizumab trial for Prostate Cancer (NCT05568550) Pembrolizumab trial for Prostate Cancer (NCT05568550). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05568550. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05568550.mp4 2026-10-31T22:09:48.027Z 81 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-and-enfortumab-vedotin-with-pembrolizumab-prior-to-nct05775471 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05775471.jpg Biopsy trial for Renal Pelvis and Ureter Urothelial Carcinoma (NCT05775471) Biopsy trial for Renal Pelvis and Ureter Urothelial Carcinoma (NCT05775471). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05775471. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05775471.mp4 2026-10-31T21:51:01.555Z 86 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-and-hypofractionated-radiation-therapy-for-the-tre-nct04318717 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04318717.jpg Pembrolizumab trial for Mucosal Melanoma of the Head and Neck (NCT04318717) Pembrolizumab trial for Mucosal Melanoma of the Head and Neck (NCT04318717). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04318717. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04318717.mp4 2026-10-31T16:57:50.346Z 66 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-and-lenvatinib-in-advanced-cervical-cancer-nct04865887 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04865887.jpg Pembrolizumab trial for Cervical Cancer (NCT04865887) Pembrolizumab trial for Cervical Cancer (NCT04865887). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04865887. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04865887.mp4 2026-10-31T15:44:17.561Z 84 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-and-lenvatinib-in-mismatch-repair-proficient-recur-nct07594015 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07594015.jpg Pembrolizumab trial for Recurrent Endometrial Cancer (NCT07594015) Pembrolizumab trial for Recurrent Endometrial Cancer (NCT07594015). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07594015. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07594015.mp4 2026-10-31T15:07:22.857Z 85 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-and-odetiglucan-in-liver-predominant-metastatic-co-nct07082439 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07082439.jpg Pembrolizumab trial for Colorectal Adenocarcinoma Metastatic in the Liver (NCT07082439) Pembrolizumab trial for Colorectal Adenocarcinoma Metastatic in the Liver (NCT07082439). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07082439. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07082439.mp4 2026-10-31T06:45:00.095Z 92 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-combined-with-bevacizumab-with-or-without-agonist-nct05231122 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05231122.jpg Anti-CD40 Agonist Monoclonal Antibody CDX-1140 trial for Ovarian Clear Cell… (NCT05231122) Anti-CD40 Agonist Monoclonal Antibody CDX-1140 trial for Ovarian Clear Cell Adenocarcinoma (NCT05231122). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05231122. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05231122.mp4 2026-10-31T16:45:44.708Z 86 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-in-combination-with-chemotherapy-for-the-treatment-nct07275216 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07275216.jpg Biospecimen Collection trial for Classic Hodgkin Lymphoma (NCT07275216) Biospecimen Collection trial for Classic Hodgkin Lymphoma (NCT07275216). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07275216. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07275216.mp4 2026-10-31T15:18:54.699Z 79 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-n-803-alone-or-in-combination-with-pd-l1-t-hank-ce-nct06161545 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161545.jpg PD-L1 t-haNK cells trial for Stage II Squamous Cell Carcinoma of the Head and Neck (NCT06161545) PD-L1 t-haNK cells trial for Stage II Squamous Cell Carcinoma of the Head and Neck (NCT06161545). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06161545. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161545.mp4 2026-10-31T22:28:35.325Z 73 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-olaparib-and-temozolomide-for-people-with-glioma-nct05188508 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05188508.jpg Pembrolizumab trial for Glioma (NCT05188508) Pembrolizumab trial for Glioma (NCT05188508). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05188508. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05188508.mp4 2026-10-31T21:22:25.873Z 86 yes no https://www.trianglehealth.com/phase-2/pembrolizumab-plus-177lu-psma-617-in-patients-with-castration-re-nct05766371 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05766371.jpg Pembrolizumab trial for Castrate Resistant Prostate Cancer (NCT05766371) Pembrolizumab trial for Castrate Resistant Prostate Cancer (NCT05766371). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05766371. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05766371.mp4 2026-10-31T15:31:47.131Z 88 yes no https://www.trianglehealth.com/phase-2/pemetrexed-response-in-relation-to-tumor-alterations-of-gene-sta-nct06630416 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06630416.jpg Biospecimen Collection trial for Metastatic Bladder Urothelial Carcinoma (NCT06630416) Biospecimen Collection trial for Metastatic Bladder Urothelial Carcinoma (NCT06630416). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06630416. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06630416.mp4 2026-11-01T00:01:40.644Z 91 yes no https://www.trianglehealth.com/phase-2/pep-cmv-vaccine-targeting-cmv-antigen-to-treat-newly-diagnosed-p-nct05096481 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05096481.jpg PEP-CMV trial for High Grade Glioma (NCT05096481) PEP-CMV trial for High Grade Glioma (NCT05096481). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05096481. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05096481.mp4 2026-10-31T22:43:42.493Z 88 yes no https://www.trianglehealth.com/phase-2/personalized-neck-radiation-therapy-directed-by-sentinel-lymph-n-nct07121595 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07121595.jpg Biospecimen Collection trial for Oral Cavity Squamous Cell Carcinoma (NCT07121595) Biospecimen Collection trial for Oral Cavity Squamous Cell Carcinoma (NCT07121595). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07121595. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07121595.mp4 2026-10-31T20:40:40.199Z 81 yes no https://www.trianglehealth.com/phase-2/personalized-reduction-of-chemotherapy-intensity-through-ctdna-e-nct06745076 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06745076.jpg Biospecimen Collection trial for Advanced Hodgkin Lymphoma (NCT06745076) Biospecimen Collection trial for Advanced Hodgkin Lymphoma (NCT06745076). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06745076. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06745076.mp4 2026-10-31T17:50:13.889Z 75 yes no https://www.trianglehealth.com/phase-2/pet-dynamics-to-response-adapted-neoadjuvant-therapy-in-tnbc-nct06245889 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06245889.jpg Paclitaxel trial for Triple Negative Breast Cancer (NCT06245889) Paclitaxel trial for Triple Negative Breast Cancer (NCT06245889). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06245889. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06245889.mp4 2026-10-31T20:02:42.010Z 78 yes no https://www.trianglehealth.com/phase-2/ph-ii-intraperitoneal-paclitaxel-system-therapy-in-gi-ca-w-perit-nct07795749 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07795749.jpg Paclitaxel Q2W trial for Esophageal Carcinoma (NCT07795749) Paclitaxel Q2W trial for Esophageal Carcinoma (NCT07795749). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07795749. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07795749.mp4 2026-10-31T15:10:50.196Z 88 yes no https://www.trianglehealth.com/phase-2/phase-2-single-arm-rectal-cancer-brachytherapy-for-patients-with-nct07292298 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07292298.jpg High Rare Dose Rectal Brachytherapy Boost trial for Rectal Adenocarcinoma (NCT07292298) High Rare Dose Rectal Brachytherapy Boost trial for Rectal Adenocarcinoma (NCT07292298). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07292298. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07292298.mp4 2026-10-31T19:59:25.508Z 75 yes no https://www.trianglehealth.com/phase-2/phase-2-study-assessing-the-clinical-activity-and-safety-of-obec-nct07053059 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07053059.jpg Obecabtagene autoleucel trial for Acute Lymphocytic Leukemia (ALL) (NCT07053059) Obecabtagene autoleucel trial for Acute Lymphocytic Leukemia (ALL) (NCT07053059). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07053059. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07053059.mp4 2026-10-31T16:50:23.089Z 87 yes no https://www.trianglehealth.com/phase-2/phase-2-study-of-combination-tivozanib-and-nivolumab-in-advanced-nct06053658 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06053658.jpg Tivozanib trial for Renal Cell Carcinoma (NCT06053658) Tivozanib trial for Renal Cell Carcinoma (NCT06053658). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06053658. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06053658.mp4 2026-10-31T20:54:08.049Z 69 yes no https://www.trianglehealth.com/phase-2/phase-2-study-of-glofitamab-monotherapy-with-polatuzumab-vedotin-nct06043674 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06043674.jpg Glofitamab trial for Chronic Lymphocytic Leukemia (NCT06043674) Glofitamab trial for Chronic Lymphocytic Leukemia (NCT06043674). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06043674. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06043674.mp4 2026-10-31T21:17:02.956Z 82 yes no https://www.trianglehealth.com/phase-2/phase-2-study-of-mosunetuzumab-in-patients-with-chronic-lymphocy-nct07566364 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07566364.jpg Mosunetuzumab trial for Lymphocytic Leukemia (NCT07566364) Mosunetuzumab trial for Lymphocytic Leukemia (NCT07566364). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07566364. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07566364.mp4 2026-10-31T16:03:08.999Z 83 yes no https://www.trianglehealth.com/phase-2/phase-2-study-of-sr-8541a-in-combination-with-botensilimab-and-b-nct06589440 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06589440.jpg SR-8541A trial for Refractory Metastatic Microsatellite Stable Colorectal Cancer… (NCT06589440) SR-8541A trial for Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) (NCT06589440). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06589440. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06589440.mp4 2026-10-31T16:54:08.724Z 89 yes no https://www.trianglehealth.com/phase-2/phase-2-study-to-evaluate-safety-and-efficacy-of-cretostimogene-nct06567743 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06567743.jpg Cretostimogene Grenadenorepvec trial for High-Risk Non-Muscle-Invasive Bladder Cancer (NCT06567743) Cretostimogene Grenadenorepvec trial for High-Risk Non-Muscle-Invasive Bladder Cancer (NCT06567743). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06567743. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06567743.mp4 2026-10-31T19:54:50.782Z 70 yes no https://www.trianglehealth.com/phase-2/phase-2-trial-of-epcoritamab-in-combination-with-rituximab-mini-nct06045247 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06045247.jpg Prednisone trial for Large B-cell Lymphoma (NCT06045247) Prednisone trial for Large B-cell Lymphoma (NCT06045247). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06045247. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06045247.mp4 2026-10-31T07:21:09.371Z 90 yes no https://www.trianglehealth.com/phase-2/phase-2-trial-of-lisocabtagene-maraleucel-for-minimal-residual-d-nct07316010 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07316010.jpg Leukapheresis trial for Large B-cell Lymphoma (NCT07316010) Leukapheresis trial for Large B-cell Lymphoma (NCT07316010). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07316010. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07316010.mp4 2026-10-31T22:39:28.734Z 76 yes no https://www.trianglehealth.com/phase-2/phase-2-trial-of-obinutuzumab-and-cc-99282-for-patients-with-pre-nct06108232 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06108232.jpg Obinutuzumab trial for Follicular Lymphoma (NCT06108232) Obinutuzumab trial for Follicular Lymphoma (NCT06108232). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06108232. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06108232.mp4 2026-10-31T16:03:51.365Z 80 yes no https://www.trianglehealth.com/phase-2/phase-2-trial-of-zanzalintinib-and-pembrolizumab-in-select-subty-nct07283731 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07283731.jpg Zanzalintinib trial for Phase 2 (NCT07283731) Zanzalintinib trial for Phase 2 (NCT07283731). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07283731. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07283731.mp4 2026-10-31T21:45:40.006Z 87 yes no https://www.trianglehealth.com/phase-2/phase-ii-decentralized-pragmatic-trial-of-adjuvant-doxorubicin-t-nct07076186 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07076186.jpg Trabectedin trial for Uterine Leiomyosarcoma (NCT07076186) Trabectedin trial for Uterine Leiomyosarcoma (NCT07076186). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07076186. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07076186.mp4 2026-10-31T14:54:14.082Z 83 yes no https://www.trianglehealth.com/phase-2/phase-ii-protocol-of-proton-therapy-for-partial-breast-irradiati-nct01766297 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01766297.jpg Proton Radiotherapy trial for Breast Cancer (NCT01766297) Proton Radiotherapy trial for Breast Cancer (NCT01766297). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT01766297. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT01766297.mp4 2026-10-31T14:55:32.362Z 74 yes no https://www.trianglehealth.com/phase-2/phase-ii-study-assessing-efficacy-and-safety-of-asciminib-in-pat-nct06236724 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06236724.jpg Asciminib trial for Chronic Myeloid Leukemia (NCT06236724) Asciminib trial for Chronic Myeloid Leukemia (NCT06236724). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06236724. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06236724.mp4 2026-10-31T07:00:22.072Z 82 yes no https://www.trianglehealth.com/phase-2/phase-ii-study-assessing-the-safety-and-efficacy-of-dasatinib-in-nct07269470 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07269470.jpg Dasatinib trial for Chronic Myeloid Leukemia (NCT07269470) Dasatinib trial for Chronic Myeloid Leukemia (NCT07269470). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07269470. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07269470.mp4 2026-10-31T22:24:22.314Z 87 yes no https://www.trianglehealth.com/phase-2/phase-ii-study-of-asciminib-for-second-line-treatment-of-chronic-nct06629584 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06629584.jpg Asciminib trial for Malignant Solid Tumors (NCT06629584) Asciminib trial for Malignant Solid Tumors (NCT06629584). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06629584. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06629584.mp4 2026-10-31T06:51:38.750Z 94 yes no https://www.trianglehealth.com/phase-2/phase-ii-study-of-nivolumab-plus-avd-in-pediatric-adolescent-and-nct07551583 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551583.jpg Nivolumab trial for Hodgkin Lymphoma (NCT07551583) Nivolumab trial for Hodgkin Lymphoma (NCT07551583). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07551583. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551583.mp4 2026-10-31T15:18:36.615Z 77 yes no https://www.trianglehealth.com/phase-2/phase-ii-study-of-peptide-receptor-radionuclide-therapy-in-combi-nct05583708 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05583708.jpg Pembrolizumab trial for Merkel Cell Carcinoma (NCT05583708) Pembrolizumab trial for Merkel Cell Carcinoma (NCT05583708). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05583708. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05583708.mp4 2026-10-31T15:38:07.822Z 75 yes no https://www.trianglehealth.com/phase-2/phase-ii-study-of-platinum-etoposide-plus-ivonescimab-for-extens-nct07057791 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07057791.jpg Ivonescimab 10 mg/kg trial for Extensive Stage Lung Small Cell Cancer (NCT07057791) Ivonescimab 10 mg/kg trial for Extensive Stage Lung Small Cell Cancer (NCT07057791). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07057791. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07057791.mp4 2026-10-31T16:16:51.433Z 83 yes no https://www.trianglehealth.com/phase-2/phase-ii-study-of-second-line-pembrolizumab-plus-gvd-for-relapse-nct03618550 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03618550.jpg pembrolizumab trial for Hodgkin Lymphoma (NCT03618550) pembrolizumab trial for Hodgkin Lymphoma (NCT03618550). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03618550. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03618550.mp4 2026-10-31T15:55:38.000Z 77 yes no https://www.trianglehealth.com/phase-2/phase-ii-study-of-the-effects-of-laparoscopic-hyperthermic-intra-nct04107077 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04107077.jpg Cisplatin trial for Gastric Cancer (NCT04107077) Cisplatin trial for Gastric Cancer (NCT04107077). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04107077. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04107077.mp4 2026-10-31T18:53:37.805Z 76 yes no https://www.trianglehealth.com/phase-2/phase-ii-trial-comparison-of-3-vs-4-fractions-brachy-fit-nct07022470 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07022470.jpg 3-Fraction HDR Brachytherapy trial for Cervical Cancers (NCT07022470) 3-Fraction HDR Brachytherapy trial for Cervical Cancers (NCT07022470). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07022470. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07022470.mp4 2026-11-01T00:00:12.015Z 66 yes no https://www.trianglehealth.com/phase-2/phase-ii-trial-of-combination-anti-pd-1-and-aldesleukin-for-meta-nct05155033 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05155033.jpg Pembrolizumab trial for Metastatic Melanoma (NCT05155033) Pembrolizumab trial for Metastatic Melanoma (NCT05155033). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05155033. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05155033.mp4 2026-10-31T15:45:54.932Z 78 yes no https://www.trianglehealth.com/phase-2/phase-ii-trial-of-ivonescimab-in-combination-with-carboplatin-do-nct07017673 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07017673.jpg Ivonescimab trial for TNBC (NCT07017673) Ivonescimab trial for TNBC (NCT07017673). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07017673. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07017673.mp4 2026-10-31T20:29:10.204Z 92 yes no https://www.trianglehealth.com/phase-2/phase-ii-trial-of-ivonescimab-in-previously-treated-patients-wit-nct06940518 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06940518.jpg Ivonescimab trial for Ivonescimab (NCT06940518) Ivonescimab trial for Ivonescimab (NCT06940518). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06940518. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06940518.mp4 2026-10-31T21:47:21.886Z 76 yes no https://www.trianglehealth.com/phase-2/phase-ii-trial-of-neoadjuvant-chemotherapy-nac-alone-or-in-combi-nct06223568 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06223568.jpg Docetaxel trial for Squamous Cell Carcinoma of the Head and Neck (NCT06223568) Docetaxel trial for Squamous Cell Carcinoma of the Head and Neck (NCT06223568). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06223568. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06223568.mp4 2026-10-31T22:14:47.141Z 83 yes no https://www.trianglehealth.com/phase-2/phase-ii-trial-of-psa-response-based-androgen-deprivation-therap-nct07313241 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07313241.jpg Prostate Fossa Radiotherapy trial for Prostate Cancer (NCT07313241) Prostate Fossa Radiotherapy trial for Prostate Cancer (NCT07313241). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07313241. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07313241.mp4 2026-10-31T22:37:17.549Z 79 yes no https://www.trianglehealth.com/phase-2/phase-ii-trial-of-puxitatug-samrotecan-azd8205-in-advanced-recur-nct07162480 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07162480.jpg P-Sam trial for Adenoid Cystic Carcinoma (NCT07162480) P-Sam trial for Adenoid Cystic Carcinoma (NCT07162480). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07162480. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07162480.mp4 2026-10-31T15:14:32.084Z 88 yes no https://www.trianglehealth.com/phase-2/phase-ii-trial-of-sacituzumab-govitecan-in-recurrent-and-or-meta-nct05884320 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05884320.jpg Sacituzumab Govitecan trial for Gland (NCT05884320) Sacituzumab Govitecan trial for Gland (NCT05884320). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05884320. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05884320.mp4 2026-10-31T21:44:33.902Z 89 yes no https://www.trianglehealth.com/phase-2/phase-ii-trial-of-sacituzumab-tirumotecan-in-patients-with-smarc-nct07438626 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07438626.jpg Sacituzumab tirumotecan trial for Phase II (NCT07438626) Sacituzumab tirumotecan trial for Phase II (NCT07438626). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07438626. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07438626.mp4 2026-10-31T15:58:48.535Z 91 yes no https://www.trianglehealth.com/phase-2/pilot-study-of-ivonescimab-in-advanced-metastatic-cutaneous-angi-nct07655570 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07655570.jpg Ivonescimab trial for Cutaneous Angiosarcoma (NCT07655570) Ivonescimab trial for Cutaneous Angiosarcoma (NCT07655570). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07655570. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07655570.mp4 2026-10-31T21:35:59.318Z 79 yes no https://www.trianglehealth.com/phase-2/pilot-trial-of-fecal-microbiota-transplantation-for-lymphoma-pat-nct06218602 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06218602.jpg Fecal Microbiota Transplantation trial for Lymphoma (NCT06218602) Fecal Microbiota Transplantation trial for Lymphoma (NCT06218602). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06218602. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06218602.mp4 2026-10-31T22:58:53.772Z 79 yes no https://www.trianglehealth.com/phase-2/pirtobrutinib-for-the-treatment-of-elderly-patients-with-chronic-nct07685717 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07685717.jpg Biospecimen Collection trial for Chronic Lymphocytic Leukemia/Small Lymphocytic… (NCT07685717) Biospecimen Collection trial for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT07685717). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07685717. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07685717.mp4 2026-10-31T06:46:51.653Z 88 yes no https://www.trianglehealth.com/phase-2/post-autologous-transplant-maintenance-with-isatuximab-and-lenal-nct05344833 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05344833.jpg Isatuximab trial for Multiple Myeloma (NCT05344833) Isatuximab trial for Multiple Myeloma (NCT05344833). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05344833. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05344833.mp4 2026-10-31T16:33:52.431Z 75 yes no https://www.trianglehealth.com/phase-2/post-transplant-maintenance-therapy-with-isatuximab-plus-lenalid-nct05776979 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05776979.jpg Isatuximab trial for Multiple Myeloma (NCT05776979) Isatuximab trial for Multiple Myeloma (NCT05776979). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05776979. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05776979.mp4 2026-10-31T22:06:14.386Z 80 yes no https://www.trianglehealth.com/phase-2/pre-operative-atezolizumab-in-patients-with-resectable-human-pap-nct06254911 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06254911.jpg Atezolizumab trial for Oropharynx Cancer, Stage I (NCT06254911) Atezolizumab trial for Oropharynx Cancer, Stage I (NCT06254911). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06254911. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06254911.mp4 2026-10-31T20:21:44.987Z 87 yes no https://www.trianglehealth.com/phase-2/pre-radiation-chemotherapy-for-newly-diagnosed-high-grade-glioma-nct07439172 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07439172.jpg Pre-radiation temozolomide. trial for High Grade Gliomas (NCT07439172) Pre-radiation temozolomide. trial for High Grade Gliomas (NCT07439172). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07439172. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07439172.mp4 2026-10-31T07:31:59.936Z 78 yes no https://www.trianglehealth.com/phase-2/pre-transplant-purging-and-post-transplant-mrd-guided-maintenanc-nct06207799 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06207799.jpg Elranatamab trial for Multiple Myeloma (NCT06207799) Elranatamab trial for Multiple Myeloma (NCT06207799). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06207799. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06207799.mp4 2026-10-31T20:07:41.048Z 74 yes no https://www.trianglehealth.com/phase-2/precision-medicine-in-action-phase-ii-trial-of-response-adaptive-nct06444269 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06444269.jpg Radiomics on MRI trial for Breast Cancer (NCT06444269) Radiomics on MRI trial for Breast Cancer (NCT06444269). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06444269. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06444269.mp4 2026-10-31T22:22:17.764Z 79 yes no https://www.trianglehealth.com/phase-2/preoperative-pembrolizumab-and-chemotherapy-in-resectable-recurr-nct05726370 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05726370.jpg Pembrolizumab trial for Head and Neck Squamous Cell Carcinoma (NCT05726370) Pembrolizumab trial for Head and Neck Squamous Cell Carcinoma (NCT05726370). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05726370. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05726370.mp4 2026-10-31T22:54:33.256Z 74 yes no https://www.trianglehealth.com/phase-2/preoperative-radiotherapy-and-immunotherapy-for-sinonasal-and-an-nct05546827 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05546827.jpg Surgical resection trial for Sinonasal Melanoma (NCT05546827) Surgical resection trial for Sinonasal Melanoma (NCT05546827). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05546827. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05546827.mp4 2026-10-31T15:34:24.744Z 75 yes no https://www.trianglehealth.com/phase-2/propranolol-with-chemotherapy-or-chemoradiation-for-esophageal-a-nct04682158 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04682158.jpg Carboplatin trial for Esophageal Adenocarcinoma (NCT04682158) Carboplatin trial for Esophageal Adenocarcinoma (NCT04682158). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04682158. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04682158.mp4 2026-10-31T06:23:33.995Z 78 yes no https://www.trianglehealth.com/phase-2/prorad-5-prostate-radiation-in-5-fractions-phase-ii-five-fractio-nct06369246 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06369246.jpg Stereotactic Body Radiation Therapy trial for Advanced Prostate Cancer (NCT06369246) Stereotactic Body Radiation Therapy trial for Advanced Prostate Cancer (NCT06369246). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06369246. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06369246.mp4 2026-10-31T22:49:38.973Z 86 yes no https://www.trianglehealth.com/phase-2/prospective-trial-assessing-real-world-outcomes-response-to-pemb-nct06745882 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06745882.jpg Cisplatin trial for Non-small Cell Lung Cancer (NCT06745882) Cisplatin trial for Non-small Cell Lung Cancer (NCT06745882). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06745882. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06745882.mp4 2026-10-31T21:32:30.980Z 69 yes no https://www.trianglehealth.com/phase-2/prostate-cancer-treatment-using-androgen-deprivation-therapy-and-nct05790213 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05790213.jpg Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT05790213) Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT05790213). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05790213. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05790213.mp4 2026-10-31T23:57:42.879Z 76 yes no https://www.trianglehealth.com/phase-2/prostate-specific-membrane-antigen-psma-or-facbc-pet-ct-site-dir-nct04175431 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04175431.jpg Positron Emission Tomography trial for Prostate Adenocarcinoma (NCT04175431) Positron Emission Tomography trial for Prostate Adenocarcinoma (NCT04175431). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04175431. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04175431.mp4 2026-10-31T22:24:07.708Z 75 yes no https://www.trianglehealth.com/phase-2/protocol-number-hjkc3-0003-treatment-free-remission-after-ascimi-nct04838041 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04838041.jpg Asciminib 40 MG trial for Chronic Phase Chronic Myelogenous Leukemia (NCT04838041) Asciminib 40 MG trial for Chronic Phase Chronic Myelogenous Leukemia (NCT04838041). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04838041. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04838041.mp4 2026-10-31T21:41:29.184Z 79 yes no https://www.trianglehealth.com/phase-2/proton-beam-radiation-therapy-after-treatment-for-resected-n2-no-nct06008730 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06008730.jpg Biospecimen Collection trial for Resectable Lung Non-Small Cell Carcinoma (NCT06008730) Biospecimen Collection trial for Resectable Lung Non-Small Cell Carcinoma (NCT06008730). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06008730. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06008730.mp4 2026-10-31T22:35:38.222Z 63 yes no https://www.trianglehealth.com/phase-2/proton-radiation-for-unresectable-borderline-resectable-or-medic-nct02598349 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02598349.jpg Proton Radiation trial for Pancreatic Cancer (NCT02598349) Proton Radiation trial for Pancreatic Cancer (NCT02598349). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02598349. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02598349.mp4 2026-10-31T14:54:52.934Z 75 yes no https://www.trianglehealth.com/phase-2/proton-therapy-for-post-surgical-treatment-of-gynecologic-cancer-nct05758688 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05758688.jpg Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) trial for Cervical… (NCT05758688) Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) trial for Cervical Cancer (NCT05758688). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05758688. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05758688.mp4 2026-10-31T22:31:09.590Z 80 yes no https://www.trianglehealth.com/phase-2/psma-directed-para-aortic-radiation-therapy-for-oligorecurrent-p-nct06392295 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06392295.jpg Para Aortic Radiation Therapy: Photon Therapy trial for Prostate Cancer (NCT06392295) Para Aortic Radiation Therapy: Photon Therapy trial for Prostate Cancer (NCT06392295). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06392295. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06392295.mp4 2026-10-31T23:56:05.972Z 83 yes no https://www.trianglehealth.com/phase-2/psma-pet-guided-de-escalation-of-salvage-radiation-treatment-in-nct07234981 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07234981.jpg PSMA-guided Salvage Radiation trial for Prostate Cancer (NCT07234981) PSMA-guided Salvage Radiation trial for Prostate Cancer (NCT07234981). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07234981. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07234981.mp4 2026-10-31T15:11:19.412Z 73 yes no https://www.trianglehealth.com/phase-2/pt-112-in-subjects-with-thymoma-and-thymic-carcinoma-nct05104736 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05104736.jpg PT-112 trial for Thymic Epithelial Tumor (NCT05104736) PT-112 trial for Thymic Epithelial Tumor (NCT05104736). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05104736. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05104736.mp4 2026-10-31T15:53:06.878Z 74 yes no https://www.trianglehealth.com/phase-2/pulso-trial-pulsed-low-dose-rate-pldr-radiation-chemoradiation-c-nct06906887 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06906887.jpg Induction Chemotherapy (modified FLOT or modified FOLFOX-6) trial for Esophageal… (NCT06906887) Induction Chemotherapy (modified FLOT or modified FOLFOX-6) trial for Esophageal Cancer (NCT06906887). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06906887. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06906887.mp4 2026-10-31T21:00:34.010Z 77 yes no https://www.trianglehealth.com/phase-2/radiation-and-tsr-042-dostarlimab-in-people-with-endometrial-can-nct04774419 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04774419.jpg Intensity modulated radiation therapy (IMRT) trial for Endometrial Cancer (NCT04774419) Intensity modulated radiation therapy (IMRT) trial for Endometrial Cancer (NCT04774419). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04774419. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04774419.mp4 2026-10-31T21:23:16.008Z 85 yes no https://www.trianglehealth.com/phase-2/radiation-prior-to-tki-to-delay-progression-in-advanced-driver-m-nct06305715 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06305715.jpg Radiation Therapy trial for Non Small Cell Lung Cancer (NCT06305715) Radiation Therapy trial for Non Small Cell Lung Cancer (NCT06305715). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06305715. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06305715.mp4 2026-10-31T22:14:09.471Z 74 yes no https://www.trianglehealth.com/phase-2/radiation-therapy-approaches-for-people-with-prostate-cancer-nct07751159 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07751159.jpg Standard of Care HDR Brachytherapy trial for Prostate Cancer Patients (NCT07751159) Standard of Care HDR Brachytherapy trial for Prostate Cancer Patients (NCT07751159). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07751159. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07751159.mp4 2026-10-31T15:55:29.571Z 75 yes no https://www.trianglehealth.com/phase-2/radiation-therapy-with-or-without-cisplatin-in-treating-patients-nct02734537 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02734537.jpg Cisplatin trial for Head and Neck Squamous Cell Carcinoma (NCT02734537) Cisplatin trial for Head and Neck Squamous Cell Carcinoma (NCT02734537). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02734537. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02734537.mp4 2026-10-31T17:02:41.059Z 75 yes no https://www.trianglehealth.com/phase-2/radiotherapy-in-combination-with-checkpoint-inhibition-for-patie-nct06601296 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06601296.jpg IMSA101 trial for Metastatic Renal Cell Carcinoma ( mRCC) (NCT06601296) IMSA101 trial for Metastatic Renal Cell Carcinoma ( mRCC) (NCT06601296). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06601296. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06601296.mp4 2026-10-31T05:19:29.932Z 70 yes no https://www.trianglehealth.com/phase-2/ramucirumab-and-paclitaxel-or-folfiri-in-advanced-small-bowel-ca-nct04205968 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04205968.jpg Fluorouracil trial for Metastatic Small Intestinal Adenocarcinoma (NCT04205968) Fluorouracil trial for Metastatic Small Intestinal Adenocarcinoma (NCT04205968). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04205968. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04205968.mp4 2026-10-31T21:59:39.211Z 78 yes no https://www.trianglehealth.com/phase-2/rapid-analysis-and-response-evaluation-of-combination-anti-neopl-nct04449549 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04449549.jpg Nilotinib and Paclitaxel trial for Neoplasms (NCT04449549) Nilotinib and Paclitaxel trial for Neoplasms (NCT04449549). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04449549. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04449549.mp4 2026-10-31T06:31:51.385Z 79 yes no https://www.trianglehealth.com/phase-2/real-time-mri-guided-3-fraction-accelerated-partial-breast-irrad-nct03936478 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03936478.jpg MRIdian Radiation Treatment Unit trial for Breast Cancer (NCT03936478) MRIdian Radiation Treatment Unit trial for Breast Cancer (NCT03936478). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03936478. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03936478.mp4 2026-11-01T00:03:51.271Z 78 yes no https://www.trianglehealth.com/phase-2/recombinant-glycosylated-human-interleukin-7-cyt107-for-the-trea-nct07308886 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07308886.jpg CYT107 trial for Kaposi Sarcoma (NCT07308886) CYT107 trial for Kaposi Sarcoma (NCT07308886). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07308886. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07308886.mp4 2026-10-31T21:36:26.076Z 72 yes no https://www.trianglehealth.com/phase-2/rectify-1-neoadjuvant-botensilimab-balstilimab-in-mss-pmmr-early-nct07735624 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07735624.jpg Botensilimab trial for Early Rectal Cancer (NCT07735624) Botensilimab trial for Early Rectal Cancer (NCT07735624). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07735624. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07735624.mp4 2026-10-31T22:51:25.216Z 85 yes no https://www.trianglehealth.com/phase-2/recurrent-ovarian-cancers-after-parp-maintenance-sacituzumab-gov-nct07504588 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07504588.jpg Anti-VEGF Monoclonal Antibody trial for Recurrent Platinum-Sensitive Fallopian Tube… (NCT07504588) Anti-VEGF Monoclonal Antibody trial for Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma (NCT07504588). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07504588. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07504588.mp4 2026-10-31T06:21:22.813Z 86 yes no https://www.trianglehealth.com/phase-2/regorafenib-reg-and-lorigerlimab-lor-relo-regimen-in-treatment-o-nct07071961 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07071961.jpg Regorafenib (CT) trial for Colorectal Cancer (NCT07071961) Regorafenib (CT) trial for Colorectal Cancer (NCT07071961). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07071961. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07071961.mp4 2026-10-31T16:43:57.262Z 79 yes no https://www.trianglehealth.com/phase-2/regulus-mri-guided-adaptive-sabr-for-liver-cancers-nct07223307 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07223307.jpg MRI-guided adaptive stereotactic ablative body radiotherapy (SABR) trial for Liver… (NCT07223307) MRI-guided adaptive stereotactic ablative body radiotherapy (SABR) trial for Liver Cancer (NCT07223307). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07223307. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07223307.mp4 2026-10-31T05:33:37.219Z 67 yes no https://www.trianglehealth.com/phase-2/relacorilant-in-combination-with-different-treatment-regimens-in-nct06906341 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06906341.jpg Relacorilant 150 mg once daily (QD) trial for Ovarian Cancer (NCT06906341) Relacorilant 150 mg once daily (QD) trial for Ovarian Cancer (NCT06906341). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06906341. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06906341.mp4 2026-10-31T21:38:23.046Z 81 yes no https://www.trianglehealth.com/phase-2/relacorilant-with-nab-paclitaxel-and-gemcitabine-in-patients-wit-nct07259317 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07259317.jpg Relacorilant trial for Adenocarcinoma (NCT07259317) Relacorilant trial for Adenocarcinoma (NCT07259317). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07259317. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07259317.mp4 2026-10-31T06:52:54.080Z 86 yes no https://www.trianglehealth.com/phase-2/repeat-breast-conserving-surgery-followed-by-daily-partial-breas-nct06129747 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06129747.jpg Radiation Therapy trial for Breast Cancer (NCT06129747) Radiation Therapy trial for Breast Cancer (NCT06129747). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06129747. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06129747.mp4 2026-10-31T20:20:21.192Z 67 yes no https://www.trianglehealth.com/phase-2/repurposing-atovaquone-for-the-treatment-of-platinum-resistant-o-nct05998135 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05998135.jpg Atovaquone trial for Ovarian High Grade Serous Adenocarcinoma (NCT05998135) Atovaquone trial for Ovarian High Grade Serous Adenocarcinoma (NCT05998135). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05998135. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05998135.mp4 2026-10-31T20:57:56.513Z 71 yes no https://www.trianglehealth.com/phase-2/resectable-lung-cancer-cemiplimab-and-fianlimab-before-surgery-nct06918132 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06918132.jpg Biospecimen Collection trial for Lung Non-Small Cell Carcinoma (NCT06918132) Biospecimen Collection trial for Lung Non-Small Cell Carcinoma (NCT06918132). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06918132. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06918132.mp4 2026-10-31T05:16:51.846Z 86 yes no https://www.trianglehealth.com/phase-2/restoring-lymphocytes-using-nktr-255-after-chemoradiotherapy-in-nct05632809 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05632809.jpg NKTR-255 trial for Lung Cancer (NCT05632809) NKTR-255 trial for Lung Cancer (NCT05632809). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05632809. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05632809.mp4 2026-10-31T20:57:28.726Z 86 yes no https://www.trianglehealth.com/phase-2/ribociclib-and-endocrine-treatment-of-physicians-choice-for-loco-nct05467891 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05467891.jpg Ribociclib trial for Locoregional Recurrence (NCT05467891) Ribociclib trial for Locoregional Recurrence (NCT05467891). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05467891. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05467891.mp4 2026-10-31T21:52:54.448Z 84 yes no https://www.trianglehealth.com/phase-2/risk-adapted-proteomic-guided-systemic-therapy-for-previously-un-nct07250477 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07250477.jpg Systemic (ICI)-based therapy informed by the PROphet CB assay and the CARG-TT… (NCT07250477) Systemic (ICI)-based therapy informed by the PROphet CB assay and the CARG-TT assessment. trial for Non-small Cell Lung Cancer Stage IIIC (NCT07250477). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07250477. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07250477.mp4 2026-10-31T21:36:57.194Z 82 yes no https://www.trianglehealth.com/phase-2/risk-adapted-therapy-in-hpv-oropharyngeal-cancer-using-circulati-nct04900623 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04900623.jpg NavDx HPV ctDNA Testing trial for HPV-Associated Oropharyngeal Squamous Cell Carcinoma (NCT04900623) NavDx HPV ctDNA Testing trial for HPV-Associated Oropharyngeal Squamous Cell Carcinoma (NCT04900623). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04900623. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04900623.mp4 2026-10-31T20:25:03.335Z 82 yes no https://www.trianglehealth.com/phase-2/rituximab-and-zanubrutinib-in-patients-with-indolent-b-cell-lymp-nct06350318 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06350318.jpg Zanubrutinib trial for Follicular Lymphoma (NCT06350318) Zanubrutinib trial for Follicular Lymphoma (NCT06350318). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06350318. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06350318.mp4 2026-10-31T06:48:13.198Z 82 yes no https://www.trianglehealth.com/phase-2/ruxolitinib-before-during-and-after-hematopoietic-cell-transplan-nct07228624 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07228624.jpg Ruxolitinib trial for Myelodysplastic/Myeloproliferative Neoplasm (NCT07228624) Ruxolitinib trial for Myelodysplastic/Myeloproliferative Neoplasm (NCT07228624). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07228624. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07228624.mp4 2026-10-31T22:10:58.138Z 88 yes no https://www.trianglehealth.com/phase-2/ruxolitinib-for-the-treatment-of-t-cell-large-granular-lymphocyt-nct05592015 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05592015.jpg Ruxolitinib trial for T-Cell Large Granular Lymphocyte Leukemia (NCT05592015) Ruxolitinib trial for T-Cell Large Granular Lymphocyte Leukemia (NCT05592015). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05592015. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05592015.mp4 2026-10-31T20:58:10.877Z 65 yes no https://www.trianglehealth.com/phase-2/ruxolitinib-maintenance-post-hematopoietic-stem-cell-transplant-nct07356245 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07356245.jpg Ruxolitinib trial for T-cell Lymphoma (NCT07356245) Ruxolitinib trial for T-cell Lymphoma (NCT07356245). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07356245. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07356245.mp4 2026-10-31T05:32:51.132Z 86 yes no https://www.trianglehealth.com/phase-2/ruxolitinib-with-radiation-and-temozolomide-compared-to-radiatio-nct06991101 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06991101.jpg Ruxolitinib trial for Glioblastoma (NCT06991101) Ruxolitinib trial for Glioblastoma (NCT06991101). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06991101. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06991101.mp4 2026-10-31T15:38:25.241Z 85 yes no https://www.trianglehealth.com/phase-2/sacituzumab-govitecan-with-or-without-atezolizumab-immunotherapy-nct06161532 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161532.jpg Sacituzumab govitecan trial for Small Cell Carcinoma of the Bladder (NCT06161532) Sacituzumab govitecan trial for Small Cell Carcinoma of the Bladder (NCT06161532). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06161532. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161532.mp4 2026-10-31T06:26:01.104Z 80 yes no https://www.trianglehealth.com/phase-2/safety-and-efficacy-study-of-intravesical-instillation-of-tara-0-nct05951179 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05951179.jpg TARA-002 trial for Non-muscle Invasive Bladder Cancer (NCT05951179) TARA-002 trial for Non-muscle Invasive Bladder Cancer (NCT05951179). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05951179. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05951179.mp4 2026-10-31T21:44:05.125Z 91 yes no https://www.trianglehealth.com/phase-2/safety-and-efficacy-study-of-safusidenib-in-participants-with-id-nct07703436 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07703436.jpg Safusidenib trial for Grade 2 IDH1-mutant Glioma (NCT07703436) Safusidenib trial for Grade 2 IDH1-mutant Glioma (NCT07703436). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07703436. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07703436.mp4 2026-10-31T22:02:13.128Z 78 yes no https://www.trianglehealth.com/phase-2/selinexor-and-pacritinib-in-jak-inhibitor-nai-ve-mf-patients-wit-nct07447817 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07447817.jpg Pacritinib trial for Myelofibrosis (NCT07447817) Pacritinib trial for Myelofibrosis (NCT07447817). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07447817. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07447817.mp4 2026-10-31T05:32:25.785Z 74 yes no https://www.trianglehealth.com/phase-2/selpercatinib-pre-rai-in-patients-with-ret-fusion-thyroid-cancer-nct06458036 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06458036.jpg Selpercatinib Monotherapy trial for Differentiated Thyroid Cancer (NCT06458036) Selpercatinib Monotherapy trial for Differentiated Thyroid Cancer (NCT06458036). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06458036. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06458036.mp4 2026-10-31T21:11:24.142Z 77 yes no https://www.trianglehealth.com/phase-2/sequencing-antibody-drug-conjugates-in-er-her2-low-ultra-low-mbc-nct06263543 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06263543.jpg Sacituzumab govitecan trial for Breast Cancer (NCT06263543) Sacituzumab govitecan trial for Breast Cancer (NCT06263543). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06263543. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06263543.mp4 2026-10-31T16:57:49.106Z 92 yes no https://www.trianglehealth.com/phase-2/sequential-testosterone-and-enzalutamide-prevents-unfavorable-pr-nct04363164 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04363164.jpg Testosterone cypionate trial for Castration Resistant Metastatic Prostate Cancer (NCT04363164) Testosterone cypionate trial for Castration Resistant Metastatic Prostate Cancer (NCT04363164). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04363164. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04363164.mp4 2026-10-31T21:39:32.009Z 89 yes no https://www.trianglehealth.com/phase-2/sequential-treatment-of-cabozantinib-for-advanced-renal-cell-car-nct05931393 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05931393.jpg Cabozantinib 80 MG trial for RCC (NCT05931393) Cabozantinib 80 MG trial for RCC (NCT05931393). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05931393. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05931393.mp4 2026-10-31T21:57:01.728Z 75 yes no https://www.trianglehealth.com/phase-2/sfolfoxiri-in-advanced-gastroesophageal-cancer-sage-nct05332002 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05332002.jpg Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI) trial for Gastro-Intestinal… (NCT05332002) Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI) trial for Gastro-Intestinal Cancer (NCT05332002). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05332002. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05332002.mp4 2026-10-31T21:03:47.034Z 87 yes no https://www.trianglehealth.com/phase-2/short-course-adt-for-high-risk-low-intermediate-risk-artera-pros-nct07801664 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07801664.jpg Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT07801664) Androgen Deprivation Therapy (ADT) trial for Prostate Cancer (NCT07801664). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07801664. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07801664.mp4 2026-10-31T19:49:01.725Z 70 yes no https://www.trianglehealth.com/phase-2/shortening-adjuvant-photon-and-proton-irradiation-sapphire-ii-a-nct07076485 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07076485.jpg Ultrahypofractionated Radiation trial for Breast Cancer (NCT07076485) Ultrahypofractionated Radiation trial for Breast Cancer (NCT07076485). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07076485. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07076485.mp4 2026-10-31T19:59:01.582Z 71 yes no https://www.trianglehealth.com/phase-2/single-arm-study-of-neoadjuvant-dostarlimab-in-stage-ii-and-iii-nct05239546 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05239546.jpg Dostarlimab trial for Colon Cancer (NCT05239546) Dostarlimab trial for Colon Cancer (NCT05239546). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05239546. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05239546.mp4 2026-11-01T00:03:54.069Z 85 yes no https://www.trianglehealth.com/phase-2/single-fraction-interstitial-breast-brachytherapy-nct07654257 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07654257.jpg Partial Breast Irradiation trial for Breast Cancer (NCT07654257) Partial Breast Irradiation trial for Breast Cancer (NCT07654257). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07654257. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07654257.mp4 2026-10-31T21:53:17.559Z 83 yes no https://www.trianglehealth.com/phase-2/smarca4-2-inhibitor-for-pou2f3-positive-sclc-nct07551635 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551635.jpg FHD-286 trial for Small Cell Lung Cancer (NCT07551635) FHD-286 trial for Small Cell Lung Cancer (NCT07551635). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07551635. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551635.mp4 2026-10-31T06:23:35.423Z 77 yes no https://www.trianglehealth.com/phase-2/srs-compared-with-fsrs-for-treatment-of-intact-metastatic-brain-nct05222620 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05222620.jpg Questionnaire Administration trial for Metastatic Malignant Neoplasm in the Brain (NCT05222620) Questionnaire Administration trial for Metastatic Malignant Neoplasm in the Brain (NCT05222620). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05222620. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05222620.mp4 2026-10-31T07:12:13.048Z 76 yes no https://www.trianglehealth.com/phase-2/statins-in-patients-with-clonal-cytopenia-of-undetermined-signif-nct05483010 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05483010.jpg Atorvastatin trial for Clonal Cytopenia of Undetermined Significance (NCT05483010) Atorvastatin trial for Clonal Cytopenia of Undetermined Significance (NCT05483010). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05483010. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05483010.mp4 2026-10-31T21:16:56.984Z 75 yes no https://www.trianglehealth.com/phase-2/stereotactic-body-radiation-therapy-plus-immediate-or-delayed-an-nct06378866 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06378866.jpg Abiraterone trial for Recurrent Castration-Sensitive Prostate Carcinoma (NCT06378866) Abiraterone trial for Recurrent Castration-Sensitive Prostate Carcinoma (NCT06378866). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06378866. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06378866.mp4 2026-10-31T21:29:57.474Z 78 yes no https://www.trianglehealth.com/phase-2/stereotactic-brain-directed-radiation-with-or-without-aguix-gado-nct04899908 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04899908.jpg Stereotactic Radiation trial for Brain Cancer (NCT04899908) Stereotactic Radiation trial for Brain Cancer (NCT04899908). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04899908. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04899908.mp4 2026-10-31T18:20:20.522Z 85 yes no https://www.trianglehealth.com/phase-2/stereotactic-radiation-for-growing-changing-brain-metastases-wit-nct07132190 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07132190.jpg Linear accelerator-based stereotactic radiation for brain metastases using 0mm or… (NCT07132190) Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV trial for Brain Metastases, Adult (NCT07132190). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07132190. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07132190.mp4 2026-10-31T18:32:24.512Z 69 yes no https://www.trianglehealth.com/phase-2/strategic-endocrine-therapy-and-targeted-radiotherapy-for-prosta-nct07364071 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07364071.jpg Radiation therapy trial for Prostate Adenocarcinoma (NCT07364071) Radiation therapy trial for Prostate Adenocarcinoma (NCT07364071). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07364071. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07364071.mp4 2026-10-31T20:26:40.983Z 75 yes no https://www.trianglehealth.com/phase-2/study-adding-drugs-to-usual-treatment-for-large-b-cell-lymphoma-nct05890352 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05890352.jpg Biospecimen Collection trial for Grade 3b Follicular Lymphoma (NCT05890352) Biospecimen Collection trial for Grade 3b Follicular Lymphoma (NCT05890352). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05890352. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05890352.mp4 2026-10-31T05:29:23.943Z 77 yes no https://www.trianglehealth.com/phase-2/study-evaluating-dosimetry-randomized-dose-optimization-dose-esc-nct06549465 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06549465.jpg In-111 rosopatamab tetraxetan trial for PSMA PET-Positive Castration-Resistant… (NCT06549465) In-111 rosopatamab tetraxetan trial for PSMA PET-Positive Castration-Resistant Prostate Cancer (NCT06549465). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06549465. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06549465.mp4 2026-10-31T06:55:00.227Z 78 yes no https://www.trianglehealth.com/phase-2/study-of-ar-suppression-with-carotuximab-in-metastatic-castratio-nct05534646 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05534646.jpg AR Blockade trial for Castration-resistant Prostate Cancer (NCT05534646) AR Blockade trial for Castration-resistant Prostate Cancer (NCT05534646). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05534646. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05534646.mp4 2026-10-31T06:39:29.780Z 83 yes no https://www.trianglehealth.com/phase-2/study-of-belantamab-mafodotin-with-carfilzomib-pomalidomide-and-nct05789303 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05789303.jpg Belantamab mafodotin trial for Multiple Myeloma (NCT05789303) Belantamab mafodotin trial for Multiple Myeloma (NCT05789303). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05789303. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05789303.mp4 2026-10-31T21:02:52.046Z 82 yes no https://www.trianglehealth.com/phase-2/study-of-bevacizumab-in-combination-with-chemoimmunotherapy-and-nct05588388 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05588388.jpg Bevacizumab trial for Extensive-stage Small-cell Lung Cancer (NCT05588388) Bevacizumab trial for Extensive-stage Small-cell Lung Cancer (NCT05588388). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05588388. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05588388.mp4 2026-10-31T07:47:34.652Z 83 yes no https://www.trianglehealth.com/phase-2/study-of-carboplatin-and-mirvetuximab-soravtansine-in-first-line-nct04606914 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04606914.jpg mirvetuximab soravtansine (MIRV; IMGN853) trial for Ovarian Cancer (NCT04606914) mirvetuximab soravtansine (MIRV; IMGN853) trial for Ovarian Cancer (NCT04606914). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04606914. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04606914.mp4 2026-10-31T22:13:18.464Z 83 yes no https://www.trianglehealth.com/phase-2/study-of-cryoablation-and-nirogacestat-for-desmoid-tumor-nct05949099 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05949099.jpg Nirogacestat trial for Desmoid Tumor (NCT05949099) Nirogacestat trial for Desmoid Tumor (NCT05949099). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05949099. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05949099.mp4 2026-10-31T15:54:17.134Z 78 yes no https://www.trianglehealth.com/phase-2/study-of-denikitug-gs-1811-given-alone-or-with-nivolumab-or-chem-nct07546812 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07546812.jpg Denikitug trial for HER2-negative (NCT07546812) Denikitug trial for HER2-negative (NCT07546812). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07546812. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07546812.mp4 2026-10-31T15:24:50.616Z 91 yes no https://www.trianglehealth.com/phase-2/study-of-denikitug-gs-1811-given-alone-or-with-nivolumab-or-with-nct07527858 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07527858.jpg Denikitug trial for Advanced Microsatellite Stable Colorectal Cancer (NCT07527858) Denikitug trial for Advanced Microsatellite Stable Colorectal Cancer (NCT07527858). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07527858. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07527858.mp4 2026-10-31T22:02:54.878Z 83 yes no https://www.trianglehealth.com/phase-2/study-of-ev-for-recurrent-endometrial-carcinoma-nct07139977 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07139977.jpg Enfortumab Vedotin trial for Endometrial Cancer (NCT07139977) Enfortumab Vedotin trial for Endometrial Cancer (NCT07139977). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07139977. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07139977.mp4 2026-10-31T06:16:39.262Z 76 yes no https://www.trianglehealth.com/phase-2/study-of-induction-pd-1-blockade-in-subjects-with-locally-advanc-nct04165772 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04165772.jpg TSR-042 or Dostarlimab trial for Rectal Adenocarcinoma (NCT04165772) TSR-042 or Dostarlimab trial for Rectal Adenocarcinoma (NCT04165772). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04165772. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04165772.mp4 2026-10-31T22:00:46.375Z 78 yes no https://www.trianglehealth.com/phase-2/study-of-kte-x19-in-minimal-residual-disease-mrd-positive-b-cell-nct06144606 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06144606.jpg Tecartus trial for B-Cell Lymphoblastic Leukemia (NCT06144606) Tecartus trial for B-Cell Lymphoblastic Leukemia (NCT06144606). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06144606. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06144606.mp4 2026-10-31T16:35:43.091Z 79 yes no https://www.trianglehealth.com/phase-2/study-of-nalirifox-in-advanced-unresectable-small-bowel-tumors-nct06835387 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06835387.jpg Nanoliposomal irinotecan trial for Small Bowel Adenocarcinoma (NCT06835387) Nanoliposomal irinotecan trial for Small Bowel Adenocarcinoma (NCT06835387). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06835387. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06835387.mp4 2026-10-31T21:02:59.764Z 83 yes no https://www.trianglehealth.com/phase-2/study-of-olutasidenib-and-temozolomide-in-hgg-nct06161974 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161974.jpg Olutasidenib + TMZ trial for High Grade Glioma (NCT06161974) Olutasidenib + TMZ trial for High Grade Glioma (NCT06161974). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06161974. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06161974.mp4 2026-10-31T20:05:32.174Z 82 yes no https://www.trianglehealth.com/phase-2/study-of-onc206-jzp3507-in-advanced-pheochromocytoma-and-paragan-nct07282587 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07282587.jpg ONC206 trial for Advanced Pheochromocytoma and Paraganglioma (NCT07282587) ONC206 trial for Advanced Pheochromocytoma and Paraganglioma (NCT07282587). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07282587. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07282587.mp4 2026-10-31T05:24:51.559Z 84 yes no https://www.trianglehealth.com/phase-2/study-of-oral-mrt-2359-with-apalutamide-in-prostate-cancer-nct07745361 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07745361.jpg Oral MRT-2359 trial for Castration-Resistant Prostate Cancer (CRPC) (NCT07745361) Oral MRT-2359 trial for Castration-Resistant Prostate Cancer (CRPC) (NCT07745361). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07745361. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07745361.mp4 2026-10-31T15:04:17.420Z 81 yes no https://www.trianglehealth.com/phase-2/study-of-patritumab-deruxtecan-plus-pembrolizumab-with-other-ant-nct06797635 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06797635.jpg Patritumab deruxtecan trial for Breast Neoplasms (NCT06797635) Patritumab deruxtecan trial for Breast Neoplasms (NCT06797635). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06797635. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06797635.mp4 2026-10-31T15:30:10.301Z 88 yes no https://www.trianglehealth.com/phase-2/study-of-pembrolizumab-carboplatin-paclitaxel-and-radiation-for-nct06493019 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06493019.jpg Pembrolizumab trial for Anal Cancer (NCT06493019) Pembrolizumab trial for Anal Cancer (NCT06493019). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06493019. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06493019.mp4 2026-10-31T07:57:25.417Z 80 yes no https://www.trianglehealth.com/phase-2/study-of-ruxolitinib-in-relapsed-or-refractory-t-or-nk-cell-lymp-nct02974647 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02974647.jpg Ruxolitinib trial for Lymphoma (NCT02974647) Ruxolitinib trial for Lymphoma (NCT02974647). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02974647. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02974647.mp4 2026-10-31T23:03:56.774Z 70 yes no https://www.trianglehealth.com/phase-2/study-of-silevertinib-with-temozolomide-for-the-treatment-of-new-nct07326566 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07326566.jpg silevertinib in combination with temozolomide trial for Glioblastoma (GBM) (NCT07326566) silevertinib in combination with temozolomide trial for Glioblastoma (GBM) (NCT07326566). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07326566. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07326566.mp4 2026-10-31T21:54:07.491Z 84 yes no https://www.trianglehealth.com/phase-2/study-of-the-efficacy-of-intratumoral-l19il2-or-l19tnf-or-l19il2-nct06284590 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06284590.jpg L19IL2 trial for Melanoma Stage III (NCT06284590) L19IL2 trial for Melanoma Stage III (NCT06284590). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06284590. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06284590.mp4 2026-10-31T20:00:11.102Z 82 yes no https://www.trianglehealth.com/phase-2/study-to-assess-the-efficacy-and-safety-of-rina-s-in-participant-nct07288177 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07288177.jpg Rina-S trial for Non-small Cell Lung Cancer (NSCLC) (NCT07288177) Rina-S trial for Non-small Cell Lung Cancer (NSCLC) (NCT07288177). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07288177. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07288177.mp4 2026-10-31T20:55:12.144Z 83 yes no https://www.trianglehealth.com/phase-2/study-to-determine-the-efficacy-and-safety-of-asciminib-in-pedia-nct07354074 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07354074.jpg Asciminib single agent trial for Chronic Myelogenous Leukemia (NCT07354074) Asciminib single agent trial for Chronic Myelogenous Leukemia (NCT07354074). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07354074. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07354074.mp4 2026-10-31T16:40:44.939Z 81 yes no https://www.trianglehealth.com/phase-2/study-to-evaluate-sutetinib-maleate-capsule-in-locally-advanced-nct05168566 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05168566.jpg Sutetinib Maleate Capsule trial for Non-small Cell Lung Cancer (NCT05168566) Sutetinib Maleate Capsule trial for Non-small Cell Lung Cancer (NCT05168566). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05168566. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05168566.mp4 2026-10-31T05:35:56.335Z 84 yes no https://www.trianglehealth.com/phase-2/study-to-evaluate-the-safety-and-tolerability-of-camizestrant-in-nct07427394 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07427394.jpg Camizestrant trial for Advanced Breast Cancer (NCT07427394) Camizestrant trial for Advanced Breast Cancer (NCT07427394). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07427394. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07427394.mp4 2026-10-31T06:37:11.721Z 80 yes no https://www.trianglehealth.com/phase-2/subcutaneous-talquetamab-in-elderly-patients-with-multiple-myelo-nct06827860 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06827860.jpg Talquetamab trial for Multiple Myeloma in Relapse (NCT06827860) Talquetamab trial for Multiple Myeloma in Relapse (NCT06827860). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06827860. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06827860.mp4 2026-10-31T16:50:49.097Z 73 yes no https://www.trianglehealth.com/phase-2/substudy-01i-a-study-of-investigational-agents-in-participants-w-nct06780098 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780098.jpg R-DXD trial for Lung Neoplasm (NCT06780098) R-DXD trial for Lung Neoplasm (NCT06780098). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06780098. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06780098.mp4 2026-10-31T07:55:37.991Z 83 yes no https://www.trianglehealth.com/phase-2/suprachoroidal-administration-in-subjects-with-metastases-to-the-nct06643884 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06643884.jpg AU-011 trial for Eye Cancer (NCT06643884) AU-011 trial for Eye Cancer (NCT06643884). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06643884. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06643884.mp4 2026-10-31T16:08:03.842Z 76 yes no https://www.trianglehealth.com/phase-2/supraphysiological-androgen-to-enhance-treatment-activity-in-met-nct06039371 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06039371.jpg Biopsy Procedure trial for Castration-Resistant Prostate Carcinoma (NCT06039371) Biopsy Procedure trial for Castration-Resistant Prostate Carcinoma (NCT06039371). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06039371. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06039371.mp4 2026-10-31T21:27:10.620Z 94 yes no https://www.trianglehealth.com/phase-2/surovatamig-azd0486-as-monotherapy-in-participants-with-relapsed-nct06526793 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526793.jpg Surovatamig trial for B-cell Non-Hodgkin Lymphoma (NCT06526793) Surovatamig trial for B-cell Non-Hodgkin Lymphoma (NCT06526793). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06526793. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06526793.mp4 2026-10-31T22:16:52.763Z 83 yes no https://www.trianglehealth.com/phase-2/sx-682-and-atezolizumab-for-the-treatment-of-advanced-or-metasta-nct07322341 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07322341.jpg Atezolizumab trial for Advanced Lung Non-Small Cell Carcinoma (NCT07322341) Atezolizumab trial for Advanced Lung Non-Small Cell Carcinoma (NCT07322341). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07322341. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07322341.mp4 2026-10-31T22:23:47.663Z 91 yes no https://www.trianglehealth.com/phase-2/sx-682-with-pembrolizumab-for-the-treatment-of-metastatic-or-rec-nct05570825 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05570825.jpg Biopsy trial for Metastatic Lung Non-Small Cell Carcinoma (NCT05570825) Biopsy trial for Metastatic Lung Non-Small Cell Carcinoma (NCT05570825). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05570825. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05570825.mp4 2026-10-31T23:55:19.013Z 90 yes no https://www.trianglehealth.com/phase-2/t-cell-receptor-immunotherapy-for-patients-with-metastatic-non-s-nct02133196 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02133196.jpg Aldesleukin trial for Advanced Non-Small Cell Lung Cancer (NCT02133196) Aldesleukin trial for Advanced Non-Small Cell Lung Cancer (NCT02133196). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02133196. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02133196.mp4 2026-10-31T22:07:59.034Z 71 yes no https://www.trianglehealth.com/phase-2/tafasitamab-and-rituximab-for-the-treatment-of-newly-diagnosed-f-nct07731789 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07731789.jpg Rituximab trial for Classic Follicular Lymphoma (NCT07731789) Rituximab trial for Classic Follicular Lymphoma (NCT07731789). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07731789. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07731789.mp4 2026-10-31T16:26:49.574Z 75 yes no https://www.trianglehealth.com/phase-2/tagraxofusp-and-azacitidine-with-venetoclax-in-newly-diagnosed-s-nct05442216 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05442216.jpg Tagraxofusp trial for Acute Myeloid Leukemia (NCT05442216) Tagraxofusp trial for Acute Myeloid Leukemia (NCT05442216). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05442216. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05442216.mp4 2026-10-31T22:21:17.344Z 83 yes no https://www.trianglehealth.com/phase-2/tapur-testing-the-use-of-food-and-drug-administration-fda-approv-nct02693535 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02693535.jpg Sunitinib (CLOSED TO ENROLLMENT) trial for Lymphoma, Non-Hodgkin (NCT02693535) Sunitinib (CLOSED TO ENROLLMENT) trial for Lymphoma, Non-Hodgkin (NCT02693535). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02693535. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02693535.mp4 2026-10-31T21:06:25.839Z 87 yes no https://www.trianglehealth.com/phase-2/targeted-treatment-for-advanced-non-small-cell-lung-cancer-that-nct06116682 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06116682.jpg Amivantamab trial for Lung Non-Small Cell Carcinoma (NCT06116682) Amivantamab trial for Lung Non-Small Cell Carcinoma (NCT06116682). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06116682. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06116682.mp4 2026-10-31T07:37:29.540Z 85 yes no https://www.trianglehealth.com/phase-2/tarlatamab-for-the-treatment-of-extensive-stage-small-cell-lung-nct07423585 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07423585.jpg Biopsy Procedure trial for Extensive Stage Lung Small Cell Carcinoma (NCT07423585) Biopsy Procedure trial for Extensive Stage Lung Small Cell Carcinoma (NCT07423585). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07423585. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07423585.mp4 2026-10-31T22:25:25.942Z 73 yes no https://www.trianglehealth.com/phase-2/tebentafusp-in-hla-a-0201-positive-previously-untreated-metastat-nct06070012 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06070012.jpg Tebentafusp trial for Uveal Melanoma (NCT06070012) Tebentafusp trial for Uveal Melanoma (NCT06070012). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06070012. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06070012.mp4 2026-10-31T18:04:33.572Z 78 yes no https://www.trianglehealth.com/phase-2/testing-an-experimental-approach-to-treat-patients-with-plasma-c-nct07605416 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07605416.jpg Autologous Hematopoietic Stem Cell Transplantation trial for Plasma Cell Leukemia (NCT07605416) Autologous Hematopoietic Stem Cell Transplantation trial for Plasma Cell Leukemia (NCT07605416). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07605416. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07605416.mp4 2026-10-31T06:32:34.261Z 75 yes no https://www.trianglehealth.com/phase-2/testing-atezolizumab-with-selinexor-in-people-12-years-old-with-nct05333458 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05333458.jpg Atezolizumab trial for Advanced Alveolar Soft Part Sarcoma (NCT05333458) Atezolizumab trial for Advanced Alveolar Soft Part Sarcoma (NCT05333458). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05333458. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05333458.mp4 2026-10-31T06:59:42.212Z 84 yes no https://www.trianglehealth.com/phase-2/testing-drug-treatments-after-car-t-cell-therapy-in-patients-wit-nct05633615 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05633615.jpg Axicabtagene Ciloleucel trial for Diffuse Large B-Cell Lymphoma (NCT05633615) Axicabtagene Ciloleucel trial for Diffuse Large B-Cell Lymphoma (NCT05633615). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05633615. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05633615.mp4 2026-10-31T21:22:45.932Z 75 yes no https://www.trianglehealth.com/phase-2/testing-new-therapies-for-patients-with-acute-myeloid-leukemia-w-nct05554406 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05554406.jpg Azacitidine trial for Acute Myeloid Leukemia (NCT05554406) Azacitidine trial for Acute Myeloid Leukemia (NCT05554406). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05554406. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05554406.mp4 2026-10-31T05:19:49.471Z 83 yes no https://www.trianglehealth.com/phase-2/testing-nivolumab-with-or-without-ipilimumab-in-deficient-mismat-nct05112601 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05112601.jpg Biospecimen Collection trial for Endometrial Adenocarcinoma (NCT05112601) Biospecimen Collection trial for Endometrial Adenocarcinoma (NCT05112601). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05112601. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05112601.mp4 2026-10-31T05:20:38.218Z 76 yes no https://www.trianglehealth.com/phase-2/testing-of-bevacizumab-erlotinib-and-atezolizumab-in-combination-nct04981509 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04981509.jpg Atezolizumab trial for Hereditary Leiomyomatosis and Renal Cell Carcinoma (NCT04981509) Atezolizumab trial for Hereditary Leiomyomatosis and Renal Cell Carcinoma (NCT04981509). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04981509. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04981509.mp4 2026-10-31T05:30:59.603Z 80 yes no https://www.trianglehealth.com/phase-2/testing-osimertinib-as-a-treatment-for-lung-cancers-with-an-egfr-nct03191149 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03191149.jpg Biospecimen Collection trial for Advanced Lung Non-Small Cell Carcinoma (NCT03191149) Biospecimen Collection trial for Advanced Lung Non-Small Cell Carcinoma (NCT03191149). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03191149. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03191149.mp4 2026-10-31T15:42:03.393Z 83 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-an-anti-cancer-drug-cabozantinib-to-the-nct06900595 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06900595.jpg Biospecimen Collection trial for Locally Advanced Adrenal Cortical Carcinoma (NCT06900595) Biospecimen Collection trial for Locally Advanced Adrenal Cortical Carcinoma (NCT06900595). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06900595. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06900595.mp4 2026-10-31T22:27:07.549Z 75 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-an-idh2-inhibitor-enasidenib-to-usual-tr-nct06577441 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06577441.jpg Biospecimen Collection trial for Myelodysplastic Syndrome (NCT06577441) Biospecimen Collection trial for Myelodysplastic Syndrome (NCT06577441). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06577441. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06577441.mp4 2026-10-31T06:17:18.597Z 77 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-an-individualized-vaccine-to-durvalumab-nct03606967 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03606967.jpg Biopsy Procedure trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT03606967) Biopsy Procedure trial for Anatomic Stage IV Breast Cancer AJCC v8 (NCT03606967). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03606967. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03606967.mp4 2026-10-31T07:18:56.109Z 84 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-bms-986016-relatlimab-to-the-usual-immun-nct06029270 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06029270.jpg Biospecimen Collection trial for Metastatic Nasopharyngeal Carcinoma (NCT06029270) Biospecimen Collection trial for Metastatic Nasopharyngeal Carcinoma (NCT06029270). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06029270. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06029270.mp4 2026-10-31T06:30:50.698Z 80 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-cemiplimab-regn2810-to-chemotherapy-trea-nct07281417 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07281417.jpg Biopsy Procedure trial for Sinonasal Squamous Cell Carcinoma (NCT07281417) Biopsy Procedure trial for Sinonasal Squamous Cell Carcinoma (NCT07281417). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07281417. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07281417.mp4 2026-10-31T07:25:29.947Z 78 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-chemotherapy-or-chemo-immunotherapy-to-t-nct07195734 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07195734.jpg Biospecimen Collection trial for Clinical Stage II HPV-Mediated (p16-Positive)… (NCT07195734) Biospecimen Collection trial for Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (NCT07195734). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07195734. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07195734.mp4 2026-10-31T06:25:57.972Z 84 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-immunotherapy-before-surgery-for-patient-nct05647265 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05647265.jpg Nivolumab trial for Pleural Biphasic Mesothelioma (NCT05647265) Nivolumab trial for Pleural Biphasic Mesothelioma (NCT05647265). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05647265. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05647265.mp4 2026-10-31T20:24:50.012Z 79 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-stereotactic-radiation-therapy-with-immu-nct05327686 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05327686.jpg Avelumab trial for Metastatic Renal Cell Carcinoma (NCT05327686) Avelumab trial for Metastatic Renal Cell Carcinoma (NCT05327686). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05327686. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05327686.mp4 2026-10-31T21:58:30.477Z 80 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-the-anti-cancer-drug-venetoclax-and-or-t-nct06317662 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06317662.jpg Asparaginase Erwinia chrysanthemi trial for Acute Leukemia of Ambiguous Lineage (NCT06317662) Asparaginase Erwinia chrysanthemi trial for Acute Leukemia of Ambiguous Lineage (NCT06317662). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06317662. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06317662.mp4 2026-10-31T05:35:31.384Z 88 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-the-immunotherapy-drug-pembrolizumab-to-nct06770582 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06770582.jpg Biospecimen Collection trial for Non-Muscle Invasive Bladder Urothelial Carcinoma (NCT06770582) Biospecimen Collection trial for Non-Muscle Invasive Bladder Urothelial Carcinoma (NCT06770582). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06770582. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06770582.mp4 2026-10-31T22:13:41.476Z 85 yes no https://www.trianglehealth.com/phase-2/testing-the-addition-of-venetoclax-or-gemtuzumab-ozogamicin-go-t-nct06917911 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06917911.jpg Biospecimen Collection trial for Core Binding Factor Acute Myeloid Leukemia (NCT06917911) Biospecimen Collection trial for Core Binding Factor Acute Myeloid Leukemia (NCT06917911). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06917911. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06917911.mp4 2026-10-31T05:26:01.275Z 94 yes no https://www.trianglehealth.com/phase-2/testing-the-anti-cancer-drug-glofitamab-in-patients-with-mantle-nct07003295 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07003295.jpg Biospecimen Collection trial for Recurrent Mantle Cell Lymphoma (NCT07003295) Biospecimen Collection trial for Recurrent Mantle Cell Lymphoma (NCT07003295). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07003295. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07003295.mp4 2026-10-31T17:35:32.682Z 91 yes no https://www.trianglehealth.com/phase-2/testing-the-combination-of-anti-cancer-drugs-botensilimab-agen11-nct07551596 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551596.jpg Balstilimab trial for Colorectal Adenocarcinoma (NCT07551596) Balstilimab trial for Colorectal Adenocarcinoma (NCT07551596). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07551596. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07551596.mp4 2026-10-31T16:05:58.151Z 75 yes no https://www.trianglehealth.com/phase-2/testing-the-combination-of-venetoclax-and-rituximab-in-compariso-nct04840602 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04840602.jpg Biospecimen Collection trial for Lymphoplasmacytic Lymphoma (NCT04840602) Biospecimen Collection trial for Lymphoplasmacytic Lymphoma (NCT04840602). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04840602. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04840602.mp4 2026-10-31T21:13:33.195Z 75 yes no https://www.trianglehealth.com/phase-2/testing-the-effectiveness-of-a-combination-targeted-therapy-vipo-nct06649812 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06649812.jpg Biopsy Procedure trial for High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements (NCT06649812) Biopsy Procedure trial for High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements (NCT06649812). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06649812. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06649812.mp4 2026-10-31T15:44:41.729Z 83 yes no https://www.trianglehealth.com/phase-2/testing-the-effectiveness-of-the-anti-cancer-drug-mirdametinib-i-nct07061951 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07061951.jpg Biospecimen Collection trial for Recurrent Chronic Lymphocytic Leukemia (NCT07061951) Biospecimen Collection trial for Recurrent Chronic Lymphocytic Leukemia (NCT07061951). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07061951. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07061951.mp4 2026-10-31T06:44:54.421Z 83 yes no https://www.trianglehealth.com/phase-2/testing-the-effectiveness-of-two-immunotherapy-drugs-nivolumab-a-nct03866382 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03866382.jpg Biospecimen Collection trial for Bladder Adenocarcinoma (NCT03866382) Biospecimen Collection trial for Bladder Adenocarcinoma (NCT03866382). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03866382. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03866382.mp4 2026-10-31T05:31:20.717Z 75 yes no https://www.trianglehealth.com/phase-2/testing-the-investigational-agent-combination-of-daratumumab-bor-nct07085728 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07085728.jpg Cyclophosphamide trial for Myeloma Multiple (NCT07085728) Cyclophosphamide trial for Myeloma Multiple (NCT07085728). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07085728. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07085728.mp4 2026-10-31T16:46:54.209Z 87 yes no https://www.trianglehealth.com/phase-2/testing-the-investigational-medication-combination-of-daratumuma-nct06948084 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06948084.jpg Biospecimen Collection trial for Recurrent Multiple Myeloma (NCT06948084) Biospecimen Collection trial for Recurrent Multiple Myeloma (NCT06948084). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06948084. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06948084.mp4 2026-10-31T05:28:14.628Z 78 yes no https://www.trianglehealth.com/phase-2/testing-the-safety-and-effectiveness-of-radiation-based-treatmen-nct05691465 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05691465.jpg Biospecimen Collection trial for Metastatic Prostate Adenocarcinoma With… (NCT05691465) Biospecimen Collection trial for Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation (NCT05691465). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05691465. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05691465.mp4 2026-10-31T21:11:46.360Z 87 yes no https://www.trianglehealth.com/phase-2/testing-the-safety-and-feasibility-of-immunotherapy-drugs-botens-nct07516366 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07516366.jpg Balstilimab trial for Clear Cell Renal Cell Carcinoma (NCT07516366) Balstilimab trial for Clear Cell Renal Cell Carcinoma (NCT07516366). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07516366. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07516366.mp4 2026-10-31T16:13:47.896Z 80 yes no https://www.trianglehealth.com/phase-2/testing-the-use-of-ado-trastuzumab-emtansine-compared-to-the-usu-nct05408845 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05408845.jpg Biopsy Procedure trial for Metastatic Salivary Gland Carcinoma (NCT05408845) Biopsy Procedure trial for Metastatic Salivary Gland Carcinoma (NCT05408845). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05408845. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05408845.mp4 2026-10-31T21:57:27.403Z 90 yes no https://www.trianglehealth.com/phase-2/testing-the-use-of-neratinib-or-the-combination-of-neratinib-and-nct06126276 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06126276.jpg Biopsy Procedure trial for Malignant Female Reproductive System Neoplasm (NCT06126276) Biopsy Procedure trial for Malignant Female Reproductive System Neoplasm (NCT06126276). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06126276. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06126276.mp4 2026-10-31T05:26:46.739Z 83 yes no https://www.trianglehealth.com/phase-2/testing-what-happens-when-an-immunotherapy-drug-pembrolizumab-is-nct04671667 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04671667.jpg Carboplatin trial for Recurrent Head and Neck Squamous Cell Carcinoma (NCT04671667) Carboplatin trial for Recurrent Head and Neck Squamous Cell Carcinoma (NCT04671667). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04671667. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04671667.mp4 2026-10-31T21:17:59.650Z 83 yes no https://www.trianglehealth.com/phase-2/testing-whether-cemiplimab-regn2810-plus-cdx-1140-given-prior-to-nct06980038 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06980038.jpg Anti-CD40 Agonist Monoclonal Antibody CDX-1140 trial for Head and Neck Squamous Cell… (NCT06980038) Anti-CD40 Agonist Monoclonal Antibody CDX-1140 trial for Head and Neck Squamous Cell Carcinoma (NCT06980038). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06980038. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06980038.mp4 2026-10-31T06:20:20.975Z 79 yes no https://www.trianglehealth.com/phase-2/the-cosmyc-trial-combined-suppression-of-myc-nct06922318 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06922318.jpg ZEN-3694 trial for Metastatic Castration-resistant Prostate Cancer (NCT06922318) ZEN-3694 trial for Metastatic Castration-resistant Prostate Cancer (NCT06922318). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06922318. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06922318.mp4 2026-10-31T23:52:07.805Z 79 yes no https://www.trianglehealth.com/phase-2/the-miami-empire-trial-eradication-of-metastatic-pancreatic-canc-nct06843551 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06843551.jpg Stereotactic Body Radiation Therapy trial for Metastatic Pancreatic Ductal… (NCT06843551) Stereotactic Body Radiation Therapy trial for Metastatic Pancreatic Ductal Adenocarcinoma (NCT06843551). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06843551. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06843551.mp4 2026-10-31T22:45:53.685Z 83 yes no https://www.trianglehealth.com/phase-2/the-minimalist-trial-2-nct06702033 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06702033.jpg Radiation therapy trial for HPV-Related Oropharynx Squamous Cell Carcinoma (NCT06702033) Radiation therapy trial for HPV-Related Oropharynx Squamous Cell Carcinoma (NCT06702033). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06702033. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06702033.mp4 2026-10-31T21:10:53.399Z 86 yes no https://www.trianglehealth.com/phase-2/the-sappho-study-sequential-therapy-with-curative-intent-in-de-n-nct06439693 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06439693.jpg Nab-Paclitaxel trial for Breast Cancer Female (NCT06439693) Nab-Paclitaxel trial for Breast Cancer Female (NCT06439693). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06439693. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06439693.mp4 2026-10-31T20:17:27.539Z 91 yes no https://www.trianglehealth.com/phase-2/the-study-of-atezolizumab-bevacizumab-and-memantine-in-patients-nct06789757 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06789757.jpg Memantine Hydrochloride trial for Hepatocellular Carcinoma (NCT06789757) Memantine Hydrochloride trial for Hepatocellular Carcinoma (NCT06789757). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06789757. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06789757.mp4 2026-10-31T06:32:47.515Z 74 yes no https://www.trianglehealth.com/phase-2/the-sugar-study-sbrt-and-relugolix-for-prostate-cancer-nct06111781 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06111781.jpg Relugolix 120 MG [Orgovyx] trial for Prostate Cancer (NCT06111781) Relugolix 120 MG [Orgovyx] trial for Prostate Cancer (NCT06111781). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06111781. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06111781.mp4 2026-10-31T16:54:03.404Z 74 yes no https://www.trianglehealth.com/phase-2/therapy-for-newly-diagnosed-patients-with-b-cell-precursor-acute-nct06533748 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533748.jpg Dexamethasone trial for Acute Lymphoblastic Leukemia (NCT06533748) Dexamethasone trial for Acute Lymphoblastic Leukemia (NCT06533748). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06533748. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533748.mp4 2026-10-31T21:41:17.788Z 85 yes no https://www.trianglehealth.com/phase-2/three-schedules-of-cue-101-administered-before-surgery-or-defini-nct04852328 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04852328.jpg CUE-101 trial for Oropharyngeal Squamous Cell Carcinoma (NCT04852328) CUE-101 trial for Oropharyngeal Squamous Cell Carcinoma (NCT04852328). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04852328. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04852328.mp4 2026-10-31T21:32:40.590Z 94 yes no https://www.trianglehealth.com/phase-2/to-study-the-effect-of-inavolisib-in-combination-with-fulvestran-nct07368998 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07368998.jpg Inavolisib trial for Breast Cancer (NCT07368998) Inavolisib trial for Breast Cancer (NCT07368998). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07368998. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07368998.mp4 2026-10-31T06:43:35.724Z 84 yes no https://www.trianglehealth.com/phase-2/top-2301-neoadjuvant-chemo-for-nsclc-nct06385262 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06385262.jpg Alirocumab trial for Non Small Cell Lung Cancer (NCT06385262) Alirocumab trial for Non Small Cell Lung Cancer (NCT06385262). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06385262. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06385262.mp4 2026-10-31T06:22:23.135Z 81 yes no https://www.trianglehealth.com/phase-2/total-marrow-and-lymphoid-irradiation-in-combination-with-fludar-nct07582172 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07582172.jpg Biospecimen Collection trial for Acute Myeloid Leukemia With Complex Karyotype (NCT07582172) Biospecimen Collection trial for Acute Myeloid Leukemia With Complex Karyotype (NCT07582172). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07582172. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07582172.mp4 2026-10-31T15:41:29.776Z 84 yes no https://www.trianglehealth.com/phase-2/total-neoadjuvant-therapy-with-mfolfox-and-short-course-radiatio-nct04643366 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04643366.jpg Chemotherapy trial for Rectal Cancer (NCT04643366) Chemotherapy trial for Rectal Cancer (NCT04643366). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04643366. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04643366.mp4 2026-10-31T22:34:40.175Z 92 yes no https://www.trianglehealth.com/phase-2/transoral-surgical-resection-followed-by-de-escalated-adjuvant-i-nct05388773 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05388773.jpg therapeutic conventional surgery trial for Oropharynx Cancer (NCT05388773) therapeutic conventional surgery trial for Oropharynx Cancer (NCT05388773). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05388773. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05388773.mp4 2026-10-31T21:26:20.435Z 73 yes no https://www.trianglehealth.com/phase-2/treatment-for-advanced-non-small-cell-lung-cancer-with-actionabl-nct07393555 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07393555.jpg Biospecimen Collection trial for Recurrent Lung Non-Small Cell Carcinoma (NCT07393555) Biospecimen Collection trial for Recurrent Lung Non-Small Cell Carcinoma (NCT07393555). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07393555. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07393555.mp4 2026-10-31T22:22:10.163Z 98 yes no https://www.trianglehealth.com/phase-2/treatment-of-adc-refractory-breast-cancer-with-dato-dxd-or-t-dxd-nct06533826 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533826.jpg Trastuzumab Deruxtecan trial for Breast Cancer (NCT06533826) Trastuzumab Deruxtecan trial for Breast Cancer (NCT06533826). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06533826. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06533826.mp4 2026-10-31T21:09:50.060Z 83 yes no https://www.trianglehealth.com/phase-2/triage-of-advanced-cervical-cancer-through-immunotherapy-inducti-nct05475171 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05475171.jpg Lorigerlimab trial for Metastatic Cancer (NCT05475171) Lorigerlimab trial for Metastatic Cancer (NCT05475171). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05475171. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05475171.mp4 2026-10-31T22:31:34.547Z 75 yes no https://www.trianglehealth.com/phase-2/trial-comparing-lattice-radiotherapy-vs-moderately-dose-escalate-nct07594431 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07594431.jpg LATTICE Radiotherapy trial for Metastases (NCT07594431) LATTICE Radiotherapy trial for Metastases (NCT07594431). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07594431. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07594431.mp4 2026-10-31T17:21:17.517Z 74 yes no https://www.trianglehealth.com/phase-2/trial-investigating-visugromab-and-nivolumab-with-or-without-doc-nct07246863 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07246863.jpg Visugromab RDE (recommended dose for expansion) trial for Metastatic Non-Squamous… (NCT07246863) Visugromab RDE (recommended dose for expansion) trial for Metastatic Non-Squamous Non-Small Cell Lung Cancer (NCT07246863). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07246863. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07246863.mp4 2026-10-31T06:19:35.078Z 79 yes no https://www.trianglehealth.com/phase-2/trial-investigating-visugromab-in-combination-with-immunochemoth-nct07098988 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07098988.jpg Visugromab trial for Metastatic Non-Squamous Non-Small Cell Lung Cancer (NCT07098988) Visugromab trial for Metastatic Non-Squamous Non-Small Cell Lung Cancer (NCT07098988). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07098988. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07098988.mp4 2026-10-31T22:11:20.710Z 79 yes no https://www.trianglehealth.com/phase-2/trial-of-2-step-atg-for-acute-gvhd-prevention-post-myeloablative-nct06315309 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06315309.jpg ATG Combined with Tacrolimus and Mini Methotrexate trial for GVHD,Acute (NCT06315309) ATG Combined with Tacrolimus and Mini Methotrexate trial for GVHD,Acute (NCT06315309). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06315309. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06315309.mp4 2026-10-31T16:40:25.806Z 86 yes no https://www.trianglehealth.com/phase-2/trial-of-amb-05x-for-patients-with-ctdna-colorectal-cancer-after-nct06617858 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06617858.jpg AMB-05X trial for Colorectal Cancer (NCT06617858) AMB-05X trial for Colorectal Cancer (NCT06617858). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06617858. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06617858.mp4 2026-10-31T21:39:04.603Z 72 yes no https://www.trianglehealth.com/phase-2/trial-of-an-alternative-cabozantinib-dosing-schedule-in-metastat-nct05263050 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05263050.jpg Cabozantinib trial for Metastatic Renal Cell Carcinoma (NCT05263050) Cabozantinib trial for Metastatic Renal Cell Carcinoma (NCT05263050). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05263050. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05263050.mp4 2026-10-31T21:00:33.087Z 73 yes no https://www.trianglehealth.com/phase-2/trial-of-orca-t-following-reduced-intensity-or-nonmyeloablative-nct07216443 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07216443.jpg Orca-T trial for Leukemia, Myeloid, Acute (NCT07216443) Orca-T trial for Leukemia, Myeloid, Acute (NCT07216443). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07216443. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07216443.mp4 2026-10-31T22:23:03.418Z 87 yes no https://www.trianglehealth.com/phase-2/trial-of-therapies-with-it-cdc1s-combined-w-it-trastuzamab-for-h-nct07694986 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07694986.jpg cDC1 Vaccine trial for Breast Cancer (NCT07694986) cDC1 Vaccine trial for Breast Cancer (NCT07694986). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07694986. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07694986.mp4 2026-10-31T22:17:56.510Z 80 yes no https://www.trianglehealth.com/phase-2/trial-of-trastuzumab-deruxtecan-in-previously-treated-her2-nct06750484 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06750484.jpg Trastuzumab Deruxtecan trial for Breast Cancer Metastatic (NCT06750484) Trastuzumab Deruxtecan trial for Breast Cancer Metastatic (NCT06750484). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06750484. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06750484.mp4 2026-10-31T19:55:12.640Z 74 yes no https://www.trianglehealth.com/phase-2/trial-to-study-anti-hcmv-therapy-in-breast-cancer-patients-with-nct07383649 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07383649.jpg Valganciclovir trial for Brain Cancer Metastatic (NCT07383649) Valganciclovir trial for Brain Cancer Metastatic (NCT07383649). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07383649. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07383649.mp4 2026-10-31T20:06:52.883Z 73 yes no https://www.trianglehealth.com/phase-2/trial-utilizing-metronidazole-to-optimize-the-microbiome-of-rect-nct06569368 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06569368.jpg Metronidazole trial for Rectal Adenocarcinoma (NCT06569368) Metronidazole trial for Rectal Adenocarcinoma (NCT06569368). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06569368. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06569368.mp4 2026-10-31T06:38:35.895Z 70 yes no https://www.trianglehealth.com/phase-2/turkey-tail-mushroom-for-treating-post-menopausal-women-with-her-nct06450873 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06450873.jpg Coriolus Versicolor Extract trial for Estrogen Receptor-Positive Breast Carcinoma (NCT06450873) Coriolus Versicolor Extract trial for Estrogen Receptor-Positive Breast Carcinoma (NCT06450873). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06450873. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06450873.mp4 2026-10-31T06:34:07.285Z 78 yes no https://www.trianglehealth.com/phase-2/ucsd-image-guided-cognitive-sparing-radiosurgery-for-intracrania-nct04343157 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04343157.jpg Cognitive Sparing Brain Stereotactic Radiosurgery (SRS) trial for Brain Metastases,… (NCT04343157) Cognitive Sparing Brain Stereotactic Radiosurgery (SRS) trial for Brain Metastases, Adult (NCT04343157). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04343157. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04343157.mp4 2026-10-31T18:46:30.047Z 73 yes no https://www.trianglehealth.com/phase-2/ultra-hypo-fractionated-adjuvant-whole-breast-radiation-therapy-nct06902311 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06902311.jpg Breast Radiotherapy trial for Breast Cancer (NCT06902311) Breast Radiotherapy trial for Breast Cancer (NCT06902311). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06902311. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06902311.mp4 2026-10-31T19:52:10.746Z 79 yes no https://www.trianglehealth.com/phase-2/upfront-chemotherapy-with-radiation-therapy-crt-followed-by-chem-nct07603375 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07603375.jpg FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) trial for Esophageal Adenocarcinoma (NCT07603375) FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) trial for Esophageal Adenocarcinoma (NCT07603375). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07603375. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07603375.mp4 2026-10-31T20:59:03.186Z 78 yes no https://www.trianglehealth.com/phase-2/use-of-isatuximab-dexamethasone-and-lenalidomide-in-a-go-slow-fa-nct06517017 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06517017.jpg Isatuximab trial for Multiple Myeloma (NCT06517017) Isatuximab trial for Multiple Myeloma (NCT06517017). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06517017. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06517017.mp4 2026-10-31T21:55:53.296Z 73 yes no https://www.trianglehealth.com/phase-2/using-circulating-tumor-dna-to-risk-adapt-post-operative-therapy-nct06445114 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06445114.jpg Cisplatin trial for Oropharyngeal Cancer (NCT06445114) Cisplatin trial for Oropharyngeal Cancer (NCT06445114). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06445114. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06445114.mp4 2026-10-31T20:20:33.095Z 80 yes no https://www.trianglehealth.com/phase-2/venetoclax-and-hma-treatment-of-older-and-unfit-adults-with-flt3-nct06317649 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06317649.jpg Azacitidine trial for Acute Myeloid Leukemia (NCT06317649) Azacitidine trial for Acute Myeloid Leukemia (NCT06317649). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06317649. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06317649.mp4 2026-10-31T05:28:38.104Z 86 yes no https://www.trianglehealth.com/phase-2/venetoclax-cladribine-low-dose-cytarabine-and-azacitidine-in-tre-nct03586609 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03586609.jpg Azacitidine trial for Acute Myeloid Leukemia (NCT03586609) Azacitidine trial for Acute Myeloid Leukemia (NCT03586609). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT03586609. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT03586609.mp4 2026-10-31T06:47:15.482Z 95 yes no https://www.trianglehealth.com/phase-2/venetoclax-in-combination-with-cladribine-and-cytarabine-alterna-nct06504459 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06504459.jpg Azacitidine trial for Acute Monocytic Leukemia (NCT06504459) Azacitidine trial for Acute Monocytic Leukemia (NCT06504459). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06504459. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06504459.mp4 2026-10-31T22:33:38.588Z 83 yes no https://www.trianglehealth.com/phase-2/venetoclax-plus-zanubrutinib-for-the-treatment-of-chronic-lympho-nct07734038 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07734038.jpg Biospecimen Collection trial for Chronic Lymphocytic Leukemia (NCT07734038) Biospecimen Collection trial for Chronic Lymphocytic Leukemia (NCT07734038). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07734038. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07734038.mp4 2026-10-31T15:16:07.369Z 73 yes no https://www.trianglehealth.com/phase-2/venetoclax-sl-401-and-chemotherapy-for-the-treatment-of-blastic-nct04216524 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04216524.jpg Cyclophosphamide trial for Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT04216524) Cyclophosphamide trial for Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT04216524). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT04216524. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT04216524.mp4 2026-10-31T20:47:40.127Z 81 yes no https://www.trianglehealth.com/phase-2/vismodegib-combined-with-atezolizumab-in-platinum-resistant-ovar-nct05538091 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05538091.jpg Vismodegib trial for Platinum-Resistant Fallopian Tube Carcinoma (NCT05538091) Vismodegib trial for Platinum-Resistant Fallopian Tube Carcinoma (NCT05538091). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05538091. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05538091.mp4 2026-10-31T23:52:21.109Z 78 yes no https://www.trianglehealth.com/phase-2/vismodegib-fak-inhibitor-gsk2256098-capivasertib-and-abemaciclib-nct02523014 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02523014.jpg Vismodegib trial for Intracranial Meningioma (NCT02523014) Vismodegib trial for Intracranial Meningioma (NCT02523014). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT02523014. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT02523014.mp4 2026-10-31T22:15:20.471Z 95 yes no https://www.trianglehealth.com/phase-2/vista-valproic-acid-irinotecan-and-simvastatin-for-recurrent-gli-nct07831369 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07831369.jpg Valproic Acid (VPA) trial for Glioblastoma (NCT07831369) Valproic Acid (VPA) trial for Glioblastoma (NCT07831369). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07831369. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07831369.mp4 2026-10-31T21:07:40.381Z 77 yes no https://www.trianglehealth.com/phase-2/vorasidenib-study-in-pediatric-participants-with-grade-2-astrocy-nct07286292 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07286292.jpg Vorasidenib trial for Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2… (NCT07286292) Vorasidenib trial for Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation (NCT07286292). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07286292. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07286292.mp4 2026-10-31T18:25:48.071Z 80 yes no https://www.trianglehealth.com/phase-2/wp1066-and-radiation-therapy-in-treating-patients-with-newly-dia-nct05879250 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05879250.jpg Biospecimen Collection trial for Glioblastoma, IDH-Wildtype (NCT05879250) Biospecimen Collection trial for Glioblastoma, IDH-Wildtype (NCT05879250). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05879250. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05879250.mp4 2026-10-31T21:19:52.229Z 84 yes no https://www.trianglehealth.com/phase-2/xl092-for-the-treatment-of-locally-advanced-or-metastatic-radioi-nct06959641 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06959641.jpg Biospecimen Collection trial for Locally Advanced Differentiated Thyroid Gland… (NCT06959641) Biospecimen Collection trial for Locally Advanced Differentiated Thyroid Gland Carcinoma (NCT06959641). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06959641. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06959641.mp4 2026-10-31T22:47:58.429Z 80 yes no https://www.trianglehealth.com/phase-2/xl092-in-patients-with-metastatic-castration-resistant-prostate-nct06568562 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06568562.jpg XL092 trial for Metastatic Castration-resistant Prostate Cancer (NCT06568562) XL092 trial for Metastatic Castration-resistant Prostate Cancer (NCT06568562). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06568562. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06568562.mp4 2026-10-31T22:40:16.558Z 92 yes no https://www.trianglehealth.com/phase-2/xl092-zanzalintinib-for-the-treatment-of-patients-with-metastati-nct06571734 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06571734.jpg Biospecimen Collection trial for Metastatic Leiomyosarcoma (NCT06571734) Biospecimen Collection trial for Metastatic Leiomyosarcoma (NCT06571734). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06571734. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06571734.mp4 2026-10-31T06:55:48.284Z 77 yes no https://www.trianglehealth.com/phase-2/y-90-capecitabine-and-atezolizumab-for-oligometastatic-crc-nct06555133 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06555133.jpg yttrium-90 radioembolization trial for Colorectal Carcinoma Metastatic in the Liver (NCT06555133) yttrium-90 radioembolization trial for Colorectal Carcinoma Metastatic in the Liver (NCT06555133). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06555133. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06555133.mp4 2026-10-31T21:47:39.823Z 73 yes no https://www.trianglehealth.com/phase-2/zanubrutinib-bendamustine-rituximab-prev-untreated-wm-nct06561347 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06561347.jpg Zanubrutinib trial for Waldenstrom Macroglobulinemia (NCT06561347) Zanubrutinib trial for Waldenstrom Macroglobulinemia (NCT06561347). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06561347. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06561347.mp4 2026-10-31T20:04:45.633Z 85 yes no https://www.trianglehealth.com/phase-2/zanubrutinib-obinutuzumab-sonrotoclax-boson-or-bgb-16673-obinutu-nct06849713 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06849713.jpg Zanubrutinib trial for Chronic Lymphocytic Leukemia (NCT06849713) Zanubrutinib trial for Chronic Lymphocytic Leukemia (NCT06849713). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06849713. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06849713.mp4 2026-10-31T17:02:56.982Z 82 yes no https://www.trianglehealth.com/phase-2/zanzalintinib-for-metastatic-clear-cell-renal-cell-carcinoma-wit-nct07043608 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07043608.jpg Zanzalintinib trial for Clear Cell Renal Cell Cancer (ccRCC) (NCT07043608) Zanzalintinib trial for Clear Cell Renal Cell Cancer (ccRCC) (NCT07043608). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07043608. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07043608.mp4 2026-10-31T21:03:10.056Z 79 yes no https://www.trianglehealth.com/phase-2/zanzalintinib-for-the-treatment-of-advanced-thyroid-cancer-befor-nct06959511 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06959511.jpg Zanzalintinib trial for Neoadjuvant Treatment (NCT06959511) Zanzalintinib trial for Neoadjuvant Treatment (NCT06959511). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06959511. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06959511.mp4 2026-10-31T19:14:07.606Z 80 yes no https://www.trianglehealth.com/phase-2/zanzalintinib-in-men-with-aggressive-variant-prostate-cancer-nct07218666 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07218666.jpg Zanzalintinib trial for Aggressive Variant Prostate Carcinoma (NCT07218666) Zanzalintinib trial for Aggressive Variant Prostate Carcinoma (NCT07218666). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT07218666. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT07218666.mp4 2026-10-31T15:57:57.138Z 85 yes no https://www.trianglehealth.com/phase-2/zanzalintinib-maintenance-in-patients-with-high-grade-neuroendoc-nct06926634 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06926634.jpg Zanzalintinib trial for High Grade Neuroendocrine Neoplasms (NCT06926634) Zanzalintinib trial for High Grade Neuroendocrine Neoplasms (NCT06926634). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06926634. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06926634.mp4 2026-10-31T21:24:14.332Z 84 yes no https://www.trianglehealth.com/phase-2/zen003694-combined-with-talazoparib-in-patients-with-recurrent-o-nct05071937 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05071937.jpg ZEN003694 trial for Ovarian Cancer (NCT05071937) ZEN003694 trial for Ovarian Cancer (NCT05071937). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT05071937. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT05071937.mp4 2026-10-31T23:54:24.369Z 89 yes no https://www.trianglehealth.com/phase-2/ziftomenib-for-the-treatment-of-patients-with-npm1-mutated-or-km-nct06930352 https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06930352.jpg Biospecimen Collection trial for Acute Myeloid Leukemia (NCT06930352) Biospecimen Collection trial for Acute Myeloid Leukemia (NCT06930352). Who can join, how the treatment is intended to work, treatment groups and recruiting sites for NCT06930352. https://x3enz3z8axsop9x3.public.blob.vercel-storage.com/phase-2/films/NCT06930352.mp4 2026-10-31T16:47:50.593Z 74 yes no